id	sid	tid	token	lemma	pos
ajmsi-3181	1	1	pa	pa	PROPN
ajmsi-3181	1	2	ge	ge	PROPN
ajmsi-3181	1	3	1	1	NUM
ajmsi-3181	1	4	pa	pa	PROPN
ajmsi-3181	1	5	ge	ge	PROPN
ajmsi-3181	1	6	91	91	NUM
ajmsi-3181	1	7	american	american	PROPN
ajmsi-3181	1	8	journal	journal	PROPN
ajmsi-3181	1	9	of	of	ADP
ajmsi-3181	1	10	medical	medical	ADJ
ajmsi-3181	1	11	science	science	NOUN
ajmsi-3181	1	12	and	and	CCONJ
ajmsi-3181	1	13	innovation	innovation	NOUN
ajmsi-3181	1	14	(	(	PUNCT
ajmsi-3181	1	15	ajmsi	ajmsi	NOUN
ajmsi-3181	1	16	)	)	PUNCT
ajmsi-3181	1	17	gram	gram	NOUN
ajmsi-3181	1	18	-	-	PUNCT
ajmsi-3181	1	19	negative	negative	ADJ
ajmsi-3181	1	20	bacteremia	bacteremia	NOUN
ajmsi-3181	1	21	:	:	PUNCT
ajmsi-3181	1	22	epidemiology	epidemiology	NOUN
ajmsi-3181	1	23	and	and	CCONJ
ajmsi-3181	1	24	antimicrobial	antimicrobial	ADJ
ajmsi-3181	1	25	resistance	resistance	NOUN
ajmsi-3181	1	26	in	in	ADP
ajmsi-3181	1	27	qatar	qatar	PROPN
ajmsi-3181	1	28	adila	adila	PROPN
ajmsi-3181	1	29	shaukat1	shaukat1	PROPN
ajmsi-3181	1	30	*	*	PROPN
ajmsi-3181	1	31	,	,	PUNCT
ajmsi-3181	1	32	masautso	masautso	PROPN
ajmsi-3181	1	33	chaponda1	chaponda1	PROPN
ajmsi-3181	1	34	,	,	PUNCT
ajmsi-3181	1	35	walid	walid	PROPN
ajmsi-3181	1	36	al	al	PROPN
ajmsi-3181	1	37	-	-	PUNCT
ajmsi-3181	1	38	wali2	wali2	PROPN
ajmsi-3181	1	39	,	,	PUNCT
ajmsi-3181	1	40	farah	farah	PROPN
ajmsi-3181	1	41	maher3	maher3	PROPN
ajmsi-3181	1	42	,	,	PUNCT
ajmsi-3181	1	43	sara	sara	PROPN
ajmsi-3181	1	44	al	al	PROPN
ajmsi-3181	1	45	-	-	PUNCT
ajmsi-3181	1	46	balushi4	balushi4	PROPN
ajmsi-3181	1	47	,	,	PUNCT
ajmsi-3181	1	48	abdulmajeed	abdulmajeed	ADJ
ajmsi-3181	1	49	maliyakkal5	maliyakkal5	NOUN
ajmsi-3181	1	50	,	,	PUNCT
ajmsi-3181	1	51	israa	israa	ADJ
ajmsi-3181	1	52	elhakeem5	elhakeem5	PROPN
ajmsi-3181	1	53	tahani	tahani	PROPN
ajmsi-3181	1	54	al	al	PROPN
ajmsi-3181	1	55	-	-	PUNCT
ajmsi-3181	1	56	saadi2	saadi2	PROPN
ajmsi-3181	1	57	,	,	PUNCT
ajmsi-3181	1	58	ali	ali	PROPN
ajmsi-3181	1	59	omrani1	omrani1	PROPN
ajmsi-3181	1	60	,	,	PUNCT
ajmsi-3181	1	61	muna	muna	PROPN
ajmsi-3181	1	62	al	al	PROPN
ajmsi-3181	1	63	maslamani1	maslamani1	PROPN
ajmsi-3181	1	64	volume	volume	NOUN
ajmsi-3181	1	65	3	3	NUM
ajmsi-3181	1	66	issue	issue	NOUN
ajmsi-3181	1	67	2	2	NUM
ajmsi-3181	1	68	,	,	PUNCT
ajmsi-3181	1	69	year	year	NOUN
ajmsi-3181	1	70	2024	2024	NUM
ajmsi-3181	1	71	issn	issn	X
ajmsi-3181	1	72	:	:	PUNCT
ajmsi-3181	1	73	2836	2836	NUM
ajmsi-3181	1	74	-	-	SYM
ajmsi-3181	1	75	8509	8509	NUM
ajmsi-3181	1	76	(	(	PUNCT
ajmsi-3181	1	77	online	online	NOUN
ajmsi-3181	1	78	)	)	PUNCT
ajmsi-3181	1	79	doi	doi	NOUN
ajmsi-3181	1	80	:	:	PUNCT
ajmsi-3181	1	81	https://doi.org/10.54536/ajmsi.v3i2.3181	https://doi.org/10.54536/ajmsi.v3i2.3181	PROPN
ajmsi-3181	1	82	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-3181	1	83	article	article	NOUN
ajmsi-3181	1	84	information	information	NOUN
ajmsi-3181	1	85	abstract	abstract	ADV
ajmsi-3181	1	86	received	receive	VERB
ajmsi-3181	1	87	:	:	PUNCT
ajmsi-3181	1	88	september	september	PROPN
ajmsi-3181	1	89	05	05	NUM
ajmsi-3181	1	90	,	,	PUNCT
ajmsi-3181	1	91	2024	2024	NUM
ajmsi-3181	1	92	accepted	accept	VERB
ajmsi-3181	1	93	:	:	PUNCT
ajmsi-3181	1	94	october	october	PROPN
ajmsi-3181	1	95	02	02	NUM
ajmsi-3181	1	96	,	,	PUNCT
ajmsi-3181	1	97	2024	2024	NUM
ajmsi-3181	1	98	published	publish	VERB
ajmsi-3181	1	99	:	:	PUNCT
ajmsi-3181	1	100	october	october	PROPN
ajmsi-3181	1	101	05	05	NUM
ajmsi-3181	1	102	,	,	PUNCT
ajmsi-3181	1	103	2024	2024	NUM
ajmsi-3181	1	104	one	one	NUM
ajmsi-3181	1	105	of	of	ADP
ajmsi-3181	1	106	the	the	DET
ajmsi-3181	1	107	major	major	ADJ
ajmsi-3181	1	108	causes	cause	NOUN
ajmsi-3181	1	109	of	of	ADP
ajmsi-3181	1	110	morbidity	morbidity	NOUN
ajmsi-3181	1	111	and	and	CCONJ
ajmsi-3181	1	112	mortality	mortality	NOUN
ajmsi-3181	1	113	in	in	ADP
ajmsi-3181	1	114	hospitalised	hospitalise	VERB
ajmsi-3181	1	115	patients	patient	NOUN
ajmsi-3181	1	116	is	be	AUX
ajmsi-3181	1	117	the	the	DET
ajmsi-3181	1	118	presence	presence	NOUN
ajmsi-3181	1	119	of	of	ADP
ajmsi-3181	1	120	gram	gram	NOUN
ajmsi-3181	1	121	-	-	PUNCT
ajmsi-3181	1	122	negative	negative	ADJ
ajmsi-3181	1	123	bacteremia	bacteremia	NOUN
ajmsi-3181	1	124	(	(	PUNCT
ajmsi-3181	1	125	gnb	gnb	PROPN
ajmsi-3181	1	126	)	)	PUNCT
ajmsi-3181	1	127	in	in	ADP
ajmsi-3181	1	128	blood	blood	NOUN
ajmsi-3181	1	129	.	.	PUNCT
ajmsi-3181	2	1	the	the	DET
ajmsi-3181	2	2	developed	develop	VERB
ajmsi-3181	2	3	resistance	resistance	NOUN
ajmsi-3181	2	4	among	among	ADP
ajmsi-3181	2	5	the	the	DET
ajmsi-3181	2	6	bacteria	bacteria	NOUN
ajmsi-3181	2	7	poses	pose	VERB
ajmsi-3181	2	8	a	a	DET
ajmsi-3181	2	9	significant	significant	ADJ
ajmsi-3181	2	10	challenge	challenge	NOUN
ajmsi-3181	2	11	for	for	ADP
ajmsi-3181	2	12	treatment	treatment	NOUN
ajmsi-3181	2	13	.	.	PUNCT
ajmsi-3181	3	1	the	the	DET
ajmsi-3181	3	2	study	study	NOUN
ajmsi-3181	3	3	aimed	aim	VERB
ajmsi-3181	3	4	to	to	PART
ajmsi-3181	3	5	identify	identify	VERB
ajmsi-3181	3	6	the	the	DET
ajmsi-3181	3	7	gram	gram	NOUN
ajmsi-3181	3	8	-	-	PUNCT
ajmsi-3181	3	9	negative	negative	ADJ
ajmsi-3181	3	10	patient	patient	NOUN
ajmsi-3181	3	11	’s	’s	PART
ajmsi-3181	3	12	epidemiological	epidemiological	ADJ
ajmsi-3181	3	13	risk	risk	NOUN
ajmsi-3181	3	14	factors	factor	NOUN
ajmsi-3181	3	15	,	,	PUNCT
ajmsi-3181	3	16	antimicrobial	antimicrobial	ADJ
ajmsi-3181	3	17	susceptibility	susceptibility	NOUN
ajmsi-3181	3	18	patterns	pattern	NOUN
ajmsi-3181	3	19	,	,	PUNCT
ajmsi-3181	3	20	and	and	CCONJ
ajmsi-3181	3	21	clinical	clinical	ADJ
ajmsi-3181	3	22	outcomes	outcome	NOUN
ajmsi-3181	3	23	.	.	PUNCT
ajmsi-3181	4	1	a	a	DET
ajmsi-3181	4	2	retrospective	retrospective	ADJ
ajmsi-3181	4	3	observational	observational	ADJ
ajmsi-3181	4	4	study	study	NOUN
ajmsi-3181	4	5	of	of	ADP
ajmsi-3181	4	6	adult	adult	NOUN
ajmsi-3181	4	7	in	in	ADP
ajmsi-3181	4	8	-	-	PUNCT
ajmsi-3181	4	9	patients	patient	NOUN
ajmsi-3181	4	10	with	with	ADP
ajmsi-3181	4	11	gramnegative	gramnegative	ADJ
ajmsi-3181	4	12	bacteremia	bacteremia	NOUN
ajmsi-3181	4	13	was	be	AUX
ajmsi-3181	4	14	conducted	conduct	VERB
ajmsi-3181	4	15	between	between	ADP
ajmsi-3181	4	16	january	january	PROPN
ajmsi-3181	4	17	2019	2019	NUM
ajmsi-3181	4	18	and	and	CCONJ
ajmsi-3181	4	19	december	december	PROPN
ajmsi-3181	4	20	2020	2020	NUM
ajmsi-3181	4	21	in	in	ADP
ajmsi-3181	4	22	the	the	DET
ajmsi-3181	4	23	320	320	NUM
ajmsi-3181	4	24	-	-	PUNCT
ajmsi-3181	4	25	bed	bed	NOUN
ajmsi-3181	4	26	general	general	ADJ
ajmsi-3181	4	27	hospital	hospital	NOUN
ajmsi-3181	4	28	in	in	ADP
ajmsi-3181	4	29	qatar	qatar	PROPN
ajmsi-3181	4	30	.	.	PUNCT
ajmsi-3181	5	1	data	datum	NOUN
ajmsi-3181	5	2	on	on	ADP
ajmsi-3181	5	3	demographics	demographic	NOUN
ajmsi-3181	5	4	,	,	PUNCT
ajmsi-3181	5	5	antimicrobial	antimicrobial	ADJ
ajmsi-3181	5	6	resistance	resistance	NOUN
ajmsi-3181	5	7	,	,	PUNCT
ajmsi-3181	5	8	source	source	NOUN
ajmsi-3181	5	9	of	of	ADP
ajmsi-3181	5	10	infection	infection	NOUN
ajmsi-3181	5	11	,	,	PUNCT
ajmsi-3181	5	12	and	and	CCONJ
ajmsi-3181	5	13	treatment	treatment	NOUN
ajmsi-3181	5	14	were	be	AUX
ajmsi-3181	5	15	collected	collect	VERB
ajmsi-3181	5	16	.	.	PUNCT
ajmsi-3181	6	1	the	the	DET
ajmsi-3181	6	2	primary	primary	ADJ
ajmsi-3181	6	3	outcomes	outcome	NOUN
ajmsi-3181	6	4	were	be	AUX
ajmsi-3181	6	5	patients	patient	NOUN
ajmsi-3181	6	6	’	'	PUNCT
ajmsi-3181	6	7	cure	cure	NOUN
ajmsi-3181	6	8	,	,	PUNCT
ajmsi-3181	6	9	death	death	NOUN
ajmsi-3181	6	10	,	,	PUNCT
ajmsi-3181	6	11	or	or	CCONJ
ajmsi-3181	6	12	relapse	relapse	NOUN
ajmsi-3181	6	13	.	.	PUNCT
ajmsi-3181	7	1	total	total	NOUN
ajmsi-3181	7	2	of	of	ADP
ajmsi-3181	7	3	357	357	NUM
ajmsi-3181	7	4	patients	patient	NOUN
ajmsi-3181	7	5	were	be	AUX
ajmsi-3181	7	6	identified	identify	VERB
ajmsi-3181	7	7	with	with	ADP
ajmsi-3181	7	8	bacteremia	bacteremia	NOUN
ajmsi-3181	7	9	,	,	PUNCT
ajmsi-3181	7	10	the	the	DET
ajmsi-3181	7	11	most	most	ADV
ajmsi-3181	7	12	common	common	ADJ
ajmsi-3181	7	13	sources	source	NOUN
ajmsi-3181	7	14	being	be	AUX
ajmsi-3181	7	15	urinary	urinary	ADJ
ajmsi-3181	7	16	tract	tract	NOUN
ajmsi-3181	7	17	infections	infection	NOUN
ajmsi-3181	7	18	(	(	PUNCT
ajmsi-3181	7	19	39.6	39.6	NUM
ajmsi-3181	7	20	%	%	NOUN
ajmsi-3181	7	21	)	)	PUNCT
ajmsi-3181	7	22	,	,	PUNCT
ajmsi-3181	7	23	intra	intra	ADJ
ajmsi-3181	7	24	-	-	ADJ
ajmsi-3181	7	25	abdominal	abdominal	ADJ
ajmsi-3181	7	26	infections	infection	NOUN
ajmsi-3181	7	27	(	(	PUNCT
ajmsi-3181	7	28	28	28	NUM
ajmsi-3181	7	29	%	%	NOUN
ajmsi-3181	7	30	)	)	PUNCT
ajmsi-3181	7	31	,	,	PUNCT
ajmsi-3181	7	32	and	and	CCONJ
ajmsi-3181	7	33	lower	low	ADJ
ajmsi-3181	7	34	respiratory	respiratory	ADJ
ajmsi-3181	7	35	tract	tract	NOUN
ajmsi-3181	7	36	infections	infection	NOUN
ajmsi-3181	7	37	(	(	PUNCT
ajmsi-3181	7	38	9	9	NUM
ajmsi-3181	7	39	%	%	NOUN
ajmsi-3181	7	40	)	)	PUNCT
ajmsi-3181	7	41	.	.	PUNCT
ajmsi-3181	8	1	the	the	DET
ajmsi-3181	8	2	mean	mean	ADJ
ajmsi-3181	8	3	duration	duration	NOUN
ajmsi-3181	8	4	of	of	ADP
ajmsi-3181	8	5	the	the	DET
ajmsi-3181	8	6	intravenous	intravenous	ADJ
ajmsi-3181	8	7	and	and	CCONJ
ajmsi-3181	8	8	oral	oral	ADJ
ajmsi-3181	8	9	antibiotics	antibiotic	NOUN
ajmsi-3181	8	10	administration	administration	NOUN
ajmsi-3181	8	11	was	be	AUX
ajmsi-3181	8	12	14	14	NUM
ajmsi-3181	8	13	days	day	NOUN
ajmsi-3181	8	14	.	.	PUNCT
ajmsi-3181	9	1	surgical	surgical	ADJ
ajmsi-3181	9	2	source	source	NOUN
ajmsi-3181	9	3	control	control	NOUN
ajmsi-3181	9	4	was	be	AUX
ajmsi-3181	9	5	performed	perform	VERB
ajmsi-3181	9	6	in	in	ADP
ajmsi-3181	9	7	35.7	35.7	NUM
ajmsi-3181	9	8	%	%	NOUN
ajmsi-3181	9	9	of	of	ADP
ajmsi-3181	9	10	patients	patient	NOUN
ajmsi-3181	9	11	.	.	PUNCT
ajmsi-3181	10	1	common	common	ADJ
ajmsi-3181	10	2	pathogens	pathogen	NOUN
ajmsi-3181	10	3	were	be	AUX
ajmsi-3181	10	4	escherichia	escherichia	NOUN
ajmsi-3181	10	5	-	-	PUNCT
ajmsi-3181	10	6	coli	coli	NOUN
ajmsi-3181	10	7	(	(	PUNCT
ajmsi-3181	10	8	47.2	47.2	NUM
ajmsi-3181	10	9	%	%	NOUN
ajmsi-3181	10	10	)	)	PUNCT
ajmsi-3181	10	11	,	,	PUNCT
ajmsi-3181	10	12	klebsiella	klebsiella	NOUN
ajmsi-3181	10	13	pneumoniae	pneumoniae	ADJ
ajmsi-3181	10	14	(	(	PUNCT
ajmsi-3181	10	15	16.4	16.4	NUM
ajmsi-3181	10	16	%	%	NOUN
ajmsi-3181	10	17	)	)	PUNCT
ajmsi-3181	10	18	,	,	PUNCT
ajmsi-3181	10	19	salmonella	salmonella	PROPN
ajmsi-3181	10	20	enterica	enterica	PROPN
ajmsi-3181	10	21	serotype	serotype	PROPN
ajmsi-3181	10	22	typhi	typhi	PROPN
ajmsi-3181	10	23	(	(	PUNCT
ajmsi-3181	10	24	10.6	10.6	NUM
ajmsi-3181	10	25	%	%	NOUN
ajmsi-3181	10	26	)	)	PUNCT
ajmsi-3181	10	27	,	,	PUNCT
ajmsi-3181	10	28	and	and	CCONJ
ajmsi-3181	10	29	pseudomonas	pseudomonas	PROPN
ajmsi-3181	10	30	aeruginosa	aeruginosa	NOUN
ajmsi-3181	10	31	(	(	PUNCT
ajmsi-3181	10	32	7.8	7.8	NUM
ajmsi-3181	10	33	%	%	NOUN
ajmsi-3181	10	34	)	)	PUNCT
ajmsi-3181	10	35	.	.	PUNCT
ajmsi-3181	11	1	67.32	67.32	NUM
ajmsi-3181	11	2	%	%	NOUN
ajmsi-3181	11	3	fully	fully	ADV
ajmsi-3181	11	4	susceptible	susceptible	ADJ
ajmsi-3181	11	5	strains	strain	NOUN
ajmsi-3181	11	6	,	,	PUNCT
ajmsi-3181	11	7	31.56	31.56	NUM
ajmsi-3181	11	8	%	%	NOUN
ajmsi-3181	11	9	extended	extend	VERB
ajmsi-3181	11	10	-	-	PUNCT
ajmsi-3181	11	11	spectrum	spectrum	NOUN
ajmsi-3181	11	12	beta	beta	NOUN
ajmsi-3181	11	13	-	-	PUNCT
ajmsi-3181	11	14	lactamase	lactamase	NOUN
ajmsi-3181	11	15	(	(	PUNCT
ajmsi-3181	11	16	esbl	esbl	NOUN
ajmsi-3181	11	17	)	)	PUNCT
ajmsi-3181	11	18	producing	produce	VERB
ajmsi-3181	11	19	bacteria	bacteria	NOUN
ajmsi-3181	11	20	,	,	PUNCT
ajmsi-3181	11	21	and	and	CCONJ
ajmsi-3181	11	22	1.11	1.11	NUM
ajmsi-3181	11	23	%	%	NOUN
ajmsi-3181	11	24	multidrug	multidrug	NOUN
ajmsi-3181	11	25	-	-	PUNCT
ajmsi-3181	11	26	resistant	resistant	ADJ
ajmsi-3181	11	27	organisms	organism	NOUN
ajmsi-3181	11	28	(	(	PUNCT
ajmsi-3181	11	29	mdros	mdro	NOUN
ajmsi-3181	11	30	)	)	PUNCT
ajmsi-3181	11	31	were	be	AUX
ajmsi-3181	11	32	among	among	ADP
ajmsi-3181	11	33	the	the	DET
ajmsi-3181	11	34	isolates	isolate	NOUN
ajmsi-3181	11	35	.	.	PUNCT
ajmsi-3181	12	1	most	most	ADJ
ajmsi-3181	12	2	infections	infection	NOUN
ajmsi-3181	12	3	(	(	PUNCT
ajmsi-3181	12	4	68	68	NUM
ajmsi-3181	12	5	%	%	NOUN
ajmsi-3181	12	6	)	)	PUNCT
ajmsi-3181	12	7	were	be	AUX
ajmsi-3181	12	8	cured	cure	VERB
ajmsi-3181	12	9	,	,	PUNCT
ajmsi-3181	12	10	but	but	CCONJ
ajmsi-3181	12	11	5	5	NUM
ajmsi-3181	12	12	%	%	NOUN
ajmsi-3181	12	13	had	have	VERB
ajmsi-3181	12	14	recurrence	recurrence	NOUN
ajmsi-3181	12	15	within	within	ADP
ajmsi-3181	12	16	90	90	NUM
ajmsi-3181	12	17	days	day	NOUN
ajmsi-3181	12	18	of	of	ADP
ajmsi-3181	12	19	admission	admission	NOUN
ajmsi-3181	12	20	.	.	PUNCT
ajmsi-3181	13	1	infection	infection	NOUN
ajmsi-3181	13	2	-	-	PUNCT
ajmsi-3181	13	3	related	relate	VERB
ajmsi-3181	13	4	mortality	mortality	NOUN
ajmsi-3181	13	5	was	be	AUX
ajmsi-3181	13	6	8	8	NUM
ajmsi-3181	13	7	%	%	NOUN
ajmsi-3181	13	8	,	,	PUNCT
ajmsi-3181	13	9	and	and	CCONJ
ajmsi-3181	13	10	death	death	NOUN
ajmsi-3181	13	11	due	due	ADP
ajmsi-3181	13	12	to	to	ADP
ajmsi-3181	13	13	non	non	ADJ
ajmsi-3181	13	14	-	-	ADJ
ajmsi-3181	13	15	infectious	infectious	ADJ
ajmsi-3181	13	16	causes	cause	NOUN
ajmsi-3181	13	17	was	be	AUX
ajmsi-3181	13	18	2	2	NUM
ajmsi-3181	13	19	%	%	NOUN
ajmsi-3181	13	20	.	.	PUNCT
ajmsi-3181	14	1	in	in	ADP
ajmsi-3181	14	2	conclusion	conclusion	NOUN
ajmsi-3181	14	3	,	,	PUNCT
ajmsi-3181	14	4	gram	gram	NOUN
ajmsi-3181	14	5	-	-	PUNCT
ajmsi-3181	14	6	negative	negative	ADJ
ajmsi-3181	14	7	bsis	bsis	NOUN
ajmsi-3181	14	8	are	be	AUX
ajmsi-3181	14	9	severe	severe	ADJ
ajmsi-3181	14	10	infections	infection	NOUN
ajmsi-3181	14	11	with	with	ADP
ajmsi-3181	14	12	increasing	increase	VERB
ajmsi-3181	14	13	antimicrobial	antimicrobial	ADJ
ajmsi-3181	14	14	resistance	resistance	NOUN
ajmsi-3181	14	15	,	,	PUNCT
ajmsi-3181	14	16	primarily	primarily	ADV
ajmsi-3181	14	17	caused	cause	VERB
ajmsi-3181	14	18	by	by	ADP
ajmsi-3181	14	19	esblproducing	esblproduce	VERB
ajmsi-3181	14	20	bacteria	bacteria	NOUN
ajmsi-3181	14	21	.	.	PUNCT
ajmsi-3181	15	1	high	high	ADJ
ajmsi-3181	15	2	mortality	mortality	NOUN
ajmsi-3181	15	3	rates	rate	NOUN
ajmsi-3181	15	4	are	be	AUX
ajmsi-3181	15	5	linked	link	VERB
ajmsi-3181	15	6	to	to	ADP
ajmsi-3181	15	7	diabetes	diabetes	NOUN
ajmsi-3181	15	8	,	,	PUNCT
ajmsi-3181	15	9	age	age	NOUN
ajmsi-3181	15	10	,	,	PUNCT
ajmsi-3181	15	11	and	and	CCONJ
ajmsi-3181	15	12	hospitalisation	hospitalisation	NOUN
ajmsi-3181	15	13	,	,	PUNCT
ajmsi-3181	15	14	necessitating	necessitate	VERB
ajmsi-3181	15	15	antibiotic	antibiotic	ADJ
ajmsi-3181	15	16	treatment	treatment	NOUN
ajmsi-3181	15	17	optimisation	optimisation	NOUN
ajmsi-3181	15	18	.	.	PUNCT
ajmsi-3181	16	1	keywords	keyword	VERB
ajmsi-3181	16	2	antimicrobial	antimicrobial	ADJ
ajmsi-3181	16	3	resistance	resistance	NOUN
ajmsi-3181	16	4	,	,	PUNCT
ajmsi-3181	16	5	clinical	clinical	ADJ
ajmsi-3181	16	6	outcomes	outcome	NOUN
ajmsi-3181	16	7	,	,	PUNCT
ajmsi-3181	16	8	epidemiology	epidemiology	NOUN
ajmsi-3181	16	9	,	,	PUNCT
ajmsi-3181	16	10	esblproducing	esblproducing	NOUN
ajmsi-3181	16	11	bacteria	bacteria	NOUN
ajmsi-3181	16	12	,	,	PUNCT
ajmsi-3181	16	13	gramnegative	gramnegative	ADJ
ajmsi-3181	16	14	bacteremia	bacteremia	NOUN
ajmsi-3181	16	15	1	1	NUM
ajmsi-3181	16	16	infectious	infectious	ADJ
ajmsi-3181	16	17	disease	disease	NOUN
ajmsi-3181	16	18	department	department	NOUN
ajmsi-3181	16	19	,	,	PUNCT
ajmsi-3181	16	20	hamad	hamad	PROPN
ajmsi-3181	16	21	medical	medical	PROPN
ajmsi-3181	16	22	corporation	corporation	PROPN
ajmsi-3181	16	23	,	,	PUNCT
ajmsi-3181	16	24	qatar	qatar	PROPN
ajmsi-3181	16	25	&	&	CCONJ
ajmsi-3181	16	26	qatar	qatar	PROPN
ajmsi-3181	16	27	university	university	PROPN
ajmsi-3181	16	28	,	,	PUNCT
ajmsi-3181	16	29	college	college	NOUN
ajmsi-3181	16	30	of	of	ADP
ajmsi-3181	16	31	medicine	medicine	NOUN
ajmsi-3181	16	32	,	,	PUNCT
ajmsi-3181	16	33	qatar	qatar	NOUN
ajmsi-3181	16	34	2	2	NUM
ajmsi-3181	16	35	microbiology	microbiology	NOUN
ajmsi-3181	16	36	department	department	NOUN
ajmsi-3181	16	37	,	,	PUNCT
ajmsi-3181	16	38	hamad	hamad	PROPN
ajmsi-3181	16	39	medical	medical	PROPN
ajmsi-3181	16	40	corporation	corporation	PROPN
ajmsi-3181	16	41	,	,	PUNCT
ajmsi-3181	16	42	qatar	qatar	PROPN
ajmsi-3181	16	43	3	3	NUM
ajmsi-3181	16	44	pharmacy	pharmacy	NOUN
ajmsi-3181	16	45	department	department	NOUN
ajmsi-3181	16	46	,	,	PUNCT
ajmsi-3181	16	47	hamad	hamad	PROPN
ajmsi-3181	16	48	medical	medical	PROPN
ajmsi-3181	16	49	corporation	corporation	PROPN
ajmsi-3181	16	50	,	,	PUNCT
ajmsi-3181	16	51	qatar	qatar	PROPN
ajmsi-3181	16	52	4	4	NUM
ajmsi-3181	16	53	epidemiology	epidemiology	NOUN
ajmsi-3181	16	54	department	department	NOUN
ajmsi-3181	16	55	,	,	PUNCT
ajmsi-3181	16	56	cdc	cdc	PROPN
ajmsi-3181	16	57	,	,	PUNCT
ajmsi-3181	16	58	hamad	hamad	PROPN
ajmsi-3181	16	59	medical	medical	PROPN
ajmsi-3181	16	60	corporation	corporation	PROPN
ajmsi-3181	16	61	,	,	PUNCT
ajmsi-3181	16	62	qatar	qatar	PROPN
ajmsi-3181	16	63	5	5	NUM
ajmsi-3181	16	64	medicine	medicine	NOUN
ajmsi-3181	16	65	department	department	NOUN
ajmsi-3181	16	66	,	,	PUNCT
ajmsi-3181	16	67	hamad	hamad	PROPN
ajmsi-3181	16	68	medical	medical	PROPN
ajmsi-3181	16	69	corporation	corporation	PROPN
ajmsi-3181	16	70	,	,	PUNCT
ajmsi-3181	16	71	qatar	qatar	PROPN
ajmsi-3181	16	72	*	*	SYM
ajmsi-3181	16	73	corresponding	correspond	VERB
ajmsi-3181	16	74	author	author	NOUN
ajmsi-3181	16	75	’s	’s	PART
ajmsi-3181	16	76	e	e	NOUN
ajmsi-3181	16	77	-	-	NOUN
ajmsi-3181	16	78	mail	mail	NOUN
ajmsi-3181	16	79	:	:	PUNCT
ajmsi-3181	16	80	adilazia44@gmail.com	adilazia44@gmail.com	X
ajmsi-3181	16	81	introduction	introduction	NOUN
ajmsi-3181	16	82	gram	gram	NOUN
ajmsi-3181	16	83	-	-	PUNCT
ajmsi-3181	16	84	negative	negative	ADJ
ajmsi-3181	16	85	bacteria	bacteria	NOUN
ajmsi-3181	16	86	are	be	AUX
ajmsi-3181	16	87	known	know	VERB
ajmsi-3181	16	88	to	to	PART
ajmsi-3181	16	89	cause	cause	VERB
ajmsi-3181	16	90	a	a	DET
ajmsi-3181	16	91	range	range	NOUN
ajmsi-3181	16	92	of	of	ADP
ajmsi-3181	16	93	infections	infection	NOUN
ajmsi-3181	16	94	,	,	PUNCT
ajmsi-3181	16	95	including	include	VERB
ajmsi-3181	16	96	urinary	urinary	ADJ
ajmsi-3181	16	97	tract	tract	NOUN
ajmsi-3181	16	98	infections	infection	NOUN
ajmsi-3181	16	99	,	,	PUNCT
ajmsi-3181	16	100	biliary	biliary	NOUN
ajmsi-3181	16	101	infections	infection	NOUN
ajmsi-3181	16	102	,	,	PUNCT
ajmsi-3181	16	103	pneumonia	pneumonia	NOUN
ajmsi-3181	16	104	,	,	PUNCT
ajmsi-3181	16	105	and	and	CCONJ
ajmsi-3181	16	106	primary	primary	ADJ
ajmsi-3181	16	107	and	and	CCONJ
ajmsi-3181	16	108	secondary	secondary	ADJ
ajmsi-3181	16	109	bloodstream	bloodstream	NOUN
ajmsi-3181	16	110	infections	infection	NOUN
ajmsi-3181	16	111	(	(	PUNCT
ajmsi-3181	16	112	gajdács	gajdács	VERB
ajmsi-3181	16	113	et	et	PROPN
ajmsi-3181	16	114	al	al	PROPN
ajmsi-3181	16	115	.	.	PROPN
ajmsi-3181	16	116	,	,	PUNCT
ajmsi-3181	16	117	2019	2019	NUM
ajmsi-3181	16	118	;	;	PUNCT
ajmsi-3181	16	119	kim	kim	PROPN
ajmsi-3181	16	120	&	&	CCONJ
ajmsi-3181	16	121	park	park	PROPN
ajmsi-3181	16	122	,	,	PUNCT
ajmsi-3181	16	123	2018	2018	NUM
ajmsi-3181	16	124	;	;	PUNCT
ajmsi-3181	16	125	kwiecińska	kwiecińska	ADJ
ajmsi-3181	16	126	-	-	PUNCT
ajmsi-3181	16	127	piróg	piróg	NOUN
ajmsi-3181	16	128	et	et	PROPN
ajmsi-3181	16	129	al	al	PROPN
ajmsi-3181	16	130	.	.	PROPN
ajmsi-3181	16	131	,	,	PUNCT
ajmsi-3181	16	132	2018	2018	NUM
ajmsi-3181	16	133	)	)	PUNCT
ajmsi-3181	16	134	.	.	PUNCT
ajmsi-3181	17	1	factors	factor	NOUN
ajmsi-3181	17	2	that	that	PRON
ajmsi-3181	17	3	predispose	predispose	VERB
ajmsi-3181	17	4	to	to	ADP
ajmsi-3181	17	5	these	these	DET
ajmsi-3181	17	6	infections	infection	NOUN
ajmsi-3181	17	7	include	include	VERB
ajmsi-3181	17	8	extreme	extreme	ADJ
ajmsi-3181	17	9	age	age	NOUN
ajmsi-3181	17	10	,	,	PUNCT
ajmsi-3181	17	11	comorbidities	comorbiditie	NOUN
ajmsi-3181	17	12	such	such	ADJ
ajmsi-3181	17	13	as	as	ADP
ajmsi-3181	17	14	diabetes	diabetes	NOUN
ajmsi-3181	17	15	mellitus	mellitus	NOUN
ajmsi-3181	17	16	,	,	PUNCT
ajmsi-3181	17	17	immunosuppression	immunosuppression	NOUN
ajmsi-3181	17	18	,	,	PUNCT
ajmsi-3181	17	19	prior	prior	ADJ
ajmsi-3181	17	20	use	use	NOUN
ajmsi-3181	17	21	of	of	ADP
ajmsi-3181	17	22	antimicrobials	antimicrobial	NOUN
ajmsi-3181	17	23	,	,	PUNCT
ajmsi-3181	17	24	medical	medical	ADJ
ajmsi-3181	17	25	device	device	NOUN
ajmsi-3181	17	26	usage	usage	NOUN
ajmsi-3181	17	27	,	,	PUNCT
ajmsi-3181	17	28	and	and	CCONJ
ajmsi-3181	17	29	invasive	invasive	ADJ
ajmsi-3181	17	30	interventions	intervention	NOUN
ajmsi-3181	17	31	such	such	ADJ
ajmsi-3181	17	32	as	as	ADP
ajmsi-3181	17	33	surgery	surgery	NOUN
ajmsi-3181	17	34	,	,	PUNCT
ajmsi-3181	17	35	nosocomial	nosocomial	ADJ
ajmsi-3181	17	36	acquisition	acquisition	NOUN
ajmsi-3181	17	37	,	,	PUNCT
ajmsi-3181	17	38	and	and	CCONJ
ajmsi-3181	17	39	duration	duration	NOUN
ajmsi-3181	17	40	of	of	ADP
ajmsi-3181	17	41	stay	stay	NOUN
ajmsi-3181	17	42	,	,	PUNCT
ajmsi-3181	17	43	even	even	ADV
ajmsi-3181	17	44	though	though	SCONJ
ajmsi-3181	17	45	without	without	ADP
ajmsi-3181	17	46	a	a	DET
ajmsi-3181	17	47	predisposing	predispose	VERB
ajmsi-3181	17	48	factor	factor	NOUN
ajmsi-3181	17	49	,	,	PUNCT
ajmsi-3181	17	50	the	the	DET
ajmsi-3181	17	51	infection	infection	NOUN
ajmsi-3181	17	52	may	may	AUX
ajmsi-3181	17	53	also	also	ADV
ajmsi-3181	17	54	arise	arise	VERB
ajmsi-3181	17	55	(	(	PUNCT
ajmsi-3181	17	56	gajdács	gajdács	VERB
ajmsi-3181	17	57	et	et	PROPN
ajmsi-3181	17	58	al	al	PROPN
ajmsi-3181	17	59	.	.	PROPN
ajmsi-3181	17	60	,	,	PUNCT
ajmsi-3181	17	61	2019	2019	NUM
ajmsi-3181	17	62	)	)	PUNCT
ajmsi-3181	17	63	.	.	PUNCT
ajmsi-3181	18	1	one	one	NUM
ajmsi-3181	18	2	of	of	ADP
ajmsi-3181	18	3	the	the	DET
ajmsi-3181	18	4	major	major	ADJ
ajmsi-3181	18	5	factors	factor	NOUN
ajmsi-3181	18	6	contributing	contribute	VERB
ajmsi-3181	18	7	to	to	ADP
ajmsi-3181	18	8	the	the	DET
ajmsi-3181	18	9	mortality	mortality	NOUN
ajmsi-3181	18	10	and	and	CCONJ
ajmsi-3181	18	11	morbidity	morbidity	NOUN
ajmsi-3181	18	12	of	of	ADP
ajmsi-3181	18	13	hospitalised	hospitalise	VERB
ajmsi-3181	18	14	patients	patient	NOUN
ajmsi-3181	18	15	is	be	AUX
ajmsi-3181	18	16	gram	gram	NOUN
ajmsi-3181	18	17	-	-	PUNCT
ajmsi-3181	18	18	negative	negative	ADJ
ajmsi-3181	18	19	bacteremia	bacteremia	NOUN
ajmsi-3181	18	20	(	(	PUNCT
ajmsi-3181	18	21	gnb	gnb	PROPN
ajmsi-3181	18	22	)	)	PUNCT
ajmsi-3181	18	23	.	.	PUNCT
ajmsi-3181	19	1	these	these	DET
ajmsi-3181	19	2	patients	patient	NOUN
ajmsi-3181	19	3	require	require	VERB
ajmsi-3181	19	4	prompt	prompt	ADJ
ajmsi-3181	19	5	diagnosis	diagnosis	NOUN
ajmsi-3181	19	6	and	and	CCONJ
ajmsi-3181	19	7	appropriate	appropriate	ADJ
ajmsi-3181	19	8	antibiotic	antibiotic	ADJ
ajmsi-3181	19	9	therapy	therapy	NOUN
ajmsi-3181	19	10	.	.	PUNCT
ajmsi-3181	20	1	the	the	DET
ajmsi-3181	20	2	initiation	initiation	NOUN
ajmsi-3181	20	3	of	of	ADP
ajmsi-3181	20	4	appropriate	appropriate	ADJ
ajmsi-3181	20	5	antibiotics	antibiotic	NOUN
ajmsi-3181	20	6	can	can	AUX
ajmsi-3181	20	7	reduce	reduce	VERB
ajmsi-3181	20	8	mortality	mortality	NOUN
ajmsi-3181	20	9	,	,	PUNCT
ajmsi-3181	20	10	treatment	treatment	NOUN
ajmsi-3181	20	11	failure	failure	NOUN
ajmsi-3181	20	12	,	,	PUNCT
ajmsi-3181	20	13	and	and	CCONJ
ajmsi-3181	20	14	length	length	NOUN
ajmsi-3181	20	15	of	of	ADP
ajmsi-3181	20	16	stay	stay	NOUN
ajmsi-3181	20	17	,	,	PUNCT
ajmsi-3181	20	18	highlighting	highlight	VERB
ajmsi-3181	20	19	the	the	DET
ajmsi-3181	20	20	importance	importance	NOUN
ajmsi-3181	20	21	of	of	ADP
ajmsi-3181	20	22	broad	broad	ADJ
ajmsi-3181	20	23	-	-	PUNCT
ajmsi-3181	20	24	spectrum	spectrum	NOUN
ajmsi-3181	20	25	empirical	empirical	ADJ
ajmsi-3181	20	26	therapy	therapy	NOUN
ajmsi-3181	20	27	,	,	PUNCT
ajmsi-3181	20	28	diagnostic	diagnostic	ADJ
ajmsi-3181	20	29	stewardship	stewardship	NOUN
ajmsi-3181	20	30	,	,	PUNCT
ajmsi-3181	20	31	and	and	CCONJ
ajmsi-3181	20	32	rapid	rapid	ADJ
ajmsi-3181	20	33	diagnostics	diagnostic	NOUN
ajmsi-3181	20	34	for	for	ADP
ajmsi-3181	20	35	early	early	ADJ
ajmsi-3181	20	36	and	and	CCONJ
ajmsi-3181	20	37	timely	timely	ADJ
ajmsi-3181	20	38	identification	identification	NOUN
ajmsi-3181	20	39	(	(	PUNCT
ajmsi-3181	20	40	bassetti	bassetti	NOUN
ajmsi-3181	20	41	et	et	PROPN
ajmsi-3181	20	42	al	al	PROPN
ajmsi-3181	20	43	.	.	PROPN
ajmsi-3181	20	44	,	,	PUNCT
ajmsi-3181	20	45	2020	2020	NUM
ajmsi-3181	20	46	;	;	PUNCT
ajmsi-3181	20	47	gajdács	gajdács	VERB
ajmsi-3181	20	48	et	et	PROPN
ajmsi-3181	20	49	al	al	PROPN
ajmsi-3181	20	50	.	.	PROPN
ajmsi-3181	20	51	,	,	PUNCT
ajmsi-3181	20	52	2019	2019	NUM
ajmsi-3181	20	53	)	)	PUNCT
ajmsi-3181	20	54	.	.	PUNCT
ajmsi-3181	21	1	conflicting	conflict	VERB
ajmsi-3181	21	2	observations	observation	NOUN
ajmsi-3181	21	3	have	have	AUX
ajmsi-3181	21	4	resulted	result	VERB
ajmsi-3181	21	5	in	in	ADP
ajmsi-3181	21	6	uncertainty	uncertainty	NOUN
ajmsi-3181	21	7	concerning	concern	VERB
ajmsi-3181	21	8	the	the	DET
ajmsi-3181	21	9	optimum	optimum	ADJ
ajmsi-3181	21	10	duration	duration	NOUN
ajmsi-3181	21	11	of	of	ADP
ajmsi-3181	21	12	antibiotic	antibiotic	ADJ
ajmsi-3181	21	13	therapy	therapy	NOUN
ajmsi-3181	21	14	for	for	ADP
ajmsi-3181	21	15	bacteremia	bacteremia	NOUN
ajmsi-3181	21	16	caused	cause	VERB
ajmsi-3181	21	17	by	by	ADP
ajmsi-3181	21	18	gram	gram	NOUN
ajmsi-3181	21	19	-	-	PUNCT
ajmsi-3181	21	20	negative	negative	ADJ
ajmsi-3181	21	21	infections	infection	NOUN
ajmsi-3181	21	22	.	.	PUNCT
ajmsi-3181	22	1	many	many	ADJ
ajmsi-3181	22	2	believe	believe	VERB
ajmsi-3181	22	3	gram	gram	NUM
ajmsi-3181	22	4	-	-	PUNCT
ajmsi-3181	22	5	negative	negative	ADJ
ajmsi-3181	22	6	bacteremia	bacteremia	NOUN
ajmsi-3181	22	7	patients	patient	NOUN
ajmsi-3181	22	8	should	should	AUX
ajmsi-3181	22	9	be	be	AUX
ajmsi-3181	22	10	treated	treat	VERB
ajmsi-3181	22	11	with	with	ADP
ajmsi-3181	22	12	a	a	DET
ajmsi-3181	22	13	10	10	NUM
ajmsi-3181	22	14	-	-	SYM
ajmsi-3181	22	15	14	14	NUM
ajmsi-3181	22	16	-	-	PUNCT
ajmsi-3181	22	17	day	day	NOUN
ajmsi-3181	22	18	intravenous	intravenous	ADJ
ajmsi-3181	22	19	antibiotics	antibiotic	NOUN
ajmsi-3181	22	20	course	course	NOUN
ajmsi-3181	22	21	to	to	PART
ajmsi-3181	22	22	prevent	prevent	VERB
ajmsi-3181	22	23	serious	serious	ADJ
ajmsi-3181	22	24	sequelae	sequelae	PROPN
ajmsi-3181	22	25	,	,	PUNCT
ajmsi-3181	22	26	such	such	ADJ
ajmsi-3181	22	27	as	as	ADP
ajmsi-3181	22	28	abscess	abscess	ADJ
ajmsi-3181	22	29	formation	formation	NOUN
ajmsi-3181	22	30	and	and	CCONJ
ajmsi-3181	22	31	relapse	relapse	NOUN
ajmsi-3181	22	32	(	(	PUNCT
ajmsi-3181	22	33	turjeman	turjeman	NOUN
ajmsi-3181	22	34	et	et	PROPN
ajmsi-3181	22	35	al	al	PROPN
ajmsi-3181	22	36	.	.	PROPN
ajmsi-3181	22	37	,	,	PUNCT
ajmsi-3181	22	38	2023	2023	NUM
ajmsi-3181	22	39	)	)	PUNCT
ajmsi-3181	22	40	.	.	PUNCT
ajmsi-3181	23	1	recently	recently	ADV
ajmsi-3181	23	2	,	,	PUNCT
ajmsi-3181	23	3	lee	lee	PROPN
ajmsi-3181	23	4	et	et	PROPN
ajmsi-3181	23	5	al	al	PROPN
ajmsi-3181	23	6	.	.	PROPN
ajmsi-3181	23	7	(	(	PUNCT
ajmsi-3181	23	8	2019	2019	NUM
ajmsi-3181	23	9	)	)	PUNCT
ajmsi-3181	24	1	and	and	CCONJ
ajmsi-3181	24	2	yahav	yahav	VERB
ajmsi-3181	24	3	et	et	PROPN
ajmsi-3181	24	4	al	al	PROPN
ajmsi-3181	24	5	.	.	PROPN
ajmsi-3181	25	1	(	(	PUNCT
ajmsi-3181	25	2	2019	2019	NUM
ajmsi-3181	25	3	)	)	PUNCT
ajmsi-3181	25	4	have	have	AUX
ajmsi-3181	25	5	suggested	suggest	VERB
ajmsi-3181	25	6	that	that	SCONJ
ajmsi-3181	25	7	short	short	ADJ
ajmsi-3181	25	8	therapy	therapy	NOUN
ajmsi-3181	25	9	courses	course	NOUN
ajmsi-3181	25	10	are	be	AUX
ajmsi-3181	25	11	adequate	adequate	ADJ
ajmsi-3181	25	12	for	for	ADP
ajmsi-3181	25	13	uncomplicated	uncomplicated	ADJ
ajmsi-3181	25	14	bacteremia	bacteremia	NOUN
ajmsi-3181	25	15	(	(	PUNCT
ajmsi-3181	25	16	lee	lee	PROPN
ajmsi-3181	25	17	et	et	PROPN
ajmsi-3181	25	18	al	al	PROPN
ajmsi-3181	25	19	.	.	PROPN
ajmsi-3181	25	20	,	,	PUNCT
ajmsi-3181	25	21	2019	2019	NUM
ajmsi-3181	25	22	;	;	PUNCT
ajmsi-3181	25	23	yahav	yahav	VERB
ajmsi-3181	25	24	et	et	PROPN
ajmsi-3181	25	25	al	al	PROPN
ajmsi-3181	25	26	.	.	PROPN
ajmsi-3181	25	27	,	,	PUNCT
ajmsi-3181	25	28	2019	2019	NUM
ajmsi-3181	25	29	)	)	PUNCT
ajmsi-3181	25	30	.	.	PUNCT
ajmsi-3181	26	1	the	the	DET
ajmsi-3181	26	2	emerging	emerge	VERB
ajmsi-3181	26	3	resistance	resistance	NOUN
ajmsi-3181	26	4	among	among	ADP
ajmsi-3181	26	5	these	these	DET
ajmsi-3181	26	6	bacteria	bacteria	NOUN
ajmsi-3181	26	7	significantly	significantly	ADV
ajmsi-3181	26	8	challenges	challenge	VERB
ajmsi-3181	26	9	healthcare	healthcare	NOUN
ajmsi-3181	26	10	delivery	delivery	NOUN
ajmsi-3181	26	11	(	(	PUNCT
ajmsi-3181	26	12	iskandar	iskandar	PROPN
ajmsi-3181	26	13	et	et	PROPN
ajmsi-3181	26	14	al	al	PROPN
ajmsi-3181	26	15	.	.	PROPN
ajmsi-3181	26	16	,	,	PUNCT
ajmsi-3181	26	17	2021	2021	NUM
ajmsi-3181	26	18	)	)	PUNCT
ajmsi-3181	26	19	.	.	PUNCT
ajmsi-3181	27	1	infections	infection	NOUN
ajmsi-3181	27	2	by	by	ADP
ajmsi-3181	27	3	antimicrobial	antimicrobial	ADJ
ajmsi-3181	27	4	-	-	PUNCT
ajmsi-3181	27	5	resistant	resistant	ADJ
ajmsi-3181	27	6	organisms	organism	NOUN
ajmsi-3181	27	7	,	,	PUNCT
ajmsi-3181	27	8	particularly	particularly	ADV
ajmsi-3181	27	9	multidrugresistant	multidrugresistant	ADJ
ajmsi-3181	27	10	organisms	organism	NOUN
ajmsi-3181	27	11	(	(	PUNCT
ajmsi-3181	27	12	de	de	X
ajmsi-3181	27	13	waele	waele	X
ajmsi-3181	27	14	et	et	PROPN
ajmsi-3181	27	15	al	al	PROPN
ajmsi-3181	27	16	.	.	PROPN
ajmsi-3181	27	17	,	,	PUNCT
ajmsi-3181	27	18	2018	2018	NUM
ajmsi-3181	27	19	)	)	PUNCT
ajmsi-3181	27	20	,	,	PUNCT
ajmsi-3181	27	21	could	could	AUX
ajmsi-3181	27	22	result	result	VERB
ajmsi-3181	27	23	in	in	ADP
ajmsi-3181	27	24	treatment	treatment	NOUN
ajmsi-3181	27	25	failure	failure	NOUN
ajmsi-3181	27	26	,	,	PUNCT
ajmsi-3181	27	27	increased	increase	VERB
ajmsi-3181	27	28	morbidity	morbidity	NOUN
ajmsi-3181	27	29	and	and	CCONJ
ajmsi-3181	27	30	mortality	mortality	NOUN
ajmsi-3181	27	31	,	,	PUNCT
ajmsi-3181	27	32	increased	increase	VERB
ajmsi-3181	27	33	medical	medical	ADJ
ajmsi-3181	27	34	costs	cost	NOUN
ajmsi-3181	27	35	,	,	PUNCT
ajmsi-3181	27	36	prolonged	prolonged	ADJ
ajmsi-3181	27	37	hospital	hospital	NOUN
ajmsi-3181	27	38	stays	stay	NOUN
ajmsi-3181	27	39	,	,	PUNCT
ajmsi-3181	27	40	and	and	CCONJ
ajmsi-3181	27	41	increased	increase	VERB
ajmsi-3181	27	42	socioeconomic	socioeconomic	ADJ
ajmsi-3181	27	43	burden	burden	NOUN
ajmsi-3181	27	44	(	(	PUNCT
ajmsi-3181	27	45	iskandar	iskandar	NOUN
ajmsi-3181	27	46	et	et	PROPN
ajmsi-3181	27	47	al	al	PROPN
ajmsi-3181	27	48	.	.	PROPN
ajmsi-3181	27	49	,	,	PUNCT
ajmsi-3181	27	50	2021	2021	NUM
ajmsi-3181	27	51	;	;	PUNCT
ajmsi-3181	27	52	kitaya	kitaya	PROPN
ajmsi-3181	27	53	et	et	PROPN
ajmsi-3181	27	54	al	al	PROPN
ajmsi-3181	27	55	.	.	PROPN
ajmsi-3181	27	56	,	,	PUNCT
ajmsi-3181	27	57	2023	2023	NUM
ajmsi-3181	27	58	)	)	PUNCT
ajmsi-3181	27	59	.	.	PUNCT
ajmsi-3181	28	1	in	in	ADP
ajmsi-3181	28	2	high	high	ADJ
ajmsi-3181	28	3	resistance	resistance	NOUN
ajmsi-3181	28	4	rates	rate	NOUN
ajmsi-3181	28	5	,	,	PUNCT
ajmsi-3181	28	6	selecting	select	VERB
ajmsi-3181	28	7	appropriate	appropriate	ADJ
ajmsi-3181	28	8	empiric	empiric	ADJ
ajmsi-3181	28	9	antibiotic	antibiotic	ADJ
ajmsi-3181	28	10	treatment	treatment	NOUN
ajmsi-3181	28	11	for	for	ADP
ajmsi-3181	28	12	suspected	suspect	VERB
ajmsi-3181	28	13	gramnegative	gramnegative	ADJ
ajmsi-3181	28	14	infections	infection	NOUN
ajmsi-3181	28	15	is	be	AUX
ajmsi-3181	28	16	difficult	difficult	ADJ
ajmsi-3181	28	17	(	(	PUNCT
ajmsi-3181	28	18	fitzpatrick	fitzpatrick	PROPN
ajmsi-3181	28	19	et	et	PROPN
ajmsi-3181	28	20	al	al	PROPN
ajmsi-3181	28	21	.	.	PROPN
ajmsi-3181	28	22	,	,	PUNCT
ajmsi-3181	28	23	2016	2016	NUM
ajmsi-3181	28	24	)	)	PUNCT
ajmsi-3181	28	25	.	.	PUNCT
ajmsi-3181	29	1	inappropriate	inappropriate	ADJ
ajmsi-3181	29	2	empirical	empirical	ADJ
ajmsi-3181	29	3	antimicrobial	antimicrobial	ADJ
ajmsi-3181	29	4	therapy	therapy	NOUN
ajmsi-3181	29	5	has	have	AUX
ajmsi-3181	29	6	been	be	AUX
ajmsi-3181	29	7	shown	show	VERB
ajmsi-3181	29	8	to	to	PART
ajmsi-3181	29	9	predict	predict	VERB
ajmsi-3181	29	10	death	death	NOUN
ajmsi-3181	29	11	in	in	ADP
ajmsi-3181	29	12	critically	critically	ADV
ajmsi-3181	29	13	ill	ill	ADJ
ajmsi-3181	29	14	patients	patient	NOUN
ajmsi-3181	29	15	(	(	PUNCT
ajmsi-3181	29	16	turjeman	turjeman	NOUN
ajmsi-3181	29	17	et	et	PROPN
ajmsi-3181	29	18	al	al	PROPN
ajmsi-3181	29	19	.	.	PROPN
ajmsi-3181	29	20	,	,	PUNCT
ajmsi-3181	29	21	2023	2023	NUM
ajmsi-3181	29	22	)	)	PUNCT
ajmsi-3181	29	23	.	.	PUNCT
ajmsi-3181	30	1	furthermore	furthermore	ADV
ajmsi-3181	30	2	,	,	PUNCT
ajmsi-3181	30	3	prolonged	prolonged	ADJ
ajmsi-3181	30	4	antimicrobial	antimicrobial	ADJ
ajmsi-3181	30	5	exposure	exposure	NOUN
ajmsi-3181	30	6	is	be	AUX
ajmsi-3181	30	7	associated	associate	VERB
ajmsi-3181	30	8	with	with	ADP
ajmsi-3181	30	9	adverse	adverse	ADJ
ajmsi-3181	30	10	effects	effect	NOUN
ajmsi-3181	30	11	,	,	PUNCT
ajmsi-3181	30	12	increased	increase	VERB
ajmsi-3181	30	13	rates	rate	NOUN
ajmsi-3181	30	14	of	of	ADP
ajmsi-3181	30	15	clostridioides	clostridioide	NOUN
ajmsi-3181	30	16	difficile	difficile	VERB
ajmsi-3181	30	17	infection	infection	NOUN
ajmsi-3181	30	18	,	,	PUNCT
ajmsi-3181	30	19	antimicrobial	antimicrobial	ADJ
ajmsi-3181	30	20	resistance	resistance	NOUN
ajmsi-3181	30	21	,	,	PUNCT
ajmsi-3181	30	22	and	and	CCONJ
ajmsi-3181	30	23	longer	long	ADJ
ajmsi-3181	30	24	hospital	hospital	NOUN
ajmsi-3181	30	25	stays	stay	NOUN
ajmsi-3181	30	26	(	(	PUNCT
ajmsi-3181	30	27	dyer	dyer	NOUN
ajmsi-3181	30	28	et	et	PROPN
ajmsi-3181	30	29	al	al	PROPN
ajmsi-3181	30	30	.	.	PROPN
ajmsi-3181	30	31	,	,	PUNCT
ajmsi-3181	30	32	2019	2019	NUM
ajmsi-3181	30	33	)	)	PUNCT
ajmsi-3181	30	34	.	.	PUNCT
ajmsi-3181	31	1	pa	pa	PROPN
ajmsi-3181	31	2	ge	ge	PROPN
ajmsi-3181	31	3	92	92	NUM
ajmsi-3181	31	4	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-3181	31	5	am	be	AUX
ajmsi-3181	31	6	.	.	PUNCT
ajmsi-3181	32	1	j.	j.	PROPN
ajmsi-3181	32	2	med	med	PROPN
ajmsi-3181	32	3	.	.	PUNCT
ajmsi-3181	33	1	sci	sci	PROPN
ajmsi-3181	33	2	.	.	PUNCT
ajmsi-3181	33	3	innov	innov	PROPN
ajmsi-3181	33	4	.	.	PUNCT
ajmsi-3181	34	1	3(2	3(2	NUM
ajmsi-3181	34	2	)	)	PUNCT
ajmsi-3181	34	3	91	91	NUM
ajmsi-3181	34	4	-	-	SYM
ajmsi-3181	34	5	102	102	NUM
ajmsi-3181	34	6	,	,	PUNCT
ajmsi-3181	34	7	2024	2024	NUM
ajmsi-3181	34	8	different	different	ADJ
ajmsi-3181	34	9	centres	centre	NOUN
ajmsi-3181	34	10	vary	vary	VERB
ajmsi-3181	34	11	depending	depend	VERB
ajmsi-3181	34	12	on	on	ADP
ajmsi-3181	34	13	the	the	DET
ajmsi-3181	34	14	patient	patient	ADJ
ajmsi-3181	34	15	population	population	NOUN
ajmsi-3181	34	16	,	,	PUNCT
ajmsi-3181	34	17	immune	immune	ADJ
ajmsi-3181	34	18	status	status	NOUN
ajmsi-3181	34	19	,	,	PUNCT
ajmsi-3181	34	20	infection	infection	NOUN
ajmsi-3181	34	21	control	control	NOUN
ajmsi-3181	34	22	precautions	precaution	NOUN
ajmsi-3181	34	23	,	,	PUNCT
ajmsi-3181	34	24	and	and	CCONJ
ajmsi-3181	34	25	antimicrobial	antimicrobial	ADJ
ajmsi-3181	34	26	use	use	NOUN
ajmsi-3181	34	27	(	(	PUNCT
ajmsi-3181	34	28	spellberg	spellberg	PROPN
ajmsi-3181	34	29	&	&	CCONJ
ajmsi-3181	34	30	rice	rice	PROPN
ajmsi-3181	34	31	,	,	PUNCT
ajmsi-3181	34	32	2019	2019	NUM
ajmsi-3181	34	33	)	)	PUNCT
ajmsi-3181	34	34	.	.	PUNCT
ajmsi-3181	35	1	analysis	analysis	NOUN
ajmsi-3181	35	2	of	of	ADP
ajmsi-3181	35	3	local	local	ADJ
ajmsi-3181	35	4	trends	trend	NOUN
ajmsi-3181	35	5	and	and	CCONJ
ajmsi-3181	35	6	epidemiology	epidemiology	NOUN
ajmsi-3181	35	7	is	be	AUX
ajmsi-3181	35	8	necessary	necessary	ADJ
ajmsi-3181	35	9	to	to	PART
ajmsi-3181	35	10	optimise	optimise	VERB
ajmsi-3181	35	11	empirical	empirical	ADJ
ajmsi-3181	35	12	antibiotic	antibiotic	ADJ
ajmsi-3181	35	13	treatment	treatment	NOUN
ajmsi-3181	35	14	(	(	PUNCT
ajmsi-3181	35	15	yahav	yahav	VERB
ajmsi-3181	35	16	et	et	PROPN
ajmsi-3181	35	17	al	al	PROPN
ajmsi-3181	35	18	.	.	PROPN
ajmsi-3181	35	19	,	,	PUNCT
ajmsi-3181	35	20	2019	2019	NUM
ajmsi-3181	35	21	)	)	PUNCT
ajmsi-3181	35	22	.	.	PUNCT
ajmsi-3181	36	1	if	if	SCONJ
ajmsi-3181	36	2	indicated	indicate	VERB
ajmsi-3181	36	3	,	,	PUNCT
ajmsi-3181	36	4	appropriate	appropriate	ADJ
ajmsi-3181	36	5	antimicrobial	antimicrobial	ADJ
ajmsi-3181	36	6	therapy	therapy	NOUN
ajmsi-3181	36	7	with	with	ADP
ajmsi-3181	36	8	source	source	NOUN
ajmsi-3181	36	9	control	control	NOUN
ajmsi-3181	36	10	is	be	AUX
ajmsi-3181	36	11	warranted	warrant	VERB
ajmsi-3181	36	12	to	to	PART
ajmsi-3181	36	13	achieve	achieve	VERB
ajmsi-3181	36	14	optimal	optimal	ADJ
ajmsi-3181	36	15	outcomes	outcome	NOUN
ajmsi-3181	36	16	(	(	PUNCT
ajmsi-3181	36	17	turjeman	turjeman	NOUN
ajmsi-3181	36	18	et	et	PROPN
ajmsi-3181	36	19	al	al	PROPN
ajmsi-3181	36	20	.	.	PROPN
ajmsi-3181	36	21	,	,	PUNCT
ajmsi-3181	36	22	2023	2023	NUM
ajmsi-3181	36	23	)	)	PUNCT
ajmsi-3181	36	24	.	.	PUNCT
ajmsi-3181	37	1	the	the	DET
ajmsi-3181	37	2	study	study	NOUN
ajmsi-3181	37	3	aims	aim	VERB
ajmsi-3181	37	4	to	to	PART
ajmsi-3181	37	5	identify	identify	VERB
ajmsi-3181	37	6	the	the	DET
ajmsi-3181	37	7	local	local	ADJ
ajmsi-3181	37	8	epidemiologically	epidemiologically	ADV
ajmsi-3181	37	9	predisposing	predispose	VERB
ajmsi-3181	37	10	factors	factor	NOUN
ajmsi-3181	37	11	,	,	PUNCT
ajmsi-3181	37	12	antimicrobial	antimicrobial	ADJ
ajmsi-3181	37	13	susceptibility	susceptibility	NOUN
ajmsi-3181	37	14	patterns	pattern	NOUN
ajmsi-3181	37	15	,	,	PUNCT
ajmsi-3181	37	16	and	and	CCONJ
ajmsi-3181	37	17	clinical	clinical	ADJ
ajmsi-3181	37	18	outcomes	outcome	NOUN
ajmsi-3181	37	19	in	in	ADP
ajmsi-3181	37	20	adult	adult	NOUN
ajmsi-3181	37	21	patients	patient	NOUN
ajmsi-3181	37	22	with	with	ADP
ajmsi-3181	37	23	gram	gram	NOUN
ajmsi-3181	37	24	-	-	PUNCT
ajmsi-3181	37	25	negative	negative	ADJ
ajmsi-3181	37	26	bacteremia	bacteremia	NOUN
ajmsi-3181	37	27	,	,	PUNCT
ajmsi-3181	37	28	focusing	focus	VERB
ajmsi-3181	37	29	on	on	ADP
ajmsi-3181	37	30	factors	factor	NOUN
ajmsi-3181	37	31	associated	associate	VERB
ajmsi-3181	37	32	with	with	ADP
ajmsi-3181	37	33	morbidity	morbidity	NOUN
ajmsi-3181	37	34	and	and	CCONJ
ajmsi-3181	37	35	mortality	mortality	NOUN
ajmsi-3181	37	36	.	.	PUNCT
ajmsi-3181	38	1	materials	material	NOUN
ajmsi-3181	38	2	and	and	CCONJ
ajmsi-3181	38	3	methods	method	NOUN
ajmsi-3181	38	4	study	study	NOUN
ajmsi-3181	38	5	design	design	NOUN
ajmsi-3181	38	6	and	and	CCONJ
ajmsi-3181	38	7	selection	selection	NOUN
ajmsi-3181	38	8	criteria	criterion	NOUN
ajmsi-3181	38	9	a	a	DET
ajmsi-3181	38	10	retrospective	retrospective	ADJ
ajmsi-3181	38	11	cohort	cohort	NOUN
ajmsi-3181	38	12	study	study	NOUN
ajmsi-3181	38	13	was	be	AUX
ajmsi-3181	38	14	conducted	conduct	VERB
ajmsi-3181	38	15	on	on	ADP
ajmsi-3181	38	16	in	in	ADP
ajmsi-3181	38	17	-	-	PUNCT
ajmsi-3181	38	18	patient	patient	NOUN
ajmsi-3181	38	19	adults	adult	NOUN
ajmsi-3181	38	20	with	with	ADP
ajmsi-3181	38	21	gram	gram	NOUN
ajmsi-3181	38	22	-	-	PUNCT
ajmsi-3181	38	23	negative	negative	ADJ
ajmsi-3181	38	24	bacteremia	bacteremia	NOUN
ajmsi-3181	38	25	between	between	ADP
ajmsi-3181	38	26	january	january	PROPN
ajmsi-3181	38	27	2019	2019	NUM
ajmsi-3181	38	28	and	and	CCONJ
ajmsi-3181	38	29	december	december	PROPN
ajmsi-3181	38	30	2020	2020	NUM
ajmsi-3181	38	31	in	in	ADP
ajmsi-3181	38	32	a	a	DET
ajmsi-3181	38	33	320	320	NUM
ajmsi-3181	38	34	-	-	PUNCT
ajmsi-3181	38	35	bed	bed	NOUN
ajmsi-3181	38	36	general	general	ADJ
ajmsi-3181	38	37	hospital	hospital	NOUN
ajmsi-3181	38	38	in	in	ADP
ajmsi-3181	38	39	qatar	qatar	PROPN
ajmsi-3181	38	40	.	.	PUNCT
ajmsi-3181	39	1	all	all	DET
ajmsi-3181	39	2	adult	adult	NOUN
ajmsi-3181	39	3	patients	patient	NOUN
ajmsi-3181	39	4	who	who	PRON
ajmsi-3181	39	5	presented	present	VERB
ajmsi-3181	39	6	with	with	ADP
ajmsi-3181	39	7	gramnegative	gramnegative	ADJ
ajmsi-3181	39	8	bacteremia	bacteremia	NOUN
ajmsi-3181	39	9	during	during	ADP
ajmsi-3181	39	10	the	the	DET
ajmsi-3181	39	11	study	study	NOUN
ajmsi-3181	39	12	period	period	NOUN
ajmsi-3181	39	13	based	base	VERB
ajmsi-3181	39	14	on	on	ADP
ajmsi-3181	39	15	positive	positive	ADJ
ajmsi-3181	39	16	blood	blood	NOUN
ajmsi-3181	39	17	cultures	culture	NOUN
ajmsi-3181	39	18	were	be	AUX
ajmsi-3181	39	19	identified	identify	VERB
ajmsi-3181	39	20	retrospectively	retrospectively	ADV
ajmsi-3181	39	21	from	from	ADP
ajmsi-3181	39	22	the	the	DET
ajmsi-3181	39	23	microbiology	microbiology	NOUN
ajmsi-3181	39	24	lab	lab	NOUN
ajmsi-3181	39	25	through	through	ADP
ajmsi-3181	39	26	hospital	hospital	NOUN
ajmsi-3181	39	27	electronic	electronic	ADJ
ajmsi-3181	39	28	records	record	NOUN
ajmsi-3181	39	29	.	.	PUNCT
ajmsi-3181	40	1	pediatric	pediatric	ADJ
ajmsi-3181	40	2	patients	patient	NOUN
ajmsi-3181	40	3	(	(	PUNCT
ajmsi-3181	40	4	aged	age	VERB
ajmsi-3181	40	5	<	<	X
ajmsi-3181	40	6	14	14	NUM
ajmsi-3181	40	7	years	year	NOUN
ajmsi-3181	40	8	)	)	PUNCT
ajmsi-3181	40	9	and	and	CCONJ
ajmsi-3181	40	10	transit	transit	NOUN
ajmsi-3181	40	11	passengers	passenger	NOUN
ajmsi-3181	40	12	were	be	AUX
ajmsi-3181	40	13	excluded	exclude	VERB
ajmsi-3181	40	14	from	from	ADP
ajmsi-3181	40	15	the	the	DET
ajmsi-3181	40	16	study	study	NOUN
ajmsi-3181	40	17	.	.	PUNCT
ajmsi-3181	41	1	samples	sample	NOUN
ajmsi-3181	41	2	considered	consider	VERB
ajmsi-3181	41	3	contaminants	contaminant	NOUN
ajmsi-3181	41	4	,	,	PUNCT
ajmsi-3181	41	5	as	as	SCONJ
ajmsi-3181	41	6	determined	determine	VERB
ajmsi-3181	41	7	by	by	ADP
ajmsi-3181	41	8	the	the	DET
ajmsi-3181	41	9	clinical	clinical	ADJ
ajmsi-3181	41	10	picture	picture	NOUN
ajmsi-3181	41	11	and	and	CCONJ
ajmsi-3181	41	12	subsequent	subsequent	ADJ
ajmsi-3181	41	13	management	management	NOUN
ajmsi-3181	41	14	,	,	PUNCT
ajmsi-3181	41	15	were	be	AUX
ajmsi-3181	41	16	also	also	ADV
ajmsi-3181	41	17	not	not	PART
ajmsi-3181	41	18	included	include	VERB
ajmsi-3181	41	19	.	.	PUNCT
ajmsi-3181	42	1	a	a	DET
ajmsi-3181	42	2	microbiology	microbiology	NOUN
ajmsi-3181	42	3	database	database	NOUN
ajmsi-3181	42	4	was	be	AUX
ajmsi-3181	42	5	used	use	VERB
ajmsi-3181	42	6	to	to	PART
ajmsi-3181	42	7	record	record	VERB
ajmsi-3181	42	8	antimicrobial	antimicrobial	ADJ
ajmsi-3181	42	9	susceptibility	susceptibility	NOUN
ajmsi-3181	42	10	testing	test	VERB
ajmsi-3181	42	11	current	current	ADJ
ajmsi-3181	42	12	guidelines	guideline	NOUN
ajmsi-3181	42	13	from	from	ADP
ajmsi-3181	42	14	the	the	DET
ajmsi-3181	42	15	clinical	clinical	ADJ
ajmsi-3181	42	16	and	and	CCONJ
ajmsi-3181	42	17	laboratory	laboratory	NOUN
ajmsi-3181	42	18	standards	standard	NOUN
ajmsi-3181	42	19	institute	institute	PROPN
ajmsi-3181	42	20	(	(	PUNCT
ajmsi-3181	42	21	clsi	clsi	PROPN
ajmsi-3181	42	22	)	)	PUNCT
ajmsi-3181	42	23	(	(	PUNCT
ajmsi-3181	42	24	iskandar	iskandar	NOUN
ajmsi-3181	42	25	et	et	PROPN
ajmsi-3181	42	26	al	al	PROPN
ajmsi-3181	42	27	.	.	PROPN
ajmsi-3181	42	28	,	,	PUNCT
ajmsi-3181	42	29	2021	2021	NUM
ajmsi-3181	42	30	)	)	PUNCT
ajmsi-3181	42	31	.	.	PUNCT
ajmsi-3181	43	1	the	the	DET
ajmsi-3181	43	2	hospital	hospital	NOUN
ajmsi-3181	43	3	’s	’s	PART
ajmsi-3181	43	4	electronic	electronic	ADJ
ajmsi-3181	43	5	patient	patient	NOUN
ajmsi-3181	43	6	record	record	NOUN
ajmsi-3181	43	7	system	system	NOUN
ajmsi-3181	43	8	was	be	AUX
ajmsi-3181	43	9	used	use	VERB
ajmsi-3181	43	10	to	to	PART
ajmsi-3181	43	11	capture	capture	VERB
ajmsi-3181	43	12	all	all	DET
ajmsi-3181	43	13	clinical	clinical	ADJ
ajmsi-3181	43	14	data	datum	NOUN
ajmsi-3181	43	15	related	relate	VERB
ajmsi-3181	43	16	to	to	ADP
ajmsi-3181	43	17	these	these	DET
ajmsi-3181	43	18	patients	patient	NOUN
ajmsi-3181	43	19	.	.	PUNCT
ajmsi-3181	44	1	in	in	ADP
ajmsi-3181	44	2	contrast	contrast	NOUN
ajmsi-3181	44	3	,	,	PUNCT
ajmsi-3181	44	4	the	the	DET
ajmsi-3181	44	5	demographic	demographic	ADJ
ajmsi-3181	44	6	details	detail	NOUN
ajmsi-3181	44	7	,	,	PUNCT
ajmsi-3181	44	8	including	include	VERB
ajmsi-3181	44	9	age	age	NOUN
ajmsi-3181	44	10	,	,	PUNCT
ajmsi-3181	44	11	sex	sex	NOUN
ajmsi-3181	44	12	,	,	PUNCT
ajmsi-3181	44	13	comorbidities	comorbiditie	NOUN
ajmsi-3181	44	14	(	(	PUNCT
ajmsi-3181	44	15	immunosuppression	immunosuppression	NOUN
ajmsi-3181	44	16	,	,	PUNCT
ajmsi-3181	44	17	malignancy	malignancy	NOUN
ajmsi-3181	44	18	,	,	PUNCT
ajmsi-3181	44	19	pregnancy	pregnancy	NOUN
ajmsi-3181	44	20	,	,	PUNCT
ajmsi-3181	44	21	renal	renal	ADJ
ajmsi-3181	44	22	disease	disease	NOUN
ajmsi-3181	44	23	,	,	PUNCT
ajmsi-3181	44	24	diabetes	diabetes	NOUN
ajmsi-3181	44	25	,	,	PUNCT
ajmsi-3181	44	26	and	and	CCONJ
ajmsi-3181	44	27	hypertension	hypertension	NOUN
ajmsi-3181	44	28	)	)	PUNCT
ajmsi-3181	44	29	,	,	PUNCT
ajmsi-3181	44	30	and	and	CCONJ
ajmsi-3181	44	31	clinical	clinical	ADJ
ajmsi-3181	44	32	presentation	presentation	NOUN
ajmsi-3181	44	33	,	,	PUNCT
ajmsi-3181	44	34	were	be	AUX
ajmsi-3181	44	35	also	also	ADV
ajmsi-3181	44	36	recorded	record	VERB
ajmsi-3181	44	37	.	.	PUNCT
ajmsi-3181	45	1	a	a	DET
ajmsi-3181	45	2	need	need	NOUN
ajmsi-3181	45	3	for	for	ADP
ajmsi-3181	45	4	admission	admission	NOUN
ajmsi-3181	45	5	to	to	ADP
ajmsi-3181	45	6	the	the	DET
ajmsi-3181	45	7	critical	critical	ADJ
ajmsi-3181	45	8	care	care	NOUN
ajmsi-3181	45	9	unit	unit	NOUN
ajmsi-3181	45	10	was	be	AUX
ajmsi-3181	45	11	used	use	VERB
ajmsi-3181	45	12	to	to	PART
ajmsi-3181	45	13	assess	assess	VERB
ajmsi-3181	45	14	the	the	DET
ajmsi-3181	45	15	severity	severity	NOUN
ajmsi-3181	45	16	of	of	ADP
ajmsi-3181	45	17	infection	infection	NOUN
ajmsi-3181	45	18	.	.	PUNCT
ajmsi-3181	46	1	the	the	DET
ajmsi-3181	46	2	probable	probable	ADJ
ajmsi-3181	46	3	source	source	NOUN
ajmsi-3181	46	4	of	of	ADP
ajmsi-3181	46	5	infection	infection	NOUN
ajmsi-3181	46	6	,	,	PUNCT
ajmsi-3181	46	7	persistence	persistence	NOUN
ajmsi-3181	46	8	of	of	ADP
ajmsi-3181	46	9	bacteremia	bacteremia	NOUN
ajmsi-3181	46	10	beyond	beyond	ADP
ajmsi-3181	46	11	the	the	DET
ajmsi-3181	46	12	first	first	ADJ
ajmsi-3181	46	13	blood	blood	NOUN
ajmsi-3181	46	14	culture	culture	NOUN
ajmsi-3181	46	15	,	,	PUNCT
ajmsi-3181	46	16	and	and	CCONJ
ajmsi-3181	46	17	therapeutic	therapeutic	ADJ
ajmsi-3181	46	18	options	option	NOUN
ajmsi-3181	46	19	with	with	ADP
ajmsi-3181	46	20	intravenous	intravenous	ADJ
ajmsi-3181	46	21	antibiotics	antibiotic	NOUN
ajmsi-3181	46	22	alone	alone	ADJ
ajmsi-3181	46	23	or	or	CCONJ
ajmsi-3181	46	24	combined	combine	VERB
ajmsi-3181	46	25	with	with	ADP
ajmsi-3181	46	26	source	source	NOUN
ajmsi-3181	46	27	control	control	NOUN
ajmsi-3181	46	28	(	(	PUNCT
ajmsi-3181	46	29	incision	incision	NOUN
ajmsi-3181	46	30	and	and	CCONJ
ajmsi-3181	46	31	drainage	drainage	NOUN
ajmsi-3181	46	32	of	of	ADP
ajmsi-3181	46	33	abscesses	abscess	NOUN
ajmsi-3181	46	34	,	,	PUNCT
ajmsi-3181	46	35	stent	stent	NOUN
ajmsi-3181	46	36	insertion	insertion	NOUN
ajmsi-3181	46	37	)	)	PUNCT
ajmsi-3181	46	38	were	be	AUX
ajmsi-3181	46	39	examined	examine	VERB
ajmsi-3181	46	40	.	.	PUNCT
ajmsi-3181	47	1	the	the	DET
ajmsi-3181	47	2	choice	choice	NOUN
ajmsi-3181	47	3	of	of	ADP
ajmsi-3181	47	4	antibiotics	antibiotic	NOUN
ajmsi-3181	47	5	and	and	CCONJ
ajmsi-3181	47	6	duration	duration	NOUN
ajmsi-3181	47	7	of	of	ADP
ajmsi-3181	47	8	treatment	treatment	NOUN
ajmsi-3181	47	9	,	,	PUNCT
ajmsi-3181	47	10	including	include	VERB
ajmsi-3181	47	11	changes	change	NOUN
ajmsi-3181	47	12	made	make	VERB
ajmsi-3181	47	13	according	accord	VERB
ajmsi-3181	47	14	to	to	ADP
ajmsi-3181	47	15	sensitivity	sensitivity	NOUN
ajmsi-3181	47	16	,	,	PUNCT
ajmsi-3181	47	17	were	be	AUX
ajmsi-3181	47	18	also	also	ADV
ajmsi-3181	47	19	recorded	record	VERB
ajmsi-3181	47	20	.	.	PUNCT
ajmsi-3181	48	1	clinical	clinical	ADJ
ajmsi-3181	48	2	outcomes	outcome	NOUN
ajmsi-3181	48	3	were	be	AUX
ajmsi-3181	48	4	gauged	gauge	VERB
ajmsi-3181	48	5	as	as	ADP
ajmsi-3181	48	6	cure	cure	NOUN
ajmsi-3181	48	7	,	,	PUNCT
ajmsi-3181	48	8	death	death	NOUN
ajmsi-3181	48	9	,	,	PUNCT
ajmsi-3181	48	10	or	or	CCONJ
ajmsi-3181	48	11	infection	infection	NOUN
ajmsi-3181	48	12	recurrence	recurrence	NOUN
ajmsi-3181	48	13	within	within	ADP
ajmsi-3181	48	14	90	90	NUM
ajmsi-3181	48	15	days	day	NOUN
ajmsi-3181	48	16	of	of	ADP
ajmsi-3181	48	17	admission	admission	NOUN
ajmsi-3181	48	18	.	.	PUNCT
ajmsi-3181	49	1	any	any	DET
ajmsi-3181	49	2	subsequent	subsequent	ADJ
ajmsi-3181	49	3	development	development	NOUN
ajmsi-3181	49	4	of	of	ADP
ajmsi-3181	49	5	alert	alert	ADJ
ajmsi-3181	49	6	organisms	organism	NOUN
ajmsi-3181	49	7	such	such	ADJ
ajmsi-3181	49	8	as	as	ADP
ajmsi-3181	49	9	clostridium	clostridium	NOUN
ajmsi-3181	49	10	difficile	difficile	ADJ
ajmsi-3181	49	11	infection	infection	NOUN
ajmsi-3181	49	12	or	or	CCONJ
ajmsi-3181	49	13	the	the	DET
ajmsi-3181	49	14	emergence	emergence	NOUN
ajmsi-3181	49	15	of	of	ADP
ajmsi-3181	49	16	multidrugresistant	multidrugresistant	ADJ
ajmsi-3181	49	17	microorganisms	microorganism	NOUN
ajmsi-3181	49	18	90	90	NUM
ajmsi-3181	49	19	days	day	NOUN
ajmsi-3181	49	20	after	after	ADP
ajmsi-3181	49	21	admission	admission	NOUN
ajmsi-3181	49	22	was	be	AUX
ajmsi-3181	49	23	also	also	ADV
ajmsi-3181	49	24	monitored	monitor	VERB
ajmsi-3181	49	25	.	.	PUNCT
ajmsi-3181	50	1	multidrug	multidrug	VERB
ajmsi-3181	50	2	resistance	resistance	NOUN
ajmsi-3181	50	3	(	(	PUNCT
ajmsi-3181	50	4	mdr	mdr	NOUN
ajmsi-3181	50	5	)	)	PUNCT
ajmsi-3181	50	6	was	be	AUX
ajmsi-3181	50	7	defined	define	VERB
ajmsi-3181	50	8	as	as	ADP
ajmsi-3181	50	9	resistance	resistance	NOUN
ajmsi-3181	50	10	to	to	ADP
ajmsi-3181	50	11	at	at	ADV
ajmsi-3181	50	12	least	least	ADV
ajmsi-3181	50	13	one	one	NUM
ajmsi-3181	50	14	agent	agent	NOUN
ajmsi-3181	50	15	from	from	ADP
ajmsi-3181	50	16	three	three	NUM
ajmsi-3181	50	17	or	or	CCONJ
ajmsi-3181	50	18	more	more	ADJ
ajmsi-3181	50	19	antimicrobial	antimicrobial	ADJ
ajmsi-3181	50	20	classes	class	NOUN
ajmsi-3181	50	21	(	(	PUNCT
ajmsi-3181	50	22	yezli	yezli	NOUN
ajmsi-3181	50	23	et	et	PROPN
ajmsi-3181	50	24	al	al	PROPN
ajmsi-3181	50	25	.	.	PROPN
ajmsi-3181	50	26	,	,	PUNCT
ajmsi-3181	50	27	2014	2014	NUM
ajmsi-3181	50	28	)	)	PUNCT
ajmsi-3181	50	29	.	.	PUNCT
ajmsi-3181	51	1	ethical	ethical	ADJ
ajmsi-3181	51	2	approval	approval	NOUN
ajmsi-3181	51	3	this	this	DET
ajmsi-3181	51	4	study	study	NOUN
ajmsi-3181	51	5	was	be	AUX
ajmsi-3181	51	6	approved	approve	VERB
ajmsi-3181	51	7	by	by	ADP
ajmsi-3181	51	8	the	the	DET
ajmsi-3181	51	9	institutional	institutional	PROPN
ajmsi-3181	51	10	review	review	PROPN
ajmsi-3181	51	11	board	board	NOUN
ajmsi-3181	51	12	(	(	PUNCT
ajmsi-3181	51	13	irb	irb	PROPN
ajmsi-3181	51	14	)	)	PUNCT
ajmsi-3181	51	15	and	and	CCONJ
ajmsi-3181	51	16	medical	medical	ADJ
ajmsi-3181	51	17	research	research	NOUN
ajmsi-3181	51	18	and	and	CCONJ
ajmsi-3181	51	19	ethics	ethic	NOUN
ajmsi-3181	51	20	committee	committee	PROPN
ajmsi-3181	51	21	hamad	hamad	PROPN
ajmsi-3181	51	22	medical	medical	PROPN
ajmsi-3181	51	23	corporation	corporation	PROPN
ajmsi-3181	51	24	(	(	PUNCT
ajmsi-3181	51	25	protocol	protocol	NOUN
ajmsi-3181	51	26	i	i	PROPN
ajmsi-3181	51	27	d	d	PROPN
ajmsi-3181	51	28	mrc-01	mrc-01	PROPN
ajmsi-3181	51	29	-	-	NOUN
ajmsi-3181	51	30	21259	21259	NUM
ajmsi-3181	51	31	)	)	PUNCT
ajmsi-3181	51	32	.	.	PUNCT
ajmsi-3181	52	1	however	however	ADV
ajmsi-3181	52	2	,	,	PUNCT
ajmsi-3181	52	3	this	this	DET
ajmsi-3181	52	4	retrospective	retrospective	ADJ
ajmsi-3181	52	5	cohort	cohort	NOUN
ajmsi-3181	52	6	review	review	NOUN
ajmsi-3181	52	7	did	do	AUX
ajmsi-3181	52	8	not	not	PART
ajmsi-3181	52	9	obtain	obtain	VERB
ajmsi-3181	52	10	individual	individual	ADJ
ajmsi-3181	52	11	patient	patient	ADJ
ajmsi-3181	52	12	consent	consent	NOUN
ajmsi-3181	52	13	.	.	PUNCT
ajmsi-3181	53	1	statistical	statistical	ADJ
ajmsi-3181	53	2	analysis	analysis	NOUN
ajmsi-3181	53	3	statistical	statistical	ADJ
ajmsi-3181	53	4	analysis	analysis	NOUN
ajmsi-3181	53	5	was	be	AUX
ajmsi-3181	53	6	conducted	conduct	VERB
ajmsi-3181	53	7	on	on	ADP
ajmsi-3181	53	8	358	358	NUM
ajmsi-3181	53	9	patients	patient	NOUN
ajmsi-3181	53	10	using	use	VERB
ajmsi-3181	53	11	the	the	DET
ajmsi-3181	53	12	sata	sata	NOUN
ajmsi-3181	53	13	/	/	SYM
ajmsi-3181	53	14	se	se	PROPN
ajmsi-3181	53	15	14.2	14.2	NUM
ajmsi-3181	53	16	.	.	PUNCT
ajmsi-3181	54	1	the	the	DET
ajmsi-3181	54	2	study	study	NOUN
ajmsi-3181	54	3	analysed	analyse	VERB
ajmsi-3181	54	4	epidemiological	epidemiological	ADJ
ajmsi-3181	54	5	data	datum	NOUN
ajmsi-3181	54	6	,	,	PUNCT
ajmsi-3181	54	7	including	include	VERB
ajmsi-3181	54	8	descriptive	descriptive	ADJ
ajmsi-3181	54	9	statistics	statistic	NOUN
ajmsi-3181	54	10	and	and	CCONJ
ajmsi-3181	54	11	continuous	continuous	ADJ
ajmsi-3181	54	12	and	and	CCONJ
ajmsi-3181	54	13	categorical	categorical	ADJ
ajmsi-3181	54	14	variables	variable	NOUN
ajmsi-3181	54	15	.	.	PUNCT
ajmsi-3181	55	1	categorical	categorical	ADJ
ajmsi-3181	55	2	variables	variable	NOUN
ajmsi-3181	55	3	were	be	AUX
ajmsi-3181	55	4	presented	present	VERB
ajmsi-3181	55	5	as	as	ADP
ajmsi-3181	55	6	counts	count	NOUN
ajmsi-3181	55	7	and	and	CCONJ
ajmsi-3181	55	8	percentages	percentage	NOUN
ajmsi-3181	55	9	,	,	PUNCT
ajmsi-3181	55	10	whereas	whereas	SCONJ
ajmsi-3181	55	11	normal	normal	ADJ
ajmsi-3181	55	12	continuous	continuous	ADJ
ajmsi-3181	55	13	variables	variable	NOUN
ajmsi-3181	55	14	are	be	AUX
ajmsi-3181	55	15	expressed	express	VERB
ajmsi-3181	55	16	as	as	ADP
ajmsi-3181	55	17	means	mean	NOUN
ajmsi-3181	55	18	and	and	CCONJ
ajmsi-3181	55	19	standard	standard	ADJ
ajmsi-3181	55	20	deviations	deviation	NOUN
ajmsi-3181	55	21	,	,	PUNCT
ajmsi-3181	55	22	and	and	CCONJ
ajmsi-3181	55	23	non	non	ADJ
ajmsi-3181	55	24	-	-	ADJ
ajmsi-3181	55	25	normal	normal	ADJ
ajmsi-3181	55	26	variables	variable	NOUN
ajmsi-3181	55	27	are	be	AUX
ajmsi-3181	55	28	presented	present	VERB
ajmsi-3181	55	29	as	as	ADP
ajmsi-3181	55	30	medians	median	NOUN
ajmsi-3181	55	31	and	and	CCONJ
ajmsi-3181	55	32	interquartile	interquartile	NOUN
ajmsi-3181	55	33	ranges	range	NOUN
ajmsi-3181	55	34	(	(	PUNCT
ajmsi-3181	55	35	iqr	iqr	NOUN
ajmsi-3181	55	36	)	)	PUNCT
ajmsi-3181	55	37	.	.	PUNCT
ajmsi-3181	56	1	the	the	DET
ajmsi-3181	56	2	shapiro	shapiro	PROPN
ajmsi-3181	56	3	-	-	PUNCT
ajmsi-3181	56	4	wilk	wilk	NOUN
ajmsi-3181	56	5	test	test	NOUN
ajmsi-3181	56	6	and	and	CCONJ
ajmsi-3181	56	7	visual	visual	ADJ
ajmsi-3181	56	8	inspection	inspection	NOUN
ajmsi-3181	56	9	of	of	ADP
ajmsi-3181	56	10	histograms	histogram	NOUN
ajmsi-3181	56	11	were	be	AUX
ajmsi-3181	56	12	employed	employ	VERB
ajmsi-3181	56	13	to	to	PART
ajmsi-3181	56	14	assess	assess	VERB
ajmsi-3181	56	15	the	the	DET
ajmsi-3181	56	16	normality	normality	NOUN
ajmsi-3181	56	17	of	of	ADP
ajmsi-3181	56	18	the	the	DET
ajmsi-3181	56	19	data	datum	NOUN
ajmsi-3181	56	20	.	.	PUNCT
ajmsi-3181	57	1	the	the	DET
ajmsi-3181	57	2	student	student	NOUN
ajmsi-3181	57	3	’s	’s	PART
ajmsi-3181	57	4	t	t	PROPN
ajmsi-3181	57	5	-	-	PUNCT
ajmsi-3181	57	6	test	test	NOUN
ajmsi-3181	57	7	was	be	AUX
ajmsi-3181	57	8	applied	apply	VERB
ajmsi-3181	57	9	to	to	ADP
ajmsi-3181	57	10	normal	normal	ADJ
ajmsi-3181	57	11	outcomes	outcome	NOUN
ajmsi-3181	57	12	,	,	PUNCT
ajmsi-3181	57	13	the	the	DET
ajmsi-3181	57	14	mann	mann	PROPN
ajmsi-3181	57	15	-	-	PUNCT
ajmsi-3181	57	16	whitney	whitney	PROPN
ajmsi-3181	57	17	test	test	NOUN
ajmsi-3181	57	18	was	be	AUX
ajmsi-3181	57	19	applied	apply	VERB
ajmsi-3181	57	20	to	to	ADP
ajmsi-3181	57	21	non	non	ADJ
ajmsi-3181	57	22	-	-	ADJ
ajmsi-3181	57	23	normal	normal	ADJ
ajmsi-3181	57	24	outcomes	outcome	NOUN
ajmsi-3181	57	25	,	,	PUNCT
ajmsi-3181	57	26	and	and	CCONJ
ajmsi-3181	57	27	the	the	DET
ajmsi-3181	57	28	chi	chi	ADJ
ajmsi-3181	57	29	-	-	PUNCT
ajmsi-3181	57	30	square	square	ADJ
ajmsi-3181	57	31	test	test	NOUN
ajmsi-3181	57	32	was	be	AUX
ajmsi-3181	57	33	used	use	VERB
ajmsi-3181	57	34	for	for	ADP
ajmsi-3181	57	35	categorical	categorical	ADJ
ajmsi-3181	57	36	variables	variable	NOUN
ajmsi-3181	57	37	.	.	PUNCT
ajmsi-3181	58	1	survival	survival	NOUN
ajmsi-3181	58	2	analysis	analysis	NOUN
ajmsi-3181	58	3	was	be	AUX
ajmsi-3181	58	4	performed	perform	VERB
ajmsi-3181	58	5	using	use	VERB
ajmsi-3181	58	6	kaplan	kaplan	PROPN
ajmsi-3181	58	7	-	-	PUNCT
ajmsi-3181	58	8	meier	meier	PROPN
ajmsi-3181	58	9	survival	survival	NOUN
ajmsi-3181	58	10	curves	curve	NOUN
ajmsi-3181	58	11	and	and	CCONJ
ajmsi-3181	58	12	the	the	DET
ajmsi-3181	58	13	log	log	NOUN
ajmsi-3181	58	14	-	-	PUNCT
ajmsi-3181	58	15	rank	rank	NOUN
ajmsi-3181	58	16	test	test	NOUN
ajmsi-3181	58	17	to	to	PART
ajmsi-3181	58	18	assess	assess	VERB
ajmsi-3181	58	19	the	the	DET
ajmsi-3181	58	20	differences	difference	NOUN
ajmsi-3181	58	21	between	between	ADP
ajmsi-3181	58	22	the	the	DET
ajmsi-3181	58	23	groups	group	NOUN
ajmsi-3181	58	24	for	for	ADP
ajmsi-3181	58	25	variables	variable	NOUN
ajmsi-3181	58	26	associated	associate	VERB
ajmsi-3181	58	27	with	with	ADP
ajmsi-3181	58	28	mortality	mortality	NOUN
ajmsi-3181	58	29	based	base	VERB
ajmsi-3181	58	30	on	on	ADP
ajmsi-3181	58	31	univariate	univariate	ADJ
ajmsi-3181	58	32	analysis	analysis	NOUN
ajmsi-3181	58	33	.	.	PUNCT
ajmsi-3181	59	1	results	result	NOUN
ajmsi-3181	59	2	and	and	CCONJ
ajmsi-3181	59	3	discussions	discussion	NOUN
ajmsi-3181	59	4	the	the	DET
ajmsi-3181	59	5	demographic	demographic	ADJ
ajmsi-3181	59	6	and	and	CCONJ
ajmsi-3181	59	7	clinical	clinical	ADJ
ajmsi-3181	59	8	characteristics	characteristic	NOUN
ajmsi-3181	59	9	of	of	ADP
ajmsi-3181	59	10	the	the	DET
ajmsi-3181	59	11	cohort	cohort	NOUN
ajmsi-3181	59	12	with	with	ADP
ajmsi-3181	59	13	gram	gram	NOUN
ajmsi-3181	59	14	-	-	PUNCT
ajmsi-3181	59	15	negative	negative	ADJ
ajmsi-3181	59	16	bacteremia	bacteremia	NOUN
ajmsi-3181	59	17	were	be	AUX
ajmsi-3181	59	18	analysed	analyse	VERB
ajmsi-3181	59	19	,	,	PUNCT
ajmsi-3181	59	20	with	with	ADP
ajmsi-3181	59	21	a	a	DET
ajmsi-3181	59	22	total	total	NOUN
ajmsi-3181	59	23	of	of	ADP
ajmsi-3181	59	24	358	358	NUM
ajmsi-3181	59	25	patients	patient	NOUN
ajmsi-3181	59	26	included	include	VERB
ajmsi-3181	59	27	in	in	ADP
ajmsi-3181	59	28	the	the	DET
ajmsi-3181	59	29	study	study	NOUN
ajmsi-3181	59	30	.	.	PUNCT
ajmsi-3181	60	1	among	among	ADP
ajmsi-3181	60	2	these	these	DET
ajmsi-3181	60	3	patients	patient	NOUN
ajmsi-3181	60	4	,	,	PUNCT
ajmsi-3181	60	5	the	the	DET
ajmsi-3181	60	6	majority	majority	NOUN
ajmsi-3181	60	7	(	(	PUNCT
ajmsi-3181	60	8	218	218	NUM
ajmsi-3181	60	9	,	,	PUNCT
ajmsi-3181	60	10	60.8	60.8	NUM
ajmsi-3181	60	11	%	%	NOUN
ajmsi-3181	60	12	)	)	PUNCT
ajmsi-3181	60	13	were	be	AUX
ajmsi-3181	60	14	male	male	ADJ
ajmsi-3181	60	15	,	,	PUNCT
ajmsi-3181	60	16	with	with	ADP
ajmsi-3181	60	17	a	a	DET
ajmsi-3181	60	18	mean	mean	ADJ
ajmsi-3181	60	19	age	age	NOUN
ajmsi-3181	60	20	of	of	ADP
ajmsi-3181	60	21	51	51	NUM
ajmsi-3181	60	22	.	.	PUNCT
ajmsi-3181	60	23	table	table	NOUN
ajmsi-3181	60	24	1	1	NUM
ajmsi-3181	60	25	describes	describe	VERB
ajmsi-3181	60	26	the	the	DET
ajmsi-3181	60	27	comorbidities	comorbiditie	NOUN
ajmsi-3181	60	28	observed	observe	VERB
ajmsi-3181	60	29	in	in	ADP
ajmsi-3181	60	30	the	the	DET
ajmsi-3181	60	31	study	study	NOUN
ajmsi-3181	60	32	population	population	NOUN
ajmsi-3181	60	33	.	.	PUNCT
ajmsi-3181	61	1	notably	notably	ADV
ajmsi-3181	61	2	,	,	PUNCT
ajmsi-3181	61	3	diabetes	diabetes	NOUN
ajmsi-3181	61	4	mellitus	mellitus	NOUN
ajmsi-3181	61	5	emerged	emerge	VERB
ajmsi-3181	61	6	as	as	ADP
ajmsi-3181	61	7	a	a	DET
ajmsi-3181	61	8	significant	significant	ADJ
ajmsi-3181	61	9	confounding	confound	VERB
ajmsi-3181	61	10	factor	factor	NOUN
ajmsi-3181	61	11	.	.	PUNCT
ajmsi-3181	62	1	patients	patient	NOUN
ajmsi-3181	62	2	’	'	PUNCT
ajmsi-3181	62	3	demographic	demographic	ADJ
ajmsi-3181	62	4	and	and	CCONJ
ajmsi-3181	62	5	clinical	clinical	ADJ
ajmsi-3181	62	6	profiles	profile	NOUN
ajmsi-3181	62	7	were	be	AUX
ajmsi-3181	62	8	stratified	stratify	VERB
ajmsi-3181	62	9	based	base	VERB
ajmsi-3181	62	10	on	on	ADP
ajmsi-3181	62	11	their	their	PRON
ajmsi-3181	62	12	diabetes	diabetes	NOUN
ajmsi-3181	62	13	status	status	NOUN
ajmsi-3181	62	14	,	,	PUNCT
ajmsi-3181	62	15	resulting	result	VERB
ajmsi-3181	62	16	in	in	ADP
ajmsi-3181	62	17	197	197	NUM
ajmsi-3181	62	18	non	non	ADJ
ajmsi-3181	62	19	-	-	ADJ
ajmsi-3181	62	20	diabetic	diabetic	ADJ
ajmsi-3181	62	21	patients	patient	NOUN
ajmsi-3181	62	22	(	(	PUNCT
ajmsi-3181	62	23	nondm	nondm	PROPN
ajmsi-3181	62	24	)	)	PUNCT
ajmsi-3181	62	25	and	and	CCONJ
ajmsi-3181	62	26	160	160	NUM
ajmsi-3181	62	27	diabetes	diabetes	NOUN
ajmsi-3181	62	28	patients	patient	NOUN
ajmsi-3181	62	29	(	(	PUNCT
ajmsi-3181	62	30	dm	dm	PROPN
ajmsi-3181	62	31	)	)	PUNCT
ajmsi-3181	62	32	.	.	PUNCT
ajmsi-3181	63	1	the	the	DET
ajmsi-3181	63	2	non	non	ADJ
ajmsi-3181	63	3	-	-	ADJ
ajmsi-3181	63	4	diabetic	diabetic	ADJ
ajmsi-3181	63	5	group	group	NOUN
ajmsi-3181	63	6	exhibited	exhibit	VERB
ajmsi-3181	63	7	a	a	DET
ajmsi-3181	63	8	significantly	significantly	ADV
ajmsi-3181	63	9	younger	young	ADJ
ajmsi-3181	63	10	age	age	NOUN
ajmsi-3181	63	11	than	than	ADP
ajmsi-3181	63	12	the	the	DET
ajmsi-3181	63	13	diabetic	diabetic	ADJ
ajmsi-3181	63	14	group	group	NOUN
ajmsi-3181	63	15	(	(	PUNCT
ajmsi-3181	63	16	median	median	ADJ
ajmsi-3181	63	17	ages	age	NOUN
ajmsi-3181	63	18	of	of	ADP
ajmsi-3181	63	19	42.5	42.5	NUM
ajmsi-3181	63	20	vs.	vs.	ADP
ajmsi-3181	63	21	60	60	NUM
ajmsi-3181	63	22	,	,	PUNCT
ajmsi-3181	63	23	respectively	respectively	ADV
ajmsi-3181	63	24	,	,	PUNCT
ajmsi-3181	63	25	p	p	X
ajmsi-3181	63	26	<	<	X
ajmsi-3181	63	27	0.001	0.001	NUM
ajmsi-3181	63	28	)	)	PUNCT
ajmsi-3181	63	29	.	.	PUNCT
ajmsi-3181	64	1	furthermore	furthermore	ADV
ajmsi-3181	64	2	,	,	PUNCT
ajmsi-3181	64	3	hypertension	hypertension	NOUN
ajmsi-3181	64	4	,	,	PUNCT
ajmsi-3181	64	5	end	end	NOUN
ajmsi-3181	64	6	-	-	PUNCT
ajmsi-3181	64	7	stage	stage	NOUN
ajmsi-3181	64	8	renal	renal	ADJ
ajmsi-3181	64	9	disease	disease	NOUN
ajmsi-3181	64	10	on	on	ADP
ajmsi-3181	64	11	hemodialysis	hemodialysis	NOUN
ajmsi-3181	64	12	,	,	PUNCT
ajmsi-3181	64	13	and	and	CCONJ
ajmsi-3181	64	14	chronic	chronic	ADJ
ajmsi-3181	64	15	kidney	kidney	NOUN
ajmsi-3181	64	16	disease	disease	NOUN
ajmsi-3181	64	17	were	be	AUX
ajmsi-3181	64	18	more	more	ADV
ajmsi-3181	64	19	prevalent	prevalent	ADJ
ajmsi-3181	64	20	in	in	ADP
ajmsi-3181	64	21	the	the	DET
ajmsi-3181	64	22	diabetic	diabetic	ADJ
ajmsi-3181	64	23	group	group	NOUN
ajmsi-3181	64	24	compared	compare	VERB
ajmsi-3181	64	25	to	to	ADP
ajmsi-3181	64	26	the	the	DET
ajmsi-3181	64	27	non	non	ADJ
ajmsi-3181	64	28	-	-	ADJ
ajmsi-3181	64	29	diabetic	diabetic	ADJ
ajmsi-3181	64	30	group	group	NOUN
ajmsi-3181	64	31	(	(	PUNCT
ajmsi-3181	64	32	p	p	X
ajmsi-3181	64	33	<	<	X
ajmsi-3181	64	34	0.001	0.001	NUM
ajmsi-3181	64	35	for	for	ADP
ajmsi-3181	64	36	all	all	PRON
ajmsi-3181	64	37	)	)	PUNCT
ajmsi-3181	64	38	.	.	PUNCT
ajmsi-3181	65	1	although	although	SCONJ
ajmsi-3181	65	2	the	the	DET
ajmsi-3181	65	3	length	length	NOUN
ajmsi-3181	65	4	of	of	ADP
ajmsi-3181	65	5	hospital	hospital	NOUN
ajmsi-3181	65	6	stay	stay	NOUN
ajmsi-3181	65	7	did	do	AUX
ajmsi-3181	65	8	not	not	PART
ajmsi-3181	65	9	differ	differ	VERB
ajmsi-3181	65	10	significantly	significantly	ADV
ajmsi-3181	65	11	between	between	ADP
ajmsi-3181	65	12	the	the	DET
ajmsi-3181	65	13	two	two	NUM
ajmsi-3181	65	14	groups	group	NOUN
ajmsi-3181	65	15	(	(	PUNCT
ajmsi-3181	65	16	p	p	X
ajmsi-3181	65	17	=	=	NOUN
ajmsi-3181	65	18	0.94	0.94	NUM
ajmsi-3181	65	19	)	)	PUNCT
ajmsi-3181	65	20	,	,	PUNCT
ajmsi-3181	65	21	primary	primary	ADJ
ajmsi-3181	65	22	bacteremia	bacteremia	NOUN
ajmsi-3181	65	23	was	be	AUX
ajmsi-3181	65	24	more	more	ADV
ajmsi-3181	65	25	common	common	ADJ
ajmsi-3181	65	26	in	in	ADP
ajmsi-3181	65	27	the	the	DET
ajmsi-3181	65	28	non	non	ADJ
ajmsi-3181	65	29	-	-	ADJ
ajmsi-3181	65	30	diabetic	diabetic	ADJ
ajmsi-3181	65	31	group	group	NOUN
ajmsi-3181	65	32	(	(	PUNCT
ajmsi-3181	65	33	p	p	X
ajmsi-3181	65	34	=	=	NOUN
ajmsi-3181	65	35	0.038	0.038	NUM
ajmsi-3181	65	36	)	)	PUNCT
ajmsi-3181	65	37	.	.	PUNCT
ajmsi-3181	66	1	bacterial	bacterial	ADJ
ajmsi-3181	66	2	isolates	isolate	NOUN
ajmsi-3181	66	3	also	also	ADV
ajmsi-3181	66	4	showed	show	VERB
ajmsi-3181	66	5	significant	significant	ADJ
ajmsi-3181	66	6	differences	difference	NOUN
ajmsi-3181	66	7	in	in	ADP
ajmsi-3181	66	8	prevalence	prevalence	NOUN
ajmsi-3181	66	9	,	,	PUNCT
ajmsi-3181	66	10	particularly	particularly	ADV
ajmsi-3181	66	11	with	with	ADP
ajmsi-3181	66	12	e.	e.	PROPN
ajmsi-3181	66	13	coli	coli	PROPN
ajmsi-3181	66	14	,	,	PUNCT
ajmsi-3181	66	15	klebsiella	klebsiella	NOUN
ajmsi-3181	66	16	,	,	PUNCT
ajmsi-3181	66	17	and	and	CCONJ
ajmsi-3181	66	18	salmonella	salmonella	NOUN
ajmsi-3181	66	19	typhi	typhi	ADJ
ajmsi-3181	66	20	.	.	PUNCT
ajmsi-3181	67	1	additionally	additionally	ADV
ajmsi-3181	67	2	,	,	PUNCT
ajmsi-3181	67	3	the	the	DET
ajmsi-3181	67	4	source	source	NOUN
ajmsi-3181	67	5	of	of	ADP
ajmsi-3181	67	6	bacteremia	bacteremia	NOUN
ajmsi-3181	67	7	varied	vary	VERB
ajmsi-3181	67	8	significantly	significantly	ADV
ajmsi-3181	67	9	between	between	ADP
ajmsi-3181	67	10	the	the	DET
ajmsi-3181	67	11	groups	group	NOUN
ajmsi-3181	67	12	,	,	PUNCT
ajmsi-3181	67	13	with	with	ADP
ajmsi-3181	67	14	urinary	urinary	ADJ
ajmsi-3181	67	15	tract	tract	NOUN
ajmsi-3181	67	16	and	and	CCONJ
ajmsi-3181	67	17	intra	intra	ADJ
ajmsi-3181	67	18	-	-	ADJ
ajmsi-3181	67	19	abdominal	abdominal	ADJ
ajmsi-3181	67	20	infections	infection	NOUN
ajmsi-3181	67	21	being	be	AUX
ajmsi-3181	67	22	prominent	prominent	ADJ
ajmsi-3181	67	23	in	in	ADP
ajmsi-3181	67	24	both	both	PRON
ajmsi-3181	67	25	.	.	PUNCT
ajmsi-3181	68	1	antibiotic	antibiotic	ADJ
ajmsi-3181	68	2	resistance	resistance	NOUN
ajmsi-3181	68	3	did	do	AUX
ajmsi-3181	68	4	not	not	PART
ajmsi-3181	68	5	notably	notably	ADV
ajmsi-3181	68	6	differ	differ	VERB
ajmsi-3181	68	7	between	between	ADP
ajmsi-3181	68	8	the	the	DET
ajmsi-3181	68	9	groups	group	NOUN
ajmsi-3181	68	10	(	(	PUNCT
ajmsi-3181	68	11	p	p	X
ajmsi-3181	68	12	=	=	NOUN
ajmsi-3181	68	13	0.49	0.49	NUM
ajmsi-3181	68	14	)	)	PUNCT
ajmsi-3181	68	15	,	,	PUNCT
ajmsi-3181	68	16	as	as	SCONJ
ajmsi-3181	68	17	shown	show	VERB
ajmsi-3181	68	18	in	in	ADP
ajmsi-3181	68	19	table	table	NOUN
ajmsi-3181	68	20	1	1	NUM
ajmsi-3181	68	21	.	.	PUNCT
ajmsi-3181	68	22	table	table	NOUN
ajmsi-3181	68	23	1	1	NUM
ajmsi-3181	68	24	:	:	PUNCT
ajmsi-3181	68	25	baseline	baseline	PROPN
ajmsi-3181	68	26	characteristics	characteristic	NOUN
ajmsi-3181	68	27	of	of	ADP
ajmsi-3181	68	28	the	the	DET
ajmsi-3181	68	29	study	study	NOUN
ajmsi-3181	68	30	population	population	NOUN
ajmsi-3181	68	31	by	by	ADP
ajmsi-3181	68	32	diabetes	diabetes	NOUN
ajmsi-3181	68	33	status	status	NOUN
ajmsi-3181	68	34	non	non	PROPN
ajmsi-3181	68	35	-	-	ADJ
ajmsi-3181	68	36	dm	dm	INTJ
ajmsi-3181	68	37	(	(	PUNCT
ajmsi-3181	68	38	n	n	NOUN
ajmsi-3181	68	39	=	=	SYM
ajmsi-3181	68	40	197	197	NUM
ajmsi-3181	68	41	)	)	PUNCT
ajmsi-3181	68	42	dm	dm	PROPN
ajmsi-3181	68	43	(	(	PUNCT
ajmsi-3181	68	44	n	n	NOUN
ajmsi-3181	68	45	=	=	SYM
ajmsi-3181	68	46	160	160	NUM
ajmsi-3181	68	47	)	)	PUNCT
ajmsi-3181	68	48	demographics	demographic	NOUN
ajmsi-3181	68	49	age	age	NOUN
ajmsi-3181	68	50	(	(	PUNCT
ajmsi-3181	68	51	wilcoxon	wilcoxon	PROPN
ajmsi-3181	68	52	rank	rank	PROPN
ajmsi-3181	68	53	)	)	PUNCT
ajmsi-3181	68	54	42.00	42.00	NUM
ajmsi-3181	68	55	(	(	PUNCT
ajmsi-3181	68	56	28.00	28.00	NUM
ajmsi-3181	68	57	-	-	SYM
ajmsi-3181	68	58	54.00	54.00	NUM
ajmsi-3181	68	59	)	)	PUNCT
ajmsi-3181	68	60	60.00	60.00	NUM
ajmsi-3181	68	61	(	(	PUNCT
ajmsi-3181	68	62	49.50	49.50	NUM
ajmsi-3181	68	63	-	-	SYM
ajmsi-3181	68	64	70.00	70.00	NUM
ajmsi-3181	68	65	)	)	PUNCT
ajmsi-3181	68	66	<	<	X
ajmsi-3181	68	67	0.001	0.001	NUM
ajmsi-3181	68	68	pa	pa	PROPN
ajmsi-3181	68	69	ge	ge	PROPN
ajmsi-3181	68	70	93	93	NUM
ajmsi-3181	68	71	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-3181	68	72	am	be	AUX
ajmsi-3181	68	73	.	.	PUNCT
ajmsi-3181	69	1	j.	j.	PROPN
ajmsi-3181	69	2	med	med	PROPN
ajmsi-3181	69	3	.	.	PUNCT
ajmsi-3181	70	1	sci	sci	PROPN
ajmsi-3181	70	2	.	.	PUNCT
ajmsi-3181	70	3	innov	innov	PROPN
ajmsi-3181	70	4	.	.	PUNCT
ajmsi-3181	71	1	3(2	3(2	NUM
ajmsi-3181	71	2	)	)	PUNCT
ajmsi-3181	71	3	91	91	NUM
ajmsi-3181	71	4	-	-	SYM
ajmsi-3181	71	5	102	102	NUM
ajmsi-3181	71	6	,	,	PUNCT
ajmsi-3181	71	7	2024	2024	NUM
ajmsi-3181	71	8	male	male	NOUN
ajmsi-3181	71	9	128	128	NUM
ajmsi-3181	71	10	(	(	PUNCT
ajmsi-3181	71	11	64.65	64.65	NUM
ajmsi-3181	71	12	%	%	NOUN
ajmsi-3181	71	13	)	)	PUNCT
ajmsi-3181	71	14	90	90	NUM
ajmsi-3181	71	15	(	(	PUNCT
ajmsi-3181	71	16	56.25	56.25	NUM
ajmsi-3181	71	17	%	%	NOUN
ajmsi-3181	71	18	)	)	PUNCT
ajmsi-3181	71	19	0.093	0.093	NUM
ajmsi-3181	71	20	comorbidities	comorbiditie	NOUN
ajmsi-3181	71	21	htn	htn	VERB
ajmsi-3181	71	22	37	37	NUM
ajmsi-3181	71	23	(	(	PUNCT
ajmsi-3181	71	24	18.76	18.76	NUM
ajmsi-3181	71	25	%	%	NOUN
ajmsi-3181	71	26	)	)	PUNCT
ajmsi-3181	71	27	115	115	NUM
ajmsi-3181	71	28	(	(	PUNCT
ajmsi-3181	71	29	71.88	71.88	NUM
ajmsi-3181	71	30	%	%	NOUN
ajmsi-3181	71	31	)	)	PUNCT
ajmsi-3181	72	1	<	<	X
ajmsi-3181	72	2	0.001	0.001	NUM
ajmsi-3181	72	3	esrd	esrd	PROPN
ajmsi-3181	72	4	hd	hd	PROPN
ajmsi-3181	72	5	07	07	NUM
ajmsi-3181	72	6	(	(	PUNCT
ajmsi-3181	72	7	3.55	3.55	NUM
ajmsi-3181	72	8	%	%	NOUN
ajmsi-3181	72	9	)	)	PUNCT
ajmsi-3181	72	10	25	25	NUM
ajmsi-3181	72	11	(	(	PUNCT
ajmsi-3181	72	12	15.63	15.63	NUM
ajmsi-3181	72	13	%	%	NOUN
ajmsi-3181	72	14	)	)	PUNCT
ajmsi-3181	73	1	<	<	X
ajmsi-3181	73	2	0.001	0.001	NUM
ajmsi-3181	73	3	ckd	ckd	NOUN
ajmsi-3181	73	4	11	11	NUM
ajmsi-3181	73	5	(	(	PUNCT
ajmsi-3181	73	6	5.58	5.58	NUM
ajmsi-3181	73	7	%	%	NOUN
ajmsi-3181	73	8	)	)	PUNCT
ajmsi-3181	73	9	33	33	NUM
ajmsi-3181	73	10	(	(	PUNCT
ajmsi-3181	73	11	20.63	20.63	NUM
ajmsi-3181	73	12	%	%	NOUN
ajmsi-3181	73	13	)	)	PUNCT
ajmsi-3181	73	14	<	<	X
ajmsi-3181	73	15	0.001	0.001	NUM
ajmsi-3181	73	16	malignancy	malignancy	NOUN
ajmsi-3181	73	17	26	26	NUM
ajmsi-3181	73	18	(	(	PUNCT
ajmsi-3181	73	19	13.20	13.20	NUM
ajmsi-3181	73	20	%	%	NOUN
ajmsi-3181	73	21	)	)	PUNCT
ajmsi-3181	73	22	9	9	NUM
ajmsi-3181	73	23	(	(	PUNCT
ajmsi-3181	73	24	5.63	5.63	NUM
ajmsi-3181	73	25	%	%	NOUN
ajmsi-3181	73	26	)	)	PUNCT
ajmsi-3181	73	27	0.012	0.012	NUM
ajmsi-3181	73	28	copd	copd	NOUN
ajmsi-3181	73	29	/	/	SYM
ajmsi-3181	73	30	asthma	asthma	NOUN
ajmsi-3181	73	31	12	12	NUM
ajmsi-3181	73	32	(	(	PUNCT
ajmsi-3181	73	33	6.09	6.09	NUM
ajmsi-3181	73	34	%	%	NOUN
ajmsi-3181	73	35	)	)	PUNCT
ajmsi-3181	73	36	12	12	NUM
ajmsi-3181	73	37	(	(	PUNCT
ajmsi-3181	73	38	7.50	7.50	NUM
ajmsi-3181	73	39	%	%	NOUN
ajmsi-3181	73	40	)	)	PUNCT
ajmsi-3181	73	41	0.59	0.59	NUM
ajmsi-3181	73	42	hiv	hiv	NOUN
ajmsi-3181	73	43	0	0	PUNCT
ajmsi-3181	73	44	(	(	PUNCT
ajmsi-3181	73	45	0.00	0.00	NUM
ajmsi-3181	73	46	%	%	NOUN
ajmsi-3181	73	47	)	)	PUNCT
ajmsi-3181	73	48	1	1	NUM
ajmsi-3181	73	49	(	(	PUNCT
ajmsi-3181	73	50	0.63	0.63	NUM
ajmsi-3181	73	51	%	%	NOUN
ajmsi-3181	73	52	)	)	PUNCT
ajmsi-3181	73	53	ihd	ihd	VERB
ajmsi-3181	73	54	7	7	NUM
ajmsi-3181	73	55	(	(	PUNCT
ajmsi-3181	73	56	3.55	3.55	NUM
ajmsi-3181	73	57	%	%	NOUN
ajmsi-3181	73	58	)	)	PUNCT
ajmsi-3181	73	59	38	38	NUM
ajmsi-3181	73	60	(	(	PUNCT
ajmsi-3181	73	61	23.75	23.75	NUM
ajmsi-3181	73	62	%	%	NOUN
ajmsi-3181	73	63	)	)	PUNCT
ajmsi-3181	74	1	<	<	X
ajmsi-3181	74	2	0.001	0.001	NUM
ajmsi-3181	74	3	hf	hf	NOUN
ajmsi-3181	74	4	10	10	NUM
ajmsi-3181	74	5	(	(	PUNCT
ajmsi-3181	74	6	5.08	5.08	NUM
ajmsi-3181	74	7	%	%	NOUN
ajmsi-3181	74	8	)	)	PUNCT
ajmsi-3181	74	9	13	13	NUM
ajmsi-3181	74	10	(	(	PUNCT
ajmsi-3181	74	11	8.13	8.13	NUM
ajmsi-3181	74	12	%	%	NOUN
ajmsi-3181	74	13	)	)	PUNCT
ajmsi-3181	74	14	0.24	0.24	NUM
ajmsi-3181	74	15	liver	liver	NOUN
ajmsi-3181	74	16	disease	disease	NOUN
ajmsi-3181	74	17	9	9	NUM
ajmsi-3181	74	18	(	(	PUNCT
ajmsi-3181	74	19	4.57	4.57	NUM
ajmsi-3181	74	20	%	%	NOUN
ajmsi-3181	74	21	)	)	PUNCT
ajmsi-3181	74	22	13	13	NUM
ajmsi-3181	74	23	(	(	PUNCT
ajmsi-3181	74	24	8.13	8.13	NUM
ajmsi-3181	74	25	%	%	NOUN
ajmsi-3181	74	26	)	)	PUNCT
ajmsi-3181	74	27	0.16	0.16	NUM
ajmsi-3181	74	28	pregnant	pregnant	ADJ
ajmsi-3181	74	29	females	female	NOUN
ajmsi-3181	74	30	(	(	PUNCT
ajmsi-3181	74	31	fisher	fisher	PROPN
ajmsi-3181	74	32	's	's	PART
ajmsi-3181	74	33	exact	exact	ADJ
ajmsi-3181	74	34	)	)	PUNCT
ajmsi-3181	74	35	7	7	NUM
ajmsi-3181	74	36	(	(	PUNCT
ajmsi-3181	74	37	10.14	10.14	NUM
ajmsi-3181	74	38	%	%	NOUN
ajmsi-3181	74	39	)	)	PUNCT
ajmsi-3181	74	40	1	1	NUM
ajmsi-3181	74	41	(	(	PUNCT
ajmsi-3181	74	42	1.43	1.43	NUM
ajmsi-3181	74	43	%	%	NOUN
ajmsi-3181	74	44	)	)	PUNCT
ajmsi-3181	74	45	0.063	0.063	NUM
ajmsi-3181	74	46	valvular	valvular	ADJ
ajmsi-3181	74	47	disease	disease	NOUN
ajmsi-3181	74	48	(	(	PUNCT
ajmsi-3181	74	49	fisher	fisher	PROPN
ajmsi-3181	74	50	’s	’s	PART
ajmsi-3181	74	51	exact	exact	ADJ
ajmsi-3181	74	52	)	)	PUNCT
ajmsi-3181	74	53	3	3	NUM
ajmsi-3181	74	54	(	(	PUNCT
ajmsi-3181	74	55	1.52	1.52	NUM
ajmsi-3181	74	56	%	%	NOUN
ajmsi-3181	74	57	)	)	PUNCT
ajmsi-3181	74	58	10	10	NUM
ajmsi-3181	74	59	(	(	PUNCT
ajmsi-3181	74	60	6.25	6.25	NUM
ajmsi-3181	74	61	%	%	NOUN
ajmsi-3181	74	62	)	)	PUNCT
ajmsi-3181	74	63	0.017	0.017	NUM
ajmsi-3181	74	64	cystic	cystic	ADJ
ajmsi-3181	74	65	fibrosis	fibrosis	NOUN
ajmsi-3181	74	66	0	0	NUM
ajmsi-3181	75	1	(	(	PUNCT
ajmsi-3181	75	2	0	0	NUM
ajmsi-3181	75	3	%	%	NOUN
ajmsi-3181	75	4	)	)	PUNCT
ajmsi-3181	75	5	0	0	NUM
ajmsi-3181	76	1	(	(	PUNCT
ajmsi-3181	76	2	0	0	NUM
ajmsi-3181	76	3	%	%	NOUN
ajmsi-3181	76	4	)	)	PUNCT
ajmsi-3181	76	5	inflammatory	inflammatory	ADJ
ajmsi-3181	76	6	bowel	bowel	NOUN
ajmsi-3181	76	7	disease	disease	NOUN
ajmsi-3181	76	8	(	(	PUNCT
ajmsi-3181	76	9	fisher	fisher	PROPN
ajmsi-3181	76	10	's	's	PART
ajmsi-3181	76	11	exact	exact	ADJ
ajmsi-3181	76	12	)	)	PUNCT
ajmsi-3181	76	13	0	0	NUM
ajmsi-3181	76	14	(	(	PUNCT
ajmsi-3181	76	15	0.00	0.00	NUM
ajmsi-3181	76	16	%	%	NOUN
ajmsi-3181	76	17	)	)	PUNCT
ajmsi-3181	76	18	1	1	NUM
ajmsi-3181	76	19	(	(	PUNCT
ajmsi-3181	76	20	0.63	0.63	NUM
ajmsi-3181	76	21	%	%	NOUN
ajmsi-3181	76	22	)	)	PUNCT
ajmsi-3181	76	23	0.45	0.45	NUM
ajmsi-3181	76	24	tuberculosis	tuberculosis	NOUN
ajmsi-3181	76	25	1	1	NUM
ajmsi-3181	76	26	(	(	PUNCT
ajmsi-3181	76	27	0.51	0.51	NUM
ajmsi-3181	76	28	%	%	NOUN
ajmsi-3181	76	29	)	)	PUNCT
ajmsi-3181	76	30	0	0	NUM
ajmsi-3181	76	31	(	(	PUNCT
ajmsi-3181	76	32	0.00	0.00	NUM
ajmsi-3181	76	33	%	%	NOUN
ajmsi-3181	76	34	)	)	PUNCT
ajmsi-3181	76	35	1	1	NUM
ajmsi-3181	76	36	immunosuppressive	immunosuppressive	ADJ
ajmsi-3181	76	37	treatment	treatment	NOUN
ajmsi-3181	76	38	15	15	NUM
ajmsi-3181	76	39	(	(	PUNCT
ajmsi-3181	76	40	7.61	7.61	NUM
ajmsi-3181	76	41	%	%	NOUN
ajmsi-3181	76	42	)	)	PUNCT
ajmsi-3181	76	43	9	9	NUM
ajmsi-3181	76	44	(	(	PUNCT
ajmsi-3181	76	45	5.63	5.63	NUM
ajmsi-3181	76	46	%	%	NOUN
ajmsi-3181	76	47	)	)	PUNCT
ajmsi-3181	76	48	0.46	0.46	NUM
ajmsi-3181	76	49	long	long	ADJ
ajmsi-3181	76	50	hospital	hospital	NOUN
ajmsi-3181	76	51	stays	stay	VERB
ajmsi-3181	76	52	10	10	NUM
ajmsi-3181	76	53	(	(	PUNCT
ajmsi-3181	76	54	5.08	5.08	NUM
ajmsi-3181	76	55	%	%	NOUN
ajmsi-3181	76	56	)	)	PUNCT
ajmsi-3181	76	57	12	12	NUM
ajmsi-3181	76	58	(	(	PUNCT
ajmsi-3181	76	59	7.50	7.50	NUM
ajmsi-3181	76	60	%	%	NOUN
ajmsi-3181	76	61	)	)	PUNCT
ajmsi-3181	76	62	0.34	0.34	NUM
ajmsi-3181	76	63	complicated	complicated	ADJ
ajmsi-3181	76	64	bacteremia	bacteremia	NOUN
ajmsi-3181	76	65	51	51	NUM
ajmsi-3181	76	66	(	(	PUNCT
ajmsi-3181	76	67	25.89	25.89	NUM
ajmsi-3181	76	68	%	%	NOUN
ajmsi-3181	76	69	)	)	PUNCT
ajmsi-3181	76	70	53	53	NUM
ajmsi-3181	76	71	(	(	PUNCT
ajmsi-3181	76	72	33.13	33.13	NUM
ajmsi-3181	76	73	%	%	NOUN
ajmsi-3181	76	74	)	)	PUNCT
ajmsi-3181	76	75	0.16	0.16	NUM
ajmsi-3181	76	76	persistence	persistence	NOUN
ajmsi-3181	76	77	13	13	NUM
ajmsi-3181	76	78	(	(	PUNCT
ajmsi-3181	76	79	6.60	6.60	NUM
ajmsi-3181	76	80	%	%	NOUN
ajmsi-3181	76	81	)	)	PUNCT
ajmsi-3181	76	82	5	5	NUM
ajmsi-3181	76	83	(	(	PUNCT
ajmsi-3181	76	84	3.13	3.13	NUM
ajmsi-3181	76	85	%	%	NOUN
ajmsi-3181	76	86	)	)	PUNCT
ajmsi-3181	76	87	0.15	0.15	NUM
ajmsi-3181	76	88	intubated	intubate	VERB
ajmsi-3181	76	89	31	31	NUM
ajmsi-3181	76	90	(	(	PUNCT
ajmsi-3181	76	91	15.74	15.74	NUM
ajmsi-3181	76	92	%	%	NOUN
ajmsi-3181	76	93	)	)	PUNCT
ajmsi-3181	76	94	29	29	NUM
ajmsi-3181	76	95	(	(	PUNCT
ajmsi-3181	76	96	18.13	18.13	NUM
ajmsi-3181	76	97	%	%	NOUN
ajmsi-3181	76	98	)	)	PUNCT
ajmsi-3181	76	99	0.56	0.56	NUM
ajmsi-3181	76	100	icu	icu	PROPN
ajmsi-3181	76	101	52	52	NUM
ajmsi-3181	76	102	(	(	PUNCT
ajmsi-3181	76	103	26.40	26.40	NUM
ajmsi-3181	76	104	%	%	NOUN
ajmsi-3181	76	105	)	)	PUNCT
ajmsi-3181	76	106	39	39	NUM
ajmsi-3181	76	107	(	(	PUNCT
ajmsi-3181	76	108	24.38	24.38	NUM
ajmsi-3181	76	109	%	%	NOUN
ajmsi-3181	76	110	)	)	PUNCT
ajmsi-3181	76	111	0.61	0.61	NUM
ajmsi-3181	76	112	readmission	readmission	NOUN
ajmsi-3181	76	113	25	25	NUM
ajmsi-3181	76	114	(	(	PUNCT
ajmsi-3181	76	115	12.69	12.69	NUM
ajmsi-3181	76	116	%	%	NOUN
ajmsi-3181	76	117	)	)	PUNCT
ajmsi-3181	76	118	23	23	NUM
ajmsi-3181	76	119	(	(	PUNCT
ajmsi-3181	76	120	14.37	14.37	NUM
ajmsi-3181	76	121	%	%	NOUN
ajmsi-3181	76	122	)	)	PUNCT
ajmsi-3181	76	123	0.88	0.88	NUM
ajmsi-3181	76	124	length	length	NOUN
ajmsi-3181	76	125	of	of	ADP
ajmsi-3181	76	126	stay	stay	NOUN
ajmsi-3181	76	127	(	(	PUNCT
ajmsi-3181	76	128	wilcoxon	wilcoxon	PROPN
ajmsi-3181	76	129	rank	rank	PROPN
ajmsi-3181	76	130	)	)	PUNCT
ajmsi-3181	76	131	35.00	35.00	NUM
ajmsi-3181	76	132	(	(	PUNCT
ajmsi-3181	76	133	16.00	16.00	NUM
ajmsi-3181	76	134	-	-	SYM
ajmsi-3181	76	135	44.00	44.00	NUM
ajmsi-3181	76	136	)	)	PUNCT
ajmsi-3181	76	137	33.00	33.00	NUM
ajmsi-3181	76	138	(	(	PUNCT
ajmsi-3181	76	139	12.00	12.00	NUM
ajmsi-3181	76	140	-	-	SYM
ajmsi-3181	76	141	46.00	46.00	NUM
ajmsi-3181	76	142	)	)	PUNCT
ajmsi-3181	76	143	0.94	0.94	NUM
ajmsi-3181	76	144	emergence	emergence	NOUN
ajmsi-3181	76	145	7	7	NUM
ajmsi-3181	76	146	(	(	PUNCT
ajmsi-3181	76	147	3.55	3.55	NUM
ajmsi-3181	76	148	%	%	NOUN
ajmsi-3181	76	149	)	)	PUNCT
ajmsi-3181	76	150	15	15	NUM
ajmsi-3181	76	151	(	(	PUNCT
ajmsi-3181	76	152	9.38	9.38	NUM
ajmsi-3181	76	153	%	%	NOUN
ajmsi-3181	76	154	)	)	PUNCT
ajmsi-3181	76	155	0.05	0.05	NUM
ajmsi-3181	76	156	c.	c.	PROPN
ajmsi-3181	76	157	diff	diff	PROPN
ajmsi-3181	76	158	2	2	NUM
ajmsi-3181	76	159	(	(	PUNCT
ajmsi-3181	76	160	1.02	1.02	NUM
ajmsi-3181	76	161	%	%	NOUN
ajmsi-3181	76	162	)	)	PUNCT
ajmsi-3181	76	163	0	0	NUM
ajmsi-3181	77	1	(	(	PUNCT
ajmsi-3181	77	2	0.00	0.00	NUM
ajmsi-3181	77	3	%	%	NOUN
ajmsi-3181	77	4	)	)	PUNCT
ajmsi-3181	77	5	0.63	0.63	NUM
ajmsi-3181	77	6	source	source	NOUN
ajmsi-3181	77	7	control	control	NOUN
ajmsi-3181	77	8	0.046	0.046	NUM
ajmsi-3181	77	9	yes	yes	NOUN
ajmsi-3181	77	10	81	81	NUM
ajmsi-3181	77	11	(	(	PUNCT
ajmsi-3181	77	12	41.12	41.12	NUM
ajmsi-3181	77	13	%	%	NOUN
ajmsi-3181	77	14	)	)	PUNCT
ajmsi-3181	77	15	47	47	NUM
ajmsi-3181	77	16	(	(	PUNCT
ajmsi-3181	77	17	29.38	29.38	NUM
ajmsi-3181	77	18	%	%	NOUN
ajmsi-3181	77	19	)	)	PUNCT
ajmsi-3181	77	20	unknown	unknown	ADJ
ajmsi-3181	77	21	36	36	NUM
ajmsi-3181	77	22	(	(	PUNCT
ajmsi-3181	77	23	18.27	18.27	NUM
ajmsi-3181	77	24	%	%	NOUN
ajmsi-3181	77	25	)	)	PUNCT
ajmsi-3181	77	26	42	42	NUM
ajmsi-3181	77	27	(	(	PUNCT
ajmsi-3181	77	28	26.25	26.25	NUM
ajmsi-3181	77	29	%	%	NOUN
ajmsi-3181	77	30	)	)	PUNCT
ajmsi-3181	77	31	abs	ab	NOUN
ajmsi-3181	77	32	previous	previous	ADJ
ajmsi-3181	77	33	36	36	NUM
ajmsi-3181	77	34	(	(	PUNCT
ajmsi-3181	77	35	18.27	18.27	NUM
ajmsi-3181	77	36	%	%	NOUN
ajmsi-3181	77	37	)	)	PUNCT
ajmsi-3181	77	38	63	63	NUM
ajmsi-3181	77	39	(	(	PUNCT
ajmsi-3181	77	40	39.38	39.38	NUM
ajmsi-3181	77	41	%	%	NOUN
ajmsi-3181	77	42	)	)	PUNCT
ajmsi-3181	78	1	<	<	X
ajmsi-3181	78	2	0.001	0.001	NUM
ajmsi-3181	78	3	completed	complete	VERB
ajmsi-3181	78	4	iv	iv	NUM
ajmsi-3181	78	5	0.008	0.008	NUM
ajmsi-3181	78	6	in	in	ADP
ajmsi-3181	78	7	-	-	PUNCT
ajmsi-3181	78	8	patient	patient	NOUN
ajmsi-3181	78	9	128	128	NUM
ajmsi-3181	78	10	(	(	PUNCT
ajmsi-3181	78	11	64.97	64.97	NUM
ajmsi-3181	78	12	%	%	NOUN
ajmsi-3181	78	13	)	)	PUNCT
ajmsi-3181	78	14	106	106	NUM
ajmsi-3181	78	15	(	(	PUNCT
ajmsi-3181	78	16	66.25	66.25	NUM
ajmsi-3181	78	17	%	%	NOUN
ajmsi-3181	78	18	)	)	PUNCT
ajmsi-3181	78	19	mhs	mhs	PROPN
ajmsi-3181	78	20	17	17	NUM
ajmsi-3181	78	21	(	(	PUNCT
ajmsi-3181	78	22	8.63	8.63	NUM
ajmsi-3181	78	23	%	%	NOUN
ajmsi-3181	78	24	)	)	PUNCT
ajmsi-3181	78	25	29	29	NUM
ajmsi-3181	78	26	(	(	PUNCT
ajmsi-3181	78	27	18.13	18.13	NUM
ajmsi-3181	78	28	%	%	NOUN
ajmsi-3181	78	29	)	)	PUNCT
ajmsi-3181	78	30	opat	opat	NOUN
ajmsi-3181	78	31	47	47	NUM
ajmsi-3181	78	32	(	(	PUNCT
ajmsi-3181	78	33	23.86	23.86	NUM
ajmsi-3181	78	34	%	%	NOUN
ajmsi-3181	78	35	)	)	PUNCT
ajmsi-3181	78	36	24	24	NUM
ajmsi-3181	78	37	(	(	PUNCT
ajmsi-3181	78	38	15.00	15.00	NUM
ajmsi-3181	78	39	%	%	NOUN
ajmsi-3181	78	40	)	)	PUNCT
ajmsi-3181	78	41	unknown	unknown	ADJ
ajmsi-3181	78	42	5	5	NUM
ajmsi-3181	78	43	(	(	PUNCT
ajmsi-3181	78	44	2.54	2.54	NUM
ajmsi-3181	78	45	%	%	NOUN
ajmsi-3181	78	46	)	)	PUNCT
ajmsi-3181	78	47	1	1	NUM
ajmsi-3181	78	48	(	(	PUNCT
ajmsi-3181	78	49	0.63	0.63	NUM
ajmsi-3181	78	50	%	%	NOUN
ajmsi-3181	78	51	)	)	PUNCT
ajmsi-3181	78	52	microbiology	microbiology	NOUN
ajmsi-3181	78	53	primary	primary	ADJ
ajmsi-3181	78	54	bacteremia	bacteremia	NOUN
ajmsi-3181	78	55	75	75	NUM
ajmsi-3181	78	56	(	(	PUNCT
ajmsi-3181	78	57	38.07	38.07	NUM
ajmsi-3181	78	58	%	%	NOUN
ajmsi-3181	78	59	)	)	PUNCT
ajmsi-3181	78	60	44	44	NUM
ajmsi-3181	78	61	(	(	PUNCT
ajmsi-3181	78	62	27.50	27.50	NUM
ajmsi-3181	78	63	%	%	NOUN
ajmsi-3181	78	64	)	)	PUNCT
ajmsi-3181	78	65	0.038	0.038	NUM
ajmsi-3181	78	66	community	community	NOUN
ajmsi-3181	78	67	-	-	PUNCT
ajmsi-3181	78	68	acquired	acquire	VERB
ajmsi-3181	78	69	bacteremia	bacteremia	NOUN
ajmsi-3181	78	70	157	157	NUM
ajmsi-3181	78	71	(	(	PUNCT
ajmsi-3181	78	72	79.70	79.70	NUM
ajmsi-3181	78	73	%	%	NOUN
ajmsi-3181	78	74	)	)	PUNCT
ajmsi-3181	78	75	131	131	NUM
ajmsi-3181	78	76	(	(	PUNCT
ajmsi-3181	78	77	81.88	81.88	NUM
ajmsi-3181	78	78	%	%	NOUN
ajmsi-3181	78	79	)	)	PUNCT
ajmsi-3181	78	80	bacterial	bacterial	ADJ
ajmsi-3181	78	81	isolates	isolate	NOUN
ajmsi-3181	78	82	0.004	0.004	NUM
ajmsi-3181	78	83	acinetobacter	acinetobacter	ADV
ajmsi-3181	78	84	3	3	NUM
ajmsi-3181	78	85	(	(	PUNCT
ajmsi-3181	78	86	1.52	1.52	NUM
ajmsi-3181	78	87	%	%	NOUN
ajmsi-3181	78	88	)	)	PUNCT
ajmsi-3181	78	89	5	5	NUM
ajmsi-3181	78	90	(	(	PUNCT
ajmsi-3181	78	91	3.13	3.13	NUM
ajmsi-3181	78	92	%	%	NOUN
ajmsi-3181	78	93	)	)	PUNCT
ajmsi-3181	78	94	brucella	brucella	NOUN
ajmsi-3181	78	95	6	6	NUM
ajmsi-3181	78	96	(	(	PUNCT
ajmsi-3181	78	97	3.03	3.03	NUM
ajmsi-3181	78	98	%	%	NOUN
ajmsi-3181	78	99	)	)	PUNCT
ajmsi-3181	78	100	2	2	NUM
ajmsi-3181	78	101	(	(	PUNCT
ajmsi-3181	78	102	1.25	1.25	NUM
ajmsi-3181	78	103	%	%	NOUN
ajmsi-3181	78	104	)	)	PUNCT
ajmsi-3181	78	105	citrobacter	citrobacter	NOUN
ajmsi-3181	78	106	1	1	NUM
ajmsi-3181	78	107	(	(	PUNCT
ajmsi-3181	78	108	0.51	0.51	NUM
ajmsi-3181	78	109	%	%	NOUN
ajmsi-3181	78	110	)	)	PUNCT
ajmsi-3181	78	111	1	1	NUM
ajmsi-3181	78	112	(	(	PUNCT
ajmsi-3181	78	113	0.63	0.63	NUM
ajmsi-3181	78	114	%	%	NOUN
ajmsi-3181	78	115	)	)	PUNCT
ajmsi-3181	78	116	e.	e.	PROPN
ajmsi-3181	78	117	coli	coli	PROPN
ajmsi-3181	78	118	90	90	NUM
ajmsi-3181	78	119	(	(	PUNCT
ajmsi-3181	78	120	45.45	45.45	NUM
ajmsi-3181	78	121	%	%	NOUN
ajmsi-3181	78	122	)	)	PUNCT
ajmsi-3181	78	123	79	79	NUM
ajmsi-3181	78	124	(	(	PUNCT
ajmsi-3181	78	125	49.38	49.38	NUM
ajmsi-3181	78	126	%	%	NOUN
ajmsi-3181	78	127	)	)	PUNCT
ajmsi-3181	78	128	enterobacter	enterobacter	NOUN
ajmsi-3181	78	129	cloacae	cloacae	NOUN
ajmsi-3181	78	130	6	6	NUM
ajmsi-3181	78	131	(	(	PUNCT
ajmsi-3181	78	132	3.03	3.03	NUM
ajmsi-3181	78	133	%	%	NOUN
ajmsi-3181	78	134	)	)	PUNCT
ajmsi-3181	78	135	2	2	NUM
ajmsi-3181	78	136	(	(	PUNCT
ajmsi-3181	78	137	1.25	1.25	NUM
ajmsi-3181	78	138	%	%	NOUN
ajmsi-3181	78	139	)	)	PUNCT
ajmsi-3181	78	140	klebsiella	klebsiella	PROPN
ajmsi-3181	78	141	28	28	NUM
ajmsi-3181	78	142	(	(	PUNCT
ajmsi-3181	78	143	14.14	14.14	NUM
ajmsi-3181	78	144	%	%	NOUN
ajmsi-3181	78	145	)	)	PUNCT
ajmsi-3181	78	146	31	31	NUM
ajmsi-3181	78	147	(	(	PUNCT
ajmsi-3181	78	148	19.38	19.38	NUM
ajmsi-3181	78	149	%	%	NOUN
ajmsi-3181	78	150	)	)	PUNCT
ajmsi-3181	78	151	non	non	ADJ
ajmsi-3181	78	152	-	-	ADJ
ajmsi-3181	78	153	typhoidal	typhoidal	ADJ
ajmsi-3181	78	154	salmonella	salmonella	NOUN
ajmsi-3181	78	155	5	5	NUM
ajmsi-3181	78	156	(	(	PUNCT
ajmsi-3181	78	157	2.53	2.53	NUM
ajmsi-3181	78	158	%	%	NOUN
ajmsi-3181	78	159	)	)	PUNCT
ajmsi-3181	78	160	0	0	NUM
ajmsi-3181	79	1	(	(	PUNCT
ajmsi-3181	79	2	0.00	0.00	NUM
ajmsi-3181	79	3	%	%	NOUN
ajmsi-3181	79	4	)	)	PUNCT
ajmsi-3181	79	5	proteus	proteus	NOUN
ajmsi-3181	79	6	2	2	NUM
ajmsi-3181	79	7	(	(	PUNCT
ajmsi-3181	79	8	1.01	1.01	NUM
ajmsi-3181	79	9	%	%	NOUN
ajmsi-3181	79	10	)	)	PUNCT
ajmsi-3181	79	11	4	4	NUM
ajmsi-3181	79	12	(	(	PUNCT
ajmsi-3181	79	13	2.50	2.50	NUM
ajmsi-3181	79	14	%	%	NOUN
ajmsi-3181	79	15	)	)	PUNCT
ajmsi-3181	79	16	pseudomonas	pseudomona	VERB
ajmsi-3181	79	17	12	12	NUM
ajmsi-3181	79	18	(	(	PUNCT
ajmsi-3181	79	19	6.06	6.06	NUM
ajmsi-3181	79	20	%	%	NOUN
ajmsi-3181	79	21	)	)	PUNCT
ajmsi-3181	79	22	15	15	NUM
ajmsi-3181	79	23	(	(	PUNCT
ajmsi-3181	79	24	9.38	9.38	NUM
ajmsi-3181	79	25	%	%	NOUN
ajmsi-3181	79	26	)	)	PUNCT
ajmsi-3181	80	1	pa	pa	PROPN
ajmsi-3181	80	2	ge	ge	PROPN
ajmsi-3181	80	3	94	94	NUM
ajmsi-3181	80	4	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-3181	80	5	am	be	AUX
ajmsi-3181	80	6	.	.	PUNCT
ajmsi-3181	81	1	j.	j.	PROPN
ajmsi-3181	81	2	med	med	PROPN
ajmsi-3181	81	3	.	.	PUNCT
ajmsi-3181	82	1	sci	sci	PROPN
ajmsi-3181	82	2	.	.	PUNCT
ajmsi-3181	82	3	innov	innov	PROPN
ajmsi-3181	82	4	.	.	PUNCT
ajmsi-3181	83	1	3(2	3(2	NUM
ajmsi-3181	83	2	)	)	PUNCT
ajmsi-3181	83	3	91	91	NUM
ajmsi-3181	83	4	-	-	SYM
ajmsi-3181	83	5	102	102	NUM
ajmsi-3181	83	6	,	,	PUNCT
ajmsi-3181	83	7	2024	2024	NUM
ajmsi-3181	83	8	figure	figure	NOUN
ajmsi-3181	83	9	1	1	NUM
ajmsi-3181	83	10	shows	show	VERB
ajmsi-3181	83	11	that	that	SCONJ
ajmsi-3181	83	12	68	68	NUM
ajmsi-3181	83	13	%	%	NOUN
ajmsi-3181	83	14	of	of	ADP
ajmsi-3181	83	15	patients	patient	NOUN
ajmsi-3181	83	16	with	with	ADP
ajmsi-3181	83	17	gram	gram	NOUN
ajmsi-3181	83	18	-	-	PUNCT
ajmsi-3181	83	19	negative	negative	ADJ
ajmsi-3181	83	20	bloodstream	bloodstream	NOUN
ajmsi-3181	83	21	infections	infection	NOUN
ajmsi-3181	83	22	(	(	PUNCT
ajmsi-3181	83	23	gnb	gnb	NOUN
ajmsi-3181	83	24	)	)	PUNCT
ajmsi-3181	83	25	successfully	successfully	ADV
ajmsi-3181	83	26	recovered	recover	VERB
ajmsi-3181	83	27	from	from	ADP
ajmsi-3181	83	28	sepsis	sepsis	NOUN
ajmsi-3181	83	29	,	,	PUNCT
ajmsi-3181	83	30	but	but	CCONJ
ajmsi-3181	83	31	8	8	NUM
ajmsi-3181	83	32	%	%	NOUN
ajmsi-3181	83	33	succumbed	succumb	VERB
ajmsi-3181	83	34	to	to	ADP
ajmsi-3181	83	35	sepsis	sepsis	NOUN
ajmsi-3181	83	36	,	,	PUNCT
ajmsi-3181	83	37	5	5	NUM
ajmsi-3181	83	38	%	%	NOUN
ajmsi-3181	83	39	experienced	experienced	ADJ
ajmsi-3181	83	40	recurrence	recurrence	NOUN
ajmsi-3181	83	41	,	,	PUNCT
ajmsi-3181	83	42	and	and	CCONJ
ajmsi-3181	83	43	6	6	NUM
ajmsi-3181	83	44	%	%	NOUN
ajmsi-3181	83	45	died	die	VERB
ajmsi-3181	83	46	from	from	ADP
ajmsi-3181	83	47	unrelated	unrelated	ADJ
ajmsi-3181	83	48	causes	cause	NOUN
ajmsi-3181	83	49	.	.	PUNCT
ajmsi-3181	84	1	5	5	NUM
ajmsi-3181	84	2	%	%	NOUN
ajmsi-3181	84	3	showed	show	VERB
ajmsi-3181	84	4	multidrug	multidrug	NOUN
ajmsi-3181	84	5	-	-	PUNCT
ajmsi-3181	84	6	resistant	resistant	ADJ
ajmsi-3181	84	7	organisms	organism	NOUN
ajmsi-3181	84	8	,	,	PUNCT
ajmsi-3181	84	9	indicating	indicate	VERB
ajmsi-3181	84	10	antimicrobial	antimicrobial	ADJ
ajmsi-3181	84	11	resistance	resistance	NOUN
ajmsi-3181	84	12	.	.	PUNCT
ajmsi-3181	85	1	2	2	NUM
ajmsi-3181	85	2	%	%	NOUN
ajmsi-3181	85	3	experienced	experience	VERB
ajmsi-3181	85	4	prolonged	prolonged	ADJ
ajmsi-3181	85	5	bacteremia	bacteremia	NOUN
ajmsi-3181	85	6	,	,	PUNCT
ajmsi-3181	85	7	and	and	CCONJ
ajmsi-3181	85	8	6	6	NUM
ajmsi-3181	85	9	%	%	NOUN
ajmsi-3181	85	10	died	die	VERB
ajmsi-3181	85	11	from	from	ADP
ajmsi-3181	85	12	unknown	unknown	ADJ
ajmsi-3181	85	13	causes	cause	NOUN
ajmsi-3181	85	14	.	.	PUNCT
ajmsi-3181	86	1	these	these	DET
ajmsi-3181	86	2	findings	finding	NOUN
ajmsi-3181	86	3	highlight	highlight	VERB
ajmsi-3181	86	4	the	the	DET
ajmsi-3181	86	5	complexity	complexity	NOUN
ajmsi-3181	86	6	of	of	ADP
ajmsi-3181	86	7	gnb	gnb	PROPN
ajmsi-3181	86	8	management	management	NOUN
ajmsi-3181	86	9	and	and	CCONJ
ajmsi-3181	86	10	the	the	DET
ajmsi-3181	86	11	need	need	NOUN
ajmsi-3181	86	12	for	for	ADP
ajmsi-3181	86	13	comprehensive	comprehensive	ADJ
ajmsi-3181	86	14	strategies	strategy	NOUN
ajmsi-3181	86	15	to	to	PART
ajmsi-3181	86	16	prevent	prevent	VERB
ajmsi-3181	86	17	adverse	adverse	ADJ
ajmsi-3181	86	18	events	event	NOUN
ajmsi-3181	86	19	.	.	PUNCT
ajmsi-3181	87	1	salmonella	salmonella	NOUN
ajmsi-3181	87	2	typhi	typhi	VERB
ajmsi-3181	87	3	33	33	NUM
ajmsi-3181	87	4	(	(	PUNCT
ajmsi-3181	87	5	16.67	16.67	NUM
ajmsi-3181	87	6	%	%	NOUN
ajmsi-3181	87	7	)	)	PUNCT
ajmsi-3181	87	8	5	5	NUM
ajmsi-3181	87	9	(	(	PUNCT
ajmsi-3181	87	10	3.13	3.13	NUM
ajmsi-3181	87	11	%	%	NOUN
ajmsi-3181	87	12	)	)	PUNCT
ajmsi-3181	87	13	serratia	serratia	NOUN
ajmsi-3181	87	14	5	5	NUM
ajmsi-3181	87	15	(	(	PUNCT
ajmsi-3181	87	16	2.53	2.53	NUM
ajmsi-3181	87	17	%	%	NOUN
ajmsi-3181	87	18	)	)	PUNCT
ajmsi-3181	87	19	6	6	NUM
ajmsi-3181	87	20	(	(	PUNCT
ajmsi-3181	87	21	3.75	3.75	NUM
ajmsi-3181	87	22	%	%	NOUN
ajmsi-3181	87	23	)	)	PUNCT
ajmsi-3181	87	24	unidentified	unidentified	ADJ
ajmsi-3181	87	25	anaerobic	anaerobic	NOUN
ajmsi-3181	87	26	bacilli	bacilli	NOUN
ajmsi-3181	87	27	0	0	NUM
ajmsi-3181	88	1	(	(	PUNCT
ajmsi-3181	88	2	0.00	0.00	NUM
ajmsi-3181	88	3	%	%	NOUN
ajmsi-3181	88	4	)	)	PUNCT
ajmsi-3181	88	5	1	1	NUM
ajmsi-3181	88	6	(	(	PUNCT
ajmsi-3181	88	7	0.63	0.63	NUM
ajmsi-3181	88	8	%	%	NOUN
ajmsi-3181	88	9	)	)	PUNCT
ajmsi-3181	88	10	pseudomonas	pseudomona	VERB
ajmsi-3181	88	11	1	1	NUM
ajmsi-3181	88	12	(	(	PUNCT
ajmsi-3181	88	13	0.51	0.51	NUM
ajmsi-3181	88	14	%	%	NOUN
ajmsi-3181	88	15	)	)	PUNCT
ajmsi-3181	88	16	0	0	NUM
ajmsi-3181	89	1	(	(	PUNCT
ajmsi-3181	89	2	0.00	0.00	NUM
ajmsi-3181	89	3	%	%	NOUN
ajmsi-3181	89	4	)	)	PUNCT
ajmsi-3181	89	5	stenotrophomonas	stenotrophomona	NOUN
ajmsi-3181	89	6	0	0	NUM
ajmsi-3181	90	1	(	(	PUNCT
ajmsi-3181	90	2	0.00	0.00	NUM
ajmsi-3181	90	3	%	%	NOUN
ajmsi-3181	90	4	)	)	PUNCT
ajmsi-3181	90	5	1	1	NUM
ajmsi-3181	90	6	(	(	PUNCT
ajmsi-3181	90	7	0.63	0.63	NUM
ajmsi-3181	90	8	%	%	NOUN
ajmsi-3181	90	9	)	)	PUNCT
ajmsi-3181	90	10	missing	miss	VERB
ajmsi-3181	90	11	6	6	NUM
ajmsi-3181	90	12	(	(	PUNCT
ajmsi-3181	90	13	3.03	3.03	NUM
ajmsi-3181	90	14	%	%	NOUN
ajmsi-3181	90	15	)	)	PUNCT
ajmsi-3181	90	16	8	8	NUM
ajmsi-3181	90	17	(	(	PUNCT
ajmsi-3181	90	18	5.00	5.00	NUM
ajmsi-3181	90	19	%	%	NOUN
ajmsi-3181	90	20	)	)	PUNCT
ajmsi-3181	90	21	resistance	resistance	NOUN
ajmsi-3181	90	22	0.49	0.49	NUM
ajmsi-3181	90	23	esbl	esbl	NOUN
ajmsi-3181	90	24	57	57	NUM
ajmsi-3181	90	25	(	(	PUNCT
ajmsi-3181	90	26	28.93	28.93	NUM
ajmsi-3181	90	27	%	%	NOUN
ajmsi-3181	90	28	)	)	PUNCT
ajmsi-3181	90	29	46	46	NUM
ajmsi-3181	90	30	(	(	PUNCT
ajmsi-3181	90	31	28.75	28.75	NUM
ajmsi-3181	90	32	%	%	NOUN
ajmsi-3181	90	33	)	)	PUNCT
ajmsi-3181	90	34	mdr	mdr	PROPN
ajmsi-3181	90	35	9	9	NUM
ajmsi-3181	90	36	(	(	PUNCT
ajmsi-3181	90	37	4.57	4.57	NUM
ajmsi-3181	90	38	%	%	NOUN
ajmsi-3181	90	39	)	)	PUNCT
ajmsi-3181	90	40	12	12	NUM
ajmsi-3181	90	41	(	(	PUNCT
ajmsi-3181	90	42	7.50	7.50	NUM
ajmsi-3181	90	43	%	%	NOUN
ajmsi-3181	90	44	)	)	PUNCT
ajmsi-3181	91	1	none	none	NOUN
ajmsi-3181	91	2	131	131	NUM
ajmsi-3181	91	3	(	(	PUNCT
ajmsi-3181	91	4	66.50	66.50	NUM
ajmsi-3181	91	5	%	%	NOUN
ajmsi-3181	91	6	)	)	PUNCT
ajmsi-3181	91	7	102	102	NUM
ajmsi-3181	91	8	(	(	PUNCT
ajmsi-3181	91	9	63.75	63.75	NUM
ajmsi-3181	91	10	%	%	NOUN
ajmsi-3181	91	11	)	)	PUNCT
ajmsi-3181	91	12	source	source	NOUN
ajmsi-3181	91	13	bacteremia	bacteremia	NOUN
ajmsi-3181	91	14	(	(	PUNCT
ajmsi-3181	91	15	fisher	fisher	PROPN
ajmsi-3181	91	16	's	's	PART
ajmsi-3181	91	17	exact	exact	ADJ
ajmsi-3181	91	18	)	)	PUNCT
ajmsi-3181	91	19	0.004	0.004	NUM
ajmsi-3181	91	20	urinary	urinary	ADJ
ajmsi-3181	91	21	tract	tract	NOUN
ajmsi-3181	91	22	infection	infection	NOUN
ajmsi-3181	91	23	71	71	NUM
ajmsi-3181	91	24	(	(	PUNCT
ajmsi-3181	91	25	36.04	36.04	NUM
ajmsi-3181	91	26	%	%	NOUN
ajmsi-3181	91	27	)	)	PUNCT
ajmsi-3181	91	28	71	71	NUM
ajmsi-3181	91	29	(	(	PUNCT
ajmsi-3181	91	30	44.38	44.38	NUM
ajmsi-3181	91	31	%	%	NOUN
ajmsi-3181	91	32	)	)	PUNCT
ajmsi-3181	91	33	bone	bone	NOUN
ajmsi-3181	91	34	and	and	CCONJ
ajmsi-3181	91	35	soft	soft	ADJ
ajmsi-3181	91	36	tissue	tissue	NOUN
ajmsi-3181	91	37	infection	infection	NOUN
ajmsi-3181	91	38	7	7	NUM
ajmsi-3181	91	39	(	(	PUNCT
ajmsi-3181	91	40	3.55	3.55	NUM
ajmsi-3181	91	41	%	%	NOUN
ajmsi-3181	91	42	)	)	PUNCT
ajmsi-3181	91	43	15	15	NUM
ajmsi-3181	91	44	(	(	PUNCT
ajmsi-3181	91	45	9.38	9.38	NUM
ajmsi-3181	91	46	%	%	NOUN
ajmsi-3181	91	47	)	)	PUNCT
ajmsi-3181	91	48	burn	burn	VERB
ajmsi-3181	91	49	wound	wound	ADJ
ajmsi-3181	91	50	infection	infection	NOUN
ajmsi-3181	91	51	3	3	NUM
ajmsi-3181	91	52	(	(	PUNCT
ajmsi-3181	91	53	1.52	1.52	NUM
ajmsi-3181	91	54	%	%	NOUN
ajmsi-3181	91	55	)	)	PUNCT
ajmsi-3181	91	56	0	0	NUM
ajmsi-3181	92	1	(	(	PUNCT
ajmsi-3181	92	2	0.00	0.00	NUM
ajmsi-3181	92	3	%	%	NOUN
ajmsi-3181	92	4	)	)	PUNCT
ajmsi-3181	92	5	cardiovascular	cardiovascular	ADJ
ajmsi-3181	92	6	infection	infection	NOUN
ajmsi-3181	92	7	1	1	NUM
ajmsi-3181	92	8	(	(	PUNCT
ajmsi-3181	92	9	0.51	0.51	NUM
ajmsi-3181	92	10	%	%	NOUN
ajmsi-3181	92	11	)	)	PUNCT
ajmsi-3181	92	12	2	2	NUM
ajmsi-3181	92	13	(	(	PUNCT
ajmsi-3181	92	14	1.25	1.25	NUM
ajmsi-3181	92	15	%	%	NOUN
ajmsi-3181	92	16	)	)	PUNCT
ajmsi-3181	92	17	intra	intra	ADJ
ajmsi-3181	92	18	-	-	ADJ
ajmsi-3181	92	19	abdominal	abdominal	ADJ
ajmsi-3181	92	20	infection	infection	NOUN
ajmsi-3181	92	21	70	70	NUM
ajmsi-3181	92	22	(	(	PUNCT
ajmsi-3181	92	23	35.53	35.53	NUM
ajmsi-3181	92	24	%	%	NOUN
ajmsi-3181	92	25	)	)	PUNCT
ajmsi-3181	92	26	31	31	NUM
ajmsi-3181	92	27	(	(	PUNCT
ajmsi-3181	92	28	19.38	19.38	NUM
ajmsi-3181	92	29	%	%	NOUN
ajmsi-3181	92	30	)	)	PUNCT
ajmsi-3181	92	31	line	line	NOUN
ajmsi-3181	92	32	related	relate	VERB
ajmsi-3181	92	33	infection	infection	NOUN
ajmsi-3181	92	34	4	4	NUM
ajmsi-3181	92	35	(	(	PUNCT
ajmsi-3181	92	36	2.03	2.03	NUM
ajmsi-3181	92	37	%	%	NOUN
ajmsi-3181	92	38	)	)	PUNCT
ajmsi-3181	92	39	7	7	NUM
ajmsi-3181	92	40	(	(	PUNCT
ajmsi-3181	92	41	4.38	4.38	NUM
ajmsi-3181	92	42	%	%	NOUN
ajmsi-3181	92	43	)	)	PUNCT
ajmsi-3181	92	44	lower	low	ADJ
ajmsi-3181	92	45	respiratory	respiratory	ADJ
ajmsi-3181	92	46	tract	tract	NOUN
ajmsi-3181	92	47	infection	infection	NOUN
ajmsi-3181	92	48	20	20	NUM
ajmsi-3181	92	49	(	(	PUNCT
ajmsi-3181	92	50	10.15	10.15	NUM
ajmsi-3181	92	51	%	%	NOUN
ajmsi-3181	92	52	)	)	PUNCT
ajmsi-3181	92	53	17	17	NUM
ajmsi-3181	92	54	(	(	PUNCT
ajmsi-3181	92	55	10.63	10.63	NUM
ajmsi-3181	92	56	%	%	NOUN
ajmsi-3181	92	57	)	)	PUNCT
ajmsi-3181	92	58	unknown	unknown	ADJ
ajmsi-3181	92	59	20	20	NUM
ajmsi-3181	92	60	(	(	PUNCT
ajmsi-3181	92	61	10.15	10.15	NUM
ajmsi-3181	92	62	%	%	NOUN
ajmsi-3181	92	63	)	)	PUNCT
ajmsi-3181	92	64	17	17	NUM
ajmsi-3181	92	65	(	(	PUNCT
ajmsi-3181	92	66	10.63	10.63	NUM
ajmsi-3181	92	67	%	%	NOUN
ajmsi-3181	92	68	)	)	PUNCT
ajmsi-3181	92	69	surgical	surgical	ADJ
ajmsi-3181	92	70	site	site	NOUN
ajmsi-3181	92	71	infection	infection	NOUN
ajmsi-3181	92	72	1	1	NUM
ajmsi-3181	92	73	(	(	PUNCT
ajmsi-3181	92	74	0.51	0.51	NUM
ajmsi-3181	92	75	%	%	NOUN
ajmsi-3181	92	76	)	)	PUNCT
ajmsi-3181	92	77	0	0	NUM
ajmsi-3181	93	1	(	(	PUNCT
ajmsi-3181	93	2	0.00	0.00	NUM
ajmsi-3181	93	3	%	%	NOUN
ajmsi-3181	93	4	)	)	PUNCT
ajmsi-3181	93	5	figure	figure	NOUN
ajmsi-3181	93	6	1	1	NUM
ajmsi-3181	93	7	:	:	PUNCT
ajmsi-3181	93	8	the	the	DET
ajmsi-3181	93	9	primary	primary	ADJ
ajmsi-3181	93	10	clinical	clinical	ADJ
ajmsi-3181	93	11	outcomes	outcome	NOUN
ajmsi-3181	93	12	of	of	ADP
ajmsi-3181	93	13	this	this	DET
ajmsi-3181	93	14	study	study	NOUN
ajmsi-3181	93	15	are	be	AUX
ajmsi-3181	93	16	shown	show	VERB
ajmsi-3181	93	17	in	in	ADP
ajmsi-3181	93	18	chart	chart	NOUN
ajmsi-3181	93	19	the	the	DET
ajmsi-3181	93	20	duration	duration	NOUN
ajmsi-3181	93	21	of	of	ADP
ajmsi-3181	93	22	treatment	treatment	NOUN
ajmsi-3181	93	23	with	with	ADP
ajmsi-3181	93	24	intravenous	intravenous	ADJ
ajmsi-3181	93	25	antibiotics	antibiotic	NOUN
ajmsi-3181	93	26	revealed	reveal	VERB
ajmsi-3181	93	27	that	that	SCONJ
ajmsi-3181	93	28	most	most	ADJ
ajmsi-3181	93	29	patients	patient	NOUN
ajmsi-3181	93	30	underwent	undergo	VERB
ajmsi-3181	93	31	a	a	DET
ajmsi-3181	93	32	short	short	ADJ
ajmsi-3181	93	33	course	course	NOUN
ajmsi-3181	93	34	of	of	ADP
ajmsi-3181	93	35	intravenous	intravenous	ADJ
ajmsi-3181	93	36	therapy	therapy	NOUN
ajmsi-3181	93	37	.	.	PUNCT
ajmsi-3181	94	1	specifically	specifically	ADV
ajmsi-3181	94	2	,	,	PUNCT
ajmsi-3181	94	3	more	more	ADJ
ajmsi-3181	94	4	than	than	ADP
ajmsi-3181	94	5	70	70	NUM
ajmsi-3181	94	6	%	%	NOUN
ajmsi-3181	94	7	of	of	ADP
ajmsi-3181	94	8	patients	patient	NOUN
ajmsi-3181	94	9	received	receive	VERB
ajmsi-3181	94	10	treatment	treatment	NOUN
ajmsi-3181	94	11	lasting	last	VERB
ajmsi-3181	94	12	less	less	ADJ
ajmsi-3181	94	13	than	than	ADP
ajmsi-3181	94	14	10	10	NUM
ajmsi-3181	94	15	days	day	NOUN
ajmsi-3181	94	16	,	,	PUNCT
ajmsi-3181	94	17	which	which	PRON
ajmsi-3181	94	18	suggests	suggest	VERB
ajmsi-3181	94	19	a	a	DET
ajmsi-3181	94	20	trend	trend	NOUN
ajmsi-3181	94	21	towards	towards	ADP
ajmsi-3181	94	22	shorter	short	ADJ
ajmsi-3181	94	23	intravenous	intravenous	ADJ
ajmsi-3181	94	24	antibiotic	antibiotic	ADJ
ajmsi-3181	94	25	therapy	therapy	NOUN
ajmsi-3181	94	26	durations	duration	NOUN
ajmsi-3181	94	27	in	in	ADP
ajmsi-3181	94	28	managing	manage	VERB
ajmsi-3181	94	29	gram	gram	NOUN
ajmsi-3181	94	30	-	-	PUNCT
ajmsi-3181	94	31	negative	negative	ADJ
ajmsi-3181	94	32	bacteremia	bacteremia	NOUN
ajmsi-3181	94	33	cases	case	NOUN
ajmsi-3181	94	34	,	,	PUNCT
ajmsi-3181	94	35	as	as	SCONJ
ajmsi-3181	94	36	shown	show	VERB
ajmsi-3181	94	37	in	in	ADP
ajmsi-3181	94	38	table	table	NOUN
ajmsi-3181	94	39	2	2	NUM
ajmsi-3181	94	40	.	.	PUNCT
ajmsi-3181	95	1	pa	pa	PROPN
ajmsi-3181	95	2	ge	ge	PROPN
ajmsi-3181	95	3	95	95	NUM
ajmsi-3181	95	4	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-3181	95	5	am	be	AUX
ajmsi-3181	95	6	.	.	PUNCT
ajmsi-3181	96	1	j.	j.	PROPN
ajmsi-3181	96	2	med	med	PROPN
ajmsi-3181	96	3	.	.	PUNCT
ajmsi-3181	97	1	sci	sci	PROPN
ajmsi-3181	97	2	.	.	PUNCT
ajmsi-3181	97	3	innov	innov	PROPN
ajmsi-3181	97	4	.	.	PUNCT
ajmsi-3181	98	1	3(2	3(2	NUM
ajmsi-3181	98	2	)	)	PUNCT
ajmsi-3181	98	3	91	91	NUM
ajmsi-3181	98	4	-	-	SYM
ajmsi-3181	98	5	102	102	NUM
ajmsi-3181	98	6	,	,	PUNCT
ajmsi-3181	98	7	2024	2024	NUM
ajmsi-3181	98	8	table	table	NOUN
ajmsi-3181	98	9	2	2	NUM
ajmsi-3181	98	10	:	:	PUNCT
ajmsi-3181	98	11	intravenous	intravenous	ADJ
ajmsi-3181	98	12	(	(	PUNCT
ajmsi-3181	98	13	iv	iv	X
ajmsi-3181	98	14	)	)	PUNCT
ajmsi-3181	98	15	treatment	treatment	NOUN
ajmsi-3181	98	16	duration	duration	NOUN
ajmsi-3181	98	17	–	–	PUNCT
ajmsi-3181	98	18	intervals	interval	NOUN
ajmsi-3181	98	19	duration	duration	NOUN
ajmsi-3181	98	20	of	of	ADP
ajmsi-3181	98	21	iv	iv	NUM
ajmsi-3181	98	22	treatment	treatment	NOUN
ajmsi-3181	98	23	(	(	PUNCT
ajmsi-3181	98	24	days	day	NOUN
ajmsi-3181	98	25	)	)	PUNCT
ajmsi-3181	98	26	counts	count	VERB
ajmsi-3181	98	27	percentages	percentage	NOUN
ajmsi-3181	98	28	%	%	INTJ
ajmsi-3181	98	29	<	<	X
ajmsi-3181	98	30	7	7	NUM
ajmsi-3181	98	31	161	161	NUM
ajmsi-3181	98	32	44.97	44.97	NUM
ajmsi-3181	98	33	7	7	NUM
ajmsi-3181	98	34	to	to	PART
ajmsi-3181	98	35	10	10	NUM
ajmsi-3181	98	36	100	100	NUM
ajmsi-3181	98	37	27.93	27.93	NUM
ajmsi-3181	98	38	11	11	NUM
ajmsi-3181	98	39	to	to	ADP
ajmsi-3181	98	40	14	14	NUM
ajmsi-3181	98	41	54	54	NUM
ajmsi-3181	98	42	15.08	15.08	NUM
ajmsi-3181	98	43	>	>	SYM
ajmsi-3181	98	44	14	14	NUM
ajmsi-3181	98	45	43	43	NUM
ajmsi-3181	98	46	12.01	12.01	NUM
ajmsi-3181	98	47	sum	sum	NOUN
ajmsi-3181	98	48	358	358	NUM
ajmsi-3181	98	49	100	100	NUM
ajmsi-3181	98	50	figure	figure	NOUN
ajmsi-3181	98	51	2	2	NUM
ajmsi-3181	98	52	shows	show	VERB
ajmsi-3181	98	53	the	the	DET
ajmsi-3181	98	54	distribution	distribution	NOUN
ajmsi-3181	98	55	of	of	ADP
ajmsi-3181	98	56	gram	gram	NOUN
ajmsi-3181	98	57	-	-	PUNCT
ajmsi-3181	98	58	negative	negative	ADJ
ajmsi-3181	98	59	bacteremia	bacteremia	NOUN
ajmsi-3181	98	60	by	by	ADP
ajmsi-3181	98	61	infection	infection	NOUN
ajmsi-3181	98	62	site	site	NOUN
ajmsi-3181	98	63	.	.	PUNCT
ajmsi-3181	99	1	urinary	urinary	ADJ
ajmsi-3181	99	2	tract	tract	NOUN
ajmsi-3181	99	3	infections	infection	NOUN
ajmsi-3181	99	4	are	be	AUX
ajmsi-3181	99	5	most	most	ADV
ajmsi-3181	99	6	common	common	ADJ
ajmsi-3181	99	7	(	(	PUNCT
ajmsi-3181	99	8	45	45	NUM
ajmsi-3181	99	9	%	%	NOUN
ajmsi-3181	99	10	)	)	PUNCT
ajmsi-3181	99	11	,	,	PUNCT
ajmsi-3181	99	12	followed	follow	VERB
ajmsi-3181	99	13	by	by	ADP
ajmsi-3181	99	14	intra	intra	ADJ
ajmsi-3181	99	15	-	-	ADJ
ajmsi-3181	99	16	abdominal	abdominal	ADJ
ajmsi-3181	99	17	infections	infection	NOUN
ajmsi-3181	99	18	(	(	PUNCT
ajmsi-3181	99	19	40	40	NUM
ajmsi-3181	99	20	%	%	NOUN
ajmsi-3181	99	21	)	)	PUNCT
ajmsi-3181	99	22	and	and	CCONJ
ajmsi-3181	99	23	lower	low	ADJ
ajmsi-3181	99	24	respiratory	respiratory	ADJ
ajmsi-3181	99	25	tract	tract	NOUN
ajmsi-3181	99	26	infections	infection	NOUN
ajmsi-3181	99	27	(	(	PUNCT
ajmsi-3181	99	28	15	15	NUM
ajmsi-3181	99	29	%	%	NOUN
ajmsi-3181	99	30	)	)	PUNCT
ajmsi-3181	99	31	.	.	PUNCT
ajmsi-3181	100	1	a	a	DET
ajmsi-3181	100	2	notable	notable	ADJ
ajmsi-3181	100	3	proportion	proportion	NOUN
ajmsi-3181	100	4	(	(	PUNCT
ajmsi-3181	100	5	10	10	NUM
ajmsi-3181	100	6	%	%	NOUN
ajmsi-3181	100	7	)	)	PUNCT
ajmsi-3181	100	8	has	have	VERB
ajmsi-3181	100	9	an	an	DET
ajmsi-3181	100	10	unknown	unknown	ADJ
ajmsi-3181	100	11	infection	infection	NOUN
ajmsi-3181	100	12	site	site	NOUN
ajmsi-3181	100	13	.	.	PUNCT
ajmsi-3181	101	1	other	other	ADJ
ajmsi-3181	101	2	sites	site	NOUN
ajmsi-3181	101	3	include	include	VERB
ajmsi-3181	101	4	bone	bone	NOUN
ajmsi-3181	101	5	and	and	CCONJ
ajmsi-3181	101	6	soft	soft	ADJ
ajmsi-3181	101	7	tissue	tissue	NOUN
ajmsi-3181	101	8	infections	infection	NOUN
ajmsi-3181	101	9	(	(	PUNCT
ajmsi-3181	101	10	5	5	NUM
ajmsi-3181	101	11	%	%	NOUN
ajmsi-3181	101	12	)	)	PUNCT
ajmsi-3181	101	13	,	,	PUNCT
ajmsi-3181	101	14	line	line	NOUN
ajmsi-3181	101	15	-	-	PUNCT
ajmsi-3181	101	16	related	relate	VERB
ajmsi-3181	101	17	infections	infection	NOUN
ajmsi-3181	101	18	(	(	PUNCT
ajmsi-3181	101	19	2.5	2.5	NUM
ajmsi-3181	101	20	%	%	NOUN
ajmsi-3181	101	21	)	)	PUNCT
ajmsi-3181	101	22	,	,	PUNCT
ajmsi-3181	101	23	cardiovascular	cardiovascular	ADJ
ajmsi-3181	101	24	infections	infection	NOUN
ajmsi-3181	101	25	(	(	PUNCT
ajmsi-3181	101	26	1	1	NUM
ajmsi-3181	101	27	%	%	NOUN
ajmsi-3181	101	28	)	)	PUNCT
ajmsi-3181	101	29	,	,	PUNCT
ajmsi-3181	101	30	and	and	CCONJ
ajmsi-3181	101	31	miscellaneous	miscellaneous	ADJ
ajmsi-3181	101	32	sources	source	NOUN
ajmsi-3181	101	33	(	(	PUNCT
ajmsi-3181	101	34	2.5	2.5	NUM
ajmsi-3181	101	35	%	%	NOUN
ajmsi-3181	101	36	)	)	PUNCT
ajmsi-3181	101	37	.	.	PUNCT
ajmsi-3181	102	1	this	this	DET
ajmsi-3181	102	2	breakdown	breakdown	NOUN
ajmsi-3181	102	3	underscores	underscore	VERB
ajmsi-3181	102	4	the	the	DET
ajmsi-3181	102	5	varied	varied	ADJ
ajmsi-3181	102	6	origins	origin	NOUN
ajmsi-3181	102	7	of	of	ADP
ajmsi-3181	102	8	gram	gram	NOUN
ajmsi-3181	102	9	-	-	PUNCT
ajmsi-3181	102	10	negative	negative	ADJ
ajmsi-3181	102	11	bacteremia	bacteremia	NOUN
ajmsi-3181	102	12	,	,	PUNCT
ajmsi-3181	102	13	emphasising	emphasise	VERB
ajmsi-3181	102	14	the	the	DET
ajmsi-3181	102	15	need	need	NOUN
ajmsi-3181	102	16	for	for	ADP
ajmsi-3181	102	17	tailored	tailor	VERB
ajmsi-3181	102	18	treatment	treatment	NOUN
ajmsi-3181	102	19	strategies	strategy	NOUN
ajmsi-3181	102	20	based	base	VERB
ajmsi-3181	102	21	on	on	ADP
ajmsi-3181	102	22	infection	infection	NOUN
ajmsi-3181	102	23	site	site	NOUN
ajmsi-3181	102	24	specificity	specificity	NOUN
ajmsi-3181	102	25	.	.	PUNCT
ajmsi-3181	103	1	figure	figure	NOUN
ajmsi-3181	103	2	2	2	NUM
ajmsi-3181	103	3	:	:	PUNCT
ajmsi-3181	104	1	epidemiology	epidemiology	NOUN
ajmsi-3181	104	2	of	of	ADP
ajmsi-3181	104	3	gram	gram	NOUN
ajmsi-3181	104	4	-	-	PUNCT
ajmsi-3181	104	5	negative	negative	ADJ
ajmsi-3181	104	6	bacteremia	bacteremia	NOUN
ajmsi-3181	104	7	escherichia	escherichia	NOUN
ajmsi-3181	104	8	coli	coli	NOUN
ajmsi-3181	104	9	was	be	AUX
ajmsi-3181	104	10	the	the	DET
ajmsi-3181	104	11	most	most	ADV
ajmsi-3181	104	12	frequently	frequently	ADV
ajmsi-3181	104	13	identified	identify	VERB
ajmsi-3181	104	14	organism	organism	NOUN
ajmsi-3181	104	15	,	,	PUNCT
ajmsi-3181	104	16	accounting	account	VERB
ajmsi-3181	104	17	for	for	ADP
ajmsi-3181	104	18	47.2	47.2	NUM
ajmsi-3181	104	19	%	%	NOUN
ajmsi-3181	104	20	of	of	ADP
ajmsi-3181	104	21	cases	case	NOUN
ajmsi-3181	104	22	,	,	PUNCT
ajmsi-3181	104	23	followed	follow	VERB
ajmsi-3181	104	24	by	by	ADP
ajmsi-3181	104	25	klebsiella	klebsiella	NOUN
ajmsi-3181	104	26	pneumoniae	pneumoniae	ADJ
ajmsi-3181	104	27	(	(	PUNCT
ajmsi-3181	104	28	16.4	16.4	NUM
ajmsi-3181	104	29	%	%	NOUN
ajmsi-3181	104	30	)	)	PUNCT
ajmsi-3181	104	31	,	,	PUNCT
ajmsi-3181	104	32	salmonella	salmonella	PROPN
ajmsi-3181	104	33	enterica	enterica	PROPN
ajmsi-3181	104	34	serotype	serotype	PROPN
ajmsi-3181	104	35	typhi	typhi	PROPN
ajmsi-3181	104	36	(	(	PUNCT
ajmsi-3181	104	37	10.6	10.6	NUM
ajmsi-3181	104	38	%	%	NOUN
ajmsi-3181	104	39	)	)	PUNCT
ajmsi-3181	104	40	,	,	PUNCT
ajmsi-3181	104	41	and	and	CCONJ
ajmsi-3181	104	42	pseudomonas	pseudomonas	PROPN
ajmsi-3181	104	43	aeruginosa	aeruginosa	NOUN
ajmsi-3181	104	44	(	(	PUNCT
ajmsi-3181	104	45	7.8	7.8	NUM
ajmsi-3181	104	46	%	%	NOUN
ajmsi-3181	104	47	)	)	PUNCT
ajmsi-3181	104	48	.	.	PUNCT
ajmsi-3181	105	1	other	other	ADJ
ajmsi-3181	105	2	less	less	ADJ
ajmsi-3181	105	3	common	common	ADJ
ajmsi-3181	105	4	organisms	organism	NOUN
ajmsi-3181	105	5	included	include	VERB
ajmsi-3181	105	6	serratia	serratia	NOUN
ajmsi-3181	105	7	marcescens	marcescen	NOUN
ajmsi-3181	105	8	(	(	PUNCT
ajmsi-3181	105	9	3	3	NUM
ajmsi-3181	105	10	%	%	NOUN
ajmsi-3181	105	11	)	)	PUNCT
ajmsi-3181	105	12	,	,	PUNCT
ajmsi-3181	105	13	acinetobacter	acinetobacter	ADV
ajmsi-3181	105	14	baumannii	baumannii	ADJ
ajmsi-3181	105	15	(	(	PUNCT
ajmsi-3181	105	16	2.2	2.2	NUM
ajmsi-3181	105	17	%	%	NOUN
ajmsi-3181	105	18	)	)	PUNCT
ajmsi-3181	105	19	,	,	PUNCT
ajmsi-3181	105	20	brucella	brucella	PROPN
ajmsi-3181	105	21	sp	sp	PROPN
ajmsi-3181	105	22	.	.	PUNCT
ajmsi-3181	106	1	(	(	PUNCT
ajmsi-3181	106	2	2.2	2.2	NUM
ajmsi-3181	106	3	%	%	NOUN
ajmsi-3181	106	4	)	)	PUNCT
ajmsi-3181	107	1	,	,	PUNCT
ajmsi-3181	107	2	non	non	ADJ
ajmsi-3181	107	3	-	-	ADJ
ajmsi-3181	107	4	typhoidal	typhoidal	ADJ
ajmsi-3181	107	5	salmonella	salmonella	NOUN
ajmsi-3181	107	6	(	(	PUNCT
ajmsi-3181	107	7	1.3	1.3	NUM
ajmsi-3181	107	8	%	%	NOUN
ajmsi-3181	107	9	)	)	PUNCT
ajmsi-3181	107	10	,	,	PUNCT
ajmsi-3181	107	11	citrobacter	citrobacter	ADJ
ajmsi-3181	107	12	sp	sp	PROPN
ajmsi-3181	107	13	.	.	PUNCT
ajmsi-3181	107	14	(	(	PUNCT
ajmsi-3181	107	15	0.5	0.5	NUM
ajmsi-3181	107	16	%	%	NOUN
ajmsi-3181	107	17	)	)	PUNCT
ajmsi-3181	107	18	,	,	PUNCT
ajmsi-3181	107	19	and	and	CCONJ
ajmsi-3181	107	20	various	various	ADJ
ajmsi-3181	107	21	others	other	NOUN
ajmsi-3181	107	22	(	(	PUNCT
ajmsi-3181	107	23	8.3	8.3	NUM
ajmsi-3181	107	24	%	%	NOUN
ajmsi-3181	107	25	)	)	PUNCT
ajmsi-3181	107	26	.	.	PUNCT
ajmsi-3181	108	1	these	these	DET
ajmsi-3181	108	2	findings	finding	NOUN
ajmsi-3181	108	3	detail	detail	VERB
ajmsi-3181	108	4	the	the	DET
ajmsi-3181	108	5	characteristics	characteristic	NOUN
ajmsi-3181	108	6	of	of	ADP
ajmsi-3181	108	7	gram	gram	NOUN
ajmsi-3181	108	8	-	-	PUNCT
ajmsi-3181	108	9	negative	negative	ADJ
ajmsi-3181	108	10	bacteria	bacteria	NOUN
ajmsi-3181	108	11	isolated	isolate	VERB
ajmsi-3181	108	12	in	in	ADP
ajmsi-3181	108	13	the	the	DET
ajmsi-3181	108	14	study	study	NOUN
ajmsi-3181	108	15	,	,	PUNCT
ajmsi-3181	108	16	highlighting	highlight	VERB
ajmsi-3181	108	17	the	the	DET
ajmsi-3181	108	18	prevalence	prevalence	NOUN
ajmsi-3181	108	19	of	of	ADP
ajmsi-3181	108	20	different	different	ADJ
ajmsi-3181	108	21	species	specie	NOUN
ajmsi-3181	108	22	contributing	contribute	VERB
ajmsi-3181	108	23	to	to	ADP
ajmsi-3181	108	24	persistent	persistent	ADJ
ajmsi-3181	108	25	bacteremia	bacteremia	NOUN
ajmsi-3181	108	26	cases	case	NOUN
ajmsi-3181	108	27	.	.	PUNCT
ajmsi-3181	109	1	additionally	additionally	ADV
ajmsi-3181	109	2	,	,	PUNCT
ajmsi-3181	109	3	the	the	DET
ajmsi-3181	109	4	mean	mean	ADJ
ajmsi-3181	109	5	duration	duration	NOUN
ajmsi-3181	109	6	of	of	ADP
ajmsi-3181	109	7	antimicrobial	antimicrobial	ADJ
ajmsi-3181	109	8	treatment	treatment	NOUN
ajmsi-3181	109	9	,	,	PUNCT
ajmsi-3181	109	10	including	include	VERB
ajmsi-3181	109	11	intravenous	intravenous	ADJ
ajmsi-3181	109	12	and	and	CCONJ
ajmsi-3181	109	13	oral	oral	ADJ
ajmsi-3181	109	14	administration	administration	NOUN
ajmsi-3181	109	15	,	,	PUNCT
ajmsi-3181	109	16	was	be	AUX
ajmsi-3181	109	17	14.6	14.6	NUM
ajmsi-3181	109	18	days	day	NOUN
ajmsi-3181	109	19	,	,	PUNCT
ajmsi-3181	109	20	with	with	ADP
ajmsi-3181	109	21	intravenous	intravenous	ADJ
ajmsi-3181	109	22	antibiotics	antibiotic	NOUN
ajmsi-3181	109	23	specifically	specifically	ADV
ajmsi-3181	109	24	administered	administer	VERB
ajmsi-3181	109	25	for	for	ADP
ajmsi-3181	109	26	an	an	DET
ajmsi-3181	109	27	average	average	ADJ
ajmsi-3181	109	28	duration	duration	NOUN
ajmsi-3181	109	29	of	of	ADP
ajmsi-3181	109	30	5.4	5.4	NUM
ajmsi-3181	109	31	days	day	NOUN
ajmsi-3181	109	32	,	,	PUNCT
ajmsi-3181	109	33	as	as	SCONJ
ajmsi-3181	109	34	shown	show	VERB
ajmsi-3181	109	35	in	in	ADP
ajmsi-3181	109	36	table	table	NOUN
ajmsi-3181	109	37	3	3	NUM
ajmsi-3181	109	38	.	.	PUNCT
ajmsi-3181	109	39	table	table	NOUN
ajmsi-3181	109	40	3	3	NUM
ajmsi-3181	109	41	:	:	PUNCT
ajmsi-3181	109	42	organisms	organism	NOUN
ajmsi-3181	109	43	isolated	isolate	VERB
ajmsi-3181	109	44	in	in	ADP
ajmsi-3181	109	45	persistent	persistent	ADJ
ajmsi-3181	109	46	bacteremia	bacteremia	NOUN
ajmsi-3181	109	47	organism	organism	NOUN
ajmsi-3181	109	48	count	count	NOUN
ajmsi-3181	109	49	(	(	PUNCT
ajmsi-3181	109	50	out	out	ADP
ajmsi-3181	109	51	of	of	ADP
ajmsi-3181	109	52	18	18	NUM
ajmsi-3181	109	53	)	)	PUNCT
ajmsi-3181	109	54	percentage	percentage	NOUN
ajmsi-3181	109	55	%	%	NOUN
ajmsi-3181	109	56	e.	e.	PROPN
ajmsi-3181	109	57	coli	coli	PROPN
ajmsi-3181	109	58	4	4	NUM
ajmsi-3181	109	59	22.22	22.22	NUM
ajmsi-3181	109	60	klebsiella	klebsiella	NOUN
ajmsi-3181	109	61	sp	sp	NOUN
ajmsi-3181	109	62	.	.	NOUN
ajmsi-3181	109	63	5	5	NUM
ajmsi-3181	109	64	27.77	27.77	NUM
ajmsi-3181	109	65	enterobacter	enterobacter	NOUN
ajmsi-3181	109	66	cloacae	cloacae	NOUN
ajmsi-3181	109	67	1	1	NUM
ajmsi-3181	109	68	5.55	5.55	NUM
ajmsi-3181	109	69	pseudomonas	pseudomona	NOUN
ajmsi-3181	109	70	sp	sp	NOUN
ajmsi-3181	109	71	.	.	NOUN
ajmsi-3181	109	72	2	2	NUM
ajmsi-3181	109	73	11.11	11.11	NUM
ajmsi-3181	109	74	salmonella	salmonella	NOUN
ajmsi-3181	109	75	typhi	typhi	VERB
ajmsi-3181	109	76	3	3	NUM
ajmsi-3181	109	77	16.66	16.66	NUM
ajmsi-3181	109	78	proteus	proteus	NOUN
ajmsi-3181	109	79	sp	sp	NOUN
ajmsi-3181	109	80	.	.	NOUN
ajmsi-3181	109	81	1	1	NUM
ajmsi-3181	109	82	5.55	5.55	NUM
ajmsi-3181	109	83	stenotrophomonas	stenotrophomona	NOUN
ajmsi-3181	109	84	maltophilia	maltophilia	VERB
ajmsi-3181	109	85	1	1	NUM
ajmsi-3181	109	86	5.55	5.55	NUM
ajmsi-3181	109	87	achromobacter	achromobacter	NOUN
ajmsi-3181	109	88	sp	sp	NOUN
ajmsi-3181	109	89	.	.	PROPN
ajmsi-3181	109	90	1	1	NUM
ajmsi-3181	109	91	5.55	5.55	NUM
ajmsi-3181	109	92	as	as	SCONJ
ajmsi-3181	109	93	illustrated	illustrate	VERB
ajmsi-3181	109	94	in	in	ADP
ajmsi-3181	109	95	figure	figure	NOUN
ajmsi-3181	109	96	3	3	NUM
ajmsi-3181	109	97	,	,	PUNCT
ajmsi-3181	109	98	gram	gram	NOUN
ajmsi-3181	109	99	-	-	PUNCT
ajmsi-3181	109	100	negative	negative	ADJ
ajmsi-3181	109	101	bacteremia	bacteremia	NOUN
ajmsi-3181	109	102	arises	arise	VERB
ajmsi-3181	109	103	from	from	ADP
ajmsi-3181	109	104	various	various	ADJ
ajmsi-3181	109	105	sources	source	NOUN
ajmsi-3181	109	106	within	within	ADP
ajmsi-3181	109	107	the	the	DET
ajmsi-3181	109	108	body	body	NOUN
ajmsi-3181	109	109	.	.	PUNCT
ajmsi-3181	110	1	the	the	DET
ajmsi-3181	110	2	most	most	ADV
ajmsi-3181	110	3	prevalent	prevalent	ADJ
ajmsi-3181	110	4	infection	infection	NOUN
ajmsi-3181	110	5	sites	site	NOUN
ajmsi-3181	110	6	of	of	ADP
ajmsi-3181	110	7	cases	case	NOUN
ajmsi-3181	110	8	originating	originate	VERB
ajmsi-3181	110	9	in	in	ADP
ajmsi-3181	110	10	the	the	DET
ajmsi-3181	110	11	urinary	urinary	ADJ
ajmsi-3181	110	12	tract	tract	NOUN
ajmsi-3181	110	13	are	be	AUX
ajmsi-3181	110	14	evident	evident	ADJ
ajmsi-3181	110	15	.	.	PUNCT
ajmsi-3181	111	1	intra	intra	ADJ
ajmsi-3181	111	2	-	-	ADJ
ajmsi-3181	111	3	abdominal	abdominal	ADJ
ajmsi-3181	111	4	infections	infection	NOUN
ajmsi-3181	111	5	and	and	CCONJ
ajmsi-3181	111	6	lower	low	ADJ
ajmsi-3181	111	7	respiratory	respiratory	ADJ
ajmsi-3181	111	8	tract	tract	NOUN
ajmsi-3181	111	9	infections	infection	NOUN
ajmsi-3181	111	10	follow	follow	VERB
ajmsi-3181	111	11	this	this	PRON
ajmsi-3181	111	12	.	.	PUNCT
ajmsi-3181	112	1	it	it	PRON
ajmsi-3181	112	2	is	be	AUX
ajmsi-3181	112	3	crucial	crucial	ADJ
ajmsi-3181	112	4	to	to	PART
ajmsi-3181	112	5	note	note	VERB
ajmsi-3181	112	6	that	that	SCONJ
ajmsi-3181	112	7	these	these	DET
ajmsi-3181	112	8	percentages	percentage	NOUN
ajmsi-3181	112	9	may	may	AUX
ajmsi-3181	112	10	not	not	PART
ajmsi-3181	112	11	match	match	VERB
ajmsi-3181	112	12	the	the	DET
ajmsi-3181	112	13	original	original	ADJ
ajmsi-3181	112	14	figure	figure	NOUN
ajmsi-3181	112	15	exactly	exactly	ADV
ajmsi-3181	112	16	due	due	ADJ
ajmsi-3181	112	17	to	to	ADP
ajmsi-3181	112	18	potential	potential	ADJ
ajmsi-3181	112	19	rounding	round	VERB
ajmsi-3181	112	20	errors	error	NOUN
ajmsi-3181	112	21	.	.	PUNCT
ajmsi-3181	113	1	pa	pa	PROPN
ajmsi-3181	113	2	ge	ge	PROPN
ajmsi-3181	113	3	96	96	NUM
ajmsi-3181	113	4	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-3181	113	5	am	be	AUX
ajmsi-3181	113	6	.	.	PUNCT
ajmsi-3181	114	1	j.	j.	PROPN
ajmsi-3181	114	2	med	med	PROPN
ajmsi-3181	114	3	.	.	PUNCT
ajmsi-3181	115	1	sci	sci	PROPN
ajmsi-3181	115	2	.	.	PUNCT
ajmsi-3181	115	3	innov	innov	PROPN
ajmsi-3181	115	4	.	.	PUNCT
ajmsi-3181	116	1	3(2	3(2	NUM
ajmsi-3181	116	2	)	)	PUNCT
ajmsi-3181	116	3	91	91	NUM
ajmsi-3181	116	4	-	-	SYM
ajmsi-3181	116	5	102	102	NUM
ajmsi-3181	116	6	,	,	PUNCT
ajmsi-3181	116	7	2024	2024	NUM
ajmsi-3181	116	8	there	there	PRON
ajmsi-3181	116	9	were	be	VERB
ajmsi-3181	116	10	four	four	NUM
ajmsi-3181	116	11	cases	case	NOUN
ajmsi-3181	116	12	of	of	ADP
ajmsi-3181	116	13	multidrug	multidrug	NOUN
ajmsi-3181	116	14	-	-	PUNCT
ajmsi-3181	116	15	resistant	resistant	ADJ
ajmsi-3181	116	16	organisms	organism	NOUN
ajmsi-3181	116	17	(	(	PUNCT
ajmsi-3181	116	18	mdros	mdro	NOUN
ajmsi-3181	116	19	)	)	PUNCT
ajmsi-3181	116	20	,	,	PUNCT
ajmsi-3181	116	21	two	two	NUM
ajmsi-3181	116	22	klebsiella	klebsiella	NOUN
ajmsi-3181	116	23	pneumoniae	pneumoniae	ADJ
ajmsi-3181	116	24	carbapenemaseproducing	carbapenemaseproduce	VERB
ajmsi-3181	116	25	enterobacteriaceae	enterobacteriaceae	PROPN
ajmsi-3181	116	26	(	(	PUNCT
ajmsi-3181	116	27	kpc	kpc	NOUN
ajmsi-3181	116	28	)	)	PUNCT
ajmsi-3181	116	29	,	,	PUNCT
ajmsi-3181	116	30	and	and	CCONJ
ajmsi-3181	116	31	two	two	NUM
ajmsi-3181	116	32	new	new	ADJ
ajmsi-3181	116	33	delhi	delhi	PROPN
ajmsi-3181	116	34	metallo	metallo	PROPN
ajmsi-3181	116	35	-	-	PUNCT
ajmsi-3181	116	36	beta	beta	NOUN
ajmsi-3181	116	37	-	-	PUNCT
ajmsi-3181	116	38	lactamase-1	lactamase-1	NOUN
ajmsi-3181	116	39	(	(	PUNCT
ajmsi-3181	116	40	nmd-1	nmd-1	NUM
ajmsi-3181	116	41	)	)	PUNCT
ajmsi-3181	116	42	.	.	PUNCT
ajmsi-3181	117	1	extendedspectrum	extendedspectrum	ADP
ajmsi-3181	117	2	beta	beta	NOUN
ajmsi-3181	117	3	-	-	PUNCT
ajmsi-3181	117	4	lactamase	lactamase	NOUN
ajmsi-3181	117	5	-	-	PUNCT
ajmsi-3181	117	6	producing	produce	VERB
ajmsi-3181	117	7	organisms	organism	NOUN
ajmsi-3181	117	8	(	(	PUNCT
ajmsi-3181	117	9	esbl	esbl	NOUN
ajmsi-3181	117	10	)	)	PUNCT
ajmsi-3181	117	11	constituted	constitute	VERB
ajmsi-3181	117	12	31.56	31.56	NUM
ajmsi-3181	117	13	%	%	NOUN
ajmsi-3181	117	14	(	(	PUNCT
ajmsi-3181	117	15	113	113	NUM
ajmsi-3181	117	16	)	)	PUNCT
ajmsi-3181	117	17	cases	case	NOUN
ajmsi-3181	117	18	.	.	PUNCT
ajmsi-3181	118	1	antibiotic	antibiotic	ADJ
ajmsi-3181	118	2	collateral	collateral	ADJ
ajmsi-3181	118	3	damage	damage	NOUN
ajmsi-3181	118	4	was	be	AUX
ajmsi-3181	118	5	noted	note	VERB
ajmsi-3181	118	6	as	as	ADP
ajmsi-3181	118	7	the	the	DET
ajmsi-3181	118	8	emergence	emergence	NOUN
ajmsi-3181	118	9	of	of	ADP
ajmsi-3181	118	10	mdro	mdro	NOUN
ajmsi-3181	118	11	in	in	ADP
ajmsi-3181	118	12	90	90	NUM
ajmsi-3181	118	13	days	day	NOUN
ajmsi-3181	118	14	in	in	ADP
ajmsi-3181	118	15	22	22	NUM
ajmsi-3181	118	16	patients	patient	NOUN
ajmsi-3181	118	17	(	(	PUNCT
ajmsi-3181	118	18	6.1	6.1	NUM
ajmsi-3181	118	19	%	%	NOUN
ajmsi-3181	118	20	)	)	PUNCT
ajmsi-3181	118	21	and	and	CCONJ
ajmsi-3181	118	22	clostridium	clostridium	NOUN
ajmsi-3181	118	23	difficile	difficile	NOUN
ajmsi-3181	118	24	in	in	ADP
ajmsi-3181	118	25	two	two	NUM
ajmsi-3181	118	26	patients	patient	NOUN
ajmsi-3181	118	27	(	(	PUNCT
ajmsi-3181	118	28	0.5	0.5	NUM
ajmsi-3181	118	29	%	%	NOUN
ajmsi-3181	118	30	)	)	PUNCT
ajmsi-3181	118	31	.	.	PUNCT
ajmsi-3181	119	1	persistent	persistent	ADJ
ajmsi-3181	119	2	bacteremia	bacteremia	NOUN
ajmsi-3181	119	3	was	be	AUX
ajmsi-3181	119	4	reported	report	VERB
ajmsi-3181	119	5	in	in	ADP
ajmsi-3181	119	6	18	18	NUM
ajmsi-3181	119	7	patients	patient	NOUN
ajmsi-3181	119	8	(	(	PUNCT
ajmsi-3181	119	9	5	5	NUM
ajmsi-3181	119	10	%	%	NOUN
ajmsi-3181	119	11	)	)	PUNCT
ajmsi-3181	119	12	,	,	PUNCT
ajmsi-3181	119	13	out	out	ADP
ajmsi-3181	119	14	of	of	ADP
ajmsi-3181	119	15	which	which	PRON
ajmsi-3181	119	16	nine	nine	NUM
ajmsi-3181	119	17	(	(	PUNCT
ajmsi-3181	119	18	50	50	NUM
ajmsi-3181	119	19	%	%	NOUN
ajmsi-3181	119	20	)	)	PUNCT
ajmsi-3181	119	21	had	have	VERB
ajmsi-3181	119	22	intra	intra	ADJ
ajmsi-3181	119	23	-	-	ADJ
ajmsi-3181	119	24	abdominal	abdominal	ADJ
ajmsi-3181	119	25	infections	infection	NOUN
ajmsi-3181	119	26	,	,	PUNCT
ajmsi-3181	119	27	three	three	NUM
ajmsi-3181	119	28	had	have	VERB
ajmsi-3181	119	29	soft	soft	ADJ
ajmsi-3181	119	30	tissue	tissue	NOUN
ajmsi-3181	119	31	infections	infection	NOUN
ajmsi-3181	119	32	(	(	PUNCT
ajmsi-3181	119	33	16.7	16.7	NUM
ajmsi-3181	119	34	%	%	NOUN
ajmsi-3181	119	35	)	)	PUNCT
ajmsi-3181	119	36	,	,	PUNCT
ajmsi-3181	119	37	two	two	NUM
ajmsi-3181	119	38	had	have	VERB
ajmsi-3181	119	39	lower	low	ADJ
ajmsi-3181	119	40	respiratory	respiratory	ADJ
ajmsi-3181	119	41	tract	tract	NOUN
ajmsi-3181	119	42	infections	infection	NOUN
ajmsi-3181	119	43	(	(	PUNCT
ajmsi-3181	119	44	11.1	11.1	NUM
ajmsi-3181	119	45	%	%	NOUN
ajmsi-3181	119	46	)	)	PUNCT
ajmsi-3181	119	47	,	,	PUNCT
ajmsi-3181	119	48	two	two	NUM
ajmsi-3181	119	49	had	have	VERB
ajmsi-3181	119	50	urinary	urinary	ADJ
ajmsi-3181	119	51	tract	tract	NOUN
ajmsi-3181	119	52	infections	infection	NOUN
ajmsi-3181	119	53	(	(	PUNCT
ajmsi-3181	119	54	11.1	11.1	NUM
ajmsi-3181	119	55	%	%	NOUN
ajmsi-3181	119	56	)	)	PUNCT
ajmsi-3181	119	57	,	,	PUNCT
ajmsi-3181	119	58	one	one	PRON
ajmsi-3181	119	59	had	have	VERB
ajmsi-3181	119	60	cardiovascular	cardiovascular	ADJ
ajmsi-3181	119	61	infection	infection	NOUN
ajmsi-3181	119	62	(	(	PUNCT
ajmsi-3181	119	63	5.5	5.5	NUM
ajmsi-3181	119	64	%	%	NOUN
ajmsi-3181	119	65	)	)	PUNCT
ajmsi-3181	119	66	,	,	PUNCT
ajmsi-3181	119	67	and	and	CCONJ
ajmsi-3181	119	68	one	one	NUM
ajmsi-3181	119	69	had	have	VERB
ajmsi-3181	119	70	line	line	NOUN
ajmsi-3181	119	71	-	-	PUNCT
ajmsi-3181	119	72	related	relate	VERB
ajmsi-3181	119	73	infection	infection	NOUN
ajmsi-3181	119	74	(	(	PUNCT
ajmsi-3181	119	75	5.5	5.5	NUM
ajmsi-3181	119	76	%	%	NOUN
ajmsi-3181	119	77	)	)	PUNCT
ajmsi-3181	119	78	,	,	PUNCT
ajmsi-3181	119	79	as	as	SCONJ
ajmsi-3181	119	80	shown	show	VERB
ajmsi-3181	119	81	in	in	ADP
ajmsi-3181	119	82	table	table	NOUN
ajmsi-3181	119	83	4	4	NUM
ajmsi-3181	119	84	.	.	PUNCT
ajmsi-3181	119	85	figure	figure	VERB
ajmsi-3181	119	86	3	3	NUM
ajmsi-3181	119	87	:	:	PUNCT
ajmsi-3181	119	88	common	common	ADJ
ajmsi-3181	119	89	sites	site	NOUN
ajmsi-3181	119	90	of	of	ADP
ajmsi-3181	119	91	infection	infection	NOUN
ajmsi-3181	119	92	in	in	ADP
ajmsi-3181	119	93	gram	gram	NOUN
ajmsi-3181	119	94	-	-	PUNCT
ajmsi-3181	119	95	negative	negative	ADJ
ajmsi-3181	119	96	bacteremia	bacteremia	NOUN
ajmsi-3181	119	97	cases	case	NOUN
ajmsi-3181	119	98	table	table	VERB
ajmsi-3181	119	99	4	4	NUM
ajmsi-3181	119	100	:	:	PUNCT
ajmsi-3181	119	101	description	description	NOUN
ajmsi-3181	119	102	of	of	ADP
ajmsi-3181	119	103	bacterial	bacterial	ADJ
ajmsi-3181	119	104	isolates	isolate	NOUN
ajmsi-3181	119	105	organisms	organism	NOUN
ajmsi-3181	119	106	count	count	VERB
ajmsi-3181	119	107	percentage	percentage	NOUN
ajmsi-3181	119	108	(	(	PUNCT
ajmsi-3181	119	109	%	%	INTJ
ajmsi-3181	119	110	)	)	PUNCT
ajmsi-3181	119	111	multidrug	multidrug	NOUN
ajmsi-3181	119	112	-	-	PUNCT
ajmsi-3181	119	113	resistant	resistant	ADJ
ajmsi-3181	119	114	organisms	organism	NOUN
ajmsi-3181	119	115	(	(	PUNCT
ajmsi-3181	119	116	mdros	mdro	NOUN
ajmsi-3181	119	117	)	)	PUNCT
ajmsi-3181	119	118	4	4	NUM
ajmsi-3181	119	119	1.11	1.11	NUM
ajmsi-3181	119	120	extended	extend	VERB
ajmsi-3181	119	121	-	-	PUNCT
ajmsi-3181	119	122	spectrum	spectrum	NOUN
ajmsi-3181	119	123	beta	beta	NOUN
ajmsi-3181	119	124	-	-	PUNCT
ajmsi-3181	119	125	lactamase	lactamase	NOUN
ajmsi-3181	119	126	-	-	PUNCT
ajmsi-3181	119	127	producing	produce	VERB
ajmsi-3181	119	128	organisms	organism	NOUN
ajmsi-3181	119	129	(	(	PUNCT
ajmsi-3181	119	130	esbl	esbl	NOUN
ajmsi-3181	119	131	)	)	PUNCT
ajmsi-3181	119	132	113	113	NUM
ajmsi-3181	119	133	31.56	31.56	NUM
ajmsi-3181	119	134	sensitive	sensitive	ADJ
ajmsi-3181	119	135	strains	strain	VERB
ajmsi-3181	119	136	241	241	NUM
ajmsi-3181	119	137	67.32	67.32	NUM
ajmsi-3181	119	138	single	single	ADJ
ajmsi-3181	119	139	microbe	microbe	NOUN
ajmsi-3181	119	140	336	336	NUM
ajmsi-3181	119	141	93.85	93.85	NUM
ajmsi-3181	119	142	polymicrobial	polymicrobial	ADJ
ajmsi-3181	119	143	22	22	NUM
ajmsi-3181	119	144	6.14	6.14	NUM
ajmsi-3181	119	145	figure	figure	NOUN
ajmsi-3181	119	146	4	4	NUM
ajmsi-3181	119	147	illustrates	illustrate	VERB
ajmsi-3181	119	148	the	the	DET
ajmsi-3181	119	149	distribution	distribution	NOUN
ajmsi-3181	119	150	of	of	ADP
ajmsi-3181	119	151	gram	gram	NOUN
ajmsi-3181	119	152	-	-	PUNCT
ajmsi-3181	119	153	negative	negative	ADJ
ajmsi-3181	119	154	bacteremia	bacteremia	NOUN
ajmsi-3181	119	155	cases	case	NOUN
ajmsi-3181	119	156	by	by	ADP
ajmsi-3181	119	157	different	different	ADJ
ajmsi-3181	119	158	bacterial	bacterial	ADJ
ajmsi-3181	119	159	types	type	NOUN
ajmsi-3181	119	160	.	.	PUNCT
ajmsi-3181	120	1	the	the	DET
ajmsi-3181	120	2	listed	list	VERB
ajmsi-3181	120	3	bacteria	bacteria	NOUN
ajmsi-3181	120	4	include	include	VERB
ajmsi-3181	120	5	escherichia	escherichia	NOUN
ajmsi-3181	120	6	coli	coli	NOUN
ajmsi-3181	120	7	,	,	PUNCT
ajmsi-3181	120	8	klebsiella	klebsiella	NOUN
ajmsi-3181	120	9	pneumoniae	pneumoniae	NOUN
ajmsi-3181	120	10	,	,	PUNCT
ajmsi-3181	120	11	salmonella	salmonella	NOUN
ajmsi-3181	120	12	typhi	typhi	VERB
ajmsi-3181	120	13	,	,	PUNCT
ajmsi-3181	120	14	pseudomonas	pseudomona	NOUN
ajmsi-3181	120	15	,	,	PUNCT
ajmsi-3181	120	16	serratia	serratia	NOUN
ajmsi-3181	120	17	,	,	PUNCT
ajmsi-3181	120	18	acinetobacter	acinetobacter	NOUN
ajmsi-3181	120	19	,	,	PUNCT
ajmsi-3181	120	20	non	non	ADJ
ajmsi-3181	120	21	-	-	ADJ
ajmsi-3181	120	22	typhoidal	typhoidal	ADJ
ajmsi-3181	120	23	salmonella	salmonella	NOUN
ajmsi-3181	120	24	,	,	PUNCT
ajmsi-3181	120	25	and	and	CCONJ
ajmsi-3181	120	26	citrobacter	citrobacter	ADV
ajmsi-3181	120	27	.	.	PUNCT
ajmsi-3181	121	1	the	the	DET
ajmsi-3181	121	2	x	x	X
ajmsi-3181	121	3	-	-	NOUN
ajmsi-3181	121	4	axis	axis	NOUN
ajmsi-3181	121	5	represents	represent	VERB
ajmsi-3181	121	6	the	the	DET
ajmsi-3181	121	7	percentage	percentage	NOUN
ajmsi-3181	121	8	of	of	ADP
ajmsi-3181	121	9	cases	case	NOUN
ajmsi-3181	121	10	for	for	ADP
ajmsi-3181	121	11	each	each	DET
ajmsi-3181	121	12	bacterial	bacterial	ADJ
ajmsi-3181	121	13	type	type	NOUN
ajmsi-3181	121	14	.	.	PUNCT
ajmsi-3181	122	1	this	this	DET
ajmsi-3181	122	2	graph	graph	NOUN
ajmsi-3181	122	3	provides	provide	VERB
ajmsi-3181	122	4	insights	insight	NOUN
ajmsi-3181	122	5	into	into	ADP
ajmsi-3181	122	6	the	the	DET
ajmsi-3181	122	7	prevalence	prevalence	NOUN
ajmsi-3181	122	8	of	of	ADP
ajmsi-3181	122	9	various	various	ADJ
ajmsi-3181	122	10	bacterial	bacterial	ADJ
ajmsi-3181	122	11	species	specie	NOUN
ajmsi-3181	122	12	causing	cause	VERB
ajmsi-3181	122	13	gram	gram	NOUN
ajmsi-3181	122	14	-	-	PUNCT
ajmsi-3181	122	15	negative	negative	ADJ
ajmsi-3181	122	16	bacteremia	bacteremia	NOUN
ajmsi-3181	122	17	,	,	PUNCT
ajmsi-3181	122	18	which	which	PRON
ajmsi-3181	122	19	is	be	AUX
ajmsi-3181	122	20	essential	essential	ADJ
ajmsi-3181	122	21	for	for	ADP
ajmsi-3181	122	22	understanding	understand	VERB
ajmsi-3181	122	23	the	the	DET
ajmsi-3181	122	24	epidemiology	epidemiology	NOUN
ajmsi-3181	122	25	and	and	CCONJ
ajmsi-3181	122	26	guiding	guide	VERB
ajmsi-3181	122	27	treatment	treatment	NOUN
ajmsi-3181	122	28	approaches	approach	NOUN
ajmsi-3181	122	29	for	for	ADP
ajmsi-3181	122	30	these	these	DET
ajmsi-3181	122	31	infections	infection	NOUN
ajmsi-3181	122	32	.	.	PUNCT
ajmsi-3181	123	1	figure	figure	VERB
ajmsi-3181	123	2	4	4	NUM
ajmsi-3181	123	3	:	:	PUNCT
ajmsi-3181	123	4	comorbidities	comorbiditie	NOUN
ajmsi-3181	123	5	in	in	ADP
ajmsi-3181	123	6	gram	gram	NOUN
ajmsi-3181	123	7	-	-	PUNCT
ajmsi-3181	123	8	negative	negative	ADJ
ajmsi-3181	123	9	bacteremia	bacteremia	NOUN
ajmsi-3181	123	10	cases	case	NOUN
ajmsi-3181	123	11	pa	pa	PROPN
ajmsi-3181	123	12	ge	ge	PROPN
ajmsi-3181	123	13	97	97	NUM
ajmsi-3181	123	14	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-3181	123	15	am	be	AUX
ajmsi-3181	123	16	.	.	PUNCT
ajmsi-3181	124	1	j.	j.	PROPN
ajmsi-3181	124	2	med	med	PROPN
ajmsi-3181	124	3	.	.	PUNCT
ajmsi-3181	125	1	sci	sci	PROPN
ajmsi-3181	125	2	.	.	PUNCT
ajmsi-3181	125	3	innov	innov	PROPN
ajmsi-3181	125	4	.	.	PUNCT
ajmsi-3181	126	1	3(2	3(2	NUM
ajmsi-3181	126	2	)	)	PUNCT
ajmsi-3181	126	3	91	91	NUM
ajmsi-3181	126	4	-	-	SYM
ajmsi-3181	126	5	102	102	NUM
ajmsi-3181	126	6	,	,	PUNCT
ajmsi-3181	126	7	2024	2024	NUM
ajmsi-3181	126	8	table	table	NOUN
ajmsi-3181	126	9	5	5	NUM
ajmsi-3181	126	10	illustrates	illustrate	VERB
ajmsi-3181	126	11	the	the	DET
ajmsi-3181	126	12	management	management	NOUN
ajmsi-3181	126	13	of	of	ADP
ajmsi-3181	126	14	source	source	NOUN
ajmsi-3181	126	15	control	control	NOUN
ajmsi-3181	126	16	in	in	ADP
ajmsi-3181	126	17	patients	patient	NOUN
ajmsi-3181	126	18	with	with	ADP
ajmsi-3181	126	19	persistent	persistent	ADJ
ajmsi-3181	126	20	bacteremia	bacteremia	NOUN
ajmsi-3181	126	21	.	.	PUNCT
ajmsi-3181	127	1	among	among	ADP
ajmsi-3181	127	2	18	18	NUM
ajmsi-3181	127	3	patients	patient	NOUN
ajmsi-3181	127	4	with	with	ADP
ajmsi-3181	127	5	persistent	persistent	ADJ
ajmsi-3181	127	6	bacteremia	bacteremia	NOUN
ajmsi-3181	127	7	,	,	PUNCT
ajmsi-3181	127	8	source	source	NOUN
ajmsi-3181	127	9	control	control	NOUN
ajmsi-3181	127	10	was	be	AUX
ajmsi-3181	127	11	performed	perform	VERB
ajmsi-3181	127	12	in	in	ADP
ajmsi-3181	127	13	seven	seven	NUM
ajmsi-3181	127	14	cases	case	NOUN
ajmsi-3181	127	15	,	,	PUNCT
ajmsi-3181	127	16	accounting	account	VERB
ajmsi-3181	127	17	for	for	ADP
ajmsi-3181	127	18	38.9	38.9	NUM
ajmsi-3181	127	19	%	%	NOUN
ajmsi-3181	127	20	of	of	ADP
ajmsi-3181	127	21	the	the	DET
ajmsi-3181	127	22	cohort	cohort	NOUN
ajmsi-3181	127	23	.	.	PUNCT
ajmsi-3181	128	1	conversely	conversely	ADV
ajmsi-3181	128	2	,	,	PUNCT
ajmsi-3181	128	3	five	five	NUM
ajmsi-3181	128	4	patients	patient	NOUN
ajmsi-3181	128	5	(	(	PUNCT
ajmsi-3181	128	6	27.8	27.8	NUM
ajmsi-3181	128	7	%	%	NOUN
ajmsi-3181	128	8	)	)	PUNCT
ajmsi-3181	128	9	did	do	AUX
ajmsi-3181	128	10	not	not	PART
ajmsi-3181	128	11	require	require	VERB
ajmsi-3181	128	12	source	source	NOUN
ajmsi-3181	128	13	control	control	NOUN
ajmsi-3181	128	14	.	.	PUNCT
ajmsi-3181	129	1	in	in	ADP
ajmsi-3181	129	2	contrast	contrast	NOUN
ajmsi-3181	129	3	,	,	PUNCT
ajmsi-3181	129	4	source	source	NOUN
ajmsi-3181	129	5	control	control	NOUN
ajmsi-3181	129	6	was	be	AUX
ajmsi-3181	129	7	deemed	deem	VERB
ajmsi-3181	129	8	necessary	necessary	ADJ
ajmsi-3181	129	9	in	in	ADP
ajmsi-3181	129	10	six	six	NUM
ajmsi-3181	129	11	cases	case	NOUN
ajmsi-3181	129	12	(	(	PUNCT
ajmsi-3181	129	13	33.3	33.3	NUM
ajmsi-3181	129	14	%	%	NOUN
ajmsi-3181	129	15	)	)	PUNCT
ajmsi-3181	129	16	but	but	CCONJ
ajmsi-3181	129	17	was	be	AUX
ajmsi-3181	129	18	not	not	PART
ajmsi-3181	129	19	carried	carry	VERB
ajmsi-3181	129	20	out	out	ADP
ajmsi-3181	129	21	due	due	ADP
ajmsi-3181	129	22	to	to	ADP
ajmsi-3181	129	23	factors	factor	NOUN
ajmsi-3181	129	24	such	such	ADJ
ajmsi-3181	129	25	as	as	ADP
ajmsi-3181	129	26	the	the	DET
ajmsi-3181	129	27	patient	patient	NOUN
ajmsi-3181	129	28	’s	’s	PART
ajmsi-3181	129	29	unstable	unstable	ADJ
ajmsi-3181	129	30	condition	condition	NOUN
ajmsi-3181	129	31	or	or	CCONJ
ajmsi-3181	129	32	inaccessible	inaccessible	ADJ
ajmsi-3181	129	33	sites	site	NOUN
ajmsi-3181	129	34	.	.	PUNCT
ajmsi-3181	130	1	table	table	NOUN
ajmsi-3181	130	2	5	5	NUM
ajmsi-3181	130	3	:	:	PUNCT
ajmsi-3181	130	4	comorbidities	comorbiditie	NOUN
ajmsi-3181	130	5	of	of	ADP
ajmsi-3181	130	6	study	study	NOUN
ajmsi-3181	130	7	population	population	NOUN
ajmsi-3181	130	8	comorbidity	comorbidity	NOUN
ajmsi-3181	130	9	number	number	NOUN
ajmsi-3181	130	10	percentage	percentage	NOUN
ajmsi-3181	130	11	(	(	PUNCT
ajmsi-3181	130	12	%	%	INTJ
ajmsi-3181	130	13	)	)	PUNCT
ajmsi-3181	130	14	diabetes	diabetes	NOUN
ajmsi-3181	130	15	mellitus	mellitus	VERB
ajmsi-3181	130	16	160	160	NUM
ajmsi-3181	130	17	44.69	44.69	NUM
ajmsi-3181	130	18	hypertension	hypertension	NOUN
ajmsi-3181	130	19	152	152	NUM
ajmsi-3181	130	20	42.45	42.45	NUM
ajmsi-3181	130	21	the	the	DET
ajmsi-3181	130	22	end	end	NOUN
ajmsi-3181	130	23	-	-	PUNCT
ajmsi-3181	130	24	stage	stage	NOUN
ajmsi-3181	130	25	renal	renal	ADJ
ajmsi-3181	130	26	disease	disease	NOUN
ajmsi-3181	130	27	of	of	ADP
ajmsi-3181	130	28	dialysis	dialysis	NOUN
ajmsi-3181	130	29	32	32	NUM
ajmsi-3181	130	30	8.93	8.93	NUM
ajmsi-3181	130	31	chronic	chronic	ADJ
ajmsi-3181	130	32	kidney	kidney	NOUN
ajmsi-3181	130	33	disease	disease	NOUN
ajmsi-3181	130	34	44	44	NUM
ajmsi-3181	130	35	12.29	12.29	NUM
ajmsi-3181	130	36	malignancy	malignancy	NOUN
ajmsi-3181	130	37	36	36	NUM
ajmsi-3181	130	38	10.05	10.05	NUM
ajmsi-3181	130	39	asthma	asthma	NOUN
ajmsi-3181	130	40	/	/	SYM
ajmsi-3181	130	41	chronic	chronic	ADJ
ajmsi-3181	130	42	obstructive	obstructive	ADJ
ajmsi-3181	130	43	pulmonary	pulmonary	ADJ
ajmsi-3181	130	44	disease	disease	NOUN
ajmsi-3181	130	45	24	24	NUM
ajmsi-3181	130	46	6.70	6.70	NUM
ajmsi-3181	130	47	human	human	ADJ
ajmsi-3181	130	48	immunodeficiency	immunodeficiency	NOUN
ajmsi-3181	130	49	virus	virus	NOUN
ajmsi-3181	130	50	1	1	NUM
ajmsi-3181	130	51	0.27	0.27	NUM
ajmsi-3181	130	52	ischemic	ischemic	ADJ
ajmsi-3181	130	53	heart	heart	NOUN
ajmsi-3181	130	54	disease	disease	NOUN
ajmsi-3181	130	55	45	45	NUM
ajmsi-3181	130	56	12.56	12.56	NUM
ajmsi-3181	130	57	heart	heart	NOUN
ajmsi-3181	130	58	failure	failure	NOUN
ajmsi-3181	130	59	23	23	NUM
ajmsi-3181	130	60	6.42	6.42	NUM
ajmsi-3181	130	61	chronic	chronic	ADJ
ajmsi-3181	130	62	liver	liver	NOUN
ajmsi-3181	130	63	disease	disease	NOUN
ajmsi-3181	130	64	22	22	NUM
ajmsi-3181	130	65	6.14	6.14	NUM
ajmsi-3181	130	66	pregnancy	pregnancy	NOUN
ajmsi-3181	130	67	8	8	NUM
ajmsi-3181	130	68	2.23	2.23	NUM
ajmsi-3181	130	69	valvular	valvular	ADJ
ajmsi-3181	130	70	disease	disease	NOUN
ajmsi-3181	130	71	13	13	NUM
ajmsi-3181	130	72	3.63	3.63	NUM
ajmsi-3181	130	73	cystic	cystic	ADJ
ajmsi-3181	130	74	fibrosis	fibrosis	NOUN
ajmsi-3181	130	75	0	0	NUM
ajmsi-3181	130	76	0	0	NUM
ajmsi-3181	130	77	inflammatory	inflammatory	ADJ
ajmsi-3181	130	78	bowel	bowel	NOUN
ajmsi-3181	130	79	disease	disease	NOUN
ajmsi-3181	130	80	1	1	NUM
ajmsi-3181	130	81	0.27	0.27	NUM
ajmsi-3181	130	82	tuberculosis	tuberculosis	NOUN
ajmsi-3181	130	83	1	1	NUM
ajmsi-3181	130	84	0.27	0.27	NUM
ajmsi-3181	130	85	immunosuppressive	immunosuppressive	ADJ
ajmsi-3181	130	86	treatment	treatment	NOUN
ajmsi-3181	130	87	24	24	NUM
ajmsi-3181	130	88	6.70	6.70	NUM
ajmsi-3181	130	89	figure	figure	NOUN
ajmsi-3181	130	90	5	5	NUM
ajmsi-3181	130	91	presents	present	VERB
ajmsi-3181	130	92	the	the	DET
ajmsi-3181	130	93	survival	survival	NOUN
ajmsi-3181	130	94	probability	probability	NOUN
ajmsi-3181	130	95	comparison	comparison	NOUN
ajmsi-3181	130	96	between	between	ADP
ajmsi-3181	130	97	diabetic	diabetic	ADJ
ajmsi-3181	130	98	and	and	CCONJ
ajmsi-3181	130	99	non	non	ADJ
ajmsi-3181	130	100	-	-	ADJ
ajmsi-3181	130	101	diabetic	diabetic	ADJ
ajmsi-3181	130	102	patients	patient	NOUN
ajmsi-3181	130	103	following	follow	VERB
ajmsi-3181	130	104	a	a	DET
ajmsi-3181	130	105	positive	positive	ADJ
ajmsi-3181	130	106	culture	culture	NOUN
ajmsi-3181	130	107	.	.	PUNCT
ajmsi-3181	131	1	according	accord	VERB
ajmsi-3181	131	2	to	to	ADP
ajmsi-3181	131	3	the	the	DET
ajmsi-3181	131	4	graph	graph	NOUN
ajmsi-3181	131	5	,	,	PUNCT
ajmsi-3181	131	6	patients	patient	NOUN
ajmsi-3181	131	7	without	without	ADP
ajmsi-3181	131	8	diabetes	diabetes	NOUN
ajmsi-3181	131	9	have	have	VERB
ajmsi-3181	131	10	a	a	DET
ajmsi-3181	131	11	better	well	ADJ
ajmsi-3181	131	12	chance	chance	NOUN
ajmsi-3181	131	13	of	of	ADP
ajmsi-3181	131	14	surviving	survive	VERB
ajmsi-3181	131	15	than	than	ADP
ajmsi-3181	131	16	those	those	PRON
ajmsi-3181	131	17	with	with	ADP
ajmsi-3181	131	18	the	the	DET
ajmsi-3181	131	19	disease	disease	NOUN
ajmsi-3181	131	20	.	.	PUNCT
ajmsi-3181	132	1	this	this	DET
ajmsi-3181	132	2	observation	observation	NOUN
ajmsi-3181	132	3	underscores	underscore	VERB
ajmsi-3181	132	4	the	the	DET
ajmsi-3181	132	5	potential	potential	ADJ
ajmsi-3181	132	6	impact	impact	NOUN
ajmsi-3181	132	7	of	of	ADP
ajmsi-3181	132	8	diabetes	diabetes	NOUN
ajmsi-3181	132	9	as	as	ADP
ajmsi-3181	132	10	a	a	DET
ajmsi-3181	132	11	comorbidity	comorbidity	NOUN
ajmsi-3181	132	12	on	on	ADP
ajmsi-3181	132	13	patient	patient	ADJ
ajmsi-3181	132	14	outcomes	outcome	NOUN
ajmsi-3181	132	15	in	in	ADP
ajmsi-3181	132	16	cases	case	NOUN
ajmsi-3181	132	17	of	of	ADP
ajmsi-3181	132	18	gram	gram	NOUN
ajmsi-3181	132	19	-	-	PUNCT
ajmsi-3181	132	20	negative	negative	ADJ
ajmsi-3181	132	21	bacteremia	bacteremia	NOUN
ajmsi-3181	132	22	.	.	PUNCT
ajmsi-3181	133	1	understanding	understand	VERB
ajmsi-3181	133	2	such	such	ADJ
ajmsi-3181	133	3	differences	difference	NOUN
ajmsi-3181	133	4	in	in	ADP
ajmsi-3181	133	5	survival	survival	NOUN
ajmsi-3181	133	6	probabilities	probability	NOUN
ajmsi-3181	133	7	can	can	AUX
ajmsi-3181	133	8	inform	inform	VERB
ajmsi-3181	133	9	clinical	clinical	ADJ
ajmsi-3181	133	10	decision	decision	NOUN
ajmsi-3181	133	11	-	-	PUNCT
ajmsi-3181	133	12	making	making	NOUN
ajmsi-3181	133	13	and	and	CCONJ
ajmsi-3181	133	14	highlight	highlight	VERB
ajmsi-3181	133	15	the	the	DET
ajmsi-3181	133	16	importance	importance	NOUN
ajmsi-3181	133	17	of	of	ADP
ajmsi-3181	133	18	tailored	tailor	VERB
ajmsi-3181	133	19	management	management	NOUN
ajmsi-3181	133	20	strategies	strategy	NOUN
ajmsi-3181	133	21	for	for	ADP
ajmsi-3181	133	22	patients	patient	NOUN
ajmsi-3181	133	23	with	with	ADP
ajmsi-3181	133	24	diabetes	diabete	NOUN
ajmsi-3181	133	25	who	who	PRON
ajmsi-3181	133	26	develop	develop	VERB
ajmsi-3181	133	27	gram	gram	NUM
ajmsi-3181	133	28	-	-	PUNCT
ajmsi-3181	133	29	negative	negative	ADJ
ajmsi-3181	133	30	bacteremia	bacteremia	NOUN
ajmsi-3181	133	31	.	.	PUNCT
ajmsi-3181	134	1	figure	figure	NOUN
ajmsi-3181	134	2	5	5	NUM
ajmsi-3181	134	3	:	:	PUNCT
ajmsi-3181	134	4	kaplan	kaplan	PROPN
ajmsi-3181	134	5	-	-	PUNCT
ajmsi-3181	134	6	meier	meier	PROPN
ajmsi-3181	134	7	survival	survival	NOUN
ajmsi-3181	134	8	analysis	analysis	NOUN
ajmsi-3181	134	9	denoting	denote	VERB
ajmsi-3181	134	10	survival	survival	NOUN
ajmsi-3181	134	11	probability	probability	NOUN
ajmsi-3181	134	12	of	of	ADP
ajmsi-3181	134	13	diabetic	diabetic	ADJ
ajmsi-3181	134	14	and	and	CCONJ
ajmsi-3181	134	15	non	non	ADJ
ajmsi-3181	134	16	-	-	ADJ
ajmsi-3181	134	17	diabetic	diabetic	ADJ
ajmsi-3181	134	18	groups	group	NOUN
ajmsi-3181	134	19	table	table	VERB
ajmsi-3181	135	1	6	6	NUM
ajmsi-3181	135	2	presents	present	VERB
ajmsi-3181	135	3	the	the	DET
ajmsi-3181	135	4	duration	duration	NOUN
ajmsi-3181	135	5	of	of	ADP
ajmsi-3181	135	6	antibiotic	antibiotic	ADJ
ajmsi-3181	135	7	treatment	treatment	NOUN
ajmsi-3181	135	8	in	in	ADP
ajmsi-3181	135	9	diabetic	diabetic	ADJ
ajmsi-3181	135	10	(	(	PUNCT
ajmsi-3181	135	11	dm	dm	PROPN
ajmsi-3181	135	12	)	)	PUNCT
ajmsi-3181	135	13	and	and	CCONJ
ajmsi-3181	135	14	non	non	ADJ
ajmsi-3181	135	15	-	-	ADJ
ajmsi-3181	135	16	diabetic	diabetic	ADJ
ajmsi-3181	135	17	(	(	PUNCT
ajmsi-3181	135	18	non	non	ADJ
ajmsi-3181	135	19	-	-	ADJ
ajmsi-3181	135	20	dm	dm	ADJ
ajmsi-3181	135	21	)	)	PUNCT
ajmsi-3181	135	22	patient	patient	NOUN
ajmsi-3181	135	23	groups	group	NOUN
ajmsi-3181	135	24	with	with	ADP
ajmsi-3181	135	25	gram	gram	NOUN
ajmsi-3181	135	26	-	-	PUNCT
ajmsi-3181	135	27	negative	negative	ADJ
ajmsi-3181	135	28	bacteremia	bacteremia	NOUN
ajmsi-3181	135	29	.	.	PUNCT
ajmsi-3181	136	1	statistical	statistical	ADJ
ajmsi-3181	136	2	analysis	analysis	NOUN
ajmsi-3181	136	3	revealed	reveal	VERB
ajmsi-3181	136	4	no	no	DET
ajmsi-3181	136	5	significant	significant	ADJ
ajmsi-3181	136	6	difference	difference	NOUN
ajmsi-3181	136	7	in	in	ADP
ajmsi-3181	136	8	the	the	DET
ajmsi-3181	136	9	duration	duration	NOUN
ajmsi-3181	136	10	of	of	ADP
ajmsi-3181	136	11	antibiotic	antibiotic	ADJ
ajmsi-3181	136	12	treatment	treatment	NOUN
ajmsi-3181	136	13	between	between	ADP
ajmsi-3181	136	14	the	the	DET
ajmsi-3181	136	15	two	two	NUM
ajmsi-3181	136	16	groups	group	NOUN
ajmsi-3181	136	17	(	(	PUNCT
ajmsi-3181	136	18	p=0.617	p=0.617	ADJ
ajmsi-3181	136	19	)	)	PUNCT
ajmsi-3181	136	20	.	.	PUNCT
ajmsi-3181	137	1	most	most	ADJ
ajmsi-3181	137	2	patients	patient	NOUN
ajmsi-3181	137	3	in	in	ADP
ajmsi-3181	137	4	both	both	DET
ajmsi-3181	137	5	groups	group	NOUN
ajmsi-3181	137	6	received	receive	VERB
ajmsi-3181	137	7	antibiotics	antibiotic	NOUN
ajmsi-3181	137	8	for	for	ADP
ajmsi-3181	137	9	more	more	ADJ
ajmsi-3181	137	10	than	than	ADP
ajmsi-3181	137	11	14	14	NUM
ajmsi-3181	137	12	days	day	NOUN
ajmsi-3181	137	13	,	,	PUNCT
ajmsi-3181	137	14	with	with	ADP
ajmsi-3181	137	15	63	63	NUM
ajmsi-3181	137	16	(	(	PUNCT
ajmsi-3181	137	17	31.98	31.98	NUM
ajmsi-3181	137	18	%	%	NOUN
ajmsi-3181	137	19	)	)	PUNCT
ajmsi-3181	137	20	in	in	ADP
ajmsi-3181	137	21	the	the	DET
ajmsi-3181	137	22	dm	dm	PROPN
ajmsi-3181	137	23	group	group	NOUN
ajmsi-3181	137	24	and	and	CCONJ
ajmsi-3181	137	25	52	52	NUM
ajmsi-3181	137	26	(	(	PUNCT
ajmsi-3181	137	27	32.5	32.5	NUM
ajmsi-3181	137	28	%	%	NOUN
ajmsi-3181	137	29	)	)	PUNCT
ajmsi-3181	137	30	in	in	ADP
ajmsi-3181	137	31	the	the	DET
ajmsi-3181	137	32	non	non	ADJ
ajmsi-3181	137	33	-	-	ADJ
ajmsi-3181	137	34	dm	dm	ADJ
ajmsi-3181	137	35	group	group	NOUN
ajmsi-3181	137	36	.	.	PUNCT
ajmsi-3181	138	1	interestingly	interestingly	ADV
ajmsi-3181	138	2	,	,	PUNCT
ajmsi-3181	138	3	a	a	DET
ajmsi-3181	138	4	pa	pa	PROPN
ajmsi-3181	138	5	ge	ge	PROPN
ajmsi-3181	138	6	98	98	NUM
ajmsi-3181	138	7	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-3181	138	8	am	be	AUX
ajmsi-3181	138	9	.	.	PUNCT
ajmsi-3181	139	1	j.	j.	PROPN
ajmsi-3181	139	2	med	med	PROPN
ajmsi-3181	139	3	.	.	PUNCT
ajmsi-3181	140	1	sci	sci	PROPN
ajmsi-3181	140	2	.	.	PUNCT
ajmsi-3181	140	3	innov	innov	PROPN
ajmsi-3181	140	4	.	.	PUNCT
ajmsi-3181	141	1	3(2	3(2	NUM
ajmsi-3181	141	2	)	)	PUNCT
ajmsi-3181	141	3	91	91	NUM
ajmsi-3181	141	4	-	-	SYM
ajmsi-3181	141	5	102	102	NUM
ajmsi-3181	141	6	,	,	PUNCT
ajmsi-3181	141	7	2024	2024	NUM
ajmsi-3181	141	8	slightly	slightly	ADV
ajmsi-3181	141	9	higher	high	ADJ
ajmsi-3181	141	10	percentage	percentage	NOUN
ajmsi-3181	141	11	of	of	ADP
ajmsi-3181	141	12	diabetic	diabetic	ADJ
ajmsi-3181	141	13	patients	patient	NOUN
ajmsi-3181	141	14	(	(	PUNCT
ajmsi-3181	141	15	10.63	10.63	NUM
ajmsi-3181	141	16	%	%	NOUN
ajmsi-3181	141	17	)	)	PUNCT
ajmsi-3181	141	18	received	receive	VERB
ajmsi-3181	141	19	antibiotics	antibiotic	NOUN
ajmsi-3181	141	20	for	for	ADP
ajmsi-3181	141	21	less	less	ADJ
ajmsi-3181	141	22	than	than	ADP
ajmsi-3181	141	23	7	7	NUM
ajmsi-3181	141	24	days	day	NOUN
ajmsi-3181	141	25	compared	compare	VERB
ajmsi-3181	141	26	to	to	ADP
ajmsi-3181	141	27	non	non	ADJ
ajmsi-3181	141	28	-	-	ADJ
ajmsi-3181	141	29	diabetic	diabetic	ADJ
ajmsi-3181	141	30	patients	patient	NOUN
ajmsi-3181	141	31	(	(	PUNCT
ajmsi-3181	141	32	8.63	8.63	NUM
ajmsi-3181	141	33	%	%	NOUN
ajmsi-3181	141	34	)	)	PUNCT
ajmsi-3181	141	35	.	.	PUNCT
ajmsi-3181	142	1	moreover	moreover	ADV
ajmsi-3181	142	2	,	,	PUNCT
ajmsi-3181	142	3	a	a	DET
ajmsi-3181	142	4	somewhat	somewhat	ADV
ajmsi-3181	142	5	higher	high	ADJ
ajmsi-3181	142	6	proportion	proportion	NOUN
ajmsi-3181	142	7	of	of	ADP
ajmsi-3181	142	8	diabetic	diabetic	ADJ
ajmsi-3181	142	9	patients	patient	NOUN
ajmsi-3181	142	10	(	(	PUNCT
ajmsi-3181	142	11	35.63	35.63	NUM
ajmsi-3181	142	12	%	%	NOUN
ajmsi-3181	142	13	)	)	PUNCT
ajmsi-3181	142	14	received	receive	VERB
ajmsi-3181	142	15	antibiotics	antibiotic	NOUN
ajmsi-3181	142	16	for	for	ADP
ajmsi-3181	142	17	11	11	NUM
ajmsi-3181	142	18	to	to	PART
ajmsi-3181	142	19	14	14	NUM
ajmsi-3181	142	20	days	day	NOUN
ajmsi-3181	142	21	compared	compare	VERB
ajmsi-3181	142	22	to	to	ADP
ajmsi-3181	142	23	non	non	ADJ
ajmsi-3181	142	24	-	-	ADJ
ajmsi-3181	142	25	diabetic	diabetic	ADJ
ajmsi-3181	142	26	patients	patient	NOUN
ajmsi-3181	142	27	(	(	PUNCT
ajmsi-3181	142	28	32.49	32.49	NUM
ajmsi-3181	142	29	%	%	NOUN
ajmsi-3181	142	30	)	)	PUNCT
ajmsi-3181	142	31	.	.	PUNCT
ajmsi-3181	143	1	table	table	NOUN
ajmsi-3181	143	2	6	6	NUM
ajmsi-3181	143	3	:	:	PUNCT
ajmsi-3181	144	1	total	total	ADJ
ajmsi-3181	144	2	duration	duration	NOUN
ajmsi-3181	144	3	of	of	ADP
ajmsi-3181	144	4	antibiotic	antibiotic	ADJ
ajmsi-3181	144	5	treatment	treatment	NOUN
ajmsi-3181	144	6	in	in	ADP
ajmsi-3181	144	7	diabetic	diabetic	ADJ
ajmsi-3181	144	8	and	and	CCONJ
ajmsi-3181	144	9	non	non	ADJ
ajmsi-3181	144	10	-	-	ADJ
ajmsi-3181	144	11	diabetic	diabetic	ADJ
ajmsi-3181	144	12	patients	patient	NOUN
ajmsi-3181	144	13	total	total	VERB
ajmsi-3181	144	14	duration	duration	NOUN
ajmsi-3181	144	15	of	of	ADP
ajmsi-3181	144	16	treatment	treatment	NOUN
ajmsi-3181	144	17	(	(	PUNCT
ajmsi-3181	144	18	days	day	NOUN
ajmsi-3181	144	19	)	)	PUNCT
ajmsi-3181	144	20	non	non	ADJ
ajmsi-3181	144	21	-	-	ADJ
ajmsi-3181	144	22	dm	dm	INTJ
ajmsi-3181	144	23	(	(	PUNCT
ajmsi-3181	144	24	n=197	n=197	NOUN
ajmsi-3181	144	25	)	)	PUNCT
ajmsi-3181	144	26	dm	dm	PROPN
ajmsi-3181	144	27	(	(	PUNCT
ajmsi-3181	144	28	n=160	n=160	PROPN
ajmsi-3181	144	29	)	)	PUNCT
ajmsi-3181	144	30	count	count	NOUN
ajmsi-3181	144	31	percentages	percentage	NOUN
ajmsi-3181	144	32	%	%	VERB
ajmsi-3181	144	33	count	count	NOUN
ajmsi-3181	144	34	percentages	percentage	NOUN
ajmsi-3181	144	35	%	%	VERB
ajmsi-3181	144	36	less	less	ADJ
ajmsi-3181	144	37	than	than	ADP
ajmsi-3181	144	38	7	7	NUM
ajmsi-3181	144	39	days	day	NOUN
ajmsi-3181	144	40	17	17	NUM
ajmsi-3181	144	41	8.63	8.63	NUM
ajmsi-3181	144	42	17	17	NUM
ajmsi-3181	144	43	10.63	10.63	NUM
ajmsi-3181	144	44	7	7	NUM
ajmsi-3181	144	45	to	to	PART
ajmsi-3181	144	46	10	10	NUM
ajmsi-3181	144	47	days	day	NOUN
ajmsi-3181	144	48	53	53	NUM
ajmsi-3181	144	49	26.90	26.90	NUM
ajmsi-3181	144	50	34	34	NUM
ajmsi-3181	144	51	21.25	21.25	NUM
ajmsi-3181	144	52	11	11	NUM
ajmsi-3181	144	53	to	to	PART
ajmsi-3181	144	54	14	14	NUM
ajmsi-3181	144	55	days	day	NOUN
ajmsi-3181	144	56	64	64	NUM
ajmsi-3181	144	57	32.49	32.49	NUM
ajmsi-3181	144	58	57	57	NUM
ajmsi-3181	144	59	35.63	35.63	NUM
ajmsi-3181	144	60	more	more	ADJ
ajmsi-3181	144	61	than	than	ADP
ajmsi-3181	144	62	14	14	NUM
ajmsi-3181	144	63	days	day	NOUN
ajmsi-3181	144	64	63	63	NUM
ajmsi-3181	144	65	31.98	31.98	NUM
ajmsi-3181	144	66	52	52	NUM
ajmsi-3181	144	67	32.5	32.5	NUM
ajmsi-3181	144	68	p	p	NOUN
ajmsi-3181	144	69	-	-	PUNCT
ajmsi-3181	144	70	value	value	NOUN
ajmsi-3181	144	71	=	=	NOUN
ajmsi-3181	144	72	0.617	0.617	NUM
ajmsi-3181	144	73	univariate	univariate	ADJ
ajmsi-3181	144	74	analysis	analysis	NOUN
ajmsi-3181	144	75	of	of	ADP
ajmsi-3181	144	76	recurrence	recurrence	NOUN
ajmsi-3181	144	77	at	at	ADP
ajmsi-3181	144	78	90	90	NUM
ajmsi-3181	144	79	days	day	NOUN
ajmsi-3181	144	80	,	,	PUNCT
ajmsi-3181	144	81	cure	cure	NOUN
ajmsi-3181	144	82	rate	rate	NOUN
ajmsi-3181	144	83	,	,	PUNCT
ajmsi-3181	144	84	and	and	CCONJ
ajmsi-3181	144	85	death	death	NOUN
ajmsi-3181	144	86	due	due	ADP
ajmsi-3181	144	87	to	to	ADP
ajmsi-3181	144	88	sepsis	sepsis	NOUN
ajmsi-3181	144	89	showed	show	VERB
ajmsi-3181	144	90	a	a	DET
ajmsi-3181	144	91	significant	significant	ADJ
ajmsi-3181	144	92	difference	difference	NOUN
ajmsi-3181	144	93	between	between	ADP
ajmsi-3181	144	94	the	the	DET
ajmsi-3181	144	95	groups	group	NOUN
ajmsi-3181	144	96	(	(	PUNCT
ajmsi-3181	144	97	p=0.037	p=0.037	NOUN
ajmsi-3181	144	98	,	,	PUNCT
ajmsi-3181	144	99	p=0.09	p=0.09	PROPN
ajmsi-3181	144	100	,	,	PUNCT
ajmsi-3181	144	101	p=0.052	p=0.052	X
ajmsi-3181	144	102	,	,	PUNCT
ajmsi-3181	144	103	respectively	respectively	ADV
ajmsi-3181	144	104	.	.	PUNCT
ajmsi-3181	145	1	the	the	DET
ajmsi-3181	145	2	sepsis	sepsis	NOUN
ajmsi-3181	145	3	outcomes	outcome	VERB
ajmsi-3181	145	4	comparison	comparison	NOUN
ajmsi-3181	145	5	revealed	reveal	VERB
ajmsi-3181	145	6	that	that	SCONJ
ajmsi-3181	145	7	diabetic	diabetic	ADJ
ajmsi-3181	145	8	patients	patient	NOUN
ajmsi-3181	145	9	had	have	VERB
ajmsi-3181	145	10	a	a	DET
ajmsi-3181	145	11	higher	high	ADJ
ajmsi-3181	145	12	death	death	NOUN
ajmsi-3181	145	13	risk	risk	NOUN
ajmsi-3181	145	14	due	due	ADP
ajmsi-3181	145	15	to	to	ADP
ajmsi-3181	145	16	sepsis	sepsis	NOUN
ajmsi-3181	145	17	(	(	PUNCT
ajmsi-3181	145	18	11.88	11.88	NUM
ajmsi-3181	145	19	%	%	NOUN
ajmsi-3181	145	20	)	)	PUNCT
ajmsi-3181	145	21	and	and	CCONJ
ajmsi-3181	145	22	recurrence	recurrence	NOUN
ajmsi-3181	145	23	within	within	ADP
ajmsi-3181	145	24	90	90	NUM
ajmsi-3181	145	25	days	day	NOUN
ajmsi-3181	145	26	(	(	PUNCT
ajmsi-3181	145	27	8.75	8.75	NUM
ajmsi-3181	145	28	%	%	NOUN
ajmsi-3181	145	29	)	)	PUNCT
ajmsi-3181	145	30	compared	compare	VERB
ajmsi-3181	145	31	to	to	ADP
ajmsi-3181	145	32	non	non	ADJ
ajmsi-3181	145	33	-	-	ADJ
ajmsi-3181	145	34	diabetic	diabetic	ADJ
ajmsi-3181	145	35	patients	patient	NOUN
ajmsi-3181	145	36	.	.	PUNCT
ajmsi-3181	146	1	additionally	additionally	ADV
ajmsi-3181	146	2	,	,	PUNCT
ajmsi-3181	146	3	the	the	DET
ajmsi-3181	146	4	cure	cure	NOUN
ajmsi-3181	146	5	rate	rate	NOUN
ajmsi-3181	146	6	is	be	AUX
ajmsi-3181	146	7	less	less	ADJ
ajmsi-3181	146	8	(	(	PUNCT
ajmsi-3181	146	9	69.38	69.38	NUM
ajmsi-3181	146	10	%	%	NOUN
ajmsi-3181	146	11	)	)	PUNCT
ajmsi-3181	146	12	in	in	ADP
ajmsi-3181	146	13	diabetic	diabetic	ADJ
ajmsi-3181	146	14	patients	patient	NOUN
ajmsi-3181	146	15	than	than	ADP
ajmsi-3181	146	16	in	in	ADP
ajmsi-3181	146	17	nondiabetic	nondiabetic	ADJ
ajmsi-3181	146	18	patients	patient	NOUN
ajmsi-3181	146	19	(	(	PUNCT
ajmsi-3181	146	20	81.73	81.73	NUM
ajmsi-3181	146	21	%	%	NOUN
ajmsi-3181	146	22	)	)	PUNCT
ajmsi-3181	146	23	,	,	PUNCT
ajmsi-3181	146	24	as	as	SCONJ
ajmsi-3181	146	25	shown	show	VERB
ajmsi-3181	146	26	in	in	ADP
ajmsi-3181	146	27	table	table	NOUN
ajmsi-3181	146	28	7	7	NUM
ajmsi-3181	146	29	.	.	PUNCT
ajmsi-3181	146	30	table	table	NOUN
ajmsi-3181	146	31	7	7	NUM
ajmsi-3181	146	32	:	:	PUNCT
ajmsi-3181	146	33	univariate	univariate	ADJ
ajmsi-3181	146	34	analysis	analysis	NOUN
ajmsi-3181	146	35	of	of	ADP
ajmsi-3181	146	36	outcomes	outcome	NOUN
ajmsi-3181	146	37	in	in	ADP
ajmsi-3181	146	38	diabetic	diabetic	ADJ
ajmsi-3181	146	39	and	and	CCONJ
ajmsi-3181	146	40	non	non	ADJ
ajmsi-3181	146	41	-	-	ADJ
ajmsi-3181	146	42	diabetic	diabetic	ADJ
ajmsi-3181	146	43	patients	patient	NOUN
ajmsi-3181	146	44	outcome	outcome	VERB
ajmsi-3181	146	45	(	(	PUNCT
ajmsi-3181	146	46	fisher	fisher	PROPN
ajmsi-3181	146	47	's	's	PART
ajmsi-3181	146	48	exact	exact	ADJ
ajmsi-3181	146	49	)	)	PUNCT
ajmsi-3181	146	50	non	non	ADJ
ajmsi-3181	146	51	-	-	ADJ
ajmsi-3181	146	52	dm	dm	INTJ
ajmsi-3181	146	53	(	(	PUNCT
ajmsi-3181	146	54	n=197	n=197	NOUN
ajmsi-3181	146	55	)	)	PUNCT
ajmsi-3181	146	56	dm	dm	PROPN
ajmsi-3181	146	57	(	(	PUNCT
ajmsi-3181	146	58	n=160	n=160	PROPN
ajmsi-3181	146	59	)	)	PUNCT
ajmsi-3181	146	60	p	p	ADJ
ajmsi-3181	146	61	-	-	PUNCT
ajmsi-3181	146	62	value	value	NOUN
ajmsi-3181	146	63	death	death	NOUN
ajmsi-3181	146	64	due	due	ADP
ajmsi-3181	146	65	to	to	ADP
ajmsi-3181	146	66	sepsis	sepsis	NOUN
ajmsi-3181	146	67	11	11	NUM
ajmsi-3181	146	68	(	(	PUNCT
ajmsi-3181	146	69	5.58	5.58	NUM
ajmsi-3181	146	70	%	%	NOUN
ajmsi-3181	146	71	)	)	PUNCT
ajmsi-3181	146	72	19	19	NUM
ajmsi-3181	146	73	(	(	PUNCT
ajmsi-3181	146	74	11.88	11.88	NUM
ajmsi-3181	146	75	%	%	NOUN
ajmsi-3181	146	76	)	)	PUNCT
ajmsi-3181	146	77	0.052	0.052	NUM
ajmsi-3181	146	78	recurrence	recurrence	NOUN
ajmsi-3181	146	79	in	in	ADP
ajmsi-3181	146	80	90	90	NUM
ajmsi-3181	146	81	days	day	NOUN
ajmsi-3181	146	82	7	7	NUM
ajmsi-3181	146	83	(	(	PUNCT
ajmsi-3181	146	84	3.55	3.55	NUM
ajmsi-3181	146	85	%	%	NOUN
ajmsi-3181	146	86	)	)	PUNCT
ajmsi-3181	146	87	14	14	NUM
ajmsi-3181	146	88	(	(	PUNCT
ajmsi-3181	146	89	8.75	8.75	NUM
ajmsi-3181	146	90	%	%	NOUN
ajmsi-3181	146	91	)	)	PUNCT
ajmsi-3181	146	92	0.037	0.037	NUM
ajmsi-3181	146	93	cured	cure	VERB
ajmsi-3181	146	94	161	161	NUM
ajmsi-3181	146	95	(	(	PUNCT
ajmsi-3181	146	96	81.73	81.73	NUM
ajmsi-3181	146	97	%	%	NOUN
ajmsi-3181	146	98	)	)	PUNCT
ajmsi-3181	146	99	111	111	NUM
ajmsi-3181	146	100	(	(	PUNCT
ajmsi-3181	146	101	69.38	69.38	NUM
ajmsi-3181	146	102	%	%	NOUN
ajmsi-3181	146	103	)	)	PUNCT
ajmsi-3181	146	104	0.009	0.009	NUM
ajmsi-3181	146	105	age	age	NOUN
ajmsi-3181	146	106	,	,	PUNCT
ajmsi-3181	146	107	treatment	treatment	NOUN
ajmsi-3181	146	108	duration	duration	NOUN
ajmsi-3181	146	109	of	of	ADP
ajmsi-3181	146	110	fewer	few	ADJ
ajmsi-3181	146	111	than	than	ADP
ajmsi-3181	146	112	seven	seven	NUM
ajmsi-3181	146	113	days	day	NOUN
ajmsi-3181	146	114	,	,	PUNCT
ajmsi-3181	146	115	and	and	CCONJ
ajmsi-3181	146	116	hospital	hospital	NOUN
ajmsi-3181	146	117	-	-	PUNCT
ajmsi-3181	146	118	acquired	acquire	VERB
ajmsi-3181	146	119	infections	infection	NOUN
ajmsi-3181	146	120	showed	show	VERB
ajmsi-3181	146	121	a	a	DET
ajmsi-3181	146	122	significant	significant	ADJ
ajmsi-3181	146	123	association	association	NOUN
ajmsi-3181	146	124	with	with	ADP
ajmsi-3181	146	125	higher	high	ADJ
ajmsi-3181	146	126	mortality	mortality	NOUN
ajmsi-3181	146	127	in	in	ADP
ajmsi-3181	146	128	gram	gram	NOUN
ajmsi-3181	146	129	-	-	PUNCT
ajmsi-3181	146	130	negative	negative	ADJ
ajmsi-3181	146	131	bacteremia	bacteremia	NOUN
ajmsi-3181	146	132	in	in	ADP
ajmsi-3181	146	133	the	the	DET
ajmsi-3181	146	134	multivariate	multivariate	NOUN
ajmsi-3181	146	135	analysis	analysis	NOUN
ajmsi-3181	146	136	(	(	PUNCT
ajmsi-3181	146	137	or=1.040	or=1.040	ADJ
ajmsi-3181	146	138	,	,	PUNCT
ajmsi-3181	146	139	p=0.014	p=0.014	PRON
ajmsi-3181	146	140	)	)	PUNCT
ajmsi-3181	146	141	,	,	PUNCT
ajmsi-3181	146	142	(	(	PUNCT
ajmsi-3181	146	143	or=20.030	or=20.030	NOUN
ajmsi-3181	146	144	,	,	PUNCT
ajmsi-3181	146	145	p=0.001	p=0.001	NUM
ajmsi-3181	146	146	)	)	PUNCT
ajmsi-3181	146	147	,	,	PUNCT
ajmsi-3181	146	148	(	(	PUNCT
ajmsi-3181	146	149	or=3.517	or=3.517	X
ajmsi-3181	146	150	,	,	PUNCT
ajmsi-3181	146	151	p=0.020	p=0.020	ADV
ajmsi-3181	146	152	)	)	PUNCT
ajmsi-3181	146	153	respectively	respectively	ADV
ajmsi-3181	146	154	.	.	PUNCT
ajmsi-3181	147	1	conversely	conversely	ADV
ajmsi-3181	147	2	,	,	PUNCT
ajmsi-3181	147	3	the	the	DET
ajmsi-3181	147	4	presence	presence	NOUN
ajmsi-3181	147	5	of	of	ADP
ajmsi-3181	147	6	e.	e.	PROPN
ajmsi-3181	147	7	coli	coli	PROPN
ajmsi-3181	147	8	and	and	CCONJ
ajmsi-3181	147	9	uti	uti	PROPN
ajmsi-3181	147	10	as	as	SCONJ
ajmsi-3181	147	11	sources	source	NOUN
ajmsi-3181	147	12	of	of	ADP
ajmsi-3181	147	13	infection	infection	NOUN
ajmsi-3181	147	14	was	be	AUX
ajmsi-3181	147	15	not	not	PART
ajmsi-3181	147	16	significantly	significantly	ADV
ajmsi-3181	147	17	associated	associate	VERB
ajmsi-3181	147	18	with	with	ADP
ajmsi-3181	147	19	mortality	mortality	NOUN
ajmsi-3181	147	20	due	due	ADP
ajmsi-3181	147	21	to	to	ADP
ajmsi-3181	147	22	sepsis	sepsis	NOUN
ajmsi-3181	147	23	.	.	PUNCT
ajmsi-3181	148	1	kaplan	kaplan	PROPN
ajmsi-3181	148	2	-	-	PUNCT
ajmsi-3181	148	3	meier	meier	PROPN
ajmsi-3181	148	4	survival	survival	NOUN
ajmsi-3181	148	5	analysis	analysis	NOUN
ajmsi-3181	148	6	was	be	AUX
ajmsi-3181	148	7	used	use	VERB
ajmsi-3181	148	8	to	to	PART
ajmsi-3181	148	9	assess	assess	VERB
ajmsi-3181	148	10	the	the	DET
ajmsi-3181	148	11	survival	survival	NOUN
ajmsi-3181	148	12	probability	probability	NOUN
ajmsi-3181	148	13	of	of	ADP
ajmsi-3181	148	14	the	the	DET
ajmsi-3181	148	15	diabetic	diabetic	ADJ
ajmsi-3181	148	16	and	and	CCONJ
ajmsi-3181	148	17	non	non	ADJ
ajmsi-3181	148	18	-	-	ADJ
ajmsi-3181	148	19	diabetic	diabetic	ADJ
ajmsi-3181	148	20	groups	group	NOUN
ajmsi-3181	148	21	.	.	PUNCT
ajmsi-3181	149	1	the	the	DET
ajmsi-3181	149	2	log	log	NOUN
ajmsi-3181	149	3	-	-	PUNCT
ajmsi-3181	149	4	rank	rank	NOUN
ajmsi-3181	149	5	test	test	NOUN
ajmsi-3181	149	6	result	result	NOUN
ajmsi-3181	149	7	was	be	AUX
ajmsi-3181	149	8	insignificant	insignificant	ADJ
ajmsi-3181	149	9	(	(	PUNCT
ajmsi-3181	149	10	p=0.934	p=0.934	NOUN
ajmsi-3181	149	11	)	)	PUNCT
ajmsi-3181	149	12	,	,	PUNCT
ajmsi-3181	149	13	as	as	SCONJ
ajmsi-3181	149	14	shown	show	VERB
ajmsi-3181	149	15	in	in	ADP
ajmsi-3181	149	16	table	table	NOUN
ajmsi-3181	149	17	8	8	NUM
ajmsi-3181	149	18	.	.	PUNCT
ajmsi-3181	149	19	table	table	NOUN
ajmsi-3181	149	20	8	8	NUM
ajmsi-3181	149	21	:	:	PUNCT
ajmsi-3181	149	22	multivariate	multivariate	VERB
ajmsi-3181	149	23	analysis	analysis	NOUN
ajmsi-3181	149	24	of	of	ADP
ajmsi-3181	149	25	factors	factor	NOUN
ajmsi-3181	149	26	associated	associate	VERB
ajmsi-3181	149	27	with	with	ADP
ajmsi-3181	149	28	mortality	mortality	NOUN
ajmsi-3181	149	29	in	in	ADP
ajmsi-3181	149	30	gram	gram	NOUN
ajmsi-3181	149	31	-	-	PUNCT
ajmsi-3181	149	32	negative	negative	ADJ
ajmsi-3181	149	33	bacteremia	bacteremia	NOUN
ajmsi-3181	149	34	patients	patient	NOUN
ajmsi-3181	149	35	adjusting	adjust	VERB
ajmsi-3181	149	36	for	for	ADP
ajmsi-3181	149	37	baseline	baseline	ADJ
ajmsi-3181	149	38	characteristics	characteristic	NOUN
ajmsi-3181	149	39	variable	variable	NOUN
ajmsi-3181	149	40	or	or	CCONJ
ajmsi-3181	149	41	p	p	NOUN
ajmsi-3181	149	42	-	-	PUNCT
ajmsi-3181	149	43	value	value	NOUN
ajmsi-3181	149	44	95	95	NUM
ajmsi-3181	149	45	%	%	NOUN
ajmsi-3181	149	46	confidence	confidence	NOUN
ajmsi-3181	149	47	interval	interval	NOUN
ajmsi-3181	149	48	age	age	NOUN
ajmsi-3181	149	49	1.040	1.040	NUM
ajmsi-3181	149	50	0.014	0.014	NUM
ajmsi-3181	149	51	1.008	1.008	NUM
ajmsi-3181	149	52	1.072	1.072	NUM
ajmsi-3181	149	53	male	male	NOUN
ajmsi-3181	149	54	1.609	1.609	NUM
ajmsi-3181	149	55	0.448	0.448	NUM
ajmsi-3181	149	56	0.471	0.471	NUM
ajmsi-3181	149	57	5.496	5.496	NUM
ajmsi-3181	149	58	dm	dm	NUM
ajmsi-3181	149	59	1.008	1.008	NUM
ajmsi-3181	149	60	0.990	0.990	NUM
ajmsi-3181	149	61	0.314	0.314	NUM
ajmsi-3181	149	62	5.496	5.496	NUM
ajmsi-3181	149	63	htn	htn	NOUN
ajmsi-3181	149	64	4.060	4.060	NUM
ajmsi-3181	149	65	0.056	0.056	NUM
ajmsi-3181	149	66	0.967	0.967	NUM
ajmsi-3181	149	67	17.049	17.049	NUM
ajmsi-3181	149	68	esrd	esrd	PROPN
ajmsi-3181	149	69	/	/	SYM
ajmsi-3181	149	70	hd	hd	PROPN
ajmsi-3181	149	71	1.237	1.237	NUM
ajmsi-3181	149	72	0.756	0.756	NUM
ajmsi-3181	149	73	0.324	0.324	NUM
ajmsi-3181	149	74	4.716	4.716	NUM
ajmsi-3181	149	75	less	less	ADJ
ajmsi-3181	149	76	than	than	ADP
ajmsi-3181	149	77	7	7	NUM
ajmsi-3181	149	78	days	day	NOUN
ajmsi-3181	149	79	of	of	ADP
ajmsi-3181	149	80	treatment	treatment	NOUN
ajmsi-3181	149	81	20.030	20.030	NUM
ajmsi-3181	149	82	<	<	NOUN
ajmsi-3181	149	83	0.001	0.001	NUM
ajmsi-3181	149	84	5.454	5.454	NUM
ajmsi-3181	149	85	75.038	75.038	NUM
ajmsi-3181	149	86	hospital	hospital	NOUN
ajmsi-3181	149	87	-	-	PUNCT
ajmsi-3181	149	88	acquired	acquire	VERB
ajmsi-3181	149	89	3.517	3.517	NUM
ajmsi-3181	149	90	0.020	0.020	NUM
ajmsi-3181	149	91	1.217	1.217	NUM
ajmsi-3181	149	92	10.168	10.168	NUM
ajmsi-3181	149	93	secondary	secondary	ADJ
ajmsi-3181	149	94	1.394	1.394	NUM
ajmsi-3181	149	95	0.559	0.559	NUM
ajmsi-3181	149	96	0.457	0.457	NUM
ajmsi-3181	149	97	4.253	4.253	NUM
ajmsi-3181	149	98	mdr	mdr	NOUN
ajmsi-3181	149	99	0.588	0.588	NUM
ajmsi-3181	149	100	0.547	0.547	NUM
ajmsi-3181	149	101	0.104	0.104	NUM
ajmsi-3181	149	102	3.309	3.309	NUM
ajmsi-3181	149	103	e.	e.	PROPN
ajmsi-3181	149	104	coli	coli	NOUN
ajmsi-3181	149	105	0.457	0.457	NUM
ajmsi-3181	149	106	0.192	0.192	NUM
ajmsi-3181	149	107	0.141	0.141	NUM
ajmsi-3181	149	108	1.482	1.482	NUM
ajmsi-3181	149	109	uti	uti	PROPN
ajmsi-3181	149	110	a	a	DET
ajmsi-3181	149	111	source	source	NOUN
ajmsi-3181	149	112	of	of	ADP
ajmsi-3181	149	113	infection	infection	NOUN
ajmsi-3181	149	114	0.043	0.043	NUM
ajmsi-3181	149	115	0.007	0.007	NUM
ajmsi-3181	149	116	0.004	0.004	NUM
ajmsi-3181	149	117	0.040	0.040	NUM
ajmsi-3181	149	118	discussion	discussion	NOUN
ajmsi-3181	149	119	gnb	gnb	PROPN
ajmsi-3181	149	120	bloodstream	bloodstream	NOUN
ajmsi-3181	149	121	infections	infection	NOUN
ajmsi-3181	149	122	pose	pose	VERB
ajmsi-3181	149	123	a	a	DET
ajmsi-3181	149	124	serious	serious	ADJ
ajmsi-3181	149	125	health	health	NOUN
ajmsi-3181	149	126	problem	problem	NOUN
ajmsi-3181	149	127	globally	globally	ADV
ajmsi-3181	149	128	and	and	CCONJ
ajmsi-3181	149	129	in	in	ADP
ajmsi-3181	149	130	the	the	DET
ajmsi-3181	149	131	middle	middle	PROPN
ajmsi-3181	149	132	east	east	PROPN
ajmsi-3181	149	133	,	,	PUNCT
ajmsi-3181	149	134	where	where	SCONJ
ajmsi-3181	149	135	antimicrobial	antimicrobial	ADJ
ajmsi-3181	149	136	resistance	resistance	NOUN
ajmsi-3181	149	137	is	be	AUX
ajmsi-3181	149	138	rising	rise	VERB
ajmsi-3181	149	139	(	(	PUNCT
ajmsi-3181	149	140	inam	inam	NOUN
ajmsi-3181	149	141	et	et	PROPN
ajmsi-3181	149	142	al	al	PROPN
ajmsi-3181	149	143	.	.	PROPN
ajmsi-3181	149	144	,	,	PUNCT
ajmsi-3181	149	145	2023	2023	NUM
ajmsi-3181	149	146	)	)	PUNCT
ajmsi-3181	149	147	.	.	PUNCT
ajmsi-3181	150	1	several	several	ADJ
ajmsi-3181	150	2	studies	study	NOUN
ajmsi-3181	150	3	have	have	AUX
ajmsi-3181	150	4	been	be	AUX
ajmsi-3181	150	5	conducted	conduct	VERB
ajmsi-3181	150	6	in	in	ADP
ajmsi-3181	150	7	this	this	DET
ajmsi-3181	150	8	region	region	NOUN
ajmsi-3181	150	9	to	to	PART
ajmsi-3181	150	10	understand	understand	VERB
ajmsi-3181	150	11	this	this	DET
ajmsi-3181	150	12	condition	condition	NOUN
ajmsi-3181	150	13	’s	’s	PART
ajmsi-3181	150	14	epidemiology	epidemiology	NOUN
ajmsi-3181	150	15	and	and	CCONJ
ajmsi-3181	150	16	risk	risk	NOUN
ajmsi-3181	150	17	factors	factor	NOUN
ajmsi-3181	150	18	.	.	PUNCT
ajmsi-3181	151	1	the	the	DET
ajmsi-3181	151	2	emergence	emergence	NOUN
ajmsi-3181	151	3	of	of	ADP
ajmsi-3181	151	4	antimicrobial	antimicrobial	ADJ
ajmsi-3181	151	5	resistance	resistance	NOUN
ajmsi-3181	151	6	(	(	PUNCT
ajmsi-3181	151	7	amr	amr	NOUN
ajmsi-3181	151	8	)	)	PUNCT
ajmsi-3181	151	9	has	have	AUX
ajmsi-3181	151	10	been	be	AUX
ajmsi-3181	151	11	the	the	DET
ajmsi-3181	151	12	top	top	ADJ
ajmsi-3181	151	13	agenda	agenda	NOUN
ajmsi-3181	151	14	item	item	NOUN
ajmsi-3181	151	15	for	for	ADP
ajmsi-3181	151	16	the	the	DET
ajmsi-3181	151	17	past	past	ADJ
ajmsi-3181	151	18	four	four	NUM
ajmsi-3181	151	19	years	year	NOUN
ajmsi-3181	151	20	for	for	ADP
ajmsi-3181	151	21	the	the	DET
ajmsi-3181	151	22	gulf	gulf	PROPN
ajmsi-3181	151	23	cooperation	cooperation	PROPN
ajmsi-3181	151	24	council	council	PROPN
ajmsi-3181	151	25	centre	centre	NOUN
ajmsi-3181	151	26	for	for	ADP
ajmsi-3181	151	27	infection	infection	NOUN
ajmsi-3181	151	28	control	control	NOUN
ajmsi-3181	151	29	(	(	PUNCT
ajmsi-3181	151	30	gcc	gcc	NOUN
ajmsi-3181	151	31	-	-	PUNCT
ajmsi-3181	151	32	ic	ic	NOUN
ajmsi-3181	151	33	)	)	PUNCT
ajmsi-3181	151	34	(	(	PUNCT
ajmsi-3181	151	35	al	al	PROPN
ajmsi-3181	151	36	muhairi	muhairi	PROPN
ajmsi-3181	151	37	et	et	PROPN
ajmsi-3181	151	38	al	al	PROPN
ajmsi-3181	151	39	.	.	PROPN
ajmsi-3181	151	40	,	,	PUNCT
ajmsi-3181	151	41	2019	2019	NUM
ajmsi-3181	151	42	)	)	PUNCT
ajmsi-3181	151	43	.	.	PUNCT
ajmsi-3181	152	1	a	a	DET
ajmsi-3181	152	2	previous	previous	ADJ
ajmsi-3181	152	3	study	study	NOUN
ajmsi-3181	152	4	on	on	ADP
ajmsi-3181	152	5	the	the	DET
ajmsi-3181	152	6	epidemiology	epidemiology	NOUN
ajmsi-3181	152	7	of	of	ADP
ajmsi-3181	152	8	all	all	DET
ajmsi-3181	152	9	bacteremia	bacteremia	NOUN
ajmsi-3181	152	10	patients	patient	NOUN
ajmsi-3181	152	11	in	in	ADP
ajmsi-3181	152	12	qatar	qatar	PROPN
ajmsi-3181	152	13	found	find	VERB
ajmsi-3181	152	14	452	452	NUM
ajmsi-3181	152	15	cases	case	NOUN
ajmsi-3181	152	16	of	of	ADP
ajmsi-3181	152	17	bacteremia	bacteremia	NOUN
ajmsi-3181	152	18	with	with	ADP
ajmsi-3181	152	19	63	63	NUM
ajmsi-3181	152	20	%	%	NOUN
ajmsi-3181	152	21	grampa	grampa	NOUN
ajmsi-3181	152	22	ge	ge	PROPN
ajmsi-3181	152	23	99	99	NUM
ajmsi-3181	152	24	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-3181	152	25	am	be	AUX
ajmsi-3181	152	26	.	.	PUNCT
ajmsi-3181	153	1	j.	j.	PROPN
ajmsi-3181	153	2	med	med	PROPN
ajmsi-3181	153	3	.	.	PUNCT
ajmsi-3181	154	1	sci	sci	PROPN
ajmsi-3181	154	2	.	.	PUNCT
ajmsi-3181	154	3	innov	innov	PROPN
ajmsi-3181	154	4	.	.	PUNCT
ajmsi-3181	155	1	3(2	3(2	NUM
ajmsi-3181	155	2	)	)	PUNCT
ajmsi-3181	155	3	91	91	NUM
ajmsi-3181	155	4	-	-	SYM
ajmsi-3181	155	5	102	102	NUM
ajmsi-3181	155	6	,	,	PUNCT
ajmsi-3181	155	7	2024	2024	NUM
ajmsi-3181	155	8	negative	negative	ADJ
ajmsi-3181	155	9	organisms	organism	NOUN
ajmsi-3181	155	10	(	(	PUNCT
ajmsi-3181	155	11	borgio	borgio	NOUN
ajmsi-3181	155	12	et	et	PROPN
ajmsi-3181	155	13	al	al	PROPN
ajmsi-3181	155	14	.	.	PROPN
ajmsi-3181	155	15	,	,	PUNCT
ajmsi-3181	155	16	2021	2021	NUM
ajmsi-3181	155	17	)	)	PUNCT
ajmsi-3181	155	18	,	,	PUNCT
ajmsi-3181	155	19	with	with	ADP
ajmsi-3181	155	20	escherichia	escherichia	NOUN
ajmsi-3181	155	21	coli	coli	NOUN
ajmsi-3181	155	22	as	as	ADP
ajmsi-3181	155	23	the	the	DET
ajmsi-3181	155	24	most	most	ADV
ajmsi-3181	155	25	common	common	ADJ
ajmsi-3181	155	26	isolate	isolate	NOUN
ajmsi-3181	155	27	.	.	PUNCT
ajmsi-3181	156	1	the	the	DET
ajmsi-3181	156	2	present	present	ADJ
ajmsi-3181	156	3	study	study	NOUN
ajmsi-3181	156	4	also	also	ADV
ajmsi-3181	156	5	found	find	VERB
ajmsi-3181	156	6	e.	e.	PROPN
ajmsi-3181	156	7	coli	coli	PROPN
ajmsi-3181	156	8	to	to	PART
ajmsi-3181	156	9	be	be	AUX
ajmsi-3181	156	10	the	the	DET
ajmsi-3181	156	11	predominant	predominant	ADJ
ajmsi-3181	156	12	bacterium	bacterium	NOUN
ajmsi-3181	156	13	(	(	PUNCT
ajmsi-3181	156	14	47.2	47.2	NUM
ajmsi-3181	156	15	%	%	NOUN
ajmsi-3181	156	16	)	)	PUNCT
ajmsi-3181	156	17	,	,	PUNCT
ajmsi-3181	156	18	followed	follow	VERB
ajmsi-3181	156	19	by	by	ADP
ajmsi-3181	156	20	klebsiella	klebsiella	NOUN
ajmsi-3181	156	21	pneumoniae	pneumoniae	ADJ
ajmsi-3181	156	22	(	(	PUNCT
ajmsi-3181	156	23	16.4	16.4	NUM
ajmsi-3181	156	24	%	%	NOUN
ajmsi-3181	156	25	)	)	PUNCT
ajmsi-3181	156	26	.	.	PUNCT
ajmsi-3181	157	1	many	many	ADJ
ajmsi-3181	157	2	cases	case	NOUN
ajmsi-3181	157	3	of	of	ADP
ajmsi-3181	157	4	salmonella	salmonella	NOUN
ajmsi-3181	157	5	bloodstream	bloodstream	NOUN
ajmsi-3181	157	6	infections	infection	NOUN
ajmsi-3181	157	7	(	(	PUNCT
ajmsi-3181	157	8	10.6	10.6	NUM
ajmsi-3181	157	9	%	%	NOUN
ajmsi-3181	157	10	)	)	PUNCT
ajmsi-3181	157	11	in	in	ADP
ajmsi-3181	157	12	our	our	PRON
ajmsi-3181	157	13	centre	centre	NOUN
ajmsi-3181	157	14	were	be	AUX
ajmsi-3181	157	15	identified	identify	VERB
ajmsi-3181	157	16	mainly	mainly	ADV
ajmsi-3181	157	17	as	as	ADP
ajmsi-3181	157	18	travellers	traveller	NOUN
ajmsi-3181	157	19	or	or	CCONJ
ajmsi-3181	157	20	immigrants	immigrant	NOUN
ajmsi-3181	157	21	from	from	ADP
ajmsi-3181	157	22	southeast	southeast	PROPN
ajmsi-3181	157	23	asia	asia	PROPN
ajmsi-3181	157	24	.	.	PUNCT
ajmsi-3181	158	1	salmonella	salmonella	PROPN
ajmsi-3181	158	2	typhi	typhi	NOUN
ajmsi-3181	158	3	was	be	AUX
ajmsi-3181	158	4	10.6	10.6	NUM
ajmsi-3181	158	5	%	%	NOUN
ajmsi-3181	158	6	,	,	PUNCT
ajmsi-3181	158	7	and	and	CCONJ
ajmsi-3181	158	8	non	non	ADJ
ajmsi-3181	158	9	-	-	ADJ
ajmsi-3181	158	10	typhoidal	typhoidal	ADJ
ajmsi-3181	158	11	salmonella	salmonella	NOUN
ajmsi-3181	158	12	constituted	constitute	VERB
ajmsi-3181	158	13	1.3	1.3	NUM
ajmsi-3181	158	14	%	%	NOUN
ajmsi-3181	158	15	of	of	ADP
ajmsi-3181	158	16	cases	case	NOUN
ajmsi-3181	158	17	.	.	PUNCT
ajmsi-3181	159	1	an	an	DET
ajmsi-3181	159	2	earlier	early	ADJ
ajmsi-3181	159	3	study	study	NOUN
ajmsi-3181	159	4	by	by	ADP
ajmsi-3181	159	5	qatar	qatar	PROPN
ajmsi-3181	159	6	found	find	VERB
ajmsi-3181	159	7	that	that	SCONJ
ajmsi-3181	159	8	97	97	NUM
ajmsi-3181	159	9	%	%	NOUN
ajmsi-3181	159	10	of	of	ADP
ajmsi-3181	159	11	patients	patient	NOUN
ajmsi-3181	159	12	had	have	VERB
ajmsi-3181	159	13	a	a	DET
ajmsi-3181	159	14	history	history	NOUN
ajmsi-3181	159	15	of	of	ADP
ajmsi-3181	159	16	travel	travel	NOUN
ajmsi-3181	159	17	to	to	ADP
ajmsi-3181	159	18	endemic	endemic	ADJ
ajmsi-3181	159	19	areas	area	NOUN
ajmsi-3181	159	20	(	(	PUNCT
ajmsi-3181	159	21	ahmedullah	ahmedullah	PROPN
ajmsi-3181	159	22	et	et	PROPN
ajmsi-3181	159	23	al	al	PROPN
ajmsi-3181	159	24	.	.	PROPN
ajmsi-3181	159	25	,	,	PUNCT
ajmsi-3181	159	26	2018	2018	NUM
ajmsi-3181	159	27	)	)	PUNCT
ajmsi-3181	159	28	.	.	PUNCT
ajmsi-3181	160	1	salmonella	salmonella	PROPN
ajmsi-3181	160	2	typhi	typhi	VERB
ajmsi-3181	160	3	isolates	isolate	NOUN
ajmsi-3181	160	4	from	from	ADP
ajmsi-3181	160	5	the	the	DET
ajmsi-3181	160	6	present	present	ADJ
ajmsi-3181	160	7	study	study	NOUN
ajmsi-3181	160	8	centre	centre	NOUN
ajmsi-3181	160	9	demonstrated	demonstrate	VERB
ajmsi-3181	160	10	high	high	ADJ
ajmsi-3181	160	11	levels	level	NOUN
ajmsi-3181	160	12	of	of	ADP
ajmsi-3181	160	13	resistance	resistance	NOUN
ajmsi-3181	160	14	to	to	ADP
ajmsi-3181	160	15	ciprofloxacin	ciprofloxacin	PROPN
ajmsi-3181	160	16	(	(	PUNCT
ajmsi-3181	160	17	40	40	NUM
ajmsi-3181	160	18	%	%	NOUN
ajmsi-3181	160	19	)	)	PUNCT
ajmsi-3181	160	20	but	but	CCONJ
ajmsi-3181	160	21	were	be	AUX
ajmsi-3181	160	22	susceptible	susceptible	ADJ
ajmsi-3181	160	23	to	to	ADP
ajmsi-3181	160	24	ceftriaxone	ceftriaxone	PROPN
ajmsi-3181	160	25	.	.	PUNCT
ajmsi-3181	161	1	among	among	ADP
ajmsi-3181	161	2	the	the	DET
ajmsi-3181	161	3	cases	case	NOUN
ajmsi-3181	161	4	,	,	PUNCT
ajmsi-3181	161	5	the	the	DET
ajmsi-3181	161	6	brucella	brucella	NOUN
ajmsi-3181	161	7	sp	sp	VERB
ajmsi-3181	161	8	.	.	PROPN
ajmsi-3181	161	9	was	be	AUX
ajmsi-3181	161	10	identified	identify	VERB
ajmsi-3181	161	11	in	in	ADP
ajmsi-3181	161	12	eight	eight	NUM
ajmsi-3181	161	13	patients	patient	NOUN
ajmsi-3181	161	14	(	(	PUNCT
ajmsi-3181	161	15	2.2	2.2	NUM
ajmsi-3181	161	16	%	%	NOUN
ajmsi-3181	161	17	)	)	PUNCT
ajmsi-3181	161	18	.	.	PUNCT
ajmsi-3181	162	1	in	in	ADP
ajmsi-3181	162	2	the	the	DET
ajmsi-3181	162	3	middle	middle	PROPN
ajmsi-3181	162	4	east	east	PROPN
ajmsi-3181	162	5	and	and	CCONJ
ajmsi-3181	162	6	north	north	PROPN
ajmsi-3181	162	7	africa	africa	PROPN
ajmsi-3181	162	8	(	(	PUNCT
ajmsi-3181	162	9	mena	mena	PROPN
ajmsi-3181	162	10	)	)	PUNCT
ajmsi-3181	162	11	region	region	NOUN
ajmsi-3181	162	12	,	,	PUNCT
ajmsi-3181	162	13	brucellosis	brucellosis	NOUN
ajmsi-3181	162	14	is	be	AUX
ajmsi-3181	162	15	not	not	PART
ajmsi-3181	162	16	uncommon	uncommon	ADJ
ajmsi-3181	162	17	as	as	ADP
ajmsi-3181	162	18	a	a	DET
ajmsi-3181	162	19	blood	blood	NOUN
ajmsi-3181	162	20	culture	culture	NOUN
ajmsi-3181	162	21	isolate	isolate	NOUN
ajmsi-3181	162	22	(	(	PUNCT
ajmsi-3181	162	23	wareth	wareth	PROPN
ajmsi-3181	162	24	et	et	PROPN
ajmsi-3181	162	25	al	al	PROPN
ajmsi-3181	162	26	.	.	PROPN
ajmsi-3181	162	27	,	,	PUNCT
ajmsi-3181	162	28	2022	2022	NUM
ajmsi-3181	162	29	)	)	PUNCT
ajmsi-3181	162	30	.	.	PUNCT
ajmsi-3181	163	1	usually	usually	ADV
ajmsi-3181	163	2	,	,	PUNCT
ajmsi-3181	163	3	there	there	PRON
ajmsi-3181	163	4	is	be	VERB
ajmsi-3181	163	5	a	a	DET
ajmsi-3181	163	6	history	history	NOUN
ajmsi-3181	163	7	of	of	ADP
ajmsi-3181	163	8	exposure	exposure	NOUN
ajmsi-3181	163	9	to	to	ADP
ajmsi-3181	163	10	cattle	cattle	NOUN
ajmsi-3181	163	11	and	and	CCONJ
ajmsi-3181	163	12	camels	camel	NOUN
ajmsi-3181	163	13	,	,	PUNCT
ajmsi-3181	163	14	either	either	CCONJ
ajmsi-3181	163	15	through	through	ADP
ajmsi-3181	163	16	occupational	occupational	ADJ
ajmsi-3181	163	17	exposure	exposure	NOUN
ajmsi-3181	163	18	or	or	CCONJ
ajmsi-3181	163	19	consumption	consumption	NOUN
ajmsi-3181	163	20	of	of	ADP
ajmsi-3181	163	21	dairy	dairy	NOUN
ajmsi-3181	163	22	products	product	NOUN
ajmsi-3181	163	23	.	.	PUNCT
ajmsi-3181	164	1	mdros	mdro	NOUN
ajmsi-3181	164	2	and	and	CCONJ
ajmsi-3181	164	3	esbl	esbl	NOUN
ajmsi-3181	164	4	-	-	PUNCT
ajmsi-3181	164	5	producing	produce	VERB
ajmsi-3181	164	6	isolates	isolate	NOUN
ajmsi-3181	164	7	comprised	comprise	VERB
ajmsi-3181	164	8	34	34	NUM
ajmsi-3181	164	9	%	%	NOUN
ajmsi-3181	164	10	of	of	ADP
ajmsi-3181	164	11	the	the	DET
ajmsi-3181	164	12	samples	sample	NOUN
ajmsi-3181	164	13	,	,	PUNCT
ajmsi-3181	164	14	while	while	SCONJ
ajmsi-3181	164	15	the	the	DET
ajmsi-3181	164	16	rest	rest	NOUN
ajmsi-3181	164	17	were	be	AUX
ajmsi-3181	164	18	sensitive	sensitive	ADJ
ajmsi-3181	164	19	strains	strain	NOUN
ajmsi-3181	164	20	(	(	PUNCT
ajmsi-3181	164	21	66	66	NUM
ajmsi-3181	164	22	%	%	NOUN
ajmsi-3181	164	23	)	)	PUNCT
ajmsi-3181	164	24	.	.	PUNCT
ajmsi-3181	165	1	previous	previous	ADJ
ajmsi-3181	165	2	studies	study	NOUN
ajmsi-3181	165	3	also	also	ADV
ajmsi-3181	165	4	found	find	VERB
ajmsi-3181	165	5	a	a	DET
ajmsi-3181	165	6	higher	high	ADJ
ajmsi-3181	165	7	prevalence	prevalence	NOUN
ajmsi-3181	165	8	of	of	ADP
ajmsi-3181	165	9	esbl	esbl	NOUN
ajmsi-3181	165	10	-	-	PUNCT
ajmsi-3181	165	11	producing	produce	VERB
ajmsi-3181	165	12	e.	e.	NOUN
ajmsi-3181	165	13	coli	coli	NOUN
ajmsi-3181	165	14	and	and	CCONJ
ajmsi-3181	165	15	klebsiella	klebsiella	NOUN
ajmsi-3181	165	16	pneumoniae	pneumoniae	ADJ
ajmsi-3181	165	17	(	(	PUNCT
ajmsi-3181	165	18	55.7	55.7	NUM
ajmsi-3181	165	19	%	%	NOUN
ajmsi-3181	165	20	)	)	PUNCT
ajmsi-3181	165	21	than	than	ADP
ajmsi-3181	165	22	present	present	ADJ
ajmsi-3181	165	23	findings	finding	NOUN
ajmsi-3181	165	24	(	(	PUNCT
ajmsi-3181	165	25	sid	sid	PROPN
ajmsi-3181	165	26	ahmed	ahmed	PROPN
ajmsi-3181	165	27	et	et	PROPN
ajmsi-3181	165	28	al	al	PROPN
ajmsi-3181	165	29	.	.	PROPN
ajmsi-3181	165	30	,	,	PUNCT
ajmsi-3181	165	31	2023	2023	NUM
ajmsi-3181	165	32	)	)	PUNCT
ajmsi-3181	165	33	,	,	PUNCT
ajmsi-3181	165	34	which	which	PRON
ajmsi-3181	165	35	indicates	indicate	VERB
ajmsi-3181	165	36	the	the	DET
ajmsi-3181	165	37	implementation	implementation	NOUN
ajmsi-3181	165	38	of	of	ADP
ajmsi-3181	165	39	antimicrobial	antimicrobial	ADJ
ajmsi-3181	165	40	stewardship	stewardship	NOUN
ajmsi-3181	165	41	practices	practice	NOUN
ajmsi-3181	165	42	and	and	CCONJ
ajmsi-3181	165	43	monitoring	monitor	VERB
ajmsi-3181	165	44	the	the	DET
ajmsi-3181	165	45	appropriateness	appropriateness	NOUN
ajmsi-3181	165	46	of	of	ADP
ajmsi-3181	165	47	antimicrobials	antimicrobial	NOUN
ajmsi-3181	165	48	and	and	CCONJ
ajmsi-3181	165	49	their	their	PRON
ajmsi-3181	165	50	consumption	consumption	NOUN
ajmsi-3181	165	51	.	.	PUNCT
ajmsi-3181	166	1	in	in	ADP
ajmsi-3181	166	2	addition	addition	NOUN
ajmsi-3181	166	3	,	,	PUNCT
ajmsi-3181	166	4	previous	previous	ADJ
ajmsi-3181	166	5	studies	study	NOUN
ajmsi-3181	166	6	from	from	ADP
ajmsi-3181	166	7	qatar	qatar	PROPN
ajmsi-3181	166	8	reported	report	VERB
ajmsi-3181	166	9	4.4	4.4	NUM
ajmsi-3181	166	10	%	%	NOUN
ajmsi-3181	166	11	mdr	mdr	PROPN
ajmsi-3181	166	12	isolates	isolate	NOUN
ajmsi-3181	166	13	of	of	ADP
ajmsi-3181	166	14	pseudomonas	pseudomona	NOUN
ajmsi-3181	166	15	aeruginosa	aeruginosa	NOUN
ajmsi-3181	166	16	(	(	PUNCT
ajmsi-3181	166	17	p.	p.	NOUN
ajmsi-3181	166	18	aeruginosa	aeruginosa	PROPN
ajmsi-3181	166	19	)	)	PUNCT
ajmsi-3181	166	20	(	(	PUNCT
ajmsi-3181	166	21	ahmed	ahmed	PROPN
ajmsi-3181	166	22	et	et	PROPN
ajmsi-3181	166	23	al	al	PROPN
ajmsi-3181	166	24	.	.	PROPN
ajmsi-3181	166	25	,	,	PUNCT
ajmsi-3181	166	26	2019	2019	NUM
ajmsi-3181	166	27	)	)	PUNCT
ajmsi-3181	166	28	;	;	PUNCT
ajmsi-3181	166	29	however	however	ADV
ajmsi-3181	166	30	,	,	PUNCT
ajmsi-3181	166	31	out	out	ADP
ajmsi-3181	166	32	of	of	ADP
ajmsi-3181	166	33	28	28	NUM
ajmsi-3181	166	34	patients	patient	NOUN
ajmsi-3181	166	35	with	with	ADP
ajmsi-3181	166	36	p.	p.	NOUN
ajmsi-3181	166	37	aeruginosa	aeruginosa	PROPN
ajmsi-3181	166	38	bloodstream	bloodstream	NOUN
ajmsi-3181	166	39	infection	infection	NOUN
ajmsi-3181	166	40	(	(	PUNCT
ajmsi-3181	166	41	7.8	7.8	NUM
ajmsi-3181	166	42	%	%	NOUN
ajmsi-3181	166	43	)	)	PUNCT
ajmsi-3181	166	44	,	,	PUNCT
ajmsi-3181	166	45	only	only	ADV
ajmsi-3181	166	46	2	2	NUM
ajmsi-3181	166	47	patients	patient	NOUN
ajmsi-3181	166	48	(	(	PUNCT
ajmsi-3181	166	49	0.56	0.56	NUM
ajmsi-3181	166	50	%	%	NOUN
ajmsi-3181	166	51	)	)	PUNCT
ajmsi-3181	166	52	were	be	AUX
ajmsi-3181	166	53	multidrug	multidrug	NOUN
ajmsi-3181	166	54	-	-	PUNCT
ajmsi-3181	166	55	resistant	resistant	ADJ
ajmsi-3181	166	56	,	,	PUNCT
ajmsi-3181	166	57	which	which	PRON
ajmsi-3181	166	58	is	be	AUX
ajmsi-3181	166	59	in	in	ADP
ajmsi-3181	166	60	contrast	contrast	NOUN
ajmsi-3181	166	61	to	to	ADP
ajmsi-3181	166	62	studies	study	NOUN
ajmsi-3181	166	63	from	from	ADP
ajmsi-3181	166	64	saudi	saudi	PROPN
ajmsi-3181	166	65	arabia	arabia	PROPN
ajmsi-3181	166	66	with	with	ADP
ajmsi-3181	166	67	a	a	DET
ajmsi-3181	166	68	high	high	ADJ
ajmsi-3181	166	69	prevalence	prevalence	NOUN
ajmsi-3181	166	70	of	of	ADP
ajmsi-3181	166	71	multidrugresistant	multidrugresistant	ADJ
ajmsi-3181	166	72	(	(	PUNCT
ajmsi-3181	166	73	mdr	mdr	PROPN
ajmsi-3181	166	74	)	)	PUNCT
ajmsi-3181	166	75	bacteria	bacteria	NOUN
ajmsi-3181	166	76	,	,	PUNCT
ajmsi-3181	166	77	with	with	ADP
ajmsi-3181	166	78	more	more	ADJ
ajmsi-3181	166	79	than	than	ADP
ajmsi-3181	166	80	50	50	NUM
ajmsi-3181	166	81	%	%	NOUN
ajmsi-3181	166	82	of	of	ADP
ajmsi-3181	166	83	the	the	DET
ajmsi-3181	166	84	isolates	isolate	NOUN
ajmsi-3181	166	85	resistant	resistant	ADJ
ajmsi-3181	166	86	to	to	ADP
ajmsi-3181	166	87	at	at	ADV
ajmsi-3181	166	88	least	least	ADV
ajmsi-3181	166	89	one	one	NUM
ajmsi-3181	166	90	antimicrobial	antimicrobial	ADJ
ajmsi-3181	166	91	agent	agent	NOUN
ajmsi-3181	166	92	(	(	PUNCT
ajmsi-3181	166	93	yezli	yezli	NOUN
ajmsi-3181	166	94	et	et	PROPN
ajmsi-3181	166	95	al	al	PROPN
ajmsi-3181	166	96	.	.	PROPN
ajmsi-3181	166	97	,	,	PUNCT
ajmsi-3181	166	98	2014	2014	NUM
ajmsi-3181	166	99	)	)	PUNCT
ajmsi-3181	166	100	.	.	PUNCT
ajmsi-3181	167	1	although	although	SCONJ
ajmsi-3181	167	2	p.	p.	PROPN
ajmsi-3181	167	3	aeruginosa	aeruginosa	PROPN
ajmsi-3181	167	4	remains	remain	VERB
ajmsi-3181	167	5	susceptible	susceptible	ADJ
ajmsi-3181	167	6	to	to	ADP
ajmsi-3181	167	7	carbapenems	carbapenem	NOUN
ajmsi-3181	167	8	,	,	PUNCT
ajmsi-3181	167	9	quinolones	quinolone	NOUN
ajmsi-3181	167	10	,	,	PUNCT
ajmsi-3181	167	11	and	and	CCONJ
ajmsi-3181	167	12	aminoglycosides	aminoglycoside	NOUN
ajmsi-3181	167	13	in	in	ADP
ajmsi-3181	167	14	most	most	ADJ
ajmsi-3181	167	15	centres	centre	NOUN
ajmsi-3181	167	16	in	in	ADP
ajmsi-3181	167	17	saudi	saudi	PROPN
ajmsi-3181	167	18	arabia	arabia	PROPN
ajmsi-3181	167	19	,	,	PUNCT
ajmsi-3181	167	20	its	its	PRON
ajmsi-3181	167	21	resistance	resistance	NOUN
ajmsi-3181	167	22	is	be	AUX
ajmsi-3181	167	23	still	still	ADV
ajmsi-3181	167	24	on	on	ADP
ajmsi-3181	167	25	the	the	DET
ajmsi-3181	167	26	rise	rise	NOUN
ajmsi-3181	167	27	.	.	PUNCT
ajmsi-3181	168	1	similarly	similarly	ADV
ajmsi-3181	168	2	,	,	PUNCT
ajmsi-3181	168	3	enterobacteriaceae	enterobacteriaceae	PROPN
ajmsi-3181	168	4	,	,	PUNCT
ajmsi-3181	168	5	escherichia	escherichia	NOUN
ajmsi-3181	168	6	coli	coli	NOUN
ajmsi-3181	168	7	,	,	PUNCT
ajmsi-3181	168	8	klebsiella	klebsiella	NOUN
ajmsi-3181	168	9	pneumoniae	pneumoniae	ADJ
ajmsi-3181	168	10	,	,	PUNCT
ajmsi-3181	168	11	and	and	CCONJ
ajmsi-3181	168	12	enterobacter	enterobacter	ADJ
ajmsi-3181	168	13	sp	sp	NOUN
ajmsi-3181	168	14	.	.	PUNCT
ajmsi-3181	169	1	amr	amr	PROPN
ajmsi-3181	169	2	is	be	AUX
ajmsi-3181	169	3	increasing	increase	VERB
ajmsi-3181	169	4	,	,	PUNCT
ajmsi-3181	169	5	especially	especially	ADV
ajmsi-3181	169	6	in	in	ADP
ajmsi-3181	169	7	gram	gram	NOUN
ajmsi-3181	169	8	-	-	PUNCT
ajmsi-3181	169	9	negative	negative	ADJ
ajmsi-3181	169	10	infections	infection	NOUN
ajmsi-3181	169	11	in	in	ADP
ajmsi-3181	169	12	the	the	DET
ajmsi-3181	169	13	middle	middle	PROPN
ajmsi-3181	169	14	east	east	PROPN
ajmsi-3181	169	15	(	(	PUNCT
ajmsi-3181	169	16	sid	sid	PROPN
ajmsi-3181	169	17	ahmed	ahmed	PROPN
ajmsi-3181	169	18	et	et	PROPN
ajmsi-3181	169	19	al	al	PROPN
ajmsi-3181	169	20	.	.	PROPN
ajmsi-3181	169	21	,	,	PUNCT
ajmsi-3181	169	22	2023	2023	NUM
ajmsi-3181	169	23	)	)	PUNCT
ajmsi-3181	169	24	.	.	PUNCT
ajmsi-3181	170	1	prior	prior	ADJ
ajmsi-3181	170	2	use	use	NOUN
ajmsi-3181	170	3	of	of	ADP
ajmsi-3181	170	4	antimicrobials	antimicrobial	NOUN
ajmsi-3181	170	5	is	be	AUX
ajmsi-3181	170	6	an	an	DET
ajmsi-3181	170	7	established	establish	VERB
ajmsi-3181	170	8	independent	independent	ADJ
ajmsi-3181	170	9	risk	risk	NOUN
ajmsi-3181	170	10	factor	factor	NOUN
ajmsi-3181	170	11	for	for	ADP
ajmsi-3181	170	12	the	the	DET
ajmsi-3181	170	13	emergence	emergence	NOUN
ajmsi-3181	170	14	of	of	ADP
ajmsi-3181	170	15	mdros	mdro	NOUN
ajmsi-3181	170	16	(	(	PUNCT
ajmsi-3181	170	17	ahmed	ahmed	PROPN
ajmsi-3181	170	18	et	et	PROPN
ajmsi-3181	170	19	al	al	PROPN
ajmsi-3181	170	20	.	.	PROPN
ajmsi-3181	170	21	,	,	PUNCT
ajmsi-3181	170	22	2019	2019	NUM
ajmsi-3181	170	23	)	)	PUNCT
ajmsi-3181	170	24	.	.	PUNCT
ajmsi-3181	171	1	in	in	ADP
ajmsi-3181	171	2	qatar	qatar	PROPN
ajmsi-3181	171	3	,	,	PUNCT
ajmsi-3181	171	4	about	about	ADP
ajmsi-3181	171	5	half	half	NOUN
ajmsi-3181	171	6	of	of	ADP
ajmsi-3181	171	7	the	the	DET
ajmsi-3181	171	8	cases	case	NOUN
ajmsi-3181	171	9	of	of	ADP
ajmsi-3181	171	10	klebsiella	klebsiella	NOUN
ajmsi-3181	171	11	pneumonia	pneumonia	NOUN
ajmsi-3181	171	12	are	be	AUX
ajmsi-3181	171	13	reported	report	VERB
ajmsi-3181	171	14	as	as	ADP
ajmsi-3181	171	15	extendedspectrum	extendedspectrum	ADP
ajmsi-3181	171	16	β	β	NOUN
ajmsi-3181	171	17	-	-	NOUN
ajmsi-3181	171	18	lactamase	lactamase	ADJ
ajmsi-3181	171	19	(	(	PUNCT
ajmsi-3181	171	20	esbl	esbl	NOUN
ajmsi-3181	171	21	)	)	PUNCT
ajmsi-3181	171	22	producers	producer	NOUN
ajmsi-3181	171	23	(	(	PUNCT
ajmsi-3181	171	24	alsamawi	alsamawi	PROPN
ajmsi-3181	171	25	et	et	PROPN
ajmsi-3181	171	26	al	al	PROPN
ajmsi-3181	171	27	.	.	PROPN
ajmsi-3181	171	28	,	,	PUNCT
ajmsi-3181	171	29	2022	2022	NUM
ajmsi-3181	171	30	)	)	PUNCT
ajmsi-3181	171	31	.	.	PUNCT
ajmsi-3181	172	1	a	a	DET
ajmsi-3181	172	2	survey	survey	NOUN
ajmsi-3181	172	3	from	from	ADP
ajmsi-3181	172	4	oman	oman	PROPN
ajmsi-3181	172	5	found	find	VERB
ajmsi-3181	172	6	escherichia	escherichia	NOUN
ajmsi-3181	172	7	coli	coli	NOUN
ajmsi-3181	172	8	(	(	PUNCT
ajmsi-3181	172	9	32.39	32.39	NUM
ajmsi-3181	172	10	%	%	NOUN
ajmsi-3181	172	11	)	)	PUNCT
ajmsi-3181	172	12	,	,	PUNCT
ajmsi-3181	172	13	p.aeroginosa	p.aeroginosa	PROPN
ajmsi-3181	172	14	(	(	PUNCT
ajmsi-3181	172	15	22.16	22.16	NUM
ajmsi-3181	172	16	%	%	NOUN
ajmsi-3181	172	17	)	)	PUNCT
ajmsi-3181	172	18	,	,	PUNCT
ajmsi-3181	172	19	klebsiella	klebsiella	NOUN
ajmsi-3181	172	20	pneumoniae	pneumoniae	ADJ
ajmsi-3181	172	21	(	(	PUNCT
ajmsi-3181	172	22	19.97	19.97	NUM
ajmsi-3181	172	23	%	%	NOUN
ajmsi-3181	172	24	)	)	PUNCT
ajmsi-3181	172	25	,	,	PUNCT
ajmsi-3181	172	26	and	and	CCONJ
ajmsi-3181	172	27	acinetobacter	acinetobacter	ADV
ajmsi-3181	172	28	baumannii	baumannii	ADJ
ajmsi-3181	172	29	(	(	PUNCT
ajmsi-3181	172	30	5.22	5.22	NUM
ajmsi-3181	172	31	%	%	NOUN
ajmsi-3181	172	32	)	)	PUNCT
ajmsi-3181	172	33	,	,	PUNCT
ajmsi-3181	172	34	with	with	ADP
ajmsi-3181	172	35	growing	grow	VERB
ajmsi-3181	172	36	resistance	resistance	NOUN
ajmsi-3181	172	37	against	against	ADP
ajmsi-3181	172	38	ciprofloxacin	ciprofloxacin	PROPN
ajmsi-3181	172	39	and	and	CCONJ
ajmsi-3181	172	40	meropenem	meropenem	PROPN
ajmsi-3181	172	41	(	(	PUNCT
ajmsi-3181	172	42	sathya	sathya	PROPN
ajmsi-3181	172	43	kumar	kumar	PROPN
ajmsi-3181	172	44	et	et	PROPN
ajmsi-3181	172	45	al	al	PROPN
ajmsi-3181	172	46	.	.	PROPN
ajmsi-3181	172	47	,	,	PUNCT
ajmsi-3181	172	48	2023	2023	NUM
ajmsi-3181	172	49	)	)	PUNCT
ajmsi-3181	172	50	.	.	PUNCT
ajmsi-3181	173	1	the	the	DET
ajmsi-3181	173	2	factors	factor	NOUN
ajmsi-3181	173	3	included	include	VERB
ajmsi-3181	173	4	prolonged	prolonged	ADJ
ajmsi-3181	173	5	hospital	hospital	NOUN
ajmsi-3181	173	6	stay	stay	NOUN
ajmsi-3181	173	7	,	,	PUNCT
ajmsi-3181	173	8	intravenous	intravenous	ADJ
ajmsi-3181	173	9	cannulation	cannulation	NOUN
ajmsi-3181	173	10	,	,	PUNCT
ajmsi-3181	173	11	multiple	multiple	ADJ
ajmsi-3181	173	12	co	co	ADJ
ajmsi-3181	173	13	-	-	ADJ
ajmsi-3181	173	14	morbid	morbid	ADJ
ajmsi-3181	173	15	conditions	condition	NOUN
ajmsi-3181	173	16	,	,	PUNCT
ajmsi-3181	173	17	and	and	CCONJ
ajmsi-3181	173	18	previous	previous	ADJ
ajmsi-3181	173	19	antibiotic	antibiotic	ADJ
ajmsi-3181	173	20	exposure	exposure	NOUN
ajmsi-3181	173	21	,	,	PUNCT
ajmsi-3181	173	22	which	which	PRON
ajmsi-3181	173	23	are	be	AUX
ajmsi-3181	173	24	attributed	attribute	VERB
ajmsi-3181	173	25	to	to	ADP
ajmsi-3181	173	26	the	the	DET
ajmsi-3181	173	27	resistance	resistance	NOUN
ajmsi-3181	173	28	in	in	ADP
ajmsi-3181	173	29	the	the	DET
ajmsi-3181	173	30	present	present	ADJ
ajmsi-3181	173	31	study	study	NOUN
ajmsi-3181	173	32	.	.	PUNCT
ajmsi-3181	174	1	a	a	DET
ajmsi-3181	174	2	study	study	NOUN
ajmsi-3181	174	3	in	in	ADP
ajmsi-3181	174	4	iran	iran	PROPN
ajmsi-3181	174	5	demonstrated	demonstrate	VERB
ajmsi-3181	174	6	that	that	SCONJ
ajmsi-3181	174	7	the	the	DET
ajmsi-3181	174	8	most	most	ADV
ajmsi-3181	174	9	common	common	ADJ
ajmsi-3181	174	10	gram	gram	NOUN
ajmsi-3181	174	11	-	-	PUNCT
ajmsi-3181	174	12	negative	negative	ADJ
ajmsi-3181	174	13	infections	infection	NOUN
ajmsi-3181	174	14	included	include	VERB
ajmsi-3181	174	15	klebsiella	klebsiella	NOUN
ajmsi-3181	174	16	pneumoniae	pneumoniae	NOUN
ajmsi-3181	174	17	,	,	PUNCT
ajmsi-3181	174	18	escherichia	escherichia	NOUN
ajmsi-3181	174	19	coli	coli	NOUN
ajmsi-3181	174	20	,	,	PUNCT
ajmsi-3181	174	21	serratia	serratia	NOUN
ajmsi-3181	174	22	marcescens	marcescen	NOUN
ajmsi-3181	174	23	,	,	PUNCT
ajmsi-3181	174	24	and	and	CCONJ
ajmsi-3181	174	25	pseudomonas	pseudomonas	PROPN
ajmsi-3181	174	26	aeruginosa	aeruginosa	NOUN
ajmsi-3181	174	27	(	(	PUNCT
ajmsi-3181	174	28	mahmoudi	mahmoudi	NOUN
ajmsi-3181	174	29	et	et	PROPN
ajmsi-3181	174	30	al	al	PROPN
ajmsi-3181	174	31	.	.	PROPN
ajmsi-3181	174	32	,	,	PUNCT
ajmsi-3181	174	33	2023	2023	NUM
ajmsi-3181	174	34	)	)	PUNCT
ajmsi-3181	174	35	.	.	PUNCT
ajmsi-3181	175	1	the	the	DET
ajmsi-3181	175	2	study	study	NOUN
ajmsi-3181	175	3	also	also	ADV
ajmsi-3181	175	4	found	find	VERB
ajmsi-3181	175	5	a	a	DET
ajmsi-3181	175	6	high	high	ADJ
ajmsi-3181	175	7	prevalence	prevalence	NOUN
ajmsi-3181	175	8	of	of	ADP
ajmsi-3181	175	9	carbapenem	carbapenem	NOUN
ajmsi-3181	175	10	-	-	PUNCT
ajmsi-3181	175	11	resistant	resistant	ADJ
ajmsi-3181	175	12	isolates	isolate	NOUN
ajmsi-3181	175	13	,	,	PUNCT
ajmsi-3181	175	14	with	with	ADP
ajmsi-3181	175	15	more	more	ADJ
ajmsi-3181	175	16	than	than	ADP
ajmsi-3181	175	17	70	70	NUM
ajmsi-3181	175	18	%	%	NOUN
ajmsi-3181	175	19	klebsiella	klebsiella	NOUN
ajmsi-3181	175	20	pneumoniae	pneumoniae	ADJ
ajmsi-3181	175	21	carbapenemresistant	carbapenemresistant	NOUN
ajmsi-3181	175	22	;	;	PUNCT
ajmsi-3181	175	23	therefore	therefore	ADV
ajmsi-3181	175	24	,	,	PUNCT
ajmsi-3181	175	25	the	the	DET
ajmsi-3181	175	26	implementation	implementation	NOUN
ajmsi-3181	175	27	of	of	ADP
ajmsi-3181	175	28	antimicrobial	antimicrobial	ADJ
ajmsi-3181	175	29	stewardship	stewardship	NOUN
ajmsi-3181	175	30	and	and	CCONJ
ajmsi-3181	175	31	infection	infection	NOUN
ajmsi-3181	175	32	prevention	prevention	NOUN
ajmsi-3181	175	33	measures	measure	NOUN
ajmsi-3181	175	34	is	be	AUX
ajmsi-3181	175	35	necessary	necessary	ADJ
ajmsi-3181	175	36	to	to	PART
ajmsi-3181	175	37	control	control	VERB
ajmsi-3181	175	38	the	the	DET
ajmsi-3181	175	39	emergence	emergence	NOUN
ajmsi-3181	175	40	and	and	CCONJ
ajmsi-3181	175	41	subsequent	subsequent	ADJ
ajmsi-3181	175	42	spread	spread	NOUN
ajmsi-3181	175	43	of	of	ADP
ajmsi-3181	175	44	amr	amr	NOUN
ajmsi-3181	175	45	,	,	PUNCT
ajmsi-3181	175	46	as	as	SCONJ
ajmsi-3181	175	47	they	they	PRON
ajmsi-3181	175	48	are	be	AUX
ajmsi-3181	175	49	two	two	NUM
ajmsi-3181	175	50	facets	facet	NOUN
ajmsi-3181	175	51	of	of	ADP
ajmsi-3181	175	52	the	the	DET
ajmsi-3181	175	53	same	same	ADJ
ajmsi-3181	175	54	coin	coin	NOUN
ajmsi-3181	175	55	.	.	PUNCT
ajmsi-3181	176	1	in	in	ADP
ajmsi-3181	176	2	sub	sub	ADJ
ajmsi-3181	176	3	-	-	ADJ
ajmsi-3181	176	4	saharan	saharan	ADJ
ajmsi-3181	176	5	africa	africa	PROPN
ajmsi-3181	176	6	,	,	PUNCT
ajmsi-3181	176	7	the	the	DET
ajmsi-3181	176	8	levels	level	NOUN
ajmsi-3181	176	9	of	of	ADP
ajmsi-3181	176	10	third	third	ADJ
ajmsi-3181	176	11	-	-	PUNCT
ajmsi-3181	176	12	generation	generation	NOUN
ajmsi-3181	176	13	cephalosporins	cephalosporin	NOUN
ajmsi-3181	176	14	resistance	resistance	NOUN
ajmsi-3181	176	15	in	in	ADP
ajmsi-3181	176	16	the	the	DET
ajmsi-3181	176	17	bloodstream	bloodstream	NOUN
ajmsi-3181	176	18	are	be	AUX
ajmsi-3181	176	19	reported	report	VERB
ajmsi-3181	176	20	to	to	PART
ajmsi-3181	176	21	be	be	AUX
ajmsi-3181	176	22	high	high	ADJ
ajmsi-3181	176	23	in	in	ADP
ajmsi-3181	176	24	escherichia	escherichia	NOUN
ajmsi-3181	176	25	coli	coli	NOUN
ajmsi-3181	176	26	(	(	PUNCT
ajmsi-3181	176	27	18.4	18.4	NUM
ajmsi-3181	176	28	%	%	NOUN
ajmsi-3181	176	29	)	)	PUNCT
ajmsi-3181	176	30	,	,	PUNCT
ajmsi-3181	176	31	klebsiella	klebsiella	PROPN
ajmsi-3181	176	32	sp	sp	PROPN
ajmsi-3181	176	33	.	.	PROPN
ajmsi-3181	177	1	(	(	PUNCT
ajmsi-3181	177	2	54.4	54.4	NUM
ajmsi-3181	177	3	%	%	NOUN
ajmsi-3181	177	4	)	)	PUNCT
ajmsi-3181	177	5	,	,	PUNCT
ajmsi-3181	177	6	non	non	ADJ
ajmsi-3181	177	7	-	-	ADJ
ajmsi-3181	177	8	typhoidal	typhoidal	ADJ
ajmsi-3181	177	9	salmonellae	salmonellae	NOUN
ajmsi-3181	177	10	(	(	PUNCT
ajmsi-3181	177	11	1.9	1.9	NUM
ajmsi-3181	177	12	%	%	NOUN
ajmsi-3181	177	13	)	)	PUNCT
ajmsi-3181	178	1	(	(	PUNCT
ajmsi-3181	178	2	lester	lester	PROPN
ajmsi-3181	178	3	et	et	PROPN
ajmsi-3181	178	4	al	al	PROPN
ajmsi-3181	178	5	.	.	PROPN
ajmsi-3181	178	6	,	,	PUNCT
ajmsi-3181	178	7	2020	2020	NUM
ajmsi-3181	178	8	)	)	PUNCT
ajmsi-3181	178	9	.	.	PUNCT
ajmsi-3181	179	1	studies	study	NOUN
ajmsi-3181	179	2	from	from	ADP
ajmsi-3181	179	3	finland	finland	PROPN
ajmsi-3181	179	4	,	,	PUNCT
ajmsi-3181	179	5	australia	australia	PROPN
ajmsi-3181	179	6	,	,	PUNCT
ajmsi-3181	179	7	sweden	sweden	PROPN
ajmsi-3181	179	8	,	,	PUNCT
ajmsi-3181	179	9	and	and	CCONJ
ajmsi-3181	179	10	canada	canada	PROPN
ajmsi-3181	179	11	have	have	AUX
ajmsi-3181	179	12	shown	show	VERB
ajmsi-3181	179	13	increased	increase	VERB
ajmsi-3181	179	14	overall	overall	ADJ
ajmsi-3181	179	15	resistant	resistant	ADJ
ajmsi-3181	179	16	escherichia	escherichia	NOUN
ajmsi-3181	179	17	coli	coli	NOUN
ajmsi-3181	179	18	bsi	bsi	NOUN
ajmsi-3181	179	19	rates	rate	NOUN
ajmsi-3181	179	20	(	(	PUNCT
ajmsi-3181	179	21	buetti	buetti	PROPN
ajmsi-3181	179	22	et	et	PROPN
ajmsi-3181	179	23	al	al	PROPN
ajmsi-3181	179	24	.	.	PROPN
ajmsi-3181	179	25	,	,	PUNCT
ajmsi-3181	179	26	2017	2017	NUM
ajmsi-3181	179	27	)	)	PUNCT
ajmsi-3181	179	28	.	.	PUNCT
ajmsi-3181	180	1	persistent	persistent	ADJ
ajmsi-3181	180	2	bacteremia	bacteremia	NOUN
ajmsi-3181	180	3	was	be	AUX
ajmsi-3181	180	4	reported	report	VERB
ajmsi-3181	180	5	in	in	ADP
ajmsi-3181	180	6	18	18	NUM
ajmsi-3181	180	7	patients	patient	NOUN
ajmsi-3181	180	8	(	(	PUNCT
ajmsi-3181	180	9	5	5	NUM
ajmsi-3181	180	10	%	%	NOUN
ajmsi-3181	180	11	)	)	PUNCT
ajmsi-3181	180	12	,	,	PUNCT
ajmsi-3181	180	13	with	with	ADP
ajmsi-3181	180	14	the	the	DET
ajmsi-3181	180	15	most	most	ADV
ajmsi-3181	180	16	common	common	ADJ
ajmsi-3181	180	17	pathogens	pathogen	NOUN
ajmsi-3181	180	18	being	be	AUX
ajmsi-3181	180	19	klebsiella	klebsiella	NOUN
ajmsi-3181	180	20	sp	sp	PROPN
ajmsi-3181	180	21	.	.	PROPN
ajmsi-3181	180	22	and	and	CCONJ
ajmsi-3181	180	23	escherichia	escherichia	NOUN
ajmsi-3181	180	24	coli	coli	NOUN
ajmsi-3181	180	25	.	.	PUNCT
ajmsi-3181	181	1	source	source	NOUN
ajmsi-3181	181	2	control	control	NOUN
ajmsi-3181	181	3	was	be	AUX
ajmsi-3181	181	4	performed	perform	VERB
ajmsi-3181	181	5	in	in	ADP
ajmsi-3181	181	6	only	only	ADV
ajmsi-3181	181	7	one	one	NUM
ajmsi-3181	181	8	-	-	PUNCT
ajmsi-3181	181	9	third	third	NOUN
ajmsi-3181	181	10	of	of	ADP
ajmsi-3181	181	11	the	the	DET
ajmsi-3181	181	12	patients	patient	NOUN
ajmsi-3181	181	13	;	;	PUNCT
ajmsi-3181	181	14	out	out	ADP
ajmsi-3181	181	15	of	of	ADP
ajmsi-3181	181	16	30	30	NUM
ajmsi-3181	181	17	patients	patient	NOUN
ajmsi-3181	181	18	,	,	PUNCT
ajmsi-3181	181	19	13	13	NUM
ajmsi-3181	181	20	(	(	PUNCT
ajmsi-3181	181	21	43.3	43.3	NUM
ajmsi-3181	181	22	%	%	NOUN
ajmsi-3181	181	23	)	)	PUNCT
ajmsi-3181	181	24	have	have	AUX
ajmsi-3181	181	25	died	die	VERB
ajmsi-3181	181	26	due	due	ADP
ajmsi-3181	181	27	to	to	ADP
ajmsi-3181	181	28	persistent	persistent	ADJ
ajmsi-3181	181	29	bacteremia	bacteremia	NOUN
ajmsi-3181	181	30	;	;	PUNCT
ajmsi-3181	181	31	source	source	NOUN
ajmsi-3181	181	32	control	control	NOUN
ajmsi-3181	181	33	was	be	AUX
ajmsi-3181	181	34	performed	perform	VERB
ajmsi-3181	181	35	for	for	ADP
ajmsi-3181	181	36	eight	eight	NUM
ajmsi-3181	181	37	of	of	ADP
ajmsi-3181	181	38	them	they	PRON
ajmsi-3181	181	39	.	.	PUNCT
ajmsi-3181	182	1	persistent	persistent	ADJ
ajmsi-3181	182	2	bacteremia	bacteremia	NOUN
ajmsi-3181	182	3	is	be	AUX
ajmsi-3181	182	4	a	a	DET
ajmsi-3181	182	5	serious	serious	ADJ
ajmsi-3181	182	6	condition	condition	NOUN
ajmsi-3181	182	7	that	that	PRON
ajmsi-3181	182	8	can	can	AUX
ajmsi-3181	182	9	lead	lead	VERB
ajmsi-3181	182	10	to	to	ADP
ajmsi-3181	182	11	significant	significant	ADJ
ajmsi-3181	182	12	morbidity	morbidity	NOUN
ajmsi-3181	182	13	and	and	CCONJ
ajmsi-3181	182	14	mortality	mortality	NOUN
ajmsi-3181	182	15	and	and	CCONJ
ajmsi-3181	182	16	increased	increase	VERB
ajmsi-3181	182	17	healthcare	healthcare	NOUN
ajmsi-3181	182	18	costs	cost	NOUN
ajmsi-3181	182	19	(	(	PUNCT
ajmsi-3181	182	20	iskandar	iskandar	NOUN
ajmsi-3181	182	21	et	et	PROPN
ajmsi-3181	182	22	al	al	PROPN
ajmsi-3181	182	23	.	.	PROPN
ajmsi-3181	182	24	,	,	PUNCT
ajmsi-3181	182	25	2021	2021	NUM
ajmsi-3181	182	26	)	)	PUNCT
ajmsi-3181	182	27	.	.	PUNCT
ajmsi-3181	183	1	the	the	DET
ajmsi-3181	183	2	epidemiology	epidemiology	NOUN
ajmsi-3181	183	3	of	of	ADP
ajmsi-3181	183	4	persistent	persistent	ADJ
ajmsi-3181	183	5	gnb	gnb	PROPN
ajmsi-3181	183	6	is	be	AUX
ajmsi-3181	183	7	complex	complex	ADJ
ajmsi-3181	183	8	and	and	CCONJ
ajmsi-3181	183	9	is	be	AUX
ajmsi-3181	183	10	influenced	influence	VERB
ajmsi-3181	183	11	by	by	ADP
ajmsi-3181	183	12	factors	factor	NOUN
ajmsi-3181	183	13	such	such	ADJ
ajmsi-3181	183	14	as	as	ADP
ajmsi-3181	183	15	prior	prior	ADJ
ajmsi-3181	183	16	antibiotic	antibiotic	ADJ
ajmsi-3181	183	17	use	use	NOUN
ajmsi-3181	183	18	,	,	PUNCT
ajmsi-3181	183	19	exposure	exposure	NOUN
ajmsi-3181	183	20	to	to	ADP
ajmsi-3181	183	21	healthcare	healthcare	NOUN
ajmsi-3181	183	22	facilities	facility	NOUN
ajmsi-3181	183	23	,	,	PUNCT
ajmsi-3181	183	24	and	and	CCONJ
ajmsi-3181	183	25	comorbidities	comorbiditie	NOUN
ajmsi-3181	183	26	.	.	PUNCT
ajmsi-3181	184	1	several	several	ADJ
ajmsi-3181	184	2	studies	study	NOUN
ajmsi-3181	184	3	have	have	AUX
ajmsi-3181	184	4	identified	identify	VERB
ajmsi-3181	184	5	risk	risk	NOUN
ajmsi-3181	184	6	factors	factor	NOUN
ajmsi-3181	184	7	such	such	ADJ
ajmsi-3181	184	8	as	as	ADP
ajmsi-3181	184	9	end	end	NOUN
ajmsi-3181	184	10	-	-	PUNCT
ajmsi-3181	184	11	stage	stage	NOUN
ajmsi-3181	184	12	renal	renal	ADJ
ajmsi-3181	184	13	disease	disease	NOUN
ajmsi-3181	184	14	(	(	PUNCT
ajmsi-3181	184	15	esrd	esrd	PROPN
ajmsi-3181	184	16	)	)	PUNCT
ajmsi-3181	184	17	during	during	ADP
ajmsi-3181	184	18	hemodialysis	hemodialysis	NOUN
ajmsi-3181	184	19	,	,	PUNCT
ajmsi-3181	184	20	intravascular	intravascular	ADJ
ajmsi-3181	184	21	devices	device	NOUN
ajmsi-3181	184	22	,	,	PUNCT
ajmsi-3181	184	23	bacteremia	bacteremia	NOUN
ajmsi-3181	184	24	due	due	ADP
ajmsi-3181	184	25	to	to	ADP
ajmsi-3181	184	26	mdro	mdro	NOUN
ajmsi-3181	184	27	organisms	organism	NOUN
ajmsi-3181	184	28	,	,	PUNCT
ajmsi-3181	184	29	and	and	CCONJ
ajmsi-3181	184	30	ineffective	ineffective	ADJ
ajmsi-3181	184	31	antibiotic	antibiotic	ADJ
ajmsi-3181	184	32	therapy	therapy	NOUN
ajmsi-3181	184	33	as	as	ADP
ajmsi-3181	184	34	independent	independent	ADJ
ajmsi-3181	184	35	predictors	predictor	NOUN
ajmsi-3181	184	36	of	of	ADP
ajmsi-3181	184	37	persistent	persistent	ADJ
ajmsi-3181	184	38	gnb	gnb	PROPN
ajmsi-3181	184	39	bacteremia	bacteremia	NOUN
ajmsi-3181	184	40	(	(	PUNCT
ajmsi-3181	184	41	de	de	X
ajmsi-3181	184	42	waele	waele	PROPN
ajmsi-3181	184	43	et	et	PROPN
ajmsi-3181	184	44	al	al	PROPN
ajmsi-3181	184	45	.	.	PROPN
ajmsi-3181	184	46	,	,	PUNCT
ajmsi-3181	184	47	2018	2018	NUM
ajmsi-3181	184	48	)	)	PUNCT
ajmsi-3181	184	49	.	.	PUNCT
ajmsi-3181	185	1	the	the	DET
ajmsi-3181	185	2	incidence	incidence	NOUN
ajmsi-3181	185	3	of	of	ADP
ajmsi-3181	185	4	persistent	persistent	ADJ
ajmsi-3181	185	5	gnb	gnb	PROPN
ajmsi-3181	185	6	is	be	AUX
ajmsi-3181	185	7	increasing	increase	VERB
ajmsi-3181	185	8	,	,	PUNCT
ajmsi-3181	185	9	with	with	ADP
ajmsi-3181	185	10	higher	high	ADJ
ajmsi-3181	185	11	rates	rate	NOUN
ajmsi-3181	185	12	observed	observe	VERB
ajmsi-3181	185	13	in	in	ADP
ajmsi-3181	185	14	older	old	ADJ
ajmsi-3181	185	15	adults	adult	NOUN
ajmsi-3181	185	16	and	and	CCONJ
ajmsi-3181	185	17	patients	patient	NOUN
ajmsi-3181	185	18	with	with	ADP
ajmsi-3181	185	19	comorbidities	comorbiditie	NOUN
ajmsi-3181	185	20	(	(	PUNCT
ajmsi-3181	185	21	de	de	X
ajmsi-3181	185	22	waele	waele	X
ajmsi-3181	185	23	et	et	PROPN
ajmsi-3181	185	24	al	al	PROPN
ajmsi-3181	185	25	.	.	PROPN
ajmsi-3181	185	26	,	,	PUNCT
ajmsi-3181	185	27	2018	2018	NUM
ajmsi-3181	185	28	)	)	PUNCT
ajmsi-3181	185	29	.	.	PUNCT
ajmsi-3181	186	1	persistent	persistent	ADJ
ajmsi-3181	186	2	gnbs	gnbs	PROPN
ajmsi-3181	186	3	are	be	AUX
ajmsi-3181	186	4	often	often	ADV
ajmsi-3181	186	5	seen	see	VERB
ajmsi-3181	186	6	in	in	ADP
ajmsi-3181	186	7	patients	patient	NOUN
ajmsi-3181	186	8	with	with	ADP
ajmsi-3181	186	9	weakened	weakened	ADJ
ajmsi-3181	186	10	immune	immune	ADJ
ajmsi-3181	186	11	systems	system	NOUN
ajmsi-3181	186	12	,	,	PUNCT
ajmsi-3181	186	13	such	such	ADJ
ajmsi-3181	186	14	as	as	ADP
ajmsi-3181	186	15	malignancies	malignancy	NOUN
ajmsi-3181	186	16	,	,	PUNCT
ajmsi-3181	186	17	hiv	hiv	PROPN
ajmsi-3181	186	18	,	,	PUNCT
ajmsi-3181	186	19	or	or	CCONJ
ajmsi-3181	186	20	organ	organ	NOUN
ajmsi-3181	186	21	transplants	transplant	NOUN
ajmsi-3181	186	22	(	(	PUNCT
ajmsi-3181	186	23	tumbarello	tumbarello	INTJ
ajmsi-3181	186	24	et	et	PROPN
ajmsi-3181	186	25	al	al	PROPN
ajmsi-3181	186	26	.	.	PROPN
ajmsi-3181	186	27	,	,	PUNCT
ajmsi-3181	186	28	2012	2012	NUM
ajmsi-3181	186	29	)	)	PUNCT
ajmsi-3181	186	30	.	.	PUNCT
ajmsi-3181	187	1	the	the	DET
ajmsi-3181	187	2	main	main	ADJ
ajmsi-3181	187	3	contributing	contribute	VERB
ajmsi-3181	187	4	factors	factor	NOUN
ajmsi-3181	187	5	to	to	ADP
ajmsi-3181	187	6	gnb	gnb	PROPN
ajmsi-3181	187	7	bacteremia	bacteremia	NOUN
ajmsi-3181	187	8	were	be	AUX
ajmsi-3181	187	9	dm2	dm2	PROPN
ajmsi-3181	187	10	,	,	PUNCT
ajmsi-3181	187	11	hypertension	hypertension	NOUN
ajmsi-3181	187	12	,	,	PUNCT
ajmsi-3181	187	13	ischemic	ischemic	ADJ
ajmsi-3181	187	14	heart	heart	NOUN
ajmsi-3181	187	15	disease	disease	NOUN
ajmsi-3181	187	16	,	,	PUNCT
ajmsi-3181	187	17	and	and	CCONJ
ajmsi-3181	187	18	chronic	chronic	ADJ
ajmsi-3181	187	19	kidney	kidney	NOUN
ajmsi-3181	187	20	disease	disease	NOUN
ajmsi-3181	187	21	in	in	ADP
ajmsi-3181	187	22	the	the	DET
ajmsi-3181	187	23	present	present	ADJ
ajmsi-3181	187	24	study	study	NOUN
ajmsi-3181	187	25	.	.	PUNCT
ajmsi-3181	188	1	approximately	approximately	ADV
ajmsi-3181	188	2	10	10	NUM
ajmsi-3181	188	3	%	%	NOUN
ajmsi-3181	188	4	of	of	ADP
ajmsi-3181	188	5	patients	patient	NOUN
ajmsi-3181	188	6	had	have	VERB
ajmsi-3181	188	7	malignancy	malignancy	NOUN
ajmsi-3181	188	8	,	,	PUNCT
ajmsi-3181	188	9	and	and	CCONJ
ajmsi-3181	188	10	6.7	6.7	NUM
ajmsi-3181	188	11	%	%	NOUN
ajmsi-3181	188	12	were	be	AUX
ajmsi-3181	188	13	on	on	ADP
ajmsi-3181	188	14	immunosuppressive	immunosuppressive	ADJ
ajmsi-3181	188	15	drugs	drug	NOUN
ajmsi-3181	188	16	.	.	PUNCT
ajmsi-3181	189	1	the	the	DET
ajmsi-3181	189	2	management	management	NOUN
ajmsi-3181	189	3	of	of	ADP
ajmsi-3181	189	4	persistent	persistent	ADJ
ajmsi-3181	189	5	bacteremia	bacteremia	NOUN
ajmsi-3181	189	6	can	can	AUX
ajmsi-3181	189	7	be	be	AUX
ajmsi-3181	189	8	challenging	challenge	VERB
ajmsi-3181	189	9	and	and	CCONJ
ajmsi-3181	189	10	requires	require	VERB
ajmsi-3181	189	11	a	a	DET
ajmsi-3181	189	12	multidisciplinary	multidisciplinary	ADJ
ajmsi-3181	189	13	approach	approach	NOUN
ajmsi-3181	189	14	.	.	PUNCT
ajmsi-3181	190	1	the	the	DET
ajmsi-3181	190	2	first	first	ADJ
ajmsi-3181	190	3	step	step	NOUN
ajmsi-3181	190	4	in	in	ADP
ajmsi-3181	190	5	management	management	NOUN
ajmsi-3181	190	6	includes	include	VERB
ajmsi-3181	190	7	identifying	identify	VERB
ajmsi-3181	190	8	the	the	DET
ajmsi-3181	190	9	source	source	NOUN
ajmsi-3181	190	10	of	of	ADP
ajmsi-3181	190	11	the	the	DET
ajmsi-3181	190	12	infection	infection	NOUN
ajmsi-3181	190	13	.	.	PUNCT
ajmsi-3181	191	1	appropriate	appropriate	ADJ
ajmsi-3181	191	2	antimicrobial	antimicrobial	ADJ
ajmsi-3181	191	3	therapy	therapy	NOUN
ajmsi-3181	191	4	should	should	AUX
ajmsi-3181	191	5	be	be	AUX
ajmsi-3181	191	6	initiated	initiate	VERB
ajmsi-3181	191	7	with	with	ADP
ajmsi-3181	191	8	proper	proper	ADJ
ajmsi-3181	191	9	source	source	NOUN
ajmsi-3181	191	10	control	control	NOUN
ajmsi-3181	191	11	,	,	PUNCT
ajmsi-3181	191	12	including	include	VERB
ajmsi-3181	191	13	removing	remove	VERB
ajmsi-3181	191	14	infected	infect	VERB
ajmsi-3181	191	15	intravascular	intravascular	ADJ
ajmsi-3181	191	16	devices	device	NOUN
ajmsi-3181	191	17	,	,	PUNCT
ajmsi-3181	191	18	such	such	ADJ
ajmsi-3181	191	19	as	as	ADP
ajmsi-3181	191	20	central	central	ADJ
ajmsi-3181	191	21	venous	venous	ADJ
ajmsi-3181	191	22	catheters	catheter	NOUN
ajmsi-3181	191	23	,	,	PUNCT
ajmsi-3181	191	24	or	or	CCONJ
ajmsi-3181	191	25	surgical	surgical	ADJ
ajmsi-3181	191	26	intervention	intervention	NOUN
ajmsi-3181	191	27	to	to	PART
ajmsi-3181	191	28	remove	remove	VERB
ajmsi-3181	191	29	infected	infected	ADJ
ajmsi-3181	191	30	tissue	tissue	NOUN
ajmsi-3181	191	31	.	.	PUNCT
ajmsi-3181	192	1	a	a	DET
ajmsi-3181	192	2	reasonable	reasonable	ADJ
ajmsi-3181	192	3	approach	approach	NOUN
ajmsi-3181	192	4	for	for	ADP
ajmsi-3181	192	5	source	source	NOUN
ajmsi-3181	192	6	control	control	NOUN
ajmsi-3181	192	7	was	be	AUX
ajmsi-3181	192	8	observed	observe	VERB
ajmsi-3181	192	9	in	in	ADP
ajmsi-3181	192	10	the	the	DET
ajmsi-3181	192	11	patient	patient	ADJ
ajmsi-3181	192	12	population	population	NOUN
ajmsi-3181	192	13	.	.	PUNCT
ajmsi-3181	193	1	fortunately	fortunately	ADV
ajmsi-3181	193	2	,	,	PUNCT
ajmsi-3181	193	3	there	there	PRON
ajmsi-3181	193	4	were	be	VERB
ajmsi-3181	193	5	only	only	ADV
ajmsi-3181	193	6	a	a	DET
ajmsi-3181	193	7	handful	handful	NOUN
ajmsi-3181	193	8	of	of	ADP
ajmsi-3181	193	9	cases	case	NOUN
ajmsi-3181	193	10	where	where	SCONJ
ajmsi-3181	193	11	it	it	PRON
ajmsi-3181	193	12	was	be	AUX
ajmsi-3181	193	13	indicated	indicate	VERB
ajmsi-3181	193	14	but	but	CCONJ
ajmsi-3181	193	15	not	not	PART
ajmsi-3181	193	16	performed	perform	VERB
ajmsi-3181	193	17	.	.	PUNCT
ajmsi-3181	194	1	appropriate	appropriate	ADJ
ajmsi-3181	194	2	antibiotic	antibiotic	ADJ
ajmsi-3181	194	3	therapy	therapy	NOUN
ajmsi-3181	194	4	should	should	AUX
ajmsi-3181	194	5	be	be	AUX
ajmsi-3181	194	6	used	use	VERB
ajmsi-3181	194	7	based	base	VERB
ajmsi-3181	194	8	on	on	ADP
ajmsi-3181	194	9	the	the	DET
ajmsi-3181	194	10	organism	organism	NOUN
ajmsi-3181	194	11	’s	’s	PART
ajmsi-3181	194	12	susceptibility	susceptibility	NOUN
ajmsi-3181	194	13	pattern	pattern	NOUN
ajmsi-3181	194	14	to	to	PART
ajmsi-3181	194	15	manage	manage	VERB
ajmsi-3181	194	16	persistent	persistent	ADJ
ajmsi-3181	194	17	gnb	gnb	PROPN
ajmsi-3181	194	18	effectively	effectively	ADV
ajmsi-3181	194	19	.	.	PUNCT
ajmsi-3181	195	1	chu	chu	PROPN
ajmsi-3181	195	2	et	et	PROPN
ajmsi-3181	195	3	al	al	PROPN
ajmsi-3181	195	4	.	.	PROPN
ajmsi-3181	195	5	found	find	VERB
ajmsi-3181	195	6	that	that	SCONJ
ajmsi-3181	195	7	inappropriate	inappropriate	ADJ
ajmsi-3181	195	8	initial	initial	ADJ
ajmsi-3181	195	9	antimicrobial	antimicrobial	ADJ
ajmsi-3181	195	10	treatment	treatment	NOUN
ajmsi-3181	195	11	increases	increase	VERB
ajmsi-3181	195	12	mortality	mortality	NOUN
ajmsi-3181	195	13	risk	risk	NOUN
ajmsi-3181	195	14	(	(	PUNCT
ajmsi-3181	195	15	chu	chu	PROPN
ajmsi-3181	195	16	et	et	NOUN
ajmsi-3181	195	17	al	al	PROPN
ajmsi-3181	195	18	.	.	PROPN
ajmsi-3181	195	19	,	,	PUNCT
ajmsi-3181	195	20	2020	2020	NUM
ajmsi-3181	195	21	)	)	PUNCT
ajmsi-3181	195	22	.	.	PUNCT
ajmsi-3181	196	1	all	all	DET
ajmsi-3181	196	2	gnb	gnb	PROPN
ajmsi-3181	196	3	bacteremia	bacteremia	NOUN
ajmsi-3181	196	4	in	in	ADP
ajmsi-3181	196	5	patients	patient	NOUN
ajmsi-3181	196	6	are	be	AUX
ajmsi-3181	196	7	reported	report	VERB
ajmsi-3181	196	8	directly	directly	ADV
ajmsi-3181	196	9	to	to	ADP
ajmsi-3181	196	10	the	the	DET
ajmsi-3181	196	11	infectious	infectious	ADJ
ajmsi-3181	196	12	disease	disease	NOUN
ajmsi-3181	196	13	physician	physician	NOUN
ajmsi-3181	196	14	on	on	ADP
ajmsi-3181	196	15	call	call	NOUN
ajmsi-3181	196	16	by	by	ADP
ajmsi-3181	196	17	the	the	DET
ajmsi-3181	196	18	clinical	clinical	ADJ
ajmsi-3181	196	19	microbiology	microbiology	NOUN
ajmsi-3181	196	20	department	department	NOUN
ajmsi-3181	196	21	as	as	ADP
ajmsi-3181	196	22	a	a	DET
ajmsi-3181	196	23	part	part	NOUN
ajmsi-3181	196	24	of	of	ADP
ajmsi-3181	196	25	the	the	DET
ajmsi-3181	196	26	antimicrobial	antimicrobial	ADJ
ajmsi-3181	196	27	stewardship	stewardship	NOUN
ajmsi-3181	196	28	pa	pa	PROPN
ajmsi-3181	196	29	ge	ge	PROPN
ajmsi-3181	196	30	10	10	NUM
ajmsi-3181	196	31	0	0	NUM
ajmsi-3181	196	32	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-3181	196	33	am	be	AUX
ajmsi-3181	196	34	.	.	PUNCT
ajmsi-3181	197	1	j.	j.	PROPN
ajmsi-3181	197	2	med	med	PROPN
ajmsi-3181	197	3	.	.	PUNCT
ajmsi-3181	198	1	sci	sci	PROPN
ajmsi-3181	198	2	.	.	PUNCT
ajmsi-3181	198	3	innov	innov	PROPN
ajmsi-3181	198	4	.	.	PUNCT
ajmsi-3181	199	1	3(2	3(2	NUM
ajmsi-3181	199	2	)	)	PUNCT
ajmsi-3181	199	3	91	91	NUM
ajmsi-3181	199	4	-	-	SYM
ajmsi-3181	199	5	102	102	NUM
ajmsi-3181	199	6	,	,	PUNCT
ajmsi-3181	199	7	2024	2024	NUM
ajmsi-3181	199	8	program	program	NOUN
ajmsi-3181	199	9	.	.	PUNCT
ajmsi-3181	200	1	as	as	ADP
ajmsi-3181	200	2	part	part	NOUN
ajmsi-3181	200	3	of	of	ADP
ajmsi-3181	200	4	the	the	DET
ajmsi-3181	200	5	same	same	ADJ
ajmsi-3181	200	6	stewardship	stewardship	NOUN
ajmsi-3181	200	7	,	,	PUNCT
ajmsi-3181	200	8	broadspectrum	broadspectrum	NOUN
ajmsi-3181	200	9	antimicrobials	antimicrobial	NOUN
ajmsi-3181	200	10	are	be	AUX
ajmsi-3181	200	11	authorised	authorise	VERB
ajmsi-3181	200	12	by	by	ADP
ajmsi-3181	200	13	infectious	infectious	ADJ
ajmsi-3181	200	14	disease	disease	NOUN
ajmsi-3181	200	15	physicians	physician	NOUN
ajmsi-3181	200	16	within	within	ADP
ajmsi-3181	200	17	48	48	NUM
ajmsi-3181	200	18	hours	hour	NOUN
ajmsi-3181	200	19	of	of	ADP
ajmsi-3181	200	20	initiation	initiation	NOUN
ajmsi-3181	200	21	.	.	PUNCT
ajmsi-3181	201	1	a	a	DET
ajmsi-3181	201	2	combination	combination	NOUN
ajmsi-3181	201	3	therapy	therapy	NOUN
ajmsi-3181	201	4	may	may	AUX
ajmsi-3181	201	5	be	be	AUX
ajmsi-3181	201	6	necessary	necessary	ADJ
ajmsi-3181	201	7	to	to	PART
ajmsi-3181	201	8	achieve	achieve	VERB
ajmsi-3181	201	9	adequate	adequate	ADJ
ajmsi-3181	201	10	bacterial	bacterial	ADJ
ajmsi-3181	201	11	clearance	clearance	NOUN
ajmsi-3181	201	12	(	(	PUNCT
ajmsi-3181	201	13	kalelkar	kalelkar	INTJ
ajmsi-3181	201	14	et	et	PROPN
ajmsi-3181	201	15	al	al	PROPN
ajmsi-3181	201	16	.	.	PROPN
ajmsi-3181	201	17	,	,	PUNCT
ajmsi-3181	201	18	2022	2022	NUM
ajmsi-3181	201	19	)	)	PUNCT
ajmsi-3181	201	20	;	;	PUNCT
ajmsi-3181	201	21	the	the	DET
ajmsi-3181	201	22	empirical	empirical	ADJ
ajmsi-3181	201	23	antimicrobials	antimicrobial	NOUN
ajmsi-3181	201	24	were	be	AUX
ajmsi-3181	201	25	started	start	VERB
ajmsi-3181	201	26	according	accord	VERB
ajmsi-3181	201	27	to	to	ADP
ajmsi-3181	201	28	study	study	NOUN
ajmsi-3181	201	29	hospital	hospital	NOUN
ajmsi-3181	201	30	guidelines	guideline	NOUN
ajmsi-3181	201	31	and	and	CCONJ
ajmsi-3181	201	32	subsequently	subsequently	ADV
ajmsi-3181	201	33	tailored	tailor	VERB
ajmsi-3181	201	34	to	to	ADP
ajmsi-3181	201	35	narrowspectrum	narrowspectrum	ADJ
ajmsi-3181	201	36	agents	agent	NOUN
ajmsi-3181	201	37	as	as	ADV
ajmsi-3181	201	38	soon	soon	ADV
ajmsi-3181	201	39	as	as	SCONJ
ajmsi-3181	201	40	sensitivities	sensitivity	NOUN
ajmsi-3181	201	41	were	be	AUX
ajmsi-3181	201	42	available	available	ADJ
ajmsi-3181	201	43	.	.	PUNCT
ajmsi-3181	202	1	local	local	ADJ
ajmsi-3181	202	2	epidemiology	epidemiology	NOUN
ajmsi-3181	202	3	of	of	ADP
ajmsi-3181	202	4	infective	infective	ADJ
ajmsi-3181	202	5	organisms	organism	NOUN
ajmsi-3181	202	6	,	,	PUNCT
ajmsi-3181	202	7	antibiograms	antibiogram	NOUN
ajmsi-3181	202	8	,	,	PUNCT
ajmsi-3181	202	9	immune	immune	ADJ
ajmsi-3181	202	10	status	status	NOUN
ajmsi-3181	202	11	,	,	PUNCT
ajmsi-3181	202	12	previous	previous	ADJ
ajmsi-3181	202	13	antimicrobial	antimicrobial	ADJ
ajmsi-3181	202	14	exposure	exposure	NOUN
ajmsi-3181	202	15	,	,	PUNCT
ajmsi-3181	202	16	possible	possible	ADJ
ajmsi-3181	202	17	source	source	NOUN
ajmsi-3181	202	18	of	of	ADP
ajmsi-3181	202	19	infection	infection	NOUN
ajmsi-3181	202	20	,	,	PUNCT
ajmsi-3181	202	21	and	and	CCONJ
ajmsi-3181	202	22	colonisation	colonisation	NOUN
ajmsi-3181	202	23	with	with	ADP
ajmsi-3181	202	24	mdr	mdr	PROPN
ajmsi-3181	202	25	bacteria	bacteria	NOUN
ajmsi-3181	202	26	and	and	CCONJ
ajmsi-3181	202	27	other	other	ADJ
ajmsi-3181	202	28	alert	alert	ADJ
ajmsi-3181	202	29	microorganisms	microorganism	NOUN
ajmsi-3181	202	30	such	such	ADJ
ajmsi-3181	202	31	as	as	ADP
ajmsi-3181	202	32	clostridium	clostridium	NOUN
ajmsi-3181	202	33	difficile	difficile	NOUN
ajmsi-3181	202	34	and	and	CCONJ
ajmsi-3181	202	35	candida	candida	PROPN
ajmsi-3181	202	36	auris	auris	PROPN
ajmsi-3181	202	37	must	must	AUX
ajmsi-3181	202	38	be	be	AUX
ajmsi-3181	202	39	considered	consider	VERB
ajmsi-3181	202	40	before	before	ADP
ajmsi-3181	202	41	initiating	initiate	VERB
ajmsi-3181	202	42	empirical	empirical	ADJ
ajmsi-3181	202	43	therapy	therapy	NOUN
ajmsi-3181	202	44	.	.	PUNCT
ajmsi-3181	203	1	initial	initial	ADJ
ajmsi-3181	203	2	broad	broad	ADJ
ajmsi-3181	203	3	-	-	PUNCT
ajmsi-3181	203	4	spectrum	spectrum	NOUN
ajmsi-3181	203	5	antibiotics	antibiotic	NOUN
ajmsi-3181	203	6	should	should	AUX
ajmsi-3181	203	7	be	be	AUX
ajmsi-3181	203	8	administered	administer	VERB
ajmsi-3181	203	9	empirically	empirically	ADV
ajmsi-3181	203	10	in	in	ADP
ajmsi-3181	203	11	severely	severely	ADV
ajmsi-3181	203	12	ill	ill	ADJ
ajmsi-3181	203	13	patients	patient	NOUN
ajmsi-3181	203	14	,	,	PUNCT
ajmsi-3181	203	15	followed	follow	VERB
ajmsi-3181	203	16	by	by	ADP
ajmsi-3181	203	17	source	source	NOUN
ajmsi-3181	203	18	identification	identification	NOUN
ajmsi-3181	203	19	and	and	CCONJ
ajmsi-3181	203	20	control	control	NOUN
ajmsi-3181	203	21	as	as	ADV
ajmsi-3181	203	22	soon	soon	ADV
ajmsi-3181	203	23	as	as	ADP
ajmsi-3181	203	24	possible	possible	ADJ
ajmsi-3181	203	25	(	(	PUNCT
ajmsi-3181	203	26	timsit	timsit	NOUN
ajmsi-3181	203	27	et	et	PROPN
ajmsi-3181	203	28	al	al	PROPN
ajmsi-3181	203	29	.	.	PROPN
ajmsi-3181	203	30	,	,	PUNCT
ajmsi-3181	203	31	2020	2020	NUM
ajmsi-3181	203	32	)	)	PUNCT
ajmsi-3181	203	33	.	.	PUNCT
ajmsi-3181	204	1	de	de	NOUN
ajmsi-3181	204	2	-	-	NOUN
ajmsi-3181	204	3	escalation	escalation	NOUN
ajmsi-3181	204	4	from	from	ADP
ajmsi-3181	204	5	a	a	DET
ajmsi-3181	204	6	broadspectrum	broadspectrum	NOUN
ajmsi-3181	204	7	to	to	ADP
ajmsi-3181	204	8	a	a	DET
ajmsi-3181	204	9	narrow	narrow	ADJ
ajmsi-3181	204	10	-	-	PUNCT
ajmsi-3181	204	11	spectrum	spectrum	NOUN
ajmsi-3181	204	12	antimicrobial	antimicrobial	ADJ
ajmsi-3181	204	13	when	when	SCONJ
ajmsi-3181	204	14	culture	culture	NOUN
ajmsi-3181	204	15	and	and	CCONJ
ajmsi-3181	204	16	sensitivity	sensitivity	NOUN
ajmsi-3181	204	17	results	result	NOUN
ajmsi-3181	204	18	are	be	AUX
ajmsi-3181	204	19	available	available	ADJ
ajmsi-3181	204	20	effectively	effectively	ADV
ajmsi-3181	204	21	reduces	reduce	VERB
ajmsi-3181	204	22	amr	amr	PROPN
ajmsi-3181	204	23	(	(	PUNCT
ajmsi-3181	204	24	lester	lester	PROPN
ajmsi-3181	204	25	et	et	PROPN
ajmsi-3181	204	26	al	al	PROPN
ajmsi-3181	204	27	.	.	PROPN
ajmsi-3181	204	28	,	,	PUNCT
ajmsi-3181	204	29	2020	2020	NUM
ajmsi-3181	204	30	)	)	PUNCT
ajmsi-3181	204	31	and	and	CCONJ
ajmsi-3181	204	32	is	be	AUX
ajmsi-3181	204	33	rigorously	rigorously	ADV
ajmsi-3181	204	34	followed	follow	VERB
ajmsi-3181	204	35	in	in	ADP
ajmsi-3181	204	36	our	our	PRON
ajmsi-3181	204	37	hospital	hospital	NOUN
ajmsi-3181	204	38	.	.	PUNCT
ajmsi-3181	205	1	on	on	ADP
ajmsi-3181	205	2	average	average	ADJ
ajmsi-3181	205	3	,	,	PUNCT
ajmsi-3181	205	4	the	the	DET
ajmsi-3181	205	5	duration	duration	NOUN
ajmsi-3181	205	6	of	of	ADP
ajmsi-3181	205	7	intravenous	intravenous	ADJ
ajmsi-3181	205	8	(	(	PUNCT
ajmsi-3181	205	9	iv	iv	X
ajmsi-3181	205	10	)	)	PUNCT
ajmsi-3181	205	11	antibiotics	antibiotic	NOUN
ajmsi-3181	205	12	was	be	AUX
ajmsi-3181	205	13	5	5	NUM
ajmsi-3181	205	14	-	-	SYM
ajmsi-3181	205	15	8	8	NUM
ajmsi-3181	205	16	days	day	NOUN
ajmsi-3181	205	17	,	,	PUNCT
ajmsi-3181	205	18	although	although	SCONJ
ajmsi-3181	205	19	longer	long	ADJ
ajmsi-3181	205	20	durations	duration	NOUN
ajmsi-3181	205	21	were	be	AUX
ajmsi-3181	205	22	used	use	VERB
ajmsi-3181	205	23	when	when	SCONJ
ajmsi-3181	205	24	the	the	DET
ajmsi-3181	205	25	underlying	underlying	ADJ
ajmsi-3181	205	26	illness	illness	NOUN
ajmsi-3181	205	27	and	and	CCONJ
ajmsi-3181	205	28	source	source	NOUN
ajmsi-3181	205	29	of	of	ADP
ajmsi-3181	205	30	infection	infection	NOUN
ajmsi-3181	205	31	were	be	AUX
ajmsi-3181	205	32	present	present	ADJ
ajmsi-3181	205	33	.	.	PUNCT
ajmsi-3181	206	1	another	another	DET
ajmsi-3181	206	2	important	important	ADJ
ajmsi-3181	206	3	intervention	intervention	NOUN
ajmsi-3181	206	4	was	be	AUX
ajmsi-3181	206	5	the	the	DET
ajmsi-3181	206	6	close	close	ADJ
ajmsi-3181	206	7	teamwork	teamwork	NOUN
ajmsi-3181	206	8	relationship	relationship	NOUN
ajmsi-3181	206	9	and	and	CCONJ
ajmsi-3181	206	10	clinical	clinical	ADJ
ajmsi-3181	206	11	discussions	discussion	NOUN
ajmsi-3181	206	12	between	between	ADP
ajmsi-3181	206	13	our	our	PRON
ajmsi-3181	206	14	infectious	infectious	ADJ
ajmsi-3181	206	15	disease	disease	NOUN
ajmsi-3181	206	16	physicians	physician	NOUN
ajmsi-3181	206	17	and	and	CCONJ
ajmsi-3181	206	18	medical	medical	ADJ
ajmsi-3181	206	19	microbiologists	microbiologist	NOUN
ajmsi-3181	206	20	in	in	ADP
ajmsi-3181	206	21	decisionmaking	decisionmake	VERB
ajmsi-3181	206	22	(	(	PUNCT
ajmsi-3181	206	23	de	de	X
ajmsi-3181	206	24	waele	waele	PROPN
ajmsi-3181	206	25	et	et	PROPN
ajmsi-3181	206	26	al	al	PROPN
ajmsi-3181	206	27	.	.	PROPN
ajmsi-3181	206	28	,	,	PUNCT
ajmsi-3181	206	29	2018	2018	NUM
ajmsi-3181	206	30	)	)	PUNCT
ajmsi-3181	206	31	.	.	PUNCT
ajmsi-3181	207	1	in	in	ADP
ajmsi-3181	207	2	south	south	PROPN
ajmsi-3181	207	3	korea	korea	PROPN
ajmsi-3181	207	4	,	,	PUNCT
ajmsi-3181	207	5	extended	extend	VERB
ajmsi-3181	207	6	-	-	PUNCT
ajmsi-3181	207	7	spectrum	spectrum	NOUN
ajmsi-3181	207	8	beta	beta	NOUN
ajmsi-3181	207	9	-	-	PUNCT
ajmsi-3181	207	10	lactamaseproducing	lactamaseproduce	VERB
ajmsi-3181	207	11	enterobacterales	enterobacterale	NOUN
ajmsi-3181	207	12	have	have	AUX
ajmsi-3181	207	13	emerged	emerge	VERB
ajmsi-3181	207	14	as	as	ADP
ajmsi-3181	207	15	a	a	DET
ajmsi-3181	207	16	significant	significant	ADJ
ajmsi-3181	207	17	cause	cause	NOUN
ajmsi-3181	207	18	of	of	ADP
ajmsi-3181	207	19	community	community	NOUN
ajmsi-3181	207	20	-	-	PUNCT
ajmsi-3181	207	21	acquired	acquire	VERB
ajmsi-3181	207	22	bacteremia	bacteremia	NOUN
ajmsi-3181	207	23	after	after	ADP
ajmsi-3181	207	24	the	the	DET
ajmsi-3181	207	25	prior	prior	ADJ
ajmsi-3181	207	26	use	use	NOUN
ajmsi-3181	207	27	of	of	ADP
ajmsi-3181	207	28	antimicrobials	antimicrobial	NOUN
ajmsi-3181	207	29	(	(	PUNCT
ajmsi-3181	207	30	timsit	timsit	NOUN
ajmsi-3181	207	31	et	et	PROPN
ajmsi-3181	207	32	al	al	PROPN
ajmsi-3181	207	33	.	.	PROPN
ajmsi-3181	207	34	,	,	PUNCT
ajmsi-3181	207	35	2020	2020	NUM
ajmsi-3181	207	36	)	)	PUNCT
ajmsi-3181	207	37	.	.	PUNCT
ajmsi-3181	208	1	the	the	DET
ajmsi-3181	208	2	present	present	ADJ
ajmsi-3181	208	3	study	study	NOUN
ajmsi-3181	208	4	did	do	AUX
ajmsi-3181	208	5	not	not	PART
ajmsi-3181	208	6	look	look	VERB
ajmsi-3181	208	7	for	for	ADP
ajmsi-3181	208	8	previous	previous	ADJ
ajmsi-3181	208	9	use	use	NOUN
ajmsi-3181	208	10	of	of	ADP
ajmsi-3181	208	11	antimicrobials	antimicrobial	NOUN
ajmsi-3181	208	12	but	but	CCONJ
ajmsi-3181	208	13	noted	note	VERB
ajmsi-3181	208	14	that	that	SCONJ
ajmsi-3181	208	15	last	last	ADJ
ajmsi-3181	208	16	hospitalisation	hospitalisation	NOUN
ajmsi-3181	208	17	and	and	CCONJ
ajmsi-3181	208	18	prolonged	prolonged	ADJ
ajmsi-3181	208	19	hospital	hospital	NOUN
ajmsi-3181	208	20	stay	stay	NOUN
ajmsi-3181	208	21	were	be	AUX
ajmsi-3181	208	22	associated	associate	VERB
ajmsi-3181	208	23	with	with	ADP
ajmsi-3181	208	24	a	a	DET
ajmsi-3181	208	25	higher	high	ADJ
ajmsi-3181	208	26	emergence	emergence	NOUN
ajmsi-3181	208	27	of	of	ADP
ajmsi-3181	208	28	resistance	resistance	NOUN
ajmsi-3181	208	29	.	.	PUNCT
ajmsi-3181	209	1	similarly	similarly	ADV
ajmsi-3181	209	2	,	,	PUNCT
ajmsi-3181	209	3	a	a	DET
ajmsi-3181	209	4	study	study	NOUN
ajmsi-3181	209	5	from	from	ADP
ajmsi-3181	209	6	lebanon	lebanon	PROPN
ajmsi-3181	209	7	reported	report	VERB
ajmsi-3181	209	8	that	that	SCONJ
ajmsi-3181	209	9	infections	infection	NOUN
ajmsi-3181	209	10	caused	cause	VERB
ajmsi-3181	209	11	by	by	ADP
ajmsi-3181	209	12	resistant	resistant	ADJ
ajmsi-3181	209	13	bacteria	bacteria	NOUN
ajmsi-3181	209	14	were	be	AUX
ajmsi-3181	209	15	associated	associate	VERB
ajmsi-3181	209	16	with	with	ADP
ajmsi-3181	209	17	a	a	DET
ajmsi-3181	209	18	significant	significant	ADJ
ajmsi-3181	209	19	increase	increase	NOUN
ajmsi-3181	209	20	in	in	ADP
ajmsi-3181	209	21	hospital	hospital	NOUN
ajmsi-3181	209	22	stays	stay	NOUN
ajmsi-3181	209	23	compared	compare	VERB
ajmsi-3181	209	24	to	to	ADP
ajmsi-3181	209	25	those	those	PRON
ajmsi-3181	209	26	with	with	ADP
ajmsi-3181	209	27	susceptible	susceptible	ADJ
ajmsi-3181	209	28	bacteria	bacteria	NOUN
ajmsi-3181	209	29	,	,	PUNCT
ajmsi-3181	209	30	leading	lead	VERB
ajmsi-3181	209	31	to	to	ADP
ajmsi-3181	209	32	higher	high	ADJ
ajmsi-3181	209	33	costs	cost	NOUN
ajmsi-3181	209	34	(	(	PUNCT
ajmsi-3181	209	35	iskandar	iskandar	NOUN
ajmsi-3181	209	36	et	et	PROPN
ajmsi-3181	209	37	al	al	PROPN
ajmsi-3181	209	38	.	.	PROPN
ajmsi-3181	209	39	,	,	PUNCT
ajmsi-3181	209	40	2021	2021	NUM
ajmsi-3181	209	41	)	)	PUNCT
ajmsi-3181	209	42	.	.	PUNCT
ajmsi-3181	210	1	the	the	DET
ajmsi-3181	210	2	duration	duration	NOUN
ajmsi-3181	210	3	of	of	ADP
ajmsi-3181	210	4	antibiotic	antibiotic	ADJ
ajmsi-3181	210	5	therapy	therapy	NOUN
ajmsi-3181	210	6	for	for	ADP
ajmsi-3181	210	7	gram	gram	NOUN
ajmsi-3181	210	8	-	-	PUNCT
ajmsi-3181	210	9	negative	negative	ADJ
ajmsi-3181	210	10	bacteremia	bacteremia	NOUN
ajmsi-3181	210	11	depends	depend	VERB
ajmsi-3181	210	12	on	on	ADP
ajmsi-3181	210	13	several	several	ADJ
ajmsi-3181	210	14	factors	factor	NOUN
ajmsi-3181	210	15	,	,	PUNCT
ajmsi-3181	210	16	such	such	ADJ
ajmsi-3181	210	17	as	as	ADP
ajmsi-3181	210	18	the	the	DET
ajmsi-3181	210	19	site	site	NOUN
ajmsi-3181	210	20	of	of	ADP
ajmsi-3181	210	21	infection	infection	NOUN
ajmsi-3181	210	22	,	,	PUNCT
ajmsi-3181	210	23	severity	severity	NOUN
ajmsi-3181	210	24	of	of	ADP
ajmsi-3181	210	25	illness	illness	NOUN
ajmsi-3181	210	26	,	,	PUNCT
ajmsi-3181	210	27	and	and	CCONJ
ajmsi-3181	210	28	the	the	DET
ajmsi-3181	210	29	type	type	NOUN
ajmsi-3181	210	30	of	of	ADP
ajmsi-3181	210	31	causative	causative	ADJ
ajmsi-3181	210	32	organism	organism	NOUN
ajmsi-3181	210	33	.	.	PUNCT
ajmsi-3181	211	1	in	in	ADP
ajmsi-3181	211	2	this	this	DET
ajmsi-3181	211	3	study	study	NOUN
ajmsi-3181	211	4	,	,	PUNCT
ajmsi-3181	211	5	many	many	ADJ
ajmsi-3181	211	6	patients	patient	NOUN
ajmsi-3181	211	7	received	receive	VERB
ajmsi-3181	211	8	iv	iv	NUM
ajmsi-3181	211	9	antibiotics	antibiotic	NOUN
ajmsi-3181	211	10	for	for	ADP
ajmsi-3181	211	11	less	less	ADJ
ajmsi-3181	211	12	than	than	ADP
ajmsi-3181	211	13	7	7	NUM
ajmsi-3181	211	14	days	day	NOUN
ajmsi-3181	211	15	,	,	PUNCT
ajmsi-3181	211	16	while	while	SCONJ
ajmsi-3181	211	17	only	only	ADV
ajmsi-3181	211	18	12	12	NUM
ajmsi-3181	211	19	%	%	NOUN
ajmsi-3181	211	20	received	receive	VERB
ajmsi-3181	211	21	treatment	treatment	NOUN
ajmsi-3181	211	22	for	for	ADP
ajmsi-3181	211	23	more	more	ADJ
ajmsi-3181	211	24	than	than	ADP
ajmsi-3181	211	25	14	14	NUM
ajmsi-3181	211	26	days	day	NOUN
ajmsi-3181	211	27	(	(	PUNCT
ajmsi-3181	211	28	either	either	CCONJ
ajmsi-3181	211	29	due	due	ADP
ajmsi-3181	211	30	to	to	ADP
ajmsi-3181	211	31	persistent	persistent	ADJ
ajmsi-3181	211	32	bacteremia	bacteremia	NOUN
ajmsi-3181	211	33	or	or	CCONJ
ajmsi-3181	211	34	complicated	complicated	ADJ
ajmsi-3181	211	35	bacteremia	bacteremia	NOUN
ajmsi-3181	211	36	)	)	PUNCT
ajmsi-3181	211	37	.	.	PUNCT
ajmsi-3181	212	1	several	several	ADJ
ajmsi-3181	212	2	studies	study	NOUN
ajmsi-3181	212	3	have	have	AUX
ajmsi-3181	212	4	determined	determine	VERB
ajmsi-3181	212	5	the	the	DET
ajmsi-3181	212	6	optimal	optimal	ADJ
ajmsi-3181	212	7	duration	duration	NOUN
ajmsi-3181	212	8	of	of	ADP
ajmsi-3181	212	9	antibiotic	antibiotic	ADJ
ajmsi-3181	212	10	therapy	therapy	NOUN
ajmsi-3181	212	11	for	for	ADP
ajmsi-3181	212	12	gram	gram	NOUN
ajmsi-3181	212	13	-	-	PUNCT
ajmsi-3181	212	14	negative	negative	ADJ
ajmsi-3181	212	15	bacteremia	bacteremia	NOUN
ajmsi-3181	212	16	(	(	PUNCT
ajmsi-3181	212	17	dyer	dyer	NOUN
ajmsi-3181	212	18	et	et	PROPN
ajmsi-3181	212	19	al	al	PROPN
ajmsi-3181	212	20	.	.	PROPN
ajmsi-3181	212	21	,	,	PUNCT
ajmsi-3181	212	22	2019	2019	NUM
ajmsi-3181	212	23	;	;	PUNCT
ajmsi-3181	212	24	lee	lee	PROPN
ajmsi-3181	212	25	et	et	PROPN
ajmsi-3181	212	26	al	al	PROPN
ajmsi-3181	212	27	.	.	PROPN
ajmsi-3181	212	28	,	,	PUNCT
ajmsi-3181	212	29	2019	2019	NUM
ajmsi-3181	212	30	)	)	PUNCT
ajmsi-3181	212	31	.	.	PUNCT
ajmsi-3181	213	1	yahav	yahav	AUX
ajmsi-3181	213	2	et	et	PROPN
ajmsi-3181	213	3	al	al	PROPN
ajmsi-3181	213	4	.	.	PROPN
ajmsi-3181	213	5	found	find	VERB
ajmsi-3181	213	6	that	that	SCONJ
ajmsi-3181	213	7	a	a	DET
ajmsi-3181	213	8	short	short	ADJ
ajmsi-3181	213	9	course	course	NOUN
ajmsi-3181	213	10	of	of	ADP
ajmsi-3181	213	11	antibiotic	antibiotic	ADJ
ajmsi-3181	213	12	therapy	therapy	NOUN
ajmsi-3181	213	13	(	(	PUNCT
ajmsi-3181	213	14	7	7	NUM
ajmsi-3181	213	15	days	day	NOUN
ajmsi-3181	213	16	)	)	PUNCT
ajmsi-3181	213	17	was	be	AUX
ajmsi-3181	213	18	as	as	ADV
ajmsi-3181	213	19	effective	effective	ADJ
ajmsi-3181	213	20	as	as	ADP
ajmsi-3181	213	21	a	a	DET
ajmsi-3181	213	22	longer	long	ADJ
ajmsi-3181	213	23	course	course	NOUN
ajmsi-3181	213	24	(	(	PUNCT
ajmsi-3181	213	25	14	14	NUM
ajmsi-3181	213	26	days	day	NOUN
ajmsi-3181	213	27	)	)	PUNCT
ajmsi-3181	213	28	in	in	ADP
ajmsi-3181	213	29	the	the	DET
ajmsi-3181	213	30	treatment	treatment	NOUN
ajmsi-3181	213	31	of	of	ADP
ajmsi-3181	213	32	gram	gram	NOUN
ajmsi-3181	213	33	-	-	PUNCT
ajmsi-3181	213	34	negative	negative	ADJ
ajmsi-3181	213	35	bacteremia	bacteremia	NOUN
ajmsi-3181	213	36	(	(	PUNCT
ajmsi-3181	213	37	yahav	yahav	VERB
ajmsi-3181	213	38	et	et	PROPN
ajmsi-3181	213	39	al	al	PROPN
ajmsi-3181	213	40	.	.	PROPN
ajmsi-3181	213	41	,	,	PUNCT
ajmsi-3181	213	42	2019	2019	NUM
ajmsi-3181	213	43	)	)	PUNCT
ajmsi-3181	213	44	.	.	PUNCT
ajmsi-3181	214	1	a	a	DET
ajmsi-3181	214	2	meta	meta	ADJ
ajmsi-3181	214	3	-	-	PUNCT
ajmsi-3181	214	4	analysis	analysis	NOUN
ajmsi-3181	214	5	of	of	ADP
ajmsi-3181	214	6	three	three	NUM
ajmsi-3181	214	7	randomised	randomised	ADJ
ajmsi-3181	214	8	controlled	control	VERB
ajmsi-3181	214	9	trials	trial	NOUN
ajmsi-3181	214	10	(	(	PUNCT
ajmsi-3181	214	11	rcts	rct	NOUN
ajmsi-3181	214	12	)	)	PUNCT
ajmsi-3181	214	13	with	with	ADP
ajmsi-3181	214	14	1121	1121	NUM
ajmsi-3181	214	15	patients	patient	NOUN
ajmsi-3181	214	16	with	with	ADP
ajmsi-3181	214	17	enterobacterale	enterobacterale	NOUN
ajmsi-3181	214	18	bacteremia	bacteremia	NOUN
ajmsi-3181	214	19	showed	show	VERB
ajmsi-3181	214	20	no	no	DET
ajmsi-3181	214	21	significant	significant	ADJ
ajmsi-3181	214	22	difference	difference	NOUN
ajmsi-3181	214	23	in	in	ADP
ajmsi-3181	214	24	90	90	NUM
ajmsi-3181	214	25	days	day	NOUN
ajmsi-3181	214	26	of	of	ADP
ajmsi-3181	214	27	mortality	mortality	NOUN
ajmsi-3181	214	28	between	between	ADP
ajmsi-3181	214	29	7	7	NUM
ajmsi-3181	214	30	and	and	CCONJ
ajmsi-3181	214	31	14	14	NUM
ajmsi-3181	214	32	days	day	NOUN
ajmsi-3181	214	33	of	of	ADP
ajmsi-3181	214	34	treatment	treatment	NOUN
ajmsi-3181	214	35	(	(	PUNCT
ajmsi-3181	214	36	turjeman	turjeman	NOUN
ajmsi-3181	214	37	et	et	PROPN
ajmsi-3181	214	38	al	al	PROPN
ajmsi-3181	214	39	.	.	PROPN
ajmsi-3181	214	40	,	,	PUNCT
ajmsi-3181	214	41	2023	2023	NUM
ajmsi-3181	214	42	)	)	PUNCT
ajmsi-3181	214	43	.	.	PUNCT
ajmsi-3181	215	1	shorter	short	ADJ
ajmsi-3181	215	2	durations	duration	NOUN
ajmsi-3181	215	3	of	of	ADP
ajmsi-3181	215	4	antimicrobials	antimicrobial	NOUN
ajmsi-3181	215	5	are	be	AUX
ajmsi-3181	215	6	advocated	advocate	VERB
ajmsi-3181	215	7	as	as	ADP
ajmsi-3181	215	8	a	a	DET
ajmsi-3181	215	9	goal	goal	NOUN
ajmsi-3181	215	10	for	for	ADP
ajmsi-3181	215	11	many	many	ADJ
ajmsi-3181	215	12	antimicrobial	antimicrobial	ADJ
ajmsi-3181	215	13	stewardship	stewardship	NOUN
ajmsi-3181	215	14	programs	program	NOUN
ajmsi-3181	215	15	to	to	PART
ajmsi-3181	215	16	treat	treat	VERB
ajmsi-3181	215	17	community	community	NOUN
ajmsi-3181	215	18	-	-	PUNCT
ajmsi-3181	215	19	acquired	acquire	VERB
ajmsi-3181	215	20	pneumonia	pneumonia	NOUN
ajmsi-3181	215	21	,	,	PUNCT
ajmsi-3181	215	22	urinary	urinary	ADJ
ajmsi-3181	215	23	tract	tract	NOUN
ajmsi-3181	215	24	infections	infection	NOUN
ajmsi-3181	215	25	,	,	PUNCT
ajmsi-3181	215	26	intra	intra	ADJ
ajmsi-3181	215	27	-	-	ADJ
ajmsi-3181	215	28	abdominal	abdominal	ADJ
ajmsi-3181	215	29	infections	infection	NOUN
ajmsi-3181	215	30	,	,	PUNCT
ajmsi-3181	215	31	and	and	CCONJ
ajmsi-3181	215	32	skin	skin	NOUN
ajmsi-3181	215	33	and	and	CCONJ
ajmsi-3181	215	34	softtissue	softtissue	NOUN
ajmsi-3181	215	35	infections	infection	NOUN
ajmsi-3181	215	36	.	.	PUNCT
ajmsi-3181	216	1	batlas	batla	NOUN
ajmsi-3181	216	2	et	et	PROPN
ajmsi-3181	216	3	al	al	PROPN
ajmsi-3181	216	4	.	.	PROPN
ajmsi-3181	216	5	reported	report	VERB
ajmsi-3181	216	6	an	an	DET
ajmsi-3181	216	7	overall	overall	ADJ
ajmsi-3181	216	8	mortality	mortality	NOUN
ajmsi-3181	216	9	at	at	ADP
ajmsi-3181	216	10	1	1	NUM
ajmsi-3181	216	11	year	year	NOUN
ajmsi-3181	216	12	of	of	ADP
ajmsi-3181	216	13	36.2	36.2	NUM
ajmsi-3181	216	14	%	%	NOUN
ajmsi-3181	216	15	,	,	PUNCT
ajmsi-3181	216	16	with	with	ADP
ajmsi-3181	216	17	18	18	NUM
ajmsi-3181	216	18	%	%	NOUN
ajmsi-3181	216	19	within	within	ADP
ajmsi-3181	216	20	the	the	DET
ajmsi-3181	216	21	first	first	ADJ
ajmsi-3181	216	22	30	30	NUM
ajmsi-3181	216	23	days	day	NOUN
ajmsi-3181	216	24	(	(	PUNCT
ajmsi-3181	216	25	baltas	balta	NOUN
ajmsi-3181	216	26	et	et	NOUN
ajmsi-3181	216	27	al	al	PROPN
ajmsi-3181	216	28	.	.	PROPN
ajmsi-3181	216	29	,	,	PUNCT
ajmsi-3181	216	30	2021	2021	NUM
ajmsi-3181	216	31	)	)	PUNCT
ajmsi-3181	216	32	.	.	PUNCT
ajmsi-3181	217	1	similarly	similarly	ADV
ajmsi-3181	217	2	,	,	PUNCT
ajmsi-3181	217	3	a	a	DET
ajmsi-3181	217	4	study	study	NOUN
ajmsi-3181	217	5	from	from	ADP
ajmsi-3181	217	6	calgary	calgary	PROPN
ajmsi-3181	217	7	found	find	VERB
ajmsi-3181	217	8	that	that	SCONJ
ajmsi-3181	217	9	28	28	NUM
ajmsi-3181	217	10	-	-	PUNCT
ajmsi-3181	217	11	day	day	NOUN
ajmsi-3181	217	12	,	,	PUNCT
ajmsi-3181	217	13	90	90	NUM
ajmsi-3181	217	14	-	-	PUNCT
ajmsi-3181	217	15	day	day	NOUN
ajmsi-3181	217	16	,	,	PUNCT
ajmsi-3181	217	17	and	and	CCONJ
ajmsi-3181	217	18	365	365	NUM
ajmsi-3181	217	19	-	-	PUNCT
ajmsi-3181	217	20	day	day	NOUN
ajmsi-3181	217	21	all	all	DET
ajmsi-3181	217	22	-	-	PUNCT
ajmsi-3181	217	23	cause	cause	NOUN
ajmsi-3181	217	24	case	case	NOUN
ajmsi-3181	217	25	-	-	PUNCT
ajmsi-3181	217	26	fatality	fatality	NOUN
ajmsi-3181	217	27	rates	rate	NOUN
ajmsi-3181	217	28	after	after	ADP
ajmsi-3181	217	29	bloodstream	bloodstream	NOUN
ajmsi-3181	217	30	infection	infection	NOUN
ajmsi-3181	217	31	were	be	AUX
ajmsi-3181	217	32	12	12	NUM
ajmsi-3181	217	33	%	%	NOUN
ajmsi-3181	217	34	,	,	PUNCT
ajmsi-3181	217	35	17	17	NUM
ajmsi-3181	217	36	%	%	NOUN
ajmsi-3181	217	37	,	,	PUNCT
ajmsi-3181	217	38	and	and	CCONJ
ajmsi-3181	217	39	25	25	NUM
ajmsi-3181	217	40	%	%	NOUN
ajmsi-3181	217	41	,	,	PUNCT
ajmsi-3181	217	42	respectively	respectively	ADV
ajmsi-3181	217	43	(	(	PUNCT
ajmsi-3181	217	44	laupland	laupland	NOUN
ajmsi-3181	217	45	et	et	PROPN
ajmsi-3181	217	46	al	al	PROPN
ajmsi-3181	217	47	.	.	PROPN
ajmsi-3181	217	48	,	,	PUNCT
ajmsi-3181	217	49	2011	2011	NUM
ajmsi-3181	217	50	)	)	PUNCT
ajmsi-3181	217	51	.	.	PUNCT
ajmsi-3181	218	1	a	a	DET
ajmsi-3181	218	2	study	study	NOUN
ajmsi-3181	218	3	by	by	ADP
ajmsi-3181	218	4	qatar	qatar	PROPN
ajmsi-3181	218	5	showed	show	VERB
ajmsi-3181	218	6	a	a	DET
ajmsi-3181	218	7	hospital	hospital	NOUN
ajmsi-3181	218	8	mortality	mortality	NOUN
ajmsi-3181	218	9	rate	rate	NOUN
ajmsi-3181	218	10	of	of	ADP
ajmsi-3181	218	11	29.7	29.7	NUM
ajmsi-3181	218	12	%	%	NOUN
ajmsi-3181	218	13	for	for	ADP
ajmsi-3181	218	14	all	all	DET
ajmsi-3181	218	15	bacteremia	bacteremia	NOUN
ajmsi-3181	218	16	cases	case	NOUN
ajmsi-3181	218	17	(	(	PUNCT
ajmsi-3181	218	18	khan	khan	PROPN
ajmsi-3181	218	19	et	et	PROPN
ajmsi-3181	218	20	al	al	PROPN
ajmsi-3181	218	21	.	.	PROPN
ajmsi-3181	218	22	,	,	PUNCT
ajmsi-3181	218	23	2010	2010	NUM
ajmsi-3181	218	24	)	)	PUNCT
ajmsi-3181	218	25	.	.	PUNCT
ajmsi-3181	219	1	a	a	DET
ajmsi-3181	219	2	larger	large	ADJ
ajmsi-3181	219	3	study	study	NOUN
ajmsi-3181	219	4	examined	examine	VERB
ajmsi-3181	219	5	the	the	DET
ajmsi-3181	219	6	epidemiology	epidemiology	NOUN
ajmsi-3181	219	7	of	of	ADP
ajmsi-3181	219	8	bloodstream	bloodstream	NOUN
ajmsi-3181	219	9	infections	infection	NOUN
ajmsi-3181	219	10	in	in	ADP
ajmsi-3181	219	11	51	51	NUM
ajmsi-3181	219	12	countries	country	NOUN
ajmsi-3181	219	13	across	across	ADP
ajmsi-3181	219	14	six	six	NUM
ajmsi-3181	219	15	continents	continent	NOUN
ajmsi-3181	219	16	in	in	ADP
ajmsi-3181	219	17	critically	critically	ADV
ajmsi-3181	219	18	ill	ill	ADJ
ajmsi-3181	219	19	patients	patient	NOUN
ajmsi-3181	219	20	,	,	PUNCT
ajmsi-3181	219	21	including	include	VERB
ajmsi-3181	219	22	covid-19	covid-19	PROPN
ajmsi-3181	219	23	patients	patient	NOUN
ajmsi-3181	219	24	(	(	PUNCT
ajmsi-3181	219	25	buetti	buetti	PROPN
ajmsi-3181	219	26	et	et	PROPN
ajmsi-3181	219	27	al	al	PROPN
ajmsi-3181	219	28	.	.	PROPN
ajmsi-3181	219	29	,	,	PUNCT
ajmsi-3181	219	30	2017	2017	NUM
ajmsi-3181	219	31	)	)	PUNCT
ajmsi-3181	219	32	,	,	PUNCT
ajmsi-3181	219	33	found	find	VERB
ajmsi-3181	219	34	that	that	SCONJ
ajmsi-3181	219	35	gram	gram	NOUN
ajmsi-3181	219	36	-	-	PUNCT
ajmsi-3181	219	37	negative	negative	ADJ
ajmsi-3181	219	38	bacteria	bacteria	NOUN
ajmsi-3181	219	39	were	be	AUX
ajmsi-3181	219	40	the	the	DET
ajmsi-3181	219	41	most	most	ADV
ajmsi-3181	219	42	common	common	ADJ
ajmsi-3181	219	43	cause	cause	NOUN
ajmsi-3181	219	44	of	of	ADP
ajmsi-3181	219	45	bloodstream	bloodstream	NOUN
ajmsi-3181	219	46	infections	infection	NOUN
ajmsi-3181	219	47	and	and	CCONJ
ajmsi-3181	219	48	the	the	DET
ajmsi-3181	219	49	overall	overall	ADJ
ajmsi-3181	219	50	mortality	mortality	NOUN
ajmsi-3181	219	51	for	for	ADP
ajmsi-3181	219	52	bloodstream	bloodstream	NOUN
ajmsi-3181	219	53	infections	infection	NOUN
ajmsi-3181	219	54	was	be	AUX
ajmsi-3181	219	55	45	45	NUM
ajmsi-3181	219	56	%	%	NOUN
ajmsi-3181	219	57	,	,	PUNCT
ajmsi-3181	219	58	with	with	ADP
ajmsi-3181	219	59	higher	high	ADJ
ajmsi-3181	219	60	rates	rate	NOUN
ajmsi-3181	219	61	reported	report	VERB
ajmsi-3181	219	62	in	in	ADP
ajmsi-3181	219	63	covid-19	covid-19	PROPN
ajmsi-3181	219	64	patients	patient	NOUN
ajmsi-3181	219	65	(	(	PUNCT
ajmsi-3181	219	66	buetti	buetti	PROPN
ajmsi-3181	219	67	et	et	PROPN
ajmsi-3181	219	68	al	al	PROPN
ajmsi-3181	219	69	.	.	PROPN
ajmsi-3181	219	70	,	,	PUNCT
ajmsi-3181	219	71	2017	2017	NUM
ajmsi-3181	219	72	)	)	PUNCT
ajmsi-3181	219	73	.	.	PUNCT
ajmsi-3181	220	1	mortality	mortality	NOUN
ajmsi-3181	220	2	due	due	ADP
ajmsi-3181	220	3	to	to	ADP
ajmsi-3181	220	4	gram	gram	NOUN
ajmsi-3181	220	5	-	-	PUNCT
ajmsi-3181	220	6	negative	negative	ADJ
ajmsi-3181	220	7	bacteremia	bacteremia	NOUN
ajmsi-3181	220	8	can	can	AUX
ajmsi-3181	220	9	vary	vary	VERB
ajmsi-3181	220	10	depending	depend	VERB
ajmsi-3181	220	11	on	on	ADP
ajmsi-3181	220	12	various	various	ADJ
ajmsi-3181	220	13	factors	factor	NOUN
ajmsi-3181	220	14	,	,	PUNCT
ajmsi-3181	220	15	such	such	ADJ
ajmsi-3181	220	16	as	as	ADP
ajmsi-3181	220	17	the	the	DET
ajmsi-3181	220	18	specific	specific	ADJ
ajmsi-3181	220	19	bacterial	bacterial	ADJ
ajmsi-3181	220	20	species	specie	NOUN
ajmsi-3181	220	21	involved	involve	VERB
ajmsi-3181	220	22	,	,	PUNCT
ajmsi-3181	220	23	age	age	NOUN
ajmsi-3181	220	24	and	and	CCONJ
ajmsi-3181	220	25	overall	overall	ADJ
ajmsi-3181	220	26	health	health	NOUN
ajmsi-3181	220	27	of	of	ADP
ajmsi-3181	220	28	the	the	DET
ajmsi-3181	220	29	patient	patient	NOUN
ajmsi-3181	220	30	,	,	PUNCT
ajmsi-3181	220	31	presence	presence	NOUN
ajmsi-3181	220	32	of	of	ADP
ajmsi-3181	220	33	underlying	underlie	VERB
ajmsi-3181	220	34	medical	medical	ADJ
ajmsi-3181	220	35	conditions	condition	NOUN
ajmsi-3181	220	36	,	,	PUNCT
ajmsi-3181	220	37	and	and	CCONJ
ajmsi-3181	220	38	promptness	promptness	NOUN
ajmsi-3181	220	39	and	and	CCONJ
ajmsi-3181	220	40	effectiveness	effectiveness	NOUN
ajmsi-3181	220	41	of	of	ADP
ajmsi-3181	220	42	treatment	treatment	NOUN
ajmsi-3181	220	43	.	.	PUNCT
ajmsi-3181	221	1	the	the	DET
ajmsi-3181	221	2	mortality	mortality	NOUN
ajmsi-3181	221	3	from	from	ADP
ajmsi-3181	221	4	gram	gram	NOUN
ajmsi-3181	221	5	-	-	PUNCT
ajmsi-3181	221	6	negative	negative	ADJ
ajmsi-3181	221	7	bacteremia	bacteremia	NOUN
ajmsi-3181	221	8	is	be	AUX
ajmsi-3181	221	9	higher	high	ADJ
ajmsi-3181	221	10	than	than	ADP
ajmsi-3181	221	11	that	that	PRON
ajmsi-3181	221	12	from	from	ADP
ajmsi-3181	221	13	gram	gram	NOUN
ajmsi-3181	221	14	-	-	PUNCT
ajmsi-3181	221	15	positive	positive	ADJ
ajmsi-3181	221	16	bacteremia	bacteremia	NOUN
ajmsi-3181	221	17	,	,	PUNCT
ajmsi-3181	221	18	with	with	ADP
ajmsi-3181	221	19	some	some	DET
ajmsi-3181	221	20	studies	study	NOUN
ajmsi-3181	221	21	suggesting	suggest	VERB
ajmsi-3181	221	22	mortality	mortality	NOUN
ajmsi-3181	221	23	ranging	range	VERB
ajmsi-3181	221	24	between	between	ADP
ajmsi-3181	221	25	20	20	NUM
ajmsi-3181	221	26	and	and	CCONJ
ajmsi-3181	221	27	50	50	NUM
ajmsi-3181	221	28	%	%	NOUN
ajmsi-3181	221	29	.	.	PUNCT
ajmsi-3181	222	1	however	however	ADV
ajmsi-3181	222	2	,	,	PUNCT
ajmsi-3181	222	3	mortality	mortality	NOUN
ajmsi-3181	222	4	rates	rate	NOUN
ajmsi-3181	222	5	can	can	AUX
ajmsi-3181	222	6	vary	vary	VERB
ajmsi-3181	222	7	widely	widely	ADV
ajmsi-3181	222	8	based	base	VERB
ajmsi-3181	222	9	on	on	ADP
ajmsi-3181	222	10	individual	individual	ADJ
ajmsi-3181	222	11	circumstances	circumstance	NOUN
ajmsi-3181	222	12	,	,	PUNCT
ajmsi-3181	222	13	and	and	CCONJ
ajmsi-3181	222	14	it	it	PRON
ajmsi-3181	222	15	is	be	AUX
ajmsi-3181	222	16	important	important	ADJ
ajmsi-3181	222	17	to	to	PART
ajmsi-3181	222	18	note	note	VERB
ajmsi-3181	222	19	that	that	PRON
ajmsi-3181	222	20	timely	timely	ADJ
ajmsi-3181	222	21	and	and	CCONJ
ajmsi-3181	222	22	appropriate	appropriate	ADJ
ajmsi-3181	222	23	antibiotic	antibiotic	ADJ
ajmsi-3181	222	24	treatment	treatment	NOUN
ajmsi-3181	222	25	can	can	AUX
ajmsi-3181	222	26	greatly	greatly	ADV
ajmsi-3181	222	27	improve	improve	VERB
ajmsi-3181	222	28	outcomes	outcome	NOUN
ajmsi-3181	222	29	in	in	ADP
ajmsi-3181	222	30	patients	patient	NOUN
ajmsi-3181	222	31	with	with	ADP
ajmsi-3181	222	32	gram	gram	NOUN
ajmsi-3181	222	33	-	-	PUNCT
ajmsi-3181	222	34	negative	negative	ADJ
ajmsi-3181	222	35	bacteremia	bacteremia	NOUN
ajmsi-3181	222	36	.	.	PUNCT
ajmsi-3181	223	1	the	the	DET
ajmsi-3181	223	2	incidence	incidence	NOUN
ajmsi-3181	223	3	and	and	CCONJ
ajmsi-3181	223	4	mortality	mortality	NOUN
ajmsi-3181	223	5	rates	rate	NOUN
ajmsi-3181	223	6	of	of	ADP
ajmsi-3181	223	7	gram	gram	NOUN
ajmsi-3181	223	8	-	-	PUNCT
ajmsi-3181	223	9	negative	negative	ADJ
ajmsi-3181	223	10	bacteremia	bacteremia	NOUN
ajmsi-3181	223	11	can	can	AUX
ajmsi-3181	223	12	vary	vary	VERB
ajmsi-3181	223	13	globally	globally	ADV
ajmsi-3181	223	14	,	,	PUNCT
ajmsi-3181	223	15	depending	depend	VERB
ajmsi-3181	223	16	on	on	ADP
ajmsi-3181	223	17	healthcare	healthcare	NOUN
ajmsi-3181	223	18	practices	practice	NOUN
ajmsi-3181	223	19	,	,	PUNCT
ajmsi-3181	223	20	antibiotic	antibiotic	ADJ
ajmsi-3181	223	21	resistance	resistance	NOUN
ajmsi-3181	223	22	patterns	pattern	NOUN
ajmsi-3181	223	23	,	,	PUNCT
ajmsi-3181	223	24	and	and	CCONJ
ajmsi-3181	223	25	population	population	NOUN
ajmsi-3181	223	26	demographics	demographic	NOUN
ajmsi-3181	223	27	.	.	PUNCT
ajmsi-3181	224	1	the	the	DET
ajmsi-3181	224	2	study	study	NOUN
ajmsi-3181	224	3	centre	centre	NOUN
ajmsi-3181	224	4	has	have	VERB
ajmsi-3181	224	5	an	an	DET
ajmsi-3181	224	6	antimicrobial	antimicrobial	ADJ
ajmsi-3181	224	7	stewardship	stewardship	NOUN
ajmsi-3181	224	8	program	program	NOUN
ajmsi-3181	224	9	with	with	ADP
ajmsi-3181	224	10	formulary	formulary	ADJ
ajmsi-3181	224	11	restriction	restriction	NOUN
ajmsi-3181	224	12	and	and	CCONJ
ajmsi-3181	224	13	preauthorisation	preauthorisation	NOUN
ajmsi-3181	224	14	of	of	ADP
ajmsi-3181	224	15	restricted	restricted	ADJ
ajmsi-3181	224	16	antimicrobials	antimicrobial	NOUN
ajmsi-3181	224	17	that	that	PRON
ajmsi-3181	224	18	aid	aid	VERB
ajmsi-3181	224	19	in	in	ADP
ajmsi-3181	224	20	appropriately	appropriately	ADV
ajmsi-3181	224	21	starting	start	VERB
ajmsi-3181	224	22	antimicrobials	antimicrobial	NOUN
ajmsi-3181	224	23	,	,	PUNCT
ajmsi-3181	224	24	particularly	particularly	ADV
ajmsi-3181	224	25	in	in	ADP
ajmsi-3181	224	26	bacteremia	bacteremia	NOUN
ajmsi-3181	224	27	cases	case	NOUN
ajmsi-3181	224	28	,	,	PUNCT
ajmsi-3181	224	29	and	and	CCONJ
ajmsi-3181	224	30	is	be	AUX
ajmsi-3181	224	31	followed	follow	VERB
ajmsi-3181	224	32	by	by	ADP
ajmsi-3181	224	33	the	the	DET
ajmsi-3181	224	34	infectious	infectious	ADJ
ajmsi-3181	224	35	disease	disease	NOUN
ajmsi-3181	224	36	team	team	NOUN
ajmsi-3181	224	37	in	in	ADP
ajmsi-3181	224	38	collaboration	collaboration	NOUN
ajmsi-3181	224	39	with	with	ADP
ajmsi-3181	224	40	the	the	DET
ajmsi-3181	224	41	medical	medical	ADJ
ajmsi-3181	224	42	microbiologist	microbiologist	NOUN
ajmsi-3181	224	43	,	,	PUNCT
ajmsi-3181	224	44	which	which	PRON
ajmsi-3181	224	45	could	could	AUX
ajmsi-3181	224	46	be	be	AUX
ajmsi-3181	224	47	one	one	NUM
ajmsi-3181	224	48	reason	reason	NOUN
ajmsi-3181	224	49	why	why	SCONJ
ajmsi-3181	224	50	the	the	DET
ajmsi-3181	224	51	mdro	mdro	NOUN
ajmsi-3181	224	52	rate	rate	NOUN
ajmsi-3181	224	53	was	be	AUX
ajmsi-3181	224	54	not	not	PART
ajmsi-3181	224	55	significantly	significantly	ADV
ajmsi-3181	224	56	high	high	ADJ
ajmsi-3181	224	57	.	.	PUNCT
ajmsi-3181	225	1	however	however	ADV
ajmsi-3181	225	2	,	,	PUNCT
ajmsi-3181	225	3	cephalosporins	cephalosporin	NOUN
ajmsi-3181	225	4	are	be	AUX
ajmsi-3181	225	5	not	not	PART
ajmsi-3181	225	6	restricted	restrict	VERB
ajmsi-3181	225	7	in	in	ADP
ajmsi-3181	225	8	clinical	clinical	ADJ
ajmsi-3181	225	9	practice	practice	NOUN
ajmsi-3181	225	10	,	,	PUNCT
ajmsi-3181	225	11	which	which	PRON
ajmsi-3181	225	12	might	might	AUX
ajmsi-3181	225	13	explain	explain	VERB
ajmsi-3181	225	14	the	the	DET
ajmsi-3181	225	15	higher	high	ADJ
ajmsi-3181	225	16	numbers	number	NOUN
ajmsi-3181	225	17	of	of	ADP
ajmsi-3181	225	18	esbl	esbl	NOUN
ajmsi-3181	225	19	-	-	PUNCT
ajmsi-3181	225	20	producing	produce	VERB
ajmsi-3181	225	21	enterobacterales	enterobacterale	NOUN
ajmsi-3181	225	22	.	.	PUNCT
ajmsi-3181	226	1	conclusion	conclusion	NOUN
ajmsi-3181	226	2	in	in	ADP
ajmsi-3181	226	3	conclusion	conclusion	NOUN
ajmsi-3181	226	4	,	,	PUNCT
ajmsi-3181	226	5	gram	gram	NOUN
ajmsi-3181	226	6	-	-	PUNCT
ajmsi-3181	226	7	negative	negative	ADJ
ajmsi-3181	226	8	bsis	bsis	NOUN
ajmsi-3181	226	9	are	be	AUX
ajmsi-3181	226	10	serious	serious	ADJ
ajmsi-3181	226	11	infections	infection	NOUN
ajmsi-3181	226	12	with	with	ADP
ajmsi-3181	226	13	increasing	increase	VERB
ajmsi-3181	226	14	antimicrobial	antimicrobial	ADJ
ajmsi-3181	226	15	resistance	resistance	NOUN
ajmsi-3181	226	16	(	(	PUNCT
ajmsi-3181	226	17	amr	amr	NOUN
ajmsi-3181	226	18	)	)	PUNCT
ajmsi-3181	226	19	.	.	PUNCT
ajmsi-3181	227	1	extendedspectrum	extendedspectrum	ADP
ajmsi-3181	227	2	beta	beta	NOUN
ajmsi-3181	227	3	-	-	PUNCT
ajmsi-3181	227	4	lactamase	lactamase	NOUN
ajmsi-3181	227	5	(	(	PUNCT
ajmsi-3181	227	6	esbl	esbl	NOUN
ajmsi-3181	227	7	)	)	PUNCT
ajmsi-3181	227	8	producing	produce	VERB
ajmsi-3181	227	9	bacteria	bacteria	NOUN
ajmsi-3181	227	10	are	be	AUX
ajmsi-3181	227	11	our	our	PRON
ajmsi-3181	227	12	centre	centre	NOUN
ajmsi-3181	227	13	’s	’s	PART
ajmsi-3181	227	14	most	most	ADV
ajmsi-3181	227	15	common	common	ADJ
ajmsi-3181	227	16	cause	cause	NOUN
ajmsi-3181	227	17	of	of	ADP
ajmsi-3181	227	18	amr	amr	PROPN
ajmsi-3181	227	19	.	.	PROPN
ajmsi-3181	227	20	diabetes	diabetes	PROPN
ajmsi-3181	227	21	mellitus-2	mellitus-2	NUM
ajmsi-3181	227	22	,	,	PUNCT
ajmsi-3181	227	23	old	old	ADJ
ajmsi-3181	227	24	age	age	NOUN
ajmsi-3181	227	25	and	and	CCONJ
ajmsi-3181	227	26	hospital	hospital	NOUN
ajmsi-3181	227	27	-	-	PUNCT
ajmsi-3181	227	28	acquired	acquire	VERB
ajmsi-3181	227	29	infections	infection	NOUN
ajmsi-3181	227	30	are	be	AUX
ajmsi-3181	227	31	risk	risk	NOUN
ajmsi-3181	227	32	factors	factor	NOUN
ajmsi-3181	227	33	leading	lead	VERB
ajmsi-3181	227	34	to	to	ADP
ajmsi-3181	227	35	higher	high	ADJ
ajmsi-3181	227	36	mortality	mortality	NOUN
ajmsi-3181	227	37	.	.	PUNCT
ajmsi-3181	228	1	healthcare	healthcare	NOUN
ajmsi-3181	228	2	professionals	professional	NOUN
ajmsi-3181	228	3	should	should	AUX
ajmsi-3181	228	4	be	be	AUX
ajmsi-3181	228	5	aware	aware	ADJ
ajmsi-3181	228	6	of	of	ADP
ajmsi-3181	228	7	the	the	DET
ajmsi-3181	228	8	risk	risk	NOUN
ajmsi-3181	228	9	factors	factor	NOUN
ajmsi-3181	228	10	associated	associate	VERB
ajmsi-3181	228	11	with	with	ADP
ajmsi-3181	228	12	this	this	DET
ajmsi-3181	228	13	condition	condition	NOUN
ajmsi-3181	228	14	and	and	CCONJ
ajmsi-3181	228	15	initiate	initiate	VERB
ajmsi-3181	228	16	empirically	empirically	ADV
ajmsi-3181	228	17	effective	effective	ADJ
ajmsi-3181	228	18	antibiotic	antibiotic	ADJ
ajmsi-3181	228	19	therapy	therapy	NOUN
ajmsi-3181	228	20	to	to	PART
ajmsi-3181	228	21	achieve	achieve	VERB
ajmsi-3181	228	22	optimal	optimal	ADJ
ajmsi-3181	228	23	treatment	treatment	NOUN
ajmsi-3181	228	24	outcomes	outcome	NOUN
ajmsi-3181	228	25	and	and	CCONJ
ajmsi-3181	228	26	prevent	prevent	VERB
ajmsi-3181	228	27	collateral	collateral	ADJ
ajmsi-3181	228	28	damage	damage	NOUN
ajmsi-3181	228	29	.	.	PUNCT
ajmsi-3181	229	1	further	further	ADJ
ajmsi-3181	229	2	research	research	NOUN
ajmsi-3181	229	3	is	be	AUX
ajmsi-3181	229	4	needed	need	VERB
ajmsi-3181	229	5	to	to	PART
ajmsi-3181	229	6	understand	understand	VERB
ajmsi-3181	229	7	better	well	ADJ
ajmsi-3181	229	8	the	the	DET
ajmsi-3181	229	9	epidemiology	epidemiology	NOUN
ajmsi-3181	229	10	and	and	CCONJ
ajmsi-3181	229	11	pathophysiology	pathophysiology	NOUN
ajmsi-3181	229	12	of	of	ADP
ajmsi-3181	229	13	gram	gram	NOUN
ajmsi-3181	229	14	-	-	PUNCT
ajmsi-3181	229	15	negative	negative	ADJ
ajmsi-3181	229	16	bacteremia	bacteremia	NOUN
ajmsi-3181	229	17	in	in	ADP
ajmsi-3181	229	18	qatar	qatar	NOUN
ajmsi-3181	229	19	and	and	CCONJ
ajmsi-3181	229	20	formulate	formulate	VERB
ajmsi-3181	229	21	effective	effective	ADJ
ajmsi-3181	229	22	targeted	target	VERB
ajmsi-3181	229	23	treatment	treatment	NOUN
ajmsi-3181	229	24	strategies	strategy	NOUN
ajmsi-3181	229	25	.	.	PUNCT
ajmsi-3181	230	1	pa	pa	PROPN
ajmsi-3181	230	2	ge	ge	PROPN
ajmsi-3181	230	3	10	10	NUM
ajmsi-3181	230	4	1	1	NUM
ajmsi-3181	230	5	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-3181	230	6	am	be	AUX
ajmsi-3181	230	7	.	.	PUNCT
ajmsi-3181	231	1	j.	j.	PROPN
ajmsi-3181	231	2	med	med	PROPN
ajmsi-3181	231	3	.	.	PUNCT
ajmsi-3181	232	1	sci	sci	PROPN
ajmsi-3181	232	2	.	.	PUNCT
ajmsi-3181	232	3	innov	innov	PROPN
ajmsi-3181	232	4	.	.	PUNCT
ajmsi-3181	233	1	3(2	3(2	NUM
ajmsi-3181	233	2	)	)	PUNCT
ajmsi-3181	233	3	91	91	NUM
ajmsi-3181	233	4	-	-	SYM
ajmsi-3181	233	5	102	102	NUM
ajmsi-3181	233	6	,	,	PUNCT
ajmsi-3181	233	7	2024	2024	NUM
ajmsi-3181	233	8	limitations	limitation	NOUN
ajmsi-3181	233	9	the	the	DET
ajmsi-3181	233	10	limitations	limitation	NOUN
ajmsi-3181	233	11	of	of	ADP
ajmsi-3181	233	12	our	our	PRON
ajmsi-3181	233	13	study	study	NOUN
ajmsi-3181	233	14	include	include	VERB
ajmsi-3181	233	15	the	the	DET
ajmsi-3181	233	16	need	need	NOUN
ajmsi-3181	233	17	for	for	ADP
ajmsi-3181	233	18	more	more	ADJ
ajmsi-3181	233	19	data	datum	NOUN
ajmsi-3181	233	20	on	on	ADP
ajmsi-3181	233	21	the	the	DET
ajmsi-3181	233	22	prior	prior	ADJ
ajmsi-3181	233	23	use	use	NOUN
ajmsi-3181	233	24	of	of	ADP
ajmsi-3181	233	25	antimicrobials	antimicrobial	NOUN
ajmsi-3181	233	26	and	and	CCONJ
ajmsi-3181	233	27	health	health	NOUN
ajmsi-3181	233	28	care	care	NOUN
ajmsi-3181	233	29	costs	cost	NOUN
ajmsi-3181	233	30	.	.	PUNCT
ajmsi-3181	234	1	the	the	DET
ajmsi-3181	234	2	long	long	ADJ
ajmsi-3181	234	3	-	-	PUNCT
ajmsi-3181	234	4	term	term	NOUN
ajmsi-3181	234	5	impact	impact	NOUN
ajmsi-3181	234	6	of	of	ADP
ajmsi-3181	234	7	gnb	gnb	PROPN
ajmsi-3181	234	8	beyond	beyond	ADP
ajmsi-3181	234	9	3	3	NUM
ajmsi-3181	234	10	months	month	NOUN
ajmsi-3181	234	11	has	have	VERB
ajmsi-3181	234	12	yet	yet	ADV
ajmsi-3181	234	13	to	to	PART
ajmsi-3181	234	14	be	be	AUX
ajmsi-3181	234	15	investigated	investigate	VERB
ajmsi-3181	234	16	.	.	PUNCT
ajmsi-3181	235	1	the	the	DET
ajmsi-3181	235	2	retrospective	retrospective	ADJ
ajmsi-3181	235	3	nature	nature	NOUN
ajmsi-3181	235	4	of	of	ADP
ajmsi-3181	235	5	this	this	DET
ajmsi-3181	235	6	study	study	NOUN
ajmsi-3181	235	7	and	and	CCONJ
ajmsi-3181	235	8	the	the	DET
ajmsi-3181	235	9	single	single	ADJ
ajmsi-3181	235	10	-	-	PUNCT
ajmsi-3181	235	11	center	center	NOUN
ajmsi-3181	235	12	data	datum	NOUN
ajmsi-3181	235	13	are	be	AUX
ajmsi-3181	235	14	other	other	ADJ
ajmsi-3181	235	15	limitations	limitation	NOUN
ajmsi-3181	235	16	.	.	PUNCT
ajmsi-3181	236	1	further	further	ADJ
ajmsi-3181	236	2	analysis	analysis	NOUN
ajmsi-3181	236	3	with	with	ADP
ajmsi-3181	236	4	a	a	DET
ajmsi-3181	236	5	larger	large	ADJ
ajmsi-3181	236	6	sample	sample	NOUN
ajmsi-3181	236	7	size	size	NOUN
ajmsi-3181	236	8	is	be	AUX
ajmsi-3181	236	9	recommended	recommend	VERB
ajmsi-3181	236	10	to	to	PART
ajmsi-3181	236	11	enhance	enhance	VERB
ajmsi-3181	236	12	the	the	DET
ajmsi-3181	236	13	understanding	understanding	NOUN
ajmsi-3181	236	14	of	of	ADP
ajmsi-3181	236	15	these	these	DET
ajmsi-3181	236	16	findings	finding	NOUN
ajmsi-3181	236	17	in	in	ADP
ajmsi-3181	236	18	clinical	clinical	ADJ
ajmsi-3181	236	19	practice	practice	NOUN
ajmsi-3181	236	20	.	.	PUNCT
ajmsi-3181	237	1	in	in	ADP
ajmsi-3181	237	2	this	this	DET
ajmsi-3181	237	3	study	study	NOUN
ajmsi-3181	237	4	,	,	PUNCT
ajmsi-3181	237	5	we	we	PRON
ajmsi-3181	237	6	only	only	ADV
ajmsi-3181	237	7	looked	look	VERB
ajmsi-3181	237	8	at	at	ADP
ajmsi-3181	237	9	long	long	ADJ
ajmsi-3181	237	10	-	-	PUNCT
ajmsi-3181	237	11	term	term	NOUN
ajmsi-3181	237	12	mortality	mortality	NOUN
ajmsi-3181	237	13	within	within	ADP
ajmsi-3181	237	14	90	90	NUM
ajmsi-3181	237	15	days	day	NOUN
ajmsi-3181	237	16	.	.	PUNCT
ajmsi-3181	238	1	still	still	ADV
ajmsi-3181	238	2	,	,	PUNCT
ajmsi-3181	238	3	collateral	collateral	ADJ
ajmsi-3181	238	4	damage	damage	NOUN
ajmsi-3181	238	5	was	be	AUX
ajmsi-3181	238	6	determined	determine	VERB
ajmsi-3181	238	7	,	,	PUNCT
ajmsi-3181	238	8	such	such	ADJ
ajmsi-3181	238	9	as	as	ADP
ajmsi-3181	238	10	the	the	DET
ajmsi-3181	238	11	emergence	emergence	NOUN
ajmsi-3181	238	12	of	of	ADP
ajmsi-3181	238	13	mdro	mdro	NOUN
ajmsi-3181	238	14	in	in	ADP
ajmsi-3181	238	15	90	90	NUM
ajmsi-3181	238	16	days	day	NOUN
ajmsi-3181	238	17	at	at	ADP
ajmsi-3181	238	18	6.1	6.1	NUM
ajmsi-3181	238	19	%	%	NOUN
ajmsi-3181	238	20	,	,	PUNCT
ajmsi-3181	238	21	while	while	SCONJ
ajmsi-3181	238	22	infection	infection	NOUN
ajmsi-3181	238	23	with	with	ADP
ajmsi-3181	238	24	clostridioides	clostridioide	NOUN
ajmsi-3181	238	25	difficile	difficile	VERB
ajmsi-3181	238	26	occurred	occur	VERB
ajmsi-3181	238	27	only	only	ADV
ajmsi-3181	238	28	in	in	ADP
ajmsi-3181	238	29	2	2	NUM
ajmsi-3181	238	30	patients	patient	NOUN
ajmsi-3181	238	31	(	(	PUNCT
ajmsi-3181	238	32	0.5	0.5	NUM
ajmsi-3181	238	33	%	%	NOUN
ajmsi-3181	238	34	)	)	PUNCT
ajmsi-3181	238	35	.	.	PUNCT
ajmsi-3181	239	1	acknowledgement	acknowledgement	PROPN
ajmsi-3181	239	2	clinical	clinical	ADJ
ajmsi-3181	239	3	microbiology	microbiology	NOUN
ajmsi-3181	239	4	department	department	PROPN
ajmsi-3181	239	5	and	and	CCONJ
ajmsi-3181	239	6	pharmacy	pharmacy	NOUN
ajmsi-3181	239	7	department	department	NOUN
ajmsi-3181	239	8	data	datum	NOUN
ajmsi-3181	239	9	availability	availability	NOUN
ajmsi-3181	239	10	statement	statement	NOUN
ajmsi-3181	239	11	the	the	DET
ajmsi-3181	239	12	data	datum	NOUN
ajmsi-3181	239	13	used	use	VERB
ajmsi-3181	239	14	to	to	PART
ajmsi-3181	239	15	support	support	VERB
ajmsi-3181	239	16	the	the	DET
ajmsi-3181	239	17	findings	finding	NOUN
ajmsi-3181	239	18	of	of	ADP
ajmsi-3181	239	19	this	this	DET
ajmsi-3181	239	20	study	study	NOUN
ajmsi-3181	239	21	were	be	AUX
ajmsi-3181	239	22	restricted	restrict	VERB
ajmsi-3181	239	23	by	by	ADP
ajmsi-3181	239	24	the	the	DET
ajmsi-3181	239	25	institutional	institutional	ADJ
ajmsi-3181	239	26	review	review	PROPN
ajmsi-3181	239	27	board	board	NOUN
ajmsi-3181	239	28	(	(	PUNCT
ajmsi-3181	239	29	irb	irb	PROPN
ajmsi-3181	239	30	)	)	PUNCT
ajmsi-3181	239	31	medical	medical	ADJ
ajmsi-3181	239	32	research	research	NOUN
ajmsi-3181	239	33	centre	centre	NOUN
ajmsi-3181	239	34	at	at	ADP
ajmsi-3181	239	35	hamad	hamad	PROPN
ajmsi-3181	239	36	medical	medical	PROPN
ajmsi-3181	239	37	corporation	corporation	PROPN
ajmsi-3181	239	38	to	to	PART
ajmsi-3181	239	39	protect	protect	VERB
ajmsi-3181	239	40	patients	patient	NOUN
ajmsi-3181	239	41	’	'	PUNCT
ajmsi-3181	239	42	privacy	privacy	NOUN
ajmsi-3181	239	43	.	.	PUNCT
ajmsi-3181	240	1	data	datum	NOUN
ajmsi-3181	240	2	can	can	AUX
ajmsi-3181	240	3	be	be	AUX
ajmsi-3181	240	4	obtained	obtain	VERB
ajmsi-3181	240	5	after	after	ADP
ajmsi-3181	240	6	irb	irb	NOUN
ajmsi-3181	240	7	approval	approval	NOUN
ajmsi-3181	240	8	for	for	ADP
ajmsi-3181	240	9	researchers	researcher	NOUN
ajmsi-3181	240	10	who	who	PRON
ajmsi-3181	240	11	meet	meet	VERB
ajmsi-3181	240	12	the	the	DET
ajmsi-3181	240	13	criteria	criterion	NOUN
ajmsi-3181	240	14	for	for	ADP
ajmsi-3181	240	15	access	access	NOUN
ajmsi-3181	240	16	to	to	ADP
ajmsi-3181	240	17	confidential	confidential	ADJ
ajmsi-3181	240	18	data	datum	NOUN
ajmsi-3181	240	19	.	.	PUNCT
ajmsi-3181	241	1	references	reference	NOUN
ajmsi-3181	241	2	ahmed	ahmed	PROPN
ajmsi-3181	241	3	,	,	PUNCT
ajmsi-3181	241	4	m.	m.	NOUN
ajmsi-3181	241	5	s.	s.	PROPN
ajmsi-3181	241	6	,	,	PUNCT
ajmsi-3181	241	7	hassan	hassan	PROPN
ajmsi-3181	241	8	,	,	PUNCT
ajmsi-3181	241	9	a.	a.	NOUN
ajmsi-3181	241	10	,	,	PUNCT
ajmsi-3181	241	11	jarir	jarir	NOUN
ajmsi-3181	241	12	,	,	PUNCT
ajmsi-3181	241	13	s.	s.	PROPN
ajmsi-3181	241	14	a.	a.	PROPN
ajmsi-3181	241	15	,	,	PUNCT
ajmsi-3181	241	16	hadi	hadi	PROPN
ajmsi-3181	241	17	,	,	PUNCT
ajmsi-3181	241	18	h.	h.	PROPN
ajmsi-3181	241	19	a.	a.	PROPN
ajmsi-3181	241	20	,	,	PUNCT
ajmsi-3181	241	21	bansal	bansal	NOUN
ajmsi-3181	241	22	,	,	PUNCT
ajmsi-3181	241	23	d.	d.	PROPN
ajmsi-3181	241	24	,	,	PUNCT
ajmsi-3181	241	25	wahab	wahab	PROPN
ajmsi-3181	241	26	,	,	PUNCT
ajmsi-3181	241	27	a.	a.	NOUN
ajmsi-3181	241	28	a.	a.	PROPN
ajmsi-3181	241	29	,	,	PUNCT
ajmsi-3181	241	30	muneer	muneer	NOUN
ajmsi-3181	241	31	,	,	PUNCT
ajmsi-3181	241	32	m.	m.	NOUN
ajmsi-3181	241	33	,	,	PUNCT
ajmsi-3181	241	34	mohamed	mohamed	PROPN
ajmsi-3181	241	35	,	,	PUNCT
ajmsi-3181	241	36	s.	s.	PROPN
ajmsi-3181	241	37	,	,	PUNCT
ajmsi-3181	241	38	zahraldin	zahraldin	NOUN
ajmsi-3181	241	39	,	,	PUNCT
ajmsi-3181	241	40	k.	k.	PROPN
ajmsi-3181	241	41	,	,	PUNCT
ajmsi-3181	241	42	&	&	CCONJ
ajmsi-3181	241	43	hamid	hamid	PROPN
ajmsi-3181	241	44	,	,	PUNCT
ajmsi-3181	241	45	j.	j.	PROPN
ajmsi-3181	241	46	(	(	PUNCT
ajmsi-3181	241	47	2019	2019	NUM
ajmsi-3181	241	48	)	)	PUNCT
ajmsi-3181	241	49	.	.	PUNCT
ajmsi-3181	242	1	emergence	emergence	NOUN
ajmsi-3181	242	2	of	of	ADP
ajmsi-3181	242	3	multidrug	multidrug	NOUN
ajmsi-3181	242	4	-	-	PUNCT
ajmsi-3181	242	5	and	and	CCONJ
ajmsi-3181	242	6	pandrug	pandrug	NOUN
ajmsi-3181	242	7	-	-	PUNCT
ajmsi-3181	242	8	resistant	resistant	ADJ
ajmsi-3181	242	9	pseudomonas	pseudomona	NOUN
ajmsi-3181	242	10	aeruginosa	aeruginosa	NOUN
ajmsi-3181	242	11	from	from	ADP
ajmsi-3181	242	12	five	five	NUM
ajmsi-3181	242	13	hospitals	hospital	NOUN
ajmsi-3181	242	14	in	in	ADP
ajmsi-3181	242	15	qatar	qatar	NOUN
ajmsi-3181	242	16	.	.	PUNCT
ajmsi-3181	243	1	infection	infection	NOUN
ajmsi-3181	243	2	prevention	prevention	NOUN
ajmsi-3181	243	3	in	in	ADP
ajmsi-3181	243	4	practice	practice	NOUN
ajmsi-3181	243	5	,	,	PUNCT
ajmsi-3181	243	6	1(3	1(3	NUM
ajmsi-3181	243	7	-	-	SYM
ajmsi-3181	243	8	4	4	NUM
ajmsi-3181	243	9	)	)	PUNCT
ajmsi-3181	243	10	,	,	PUNCT
ajmsi-3181	243	11	100027	100027	NUM
ajmsi-3181	243	12	.	.	PUNCT
ajmsi-3181	244	1	ahmedullah	ahmedullah	PROPN
ajmsi-3181	244	2	,	,	PUNCT
ajmsi-3181	244	3	h.	h.	PROPN
ajmsi-3181	244	4	,	,	PUNCT
ajmsi-3181	244	5	khan	khan	PROPN
ajmsi-3181	244	6	,	,	PUNCT
ajmsi-3181	244	7	f.	f.	PROPN
ajmsi-3181	244	8	y.	y.	PROPN
ajmsi-3181	244	9	,	,	PUNCT
ajmsi-3181	244	10	al	al	PROPN
ajmsi-3181	244	11	maslamani	maslamani	PROPN
ajmsi-3181	244	12	,	,	PUNCT
ajmsi-3181	244	13	m.	m.	NOUN
ajmsi-3181	244	14	,	,	PUNCT
ajmsi-3181	244	15	al	al	PROPN
ajmsi-3181	244	16	soub	soub	PROPN
ajmsi-3181	244	17	,	,	PUNCT
ajmsi-3181	244	18	h.	h.	PROPN
ajmsi-3181	244	19	,	,	PUNCT
ajmsi-3181	244	20	chacko	chacko	NOUN
ajmsi-3181	244	21	,	,	PUNCT
ajmsi-3181	244	22	k.	k.	PROPN
ajmsi-3181	244	23	,	,	PUNCT
ajmsi-3181	244	24	khattab	khattab	NOUN
ajmsi-3181	244	25	,	,	PUNCT
ajmsi-3181	244	26	m.	m.	NOUN
ajmsi-3181	244	27	a.	a.	PROPN
ajmsi-3181	244	28	,	,	PUNCT
ajmsi-3181	244	29	mahmoud	mahmoud	PROPN
ajmsi-3181	244	30	,	,	PUNCT
ajmsi-3181	244	31	s.	s.	PROPN
ajmsi-3181	244	32	,	,	PUNCT
ajmsi-3181	244	33	howaidy	howaidy	PROPN
ajmsi-3181	244	34	,	,	PUNCT
ajmsi-3181	244	35	f.	f.	PROPN
ajmsi-3181	244	36	,	,	PUNCT
ajmsi-3181	244	37	thapur	thapur	NOUN
ajmsi-3181	244	38	,	,	PUNCT
ajmsi-3181	244	39	m.	m.	NOUN
ajmsi-3181	244	40	,	,	PUNCT
ajmsi-3181	244	41	&	&	CCONJ
ajmsi-3181	244	42	al	al	PROPN
ajmsi-3181	244	43	madhoun	madhoun	PROPN
ajmsi-3181	244	44	,	,	PUNCT
ajmsi-3181	244	45	e.	e.	PROPN
ajmsi-3181	244	46	(	(	PUNCT
ajmsi-3181	244	47	2018	2018	NUM
ajmsi-3181	244	48	)	)	PUNCT
ajmsi-3181	244	49	.	.	PUNCT
ajmsi-3181	245	1	epidemiological	epidemiological	ADJ
ajmsi-3181	245	2	and	and	CCONJ
ajmsi-3181	245	3	clinical	clinical	ADJ
ajmsi-3181	245	4	features	feature	NOUN
ajmsi-3181	245	5	of	of	ADP
ajmsi-3181	245	6	salmonella	salmonella	NOUN
ajmsi-3181	245	7	typhi	typhi	VERB
ajmsi-3181	245	8	infection	infection	NOUN
ajmsi-3181	245	9	among	among	ADP
ajmsi-3181	245	10	adult	adult	NOUN
ajmsi-3181	245	11	patients	patient	NOUN
ajmsi-3181	245	12	in	in	ADP
ajmsi-3181	245	13	qatar	qatar	PROPN
ajmsi-3181	245	14	:	:	PUNCT
ajmsi-3181	245	15	a	a	DET
ajmsi-3181	245	16	hospital	hospital	NOUN
ajmsi-3181	245	17	-	-	PUNCT
ajmsi-3181	245	18	based	base	VERB
ajmsi-3181	245	19	study	study	NOUN
ajmsi-3181	245	20	.	.	PUNCT
ajmsi-3181	246	1	oman	oman	PROPN
ajmsi-3181	246	2	medical	medical	PROPN
ajmsi-3181	246	3	journal	journal	PROPN
ajmsi-3181	246	4	,	,	PUNCT
ajmsi-3181	246	5	33(6	33(6	PROPN
ajmsi-3181	246	6	)	)	PUNCT
ajmsi-3181	246	7	,	,	PUNCT
ajmsi-3181	246	8	468	468	X
ajmsi-3181	246	9	.	.	PUNCT
ajmsi-3181	247	1	al	al	PROPN
ajmsi-3181	247	2	muhairi	muhairi	PROPN
ajmsi-3181	247	3	,	,	PUNCT
ajmsi-3181	247	4	f.	f.	PROPN
ajmsi-3181	247	5	m.	m.	PROPN
ajmsi-3181	247	6	,	,	PUNCT
ajmsi-3181	247	7	bulshawareb	bulshawareb	PROPN
ajmsi-3181	247	8	,	,	PUNCT
ajmsi-3181	247	9	a.	a.	NOUN
ajmsi-3181	247	10	m.	m.	NOUN
ajmsi-3181	247	11	,	,	PUNCT
ajmsi-3181	247	12	al	al	PROPN
ajmsi-3181	247	13	nuaimi	nuaimi	PROPN
ajmsi-3181	247	14	,	,	PUNCT
ajmsi-3181	247	15	a.	a.	NOUN
ajmsi-3181	247	16	m.	m.	NOUN
ajmsi-3181	247	17	,	,	PUNCT
ajmsi-3181	247	18	al	al	PROPN
ajmsi-3181	247	19	hemeiri	hemeiri	PROPN
ajmsi-3181	247	20	,	,	PUNCT
ajmsi-3181	247	21	m.	m.	PROPN
ajmsi-3181	247	22	k.	k.	PROPN
ajmsi-3181	247	23	,	,	PUNCT
ajmsi-3181	247	24	al	al	PROPN
ajmsi-3181	247	25	aiyan	aiyan	PROPN
ajmsi-3181	247	26	,	,	PUNCT
ajmsi-3181	247	27	a.	a.	PROPN
ajmsi-3181	247	28	,	,	PUNCT
ajmsi-3181	247	29	&	&	CCONJ
ajmsi-3181	247	30	mohteshamuddin	mohteshamuddin	PROPN
ajmsi-3181	247	31	,	,	PUNCT
ajmsi-3181	247	32	k.	k.	PROPN
ajmsi-3181	247	33	(	(	PUNCT
ajmsi-3181	247	34	2019	2019	NUM
ajmsi-3181	247	35	)	)	PUNCT
ajmsi-3181	247	36	.	.	PUNCT
ajmsi-3181	248	1	the	the	DET
ajmsi-3181	248	2	role	role	NOUN
ajmsi-3181	248	3	of	of	ADP
ajmsi-3181	248	4	antimicrobials	antimicrobial	NOUN
ajmsi-3181	248	5	in	in	ADP
ajmsi-3181	248	6	food	food	NOUN
ajmsi-3181	248	7	animals	animal	NOUN
ajmsi-3181	248	8	in	in	ADP
ajmsi-3181	248	9	the	the	DET
ajmsi-3181	248	10	emergence	emergence	NOUN
ajmsi-3181	248	11	of	of	ADP
ajmsi-3181	248	12	resistant	resistant	ADJ
ajmsi-3181	248	13	human	human	ADJ
ajmsi-3181	248	14	pathogens	pathogen	NOUN
ajmsi-3181	248	15	.	.	PUNCT
ajmsi-3181	249	1	international	international	ADJ
ajmsi-3181	249	2	journal	journal	PROPN
ajmsi-3181	249	3	of	of	ADP
ajmsi-3181	249	4	medical	medical	ADJ
ajmsi-3181	249	5	reviews	review	NOUN
ajmsi-3181	249	6	and	and	CCONJ
ajmsi-3181	249	7	case	case	NOUN
ajmsi-3181	249	8	reports	report	NOUN
ajmsi-3181	249	9	,	,	PUNCT
ajmsi-3181	249	10	3(9	3(9	NUM
ajmsi-3181	249	11	)	)	PUNCT
ajmsi-3181	249	12	,	,	PUNCT
ajmsi-3181	249	13	598	598	NUM
ajmsi-3181	249	14	-	-	SYM
ajmsi-3181	249	15	608	608	NUM
ajmsi-3181	249	16	.	.	PUNCT
ajmsi-3181	250	1	alsamawi	alsamawi	PROPN
ajmsi-3181	250	2	,	,	PUNCT
ajmsi-3181	250	3	m.	m.	NOUN
ajmsi-3181	250	4	,	,	PUNCT
ajmsi-3181	250	5	joudeh	joudeh	NOUN
ajmsi-3181	250	6	,	,	PUNCT
ajmsi-3181	250	7	a.	a.	NOUN
ajmsi-3181	250	8	i.	i.	PROPN
ajmsi-3181	250	9	,	,	PUNCT
ajmsi-3181	250	10	eldeeb	eldeeb	PROPN
ajmsi-3181	250	11	,	,	PUNCT
ajmsi-3181	250	12	y.	y.	PROPN
ajmsi-3181	250	13	,	,	PUNCT
ajmsi-3181	250	14	al	al	PROPN
ajmsi-3181	250	15	-	-	PUNCT
ajmsi-3181	250	16	dahshan	dahshan	PROPN
ajmsi-3181	250	17	,	,	PUNCT
ajmsi-3181	250	18	a.	a.	PROPN
ajmsi-3181	250	19	,	,	PUNCT
ajmsi-3181	250	20	khan	khan	PROPN
ajmsi-3181	250	21	,	,	PUNCT
ajmsi-3181	250	22	f.	f.	PROPN
ajmsi-3181	250	23	,	,	PUNCT
ajmsi-3181	250	24	ghadban	ghadban	PROPN
ajmsi-3181	250	25	,	,	PUNCT
ajmsi-3181	250	26	w.	w.	PROPN
ajmsi-3181	250	27	,	,	PUNCT
ajmsi-3181	250	28	almaslamani	almaslamani	PROPN
ajmsi-3181	250	29	,	,	PUNCT
ajmsi-3181	250	30	m.	m.	NOUN
ajmsi-3181	250	31	,	,	PUNCT
ajmsi-3181	250	32	&	&	CCONJ
ajmsi-3181	250	33	alkhal	alkhal	NOUN
ajmsi-3181	250	34	,	,	PUNCT
ajmsi-3181	250	35	a.	a.	NOUN
ajmsi-3181	250	36	(	(	PUNCT
ajmsi-3181	250	37	2022	2022	NUM
ajmsi-3181	250	38	)	)	PUNCT
ajmsi-3181	250	39	.	.	PUNCT
ajmsi-3181	251	1	epidemiology	epidemiology	NOUN
ajmsi-3181	251	2	of	of	ADP
ajmsi-3181	251	3	extended	extend	VERB
ajmsi-3181	251	4	-	-	PUNCT
ajmsi-3181	251	5	spectrum	spectrum	NOUN
ajmsi-3181	251	6	betalactamase	betalactamase	NOUN
ajmsi-3181	251	7	producing	produce	VERB
ajmsi-3181	251	8	enterobacteriaceae	enterobacteriaceae	PROPN
ajmsi-3181	251	9	in	in	ADP
ajmsi-3181	251	10	qatar	qatar	PROPN
ajmsi-3181	251	11	:	:	PUNCT
ajmsi-3181	251	12	a	a	DET
ajmsi-3181	251	13	3	3	NUM
ajmsi-3181	251	14	-	-	PUNCT
ajmsi-3181	251	15	year	year	NOUN
ajmsi-3181	251	16	hospital	hospital	NOUN
ajmsi-3181	251	17	-	-	PUNCT
ajmsi-3181	251	18	based	base	VERB
ajmsi-3181	251	19	study	study	NOUN
ajmsi-3181	251	20	.	.	PUNCT
ajmsi-3181	252	1	frontiers	frontier	NOUN
ajmsi-3181	252	2	in	in	ADP
ajmsi-3181	252	3	antibiotics	antibiotic	NOUN
ajmsi-3181	252	4	,	,	PUNCT
ajmsi-3181	252	5	1	1	NUM
ajmsi-3181	252	6	,	,	PUNCT
ajmsi-3181	252	7	980686	980686	NUM
ajmsi-3181	252	8	.	.	PUNCT
ajmsi-3181	253	1	baltas	balta	NOUN
ajmsi-3181	253	2	,	,	PUNCT
ajmsi-3181	253	3	i.	i.	PROPN
ajmsi-3181	253	4	,	,	PUNCT
ajmsi-3181	253	5	stockdale	stockdale	PROPN
ajmsi-3181	253	6	,	,	PUNCT
ajmsi-3181	253	7	t.	t.	PROPN
ajmsi-3181	253	8	,	,	PUNCT
ajmsi-3181	253	9	tausan	tausan	ADJ
ajmsi-3181	253	10	,	,	PUNCT
ajmsi-3181	253	11	m.	m.	NOUN
ajmsi-3181	253	12	,	,	PUNCT
ajmsi-3181	253	13	kashif	kashif	PROPN
ajmsi-3181	253	14	,	,	PUNCT
ajmsi-3181	253	15	a.	a.	PROPN
ajmsi-3181	253	16	,	,	PUNCT
ajmsi-3181	253	17	anwar	anwar	PROPN
ajmsi-3181	253	18	,	,	PUNCT
ajmsi-3181	253	19	j.	j.	PROPN
ajmsi-3181	253	20	,	,	PUNCT
ajmsi-3181	253	21	anvar	anvar	PROPN
ajmsi-3181	253	22	,	,	PUNCT
ajmsi-3181	253	23	j.	j.	PROPN
ajmsi-3181	253	24	,	,	PUNCT
ajmsi-3181	253	25	koutoumanou	koutoumanou	PROPN
ajmsi-3181	253	26	,	,	PUNCT
ajmsi-3181	253	27	e.	e.	PROPN
ajmsi-3181	253	28	,	,	PUNCT
ajmsi-3181	253	29	sidebottom	sidebottom	PROPN
ajmsi-3181	253	30	,	,	PUNCT
ajmsi-3181	253	31	d.	d.	PROPN
ajmsi-3181	253	32	,	,	PUNCT
ajmsi-3181	253	33	garciaarias	garciaarias	PROPN
ajmsi-3181	253	34	,	,	PUNCT
ajmsi-3181	253	35	v.	v.	PROPN
ajmsi-3181	253	36	,	,	PUNCT
ajmsi-3181	253	37	&	&	CCONJ
ajmsi-3181	253	38	wright	wright	PROPN
ajmsi-3181	253	39	,	,	PUNCT
ajmsi-3181	253	40	m.	m.	NOUN
ajmsi-3181	253	41	(	(	PUNCT
ajmsi-3181	253	42	2021	2021	NUM
ajmsi-3181	253	43	)	)	PUNCT
ajmsi-3181	253	44	.	.	PUNCT
ajmsi-3181	254	1	long	long	ADJ
ajmsi-3181	254	2	-	-	PUNCT
ajmsi-3181	254	3	term	term	NOUN
ajmsi-3181	254	4	outcome	outcome	NOUN
ajmsi-3181	254	5	and	and	CCONJ
ajmsi-3181	254	6	risk	risk	NOUN
ajmsi-3181	254	7	factors	factor	NOUN
ajmsi-3181	254	8	for	for	ADP
ajmsi-3181	254	9	late	late	ADJ
ajmsi-3181	254	10	mortality	mortality	NOUN
ajmsi-3181	254	11	in	in	ADP
ajmsi-3181	254	12	gram	gram	NOUN
ajmsi-3181	254	13	-	-	PUNCT
ajmsi-3181	254	14	negative	negative	ADJ
ajmsi-3181	254	15	bacteraemia	bacteraemia	NOUN
ajmsi-3181	254	16	:	:	PUNCT
ajmsi-3181	254	17	a	a	DET
ajmsi-3181	254	18	retrospective	retrospective	ADJ
ajmsi-3181	254	19	cohort	cohort	NOUN
ajmsi-3181	254	20	study	study	NOUN
ajmsi-3181	254	21	.	.	PUNCT
ajmsi-3181	255	1	journal	journal	PROPN
ajmsi-3181	255	2	of	of	ADP
ajmsi-3181	255	3	global	global	ADJ
ajmsi-3181	255	4	antimicrobial	antimicrobial	ADJ
ajmsi-3181	255	5	resistance	resistance	NOUN
ajmsi-3181	255	6	,	,	PUNCT
ajmsi-3181	255	7	25	25	NUM
ajmsi-3181	255	8	,	,	PUNCT
ajmsi-3181	255	9	187	187	NUM
ajmsi-3181	255	10	-	-	SYM
ajmsi-3181	255	11	192	192	NUM
ajmsi-3181	255	12	.	.	PUNCT
ajmsi-3181	256	1	bassetti	bassetti	NOUN
ajmsi-3181	256	2	,	,	PUNCT
ajmsi-3181	256	3	m.	m.	NOUN
ajmsi-3181	256	4	,	,	PUNCT
ajmsi-3181	256	5	rello	rello	PROPN
ajmsi-3181	256	6	,	,	PUNCT
ajmsi-3181	256	7	j.	j.	PROPN
ajmsi-3181	256	8	,	,	PUNCT
ajmsi-3181	256	9	blasi	blasi	PROPN
ajmsi-3181	256	10	,	,	PUNCT
ajmsi-3181	256	11	f.	f.	PROPN
ajmsi-3181	256	12	,	,	PUNCT
ajmsi-3181	256	13	goossens	goossens	PROPN
ajmsi-3181	256	14	,	,	PUNCT
ajmsi-3181	256	15	h.	h.	PROPN
ajmsi-3181	256	16	,	,	PUNCT
ajmsi-3181	256	17	sotgiu	sotgiu	PROPN
ajmsi-3181	256	18	,	,	PUNCT
ajmsi-3181	256	19	g.	g.	PROPN
ajmsi-3181	256	20	,	,	PUNCT
ajmsi-3181	256	21	tavoschi	tavoschi	PROPN
ajmsi-3181	256	22	,	,	PUNCT
ajmsi-3181	256	23	l.	l.	PROPN
ajmsi-3181	256	24	,	,	PUNCT
ajmsi-3181	256	25	zasowski	zasowski	PROPN
ajmsi-3181	256	26	,	,	PUNCT
ajmsi-3181	256	27	e.	e.	PROPN
ajmsi-3181	256	28	j.	j.	PROPN
ajmsi-3181	256	29	,	,	PUNCT
ajmsi-3181	256	30	arber	arber	PROPN
ajmsi-3181	256	31	,	,	PUNCT
ajmsi-3181	256	32	m.	m.	PROPN
ajmsi-3181	256	33	r.	r.	PROPN
ajmsi-3181	256	34	,	,	PUNCT
ajmsi-3181	256	35	mccool	mccool	PROPN
ajmsi-3181	256	36	,	,	PUNCT
ajmsi-3181	256	37	r.	r.	PROPN
ajmsi-3181	256	38	,	,	PUNCT
ajmsi-3181	256	39	&	&	CCONJ
ajmsi-3181	256	40	patterson	patterson	PROPN
ajmsi-3181	256	41	,	,	PUNCT
ajmsi-3181	256	42	j.	j.	PROPN
ajmsi-3181	256	43	v.	v.	PROPN
ajmsi-3181	256	44	(	(	PUNCT
ajmsi-3181	256	45	2020	2020	NUM
ajmsi-3181	256	46	)	)	PUNCT
ajmsi-3181	256	47	.	.	PUNCT
ajmsi-3181	257	1	systematic	systematic	ADJ
ajmsi-3181	257	2	review	review	NOUN
ajmsi-3181	257	3	of	of	ADP
ajmsi-3181	257	4	the	the	DET
ajmsi-3181	257	5	impact	impact	NOUN
ajmsi-3181	257	6	of	of	ADP
ajmsi-3181	257	7	appropriate	appropriate	ADJ
ajmsi-3181	257	8	versus	versus	ADP
ajmsi-3181	257	9	inappropriate	inappropriate	ADJ
ajmsi-3181	257	10	initial	initial	ADJ
ajmsi-3181	257	11	antibiotic	antibiotic	ADJ
ajmsi-3181	257	12	therapy	therapy	NOUN
ajmsi-3181	257	13	on	on	ADP
ajmsi-3181	257	14	outcomes	outcome	NOUN
ajmsi-3181	257	15	of	of	ADP
ajmsi-3181	257	16	patients	patient	NOUN
ajmsi-3181	257	17	with	with	ADP
ajmsi-3181	257	18	severe	severe	ADJ
ajmsi-3181	257	19	bacterial	bacterial	ADJ
ajmsi-3181	257	20	infections	infection	NOUN
ajmsi-3181	257	21	.	.	PUNCT
ajmsi-3181	258	1	international	international	ADJ
ajmsi-3181	258	2	journal	journal	PROPN
ajmsi-3181	258	3	of	of	ADP
ajmsi-3181	258	4	antimicrobial	antimicrobial	ADJ
ajmsi-3181	258	5	agents	agent	NOUN
ajmsi-3181	258	6	,	,	PUNCT
ajmsi-3181	258	7	56(6	56(6	NUM
ajmsi-3181	258	8	)	)	PUNCT
ajmsi-3181	258	9	,	,	PUNCT
ajmsi-3181	258	10	106184	106184	NUM
ajmsi-3181	258	11	.	.	PUNCT
ajmsi-3181	259	1	borgio	borgio	PROPN
ajmsi-3181	259	2	,	,	PUNCT
ajmsi-3181	259	3	j.	j.	PROPN
ajmsi-3181	259	4	f.	f.	PROPN
ajmsi-3181	259	5	,	,	PUNCT
ajmsi-3181	259	6	rasdan	rasdan	PROPN
ajmsi-3181	259	7	,	,	PUNCT
ajmsi-3181	259	8	a.	a.	PROPN
ajmsi-3181	259	9	s.	s.	PROPN
ajmsi-3181	259	10	,	,	PUNCT
ajmsi-3181	259	11	sonbol	sonbol	PROPN
ajmsi-3181	259	12	,	,	PUNCT
ajmsi-3181	259	13	b.	b.	PROPN
ajmsi-3181	259	14	,	,	PUNCT
ajmsi-3181	259	15	alhamid	alhamid	PROPN
ajmsi-3181	259	16	,	,	PUNCT
ajmsi-3181	259	17	g.	g.	PROPN
ajmsi-3181	259	18	,	,	PUNCT
ajmsi-3181	259	19	almandil	almandil	PROPN
ajmsi-3181	259	20	,	,	PUNCT
ajmsi-3181	259	21	n.	n.	PROPN
ajmsi-3181	259	22	b.	b.	PROPN
ajmsi-3181	259	23	,	,	PUNCT
ajmsi-3181	259	24	&	&	CCONJ
ajmsi-3181	259	25	abdulazeez	abdulazeez	PROPN
ajmsi-3181	259	26	,	,	PUNCT
ajmsi-3181	259	27	s.	s.	PROPN
ajmsi-3181	259	28	(	(	PUNCT
ajmsi-3181	259	29	2021	2021	NUM
ajmsi-3181	259	30	)	)	PUNCT
ajmsi-3181	259	31	.	.	PUNCT
ajmsi-3181	260	1	emerging	emerge	VERB
ajmsi-3181	260	2	status	status	NOUN
ajmsi-3181	260	3	of	of	ADP
ajmsi-3181	260	4	multidrug	multidrug	NOUN
ajmsi-3181	260	5	-	-	PUNCT
ajmsi-3181	260	6	resistant	resistant	ADJ
ajmsi-3181	260	7	bacteria	bacteria	NOUN
ajmsi-3181	260	8	and	and	CCONJ
ajmsi-3181	260	9	fungi	fungus	NOUN
ajmsi-3181	260	10	in	in	ADP
ajmsi-3181	260	11	the	the	DET
ajmsi-3181	260	12	arabian	arabian	ADJ
ajmsi-3181	260	13	peninsula	peninsula	NOUN
ajmsi-3181	260	14	.	.	PUNCT
ajmsi-3181	261	1	biology	biology	NOUN
ajmsi-3181	261	2	,	,	PUNCT
ajmsi-3181	261	3	10(11	10(11	NUM
ajmsi-3181	261	4	)	)	PUNCT
ajmsi-3181	261	5	,	,	PUNCT
ajmsi-3181	261	6	1144	1144	NUM
ajmsi-3181	261	7	.	.	PUNCT
ajmsi-3181	262	1	buetti	buetti	PROPN
ajmsi-3181	262	2	,	,	PUNCT
ajmsi-3181	262	3	n.	n.	PROPN
ajmsi-3181	262	4	,	,	PUNCT
ajmsi-3181	262	5	atkinson	atkinson	PROPN
ajmsi-3181	262	6	,	,	PUNCT
ajmsi-3181	262	7	a.	a.	PROPN
ajmsi-3181	262	8	,	,	PUNCT
ajmsi-3181	262	9	kronenberg	kronenberg	PROPN
ajmsi-3181	262	10	,	,	PUNCT
ajmsi-3181	262	11	a.	a.	NOUN
ajmsi-3181	262	12	,	,	PUNCT
ajmsi-3181	262	13	marschall	marschall	PROPN
ajmsi-3181	262	14	,	,	PUNCT
ajmsi-3181	262	15	j.	j.	PROPN
ajmsi-3181	262	16	,	,	PUNCT
ajmsi-3181	262	17	&	&	CCONJ
ajmsi-3181	262	18	schrenzel	schrenzel	PROPN
ajmsi-3181	262	19	,	,	PUNCT
ajmsi-3181	262	20	j.	j.	PROPN
ajmsi-3181	262	21	(	(	PUNCT
ajmsi-3181	262	22	2017	2017	NUM
ajmsi-3181	262	23	)	)	PUNCT
ajmsi-3181	262	24	.	.	PUNCT
ajmsi-3181	263	1	different	different	ADJ
ajmsi-3181	263	2	epidemiology	epidemiology	NOUN
ajmsi-3181	263	3	of	of	ADP
ajmsi-3181	263	4	hospital	hospital	NOUN
ajmsi-3181	263	5	-	-	PUNCT
ajmsi-3181	263	6	acquired	acquire	VERB
ajmsi-3181	263	7	bloodstream	bloodstream	NOUN
ajmsi-3181	263	8	infections	infection	NOUN
ajmsi-3181	263	9	between	between	ADP
ajmsi-3181	263	10	small	small	ADJ
ajmsi-3181	263	11	community	community	NOUN
ajmsi-3181	263	12	hospitals	hospital	NOUN
ajmsi-3181	263	13	and	and	CCONJ
ajmsi-3181	263	14	large	large	ADJ
ajmsi-3181	263	15	community	community	NOUN
ajmsi-3181	263	16	hospitals	hospital	NOUN
ajmsi-3181	263	17	.	.	PUNCT
ajmsi-3181	264	1	clinical	clinical	ADJ
ajmsi-3181	264	2	infectious	infectious	ADJ
ajmsi-3181	264	3	diseases	disease	NOUN
ajmsi-3181	264	4	,	,	PUNCT
ajmsi-3181	264	5	64(7	64(7	NOUN
ajmsi-3181	264	6	)	)	PUNCT
ajmsi-3181	264	7	,	,	PUNCT
ajmsi-3181	264	8	984–985	984–985	NUM
ajmsi-3181	264	9	.	.	PUNCT
ajmsi-3181	265	1	chu	chu	PROPN
ajmsi-3181	265	2	,	,	PUNCT
ajmsi-3181	265	3	s.-m	s.-m	PROPN
ajmsi-3181	265	4	.	.	PROPN
ajmsi-3181	265	5	,	,	PUNCT
ajmsi-3181	265	6	hsu	hsu	PROPN
ajmsi-3181	265	7	,	,	PUNCT
ajmsi-3181	265	8	j.-f	j.-f	PROPN
ajmsi-3181	265	9	.	.	PUNCT
ajmsi-3181	265	10	,	,	PUNCT
ajmsi-3181	265	11	lai	lai	PROPN
ajmsi-3181	265	12	,	,	PUNCT
ajmsi-3181	265	13	m.-y	m.-y	PROPN
ajmsi-3181	265	14	.	.	PUNCT
ajmsi-3181	265	15	,	,	PUNCT
ajmsi-3181	265	16	huang	huang	PROPN
ajmsi-3181	265	17	,	,	PUNCT
ajmsi-3181	265	18	h.-r	h.-r	PROPN
ajmsi-3181	265	19	.	.	PROPN
ajmsi-3181	265	20	,	,	PUNCT
ajmsi-3181	265	21	chiang	chiang	PROPN
ajmsi-3181	265	22	,	,	PUNCT
ajmsi-3181	265	23	m.-c	m.-c	PROPN
ajmsi-3181	265	24	.	.	PUNCT
ajmsi-3181	265	25	,	,	PUNCT
ajmsi-3181	265	26	fu	fu	PROPN
ajmsi-3181	265	27	,	,	PUNCT
ajmsi-3181	265	28	r.-h	r.-h	NOUN
ajmsi-3181	265	29	.	.	PROPN
ajmsi-3181	265	30	,	,	PUNCT
ajmsi-3181	265	31	&	&	CCONJ
ajmsi-3181	265	32	tsai	tsai	PROPN
ajmsi-3181	265	33	,	,	PUNCT
ajmsi-3181	265	34	m.-h	m.-h	PROPN
ajmsi-3181	265	35	.	.	PUNCT
ajmsi-3181	266	1	(	(	PUNCT
ajmsi-3181	266	2	2020	2020	NUM
ajmsi-3181	266	3	)	)	PUNCT
ajmsi-3181	266	4	.	.	PUNCT
ajmsi-3181	267	1	risk	risk	NOUN
ajmsi-3181	267	2	factors	factor	NOUN
ajmsi-3181	267	3	of	of	ADP
ajmsi-3181	267	4	initial	initial	ADJ
ajmsi-3181	267	5	inappropriate	inappropriate	ADJ
ajmsi-3181	267	6	antibiotic	antibiotic	ADJ
ajmsi-3181	267	7	therapy	therapy	NOUN
ajmsi-3181	267	8	and	and	CCONJ
ajmsi-3181	267	9	the	the	DET
ajmsi-3181	267	10	impacts	impact	NOUN
ajmsi-3181	267	11	on	on	ADP
ajmsi-3181	267	12	outcomes	outcome	NOUN
ajmsi-3181	267	13	of	of	ADP
ajmsi-3181	267	14	neonates	neonate	NOUN
ajmsi-3181	267	15	with	with	ADP
ajmsi-3181	267	16	gram	gram	NOUN
ajmsi-3181	267	17	-	-	PUNCT
ajmsi-3181	267	18	negative	negative	ADJ
ajmsi-3181	267	19	bacteremia	bacteremia	NOUN
ajmsi-3181	267	20	.	.	PUNCT
ajmsi-3181	268	1	antibiotics	antibiotic	NOUN
ajmsi-3181	268	2	,	,	PUNCT
ajmsi-3181	268	3	9(4	9(4	NOUN
ajmsi-3181	268	4	)	)	PUNCT
ajmsi-3181	268	5	,	,	PUNCT
ajmsi-3181	268	6	203	203	NUM
ajmsi-3181	268	7	.	.	PUNCT
ajmsi-3181	268	8	de	de	PROPN
ajmsi-3181	268	9	waele	waele	PROPN
ajmsi-3181	268	10	,	,	PUNCT
ajmsi-3181	268	11	j.	j.	PROPN
ajmsi-3181	268	12	j.	j.	PROPN
ajmsi-3181	268	13	,	,	PUNCT
ajmsi-3181	268	14	akova	akova	PROPN
ajmsi-3181	268	15	,	,	PUNCT
ajmsi-3181	268	16	m.	m.	NOUN
ajmsi-3181	268	17	,	,	PUNCT
ajmsi-3181	268	18	antonelli	antonelli	PROPN
ajmsi-3181	268	19	,	,	PUNCT
ajmsi-3181	268	20	m.	m.	NOUN
ajmsi-3181	268	21	,	,	PUNCT
ajmsi-3181	268	22	canton	canton	PROPN
ajmsi-3181	268	23	,	,	PUNCT
ajmsi-3181	268	24	r.	r.	PROPN
ajmsi-3181	268	25	,	,	PUNCT
ajmsi-3181	268	26	carlet	carlet	PROPN
ajmsi-3181	268	27	,	,	PUNCT
ajmsi-3181	268	28	j.	j.	PROPN
ajmsi-3181	268	29	,	,	PUNCT
ajmsi-3181	268	30	de	de	NOUN
ajmsi-3181	268	31	backer	backer	NOUN
ajmsi-3181	268	32	,	,	PUNCT
ajmsi-3181	268	33	d.	d.	PROPN
ajmsi-3181	268	34	,	,	PUNCT
ajmsi-3181	268	35	dimopoulos	dimopoulo	NOUN
ajmsi-3181	268	36	,	,	PUNCT
ajmsi-3181	268	37	g.	g.	PROPN
ajmsi-3181	268	38	,	,	PUNCT
ajmsi-3181	268	39	garnachomontero	garnachomontero	PROPN
ajmsi-3181	268	40	,	,	PUNCT
ajmsi-3181	268	41	j.	j.	PROPN
ajmsi-3181	268	42	,	,	PUNCT
ajmsi-3181	268	43	kesecioglu	kesecioglu	PROPN
ajmsi-3181	268	44	,	,	PUNCT
ajmsi-3181	268	45	j.	j.	PROPN
ajmsi-3181	268	46	,	,	PUNCT
ajmsi-3181	268	47	&	&	CCONJ
ajmsi-3181	268	48	lipman	lipman	PROPN
ajmsi-3181	268	49	,	,	PUNCT
ajmsi-3181	268	50	j.	j.	PROPN
ajmsi-3181	268	51	(	(	PUNCT
ajmsi-3181	268	52	2018	2018	NUM
ajmsi-3181	268	53	)	)	PUNCT
ajmsi-3181	268	54	.	.	PUNCT
ajmsi-3181	269	1	antimicrobial	antimicrobial	ADJ
ajmsi-3181	269	2	resistance	resistance	NOUN
ajmsi-3181	269	3	and	and	CCONJ
ajmsi-3181	269	4	antibiotic	antibiotic	ADJ
ajmsi-3181	269	5	stewardship	stewardship	NOUN
ajmsi-3181	269	6	programs	program	NOUN
ajmsi-3181	269	7	in	in	ADP
ajmsi-3181	269	8	the	the	DET
ajmsi-3181	269	9	icu	icu	NOUN
ajmsi-3181	269	10	:	:	PUNCT
ajmsi-3181	269	11	insistence	insistence	NOUN
ajmsi-3181	269	12	and	and	CCONJ
ajmsi-3181	269	13	persistence	persistence	NOUN
ajmsi-3181	269	14	in	in	ADP
ajmsi-3181	269	15	the	the	DET
ajmsi-3181	269	16	fight	fight	NOUN
ajmsi-3181	269	17	against	against	ADP
ajmsi-3181	269	18	resistance	resistance	NOUN
ajmsi-3181	269	19	.	.	PUNCT
ajmsi-3181	270	1	a	a	DET
ajmsi-3181	270	2	position	position	NOUN
ajmsi-3181	270	3	statement	statement	NOUN
ajmsi-3181	270	4	from	from	ADP
ajmsi-3181	270	5	esicm	esicm	NOUN
ajmsi-3181	270	6	/	/	SYM
ajmsi-3181	270	7	escmid	escmid	PROPN
ajmsi-3181	270	8	/	/	SYM
ajmsi-3181	270	9	waaar	waaar	NOUN
ajmsi-3181	270	10	round	round	NOUN
ajmsi-3181	270	11	table	table	NOUN
ajmsi-3181	270	12	on	on	ADP
ajmsi-3181	270	13	multidrug	multidrug	NOUN
ajmsi-3181	270	14	resistance	resistance	NOUN
ajmsi-3181	270	15	.	.	PUNCT
ajmsi-3181	271	1	intensive	intensive	ADJ
ajmsi-3181	271	2	care	care	NOUN
ajmsi-3181	271	3	medicine	medicine	NOUN
ajmsi-3181	271	4	,	,	PUNCT
ajmsi-3181	271	5	44	44	NUM
ajmsi-3181	271	6	,	,	PUNCT
ajmsi-3181	271	7	189	189	NUM
ajmsi-3181	271	8	-	-	SYM
ajmsi-3181	271	9	196	196	NUM
ajmsi-3181	271	10	.	.	PUNCT
ajmsi-3181	272	1	dyer	dyer	NOUN
ajmsi-3181	272	2	,	,	PUNCT
ajmsi-3181	272	3	a.	a.	NOUN
ajmsi-3181	272	4	p.	p.	PROPN
ajmsi-3181	272	5	,	,	PUNCT
ajmsi-3181	272	6	ashley	ashley	PROPN
ajmsi-3181	272	7	,	,	PUNCT
ajmsi-3181	272	8	e.	e.	PROPN
ajmsi-3181	272	9	d.	d.	PROPN
ajmsi-3181	272	10	,	,	PUNCT
ajmsi-3181	272	11	anderson	anderson	PROPN
ajmsi-3181	272	12	,	,	PUNCT
ajmsi-3181	272	13	d.	d.	PROPN
ajmsi-3181	272	14	j.	j.	PROPN
ajmsi-3181	272	15	,	,	PUNCT
ajmsi-3181	272	16	sarubbi	sarubbi	PROPN
ajmsi-3181	272	17	,	,	PUNCT
ajmsi-3181	272	18	c.	c.	PROPN
ajmsi-3181	272	19	,	,	PUNCT
ajmsi-3181	272	20	wrenn	wrenn	PROPN
ajmsi-3181	272	21	,	,	PUNCT
ajmsi-3181	272	22	r.	r.	PROPN
ajmsi-3181	272	23	,	,	PUNCT
ajmsi-3181	272	24	hicks	hicks	PROPN
ajmsi-3181	272	25	,	,	PUNCT
ajmsi-3181	272	26	l.	l.	PROPN
ajmsi-3181	272	27	a.	a.	PROPN
ajmsi-3181	272	28	,	,	PUNCT
ajmsi-3181	272	29	srinivasan	srinivasan	NOUN
ajmsi-3181	272	30	,	,	PUNCT
ajmsi-3181	272	31	a.	a.	NOUN
ajmsi-3181	272	32	,	,	PUNCT
ajmsi-3181	272	33	&	&	CCONJ
ajmsi-3181	272	34	moehring	moehre	VERB
ajmsi-3181	272	35	,	,	PUNCT
ajmsi-3181	272	36	r.	r.	PROPN
ajmsi-3181	272	37	w.	w.	PROPN
ajmsi-3181	272	38	(	(	PUNCT
ajmsi-3181	272	39	2019	2019	NUM
ajmsi-3181	272	40	)	)	PUNCT
ajmsi-3181	272	41	.	.	PUNCT
ajmsi-3181	273	1	total	total	ADJ
ajmsi-3181	273	2	duration	duration	NOUN
ajmsi-3181	273	3	of	of	ADP
ajmsi-3181	273	4	antimicrobial	antimicrobial	ADJ
ajmsi-3181	273	5	therapy	therapy	NOUN
ajmsi-3181	273	6	resulting	result	VERB
ajmsi-3181	273	7	from	from	ADP
ajmsi-3181	273	8	in	in	ADP
ajmsi-3181	273	9	-	-	PUNCT
ajmsi-3181	273	10	patient	patient	NOUN
ajmsi-3181	273	11	hospitalisation	hospitalisation	NOUN
ajmsi-3181	273	12	.	.	PUNCT
ajmsi-3181	274	1	infection	infection	NOUN
ajmsi-3181	274	2	control	control	PROPN
ajmsi-3181	274	3	&	&	CCONJ
ajmsi-3181	274	4	hospital	hospital	PROPN
ajmsi-3181	274	5	epidemiology	epidemiology	NOUN
ajmsi-3181	274	6	,	,	PUNCT
ajmsi-3181	274	7	40(8	40(8	NUM
ajmsi-3181	274	8	)	)	PUNCT
ajmsi-3181	274	9	,	,	PUNCT
ajmsi-3181	274	10	847	847	NUM
ajmsi-3181	274	11	-	-	SYM
ajmsi-3181	274	12	854	854	NUM
ajmsi-3181	274	13	.	.	PUNCT
ajmsi-3181	275	1	fitzpatrick	fitzpatrick	PROPN
ajmsi-3181	275	2	,	,	PUNCT
ajmsi-3181	275	3	j.	j.	PROPN
ajmsi-3181	275	4	,	,	PUNCT
ajmsi-3181	275	5	biswas	biswas	PROPN
ajmsi-3181	275	6	,	,	PUNCT
ajmsi-3181	275	7	j.	j.	PROPN
ajmsi-3181	275	8	,	,	PUNCT
ajmsi-3181	275	9	edgeworth	edgeworth	PROPN
ajmsi-3181	275	10	,	,	PUNCT
ajmsi-3181	275	11	j.	j.	PROPN
ajmsi-3181	275	12	,	,	PUNCT
ajmsi-3181	275	13	islam	islam	PROPN
ajmsi-3181	275	14	,	,	PUNCT
ajmsi-3181	275	15	j.	j.	PROPN
ajmsi-3181	275	16	,	,	PUNCT
ajmsi-3181	275	17	jenkins	jenkins	PROPN
ajmsi-3181	275	18	,	,	PUNCT
ajmsi-3181	275	19	n.	n.	NOUN
ajmsi-3181	275	20	,	,	PUNCT
ajmsi-3181	275	21	judge	judge	PROPN
ajmsi-3181	275	22	,	,	PUNCT
ajmsi-3181	275	23	r.	r.	PROPN
ajmsi-3181	275	24	,	,	PUNCT
ajmsi-3181	275	25	lavery	lavery	PROPN
ajmsi-3181	275	26	,	,	PUNCT
ajmsi-3181	275	27	a.	a.	NOUN
ajmsi-3181	275	28	,	,	PUNCT
ajmsi-3181	275	29	melzer	melzer	NOUN
ajmsi-3181	275	30	,	,	PUNCT
ajmsi-3181	275	31	m.	m.	NOUN
ajmsi-3181	275	32	,	,	PUNCT
ajmsi-3181	275	33	morris	morris	PROPN
ajmsi-3181	275	34	-	-	PUNCT
ajmsi-3181	275	35	jones	jones	PROPN
ajmsi-3181	275	36	,	,	PUNCT
ajmsi-3181	275	37	s.	s.	PROPN
ajmsi-3181	275	38	,	,	PUNCT
ajmsi-3181	275	39	&	&	CCONJ
ajmsi-3181	275	40	nsutebu	nsutebu	PROPN
ajmsi-3181	275	41	,	,	PUNCT
ajmsi-3181	275	42	e.	e.	PROPN
ajmsi-3181	275	43	(	(	PUNCT
ajmsi-3181	275	44	2016	2016	NUM
ajmsi-3181	275	45	)	)	PUNCT
ajmsi-3181	275	46	.	.	PUNCT
ajmsi-3181	276	1	gram	gram	NOUN
ajmsi-3181	276	2	-	-	PUNCT
ajmsi-3181	276	3	negative	negative	ADJ
ajmsi-3181	276	4	bacteraemia	bacteraemia	NOUN
ajmsi-3181	276	5	;	;	PUNCT
ajmsi-3181	276	6	a	a	DET
ajmsi-3181	276	7	multi	multi	ADJ
ajmsi-3181	276	8	-	-	ADJ
ajmsi-3181	276	9	centre	centre	ADJ
ajmsi-3181	276	10	prospective	prospective	ADJ
ajmsi-3181	276	11	evaluation	evaluation	NOUN
ajmsi-3181	276	12	of	of	ADP
ajmsi-3181	276	13	empiric	empiric	ADJ
ajmsi-3181	276	14	antibiotic	antibiotic	ADJ
ajmsi-3181	276	15	therapy	therapy	NOUN
ajmsi-3181	276	16	and	and	CCONJ
ajmsi-3181	276	17	outcome	outcome	NOUN
ajmsi-3181	276	18	in	in	ADP
ajmsi-3181	276	19	english	english	ADJ
ajmsi-3181	276	20	acute	acute	NOUN
ajmsi-3181	276	21	hospitals	hospital	NOUN
ajmsi-3181	276	22	.	.	PUNCT
ajmsi-3181	277	1	clinical	clinical	ADJ
ajmsi-3181	277	2	microbiology	microbiology	NOUN
ajmsi-3181	277	3	and	and	CCONJ
ajmsi-3181	277	4	infection	infection	NOUN
ajmsi-3181	277	5	,	,	PUNCT
ajmsi-3181	277	6	22(3	22(3	NUM
ajmsi-3181	277	7	)	)	PUNCT
ajmsi-3181	277	8	,	,	PUNCT
ajmsi-3181	277	9	244251	244251	NUM
ajmsi-3181	277	10	.	.	PUNCT
ajmsi-3181	278	1	gajdács	gajdács	PROPN
ajmsi-3181	278	2	,	,	PUNCT
ajmsi-3181	278	3	m.	m.	NOUN
ajmsi-3181	278	4	,	,	PUNCT
ajmsi-3181	278	5	burián	burián	NOUN
ajmsi-3181	278	6	,	,	PUNCT
ajmsi-3181	278	7	k.	k.	PROPN
ajmsi-3181	278	8	,	,	PUNCT
ajmsi-3181	278	9	&	&	CCONJ
ajmsi-3181	278	10	terhes	terhe	NOUN
ajmsi-3181	278	11	,	,	PUNCT
ajmsi-3181	278	12	g.	g.	PROPN
ajmsi-3181	278	13	(	(	PUNCT
ajmsi-3181	278	14	2019	2019	NUM
ajmsi-3181	278	15	)	)	PUNCT
ajmsi-3181	278	16	.	.	PUNCT
ajmsi-3181	279	1	resistance	resistance	NOUN
ajmsi-3181	279	2	levels	level	NOUN
ajmsi-3181	279	3	and	and	CCONJ
ajmsi-3181	279	4	epidemiology	epidemiology	NOUN
ajmsi-3181	279	5	of	of	ADP
ajmsi-3181	279	6	non	non	ADJ
ajmsi-3181	279	7	-	-	ADJ
ajmsi-3181	279	8	fermenting	fermenting	ADJ
ajmsi-3181	279	9	gramnegative	gramnegative	ADJ
ajmsi-3181	279	10	bacteria	bacteria	NOUN
ajmsi-3181	279	11	in	in	ADP
ajmsi-3181	279	12	urinary	urinary	ADJ
ajmsi-3181	279	13	tract	tract	NOUN
ajmsi-3181	279	14	infections	infection	NOUN
ajmsi-3181	279	15	of	of	ADP
ajmsi-3181	279	16	inpatients	inpatient	NOUN
ajmsi-3181	279	17	and	and	CCONJ
ajmsi-3181	279	18	outpatients	outpatient	NOUN
ajmsi-3181	279	19	(	(	PUNCT
ajmsi-3181	279	20	renfuti	renfuti	NOUN
ajmsi-3181	279	21	):	):	PUNCT
ajmsi-3181	279	22	a	a	DET
ajmsi-3181	279	23	10	10	NUM
ajmsi-3181	279	24	-	-	PUNCT
ajmsi-3181	279	25	year	year	NOUN
ajmsi-3181	279	26	epidemiological	epidemiological	ADJ
ajmsi-3181	279	27	snapshot	snapshot	NOUN
ajmsi-3181	279	28	.	.	PUNCT
ajmsi-3181	280	1	antibiotics	antibiotic	NOUN
ajmsi-3181	280	2	,	,	PUNCT
ajmsi-3181	280	3	8(3	8(3	NUM
ajmsi-3181	280	4	)	)	PUNCT
ajmsi-3181	280	5	,	,	PUNCT
ajmsi-3181	280	6	143	143	NUM
ajmsi-3181	280	7	.	.	PUNCT
ajmsi-3181	281	1	inam	inam	PROPN
ajmsi-3181	281	2	,	,	PUNCT
ajmsi-3181	281	3	s.	s.	PROPN
ajmsi-3181	281	4	,	,	PUNCT
ajmsi-3181	281	5	ikram	ikram	PROPN
ajmsi-3181	281	6	,	,	PUNCT
ajmsi-3181	281	7	s.	s.	PROPN
ajmsi-3181	281	8	,	,	PUNCT
ajmsi-3181	281	9	malik	malik	PROPN
ajmsi-3181	281	10	,	,	PUNCT
ajmsi-3181	281	11	i.	i.	PROPN
ajmsi-3181	281	12	y.	y.	PROPN
ajmsi-3181	281	13	,	,	PUNCT
ajmsi-3181	281	14	jabeen	jabeen	PROPN
ajmsi-3181	281	15	,	,	PUNCT
ajmsi-3181	281	16	k.	k.	PROPN
ajmsi-3181	281	17	,	,	PUNCT
ajmsi-3181	281	18	&	&	CCONJ
ajmsi-3181	281	19	saeed	saeed	PROPN
ajmsi-3181	281	20	,	,	PUNCT
ajmsi-3181	281	21	m.	m.	NOUN
ajmsi-3181	281	22	t.	t.	PROPN
ajmsi-3181	281	23	(	(	PUNCT
ajmsi-3181	281	24	2023	2023	NUM
ajmsi-3181	281	25	)	)	PUNCT
ajmsi-3181	281	26	.	.	PUNCT
ajmsi-3181	282	1	current	current	ADJ
ajmsi-3181	282	2	trends	trend	NOUN
ajmsi-3181	282	3	in	in	ADP
ajmsi-3181	282	4	blood	blood	NOUN
ajmsi-3181	282	5	stream	stream	NOUN
ajmsi-3181	282	6	infections	infection	NOUN
ajmsi-3181	282	7	:	:	PUNCT
ajmsi-3181	282	8	pathogens	pathogen	NOUN
ajmsi-3181	282	9	and	and	CCONJ
ajmsi-3181	282	10	their	their	PRON
ajmsi-3181	282	11	antimicrobial	antimicrobial	ADJ
ajmsi-3181	282	12	susceptibility	susceptibility	NOUN
ajmsi-3181	282	13	pattern	pattern	NOUN
ajmsi-3181	282	14	.	.	PUNCT
ajmsi-3181	283	1	pakistan	pakistan	PROPN
ajmsi-3181	283	2	postgraduate	postgraduate	PROPN
ajmsi-3181	283	3	medical	medical	PROPN
ajmsi-3181	283	4	journal	journal	NOUN
ajmsi-3181	283	5	,	,	PUNCT
ajmsi-3181	283	6	34(02	34(02	PROPN
ajmsi-3181	283	7	)	)	PUNCT
ajmsi-3181	283	8	,	,	PUNCT
ajmsi-3181	283	9	83–87	83–87	NUM
ajmsi-3181	283	10	.	.	PUNCT
ajmsi-3181	284	1	iskandar	iskandar	PROPN
ajmsi-3181	284	2	,	,	PUNCT
ajmsi-3181	284	3	k.	k.	PROPN
ajmsi-3181	284	4	,	,	PUNCT
ajmsi-3181	284	5	roques	roque	NOUN
ajmsi-3181	284	6	,	,	PUNCT
ajmsi-3181	284	7	c.	c.	NOUN
ajmsi-3181	284	8	,	,	PUNCT
ajmsi-3181	284	9	hallit	hallit	PROPN
ajmsi-3181	284	10	,	,	PUNCT
ajmsi-3181	284	11	s.	s.	PROPN
ajmsi-3181	284	12	,	,	PUNCT
ajmsi-3181	284	13	husni	husni	NOUN
ajmsi-3181	284	14	-	-	PUNCT
ajmsi-3181	284	15	samaha	samaha	PROPN
ajmsi-3181	284	16	,	,	PUNCT
ajmsi-3181	284	17	r.	r.	PROPN
ajmsi-3181	284	18	,	,	PUNCT
ajmsi-3181	284	19	dirani	dirani	PROPN
ajmsi-3181	284	20	,	,	PUNCT
ajmsi-3181	284	21	n.	n.	NOUN
ajmsi-3181	284	22	,	,	PUNCT
ajmsi-3181	284	23	rizk	rizk	PROPN
ajmsi-3181	284	24	,	,	PUNCT
ajmsi-3181	284	25	r.	r.	PROPN
ajmsi-3181	284	26	,	,	PUNCT
ajmsi-3181	284	27	abdo	abdo	PROPN
ajmsi-3181	284	28	,	,	PUNCT
ajmsi-3181	284	29	r.	r.	PROPN
ajmsi-3181	284	30	,	,	PUNCT
ajmsi-3181	284	31	yared	yared	PROPN
ajmsi-3181	284	32	,	,	PUNCT
ajmsi-3181	284	33	y.	y.	PROPN
ajmsi-3181	284	34	,	,	PUNCT
ajmsi-3181	284	35	matta	matta	PROPN
ajmsi-3181	284	36	,	,	PUNCT
ajmsi-3181	284	37	m.	m.	NOUN
ajmsi-3181	284	38	,	,	PUNCT
ajmsi-3181	284	39	&	&	CCONJ
ajmsi-3181	284	40	mostafa	mostafa	PROPN
ajmsi-3181	284	41	,	,	PUNCT
ajmsi-3181	284	42	i.	i.	PROPN
ajmsi-3181	284	43	(	(	PUNCT
ajmsi-3181	284	44	2021	2021	NUM
ajmsi-3181	284	45	)	)	PUNCT
ajmsi-3181	284	46	.	.	PUNCT
ajmsi-3181	285	1	the	the	DET
ajmsi-3181	285	2	healthcare	healthcare	NOUN
ajmsi-3181	285	3	costs	cost	NOUN
ajmsi-3181	285	4	of	of	ADP
ajmsi-3181	285	5	antimicrobial	antimicrobial	ADJ
ajmsi-3181	285	6	resistance	resistance	NOUN
ajmsi-3181	285	7	in	in	ADP
ajmsi-3181	285	8	lebanon	lebanon	PROPN
ajmsi-3181	285	9	:	:	PUNCT
ajmsi-3181	285	10	a	a	DET
ajmsi-3181	285	11	multi	multi	ADJ
ajmsi-3181	285	12	-	-	ADJ
ajmsi-3181	285	13	centre	centre	ADJ
ajmsi-3181	285	14	prospective	prospective	ADJ
ajmsi-3181	285	15	cohort	cohort	NOUN
ajmsi-3181	285	16	study	study	NOUN
ajmsi-3181	285	17	from	from	ADP
ajmsi-3181	285	18	the	the	DET
ajmsi-3181	285	19	payer	payer	NOUN
ajmsi-3181	285	20	perspective	perspective	NOUN
ajmsi-3181	285	21	.	.	PUNCT
ajmsi-3181	286	1	bmc	bmc	ADJ
ajmsi-3181	286	2	infectious	infectious	ADJ
ajmsi-3181	286	3	diseases	disease	NOUN
ajmsi-3181	286	4	,	,	PUNCT
ajmsi-3181	286	5	21(1	21(1	NUM
ajmsi-3181	286	6	)	)	PUNCT
ajmsi-3181	286	7	,	,	PUNCT
ajmsi-3181	286	8	404	404	NUM
ajmsi-3181	286	9	.	.	PUNCT
ajmsi-3181	287	1	kalelkar	kalelkar	PROPN
ajmsi-3181	287	2	,	,	PUNCT
ajmsi-3181	287	3	p.	p.	PROPN
ajmsi-3181	287	4	p.	p.	PROPN
ajmsi-3181	287	5	,	,	PUNCT
ajmsi-3181	287	6	riddick	riddick	PROPN
ajmsi-3181	287	7	,	,	PUNCT
ajmsi-3181	287	8	m.	m.	NOUN
ajmsi-3181	287	9	,	,	PUNCT
ajmsi-3181	287	10	&	&	CCONJ
ajmsi-3181	287	11	garcía	garcía	ADJ
ajmsi-3181	287	12	,	,	PUNCT
ajmsi-3181	287	13	a.	a.	NOUN
ajmsi-3181	287	14	j.	j.	PROPN
ajmsi-3181	287	15	(	(	PUNCT
ajmsi-3181	287	16	2022	2022	NUM
ajmsi-3181	287	17	)	)	PUNCT
ajmsi-3181	287	18	.	.	PUNCT
ajmsi-3181	288	1	biomaterial	biomaterial	ADJ
ajmsi-3181	288	2	-	-	PUNCT
ajmsi-3181	288	3	based	base	VERB
ajmsi-3181	288	4	antimicrobial	antimicrobial	ADJ
ajmsi-3181	288	5	therapies	therapy	NOUN
ajmsi-3181	288	6	for	for	ADP
ajmsi-3181	288	7	the	the	DET
ajmsi-3181	288	8	pa	pa	PROPN
ajmsi-3181	288	9	ge	ge	PROPN
ajmsi-3181	288	10	10	10	NUM
ajmsi-3181	288	11	2	2	NUM
ajmsi-3181	288	12	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-3181	288	13	am	be	AUX
ajmsi-3181	288	14	.	.	PUNCT
ajmsi-3181	289	1	j.	j.	PROPN
ajmsi-3181	289	2	med	med	PROPN
ajmsi-3181	289	3	.	.	PUNCT
ajmsi-3181	290	1	sci	sci	PROPN
ajmsi-3181	290	2	.	.	PUNCT
ajmsi-3181	290	3	innov	innov	PROPN
ajmsi-3181	290	4	.	.	PUNCT
ajmsi-3181	291	1	3(2	3(2	NUM
ajmsi-3181	291	2	)	)	PUNCT
ajmsi-3181	291	3	91	91	NUM
ajmsi-3181	291	4	-	-	SYM
ajmsi-3181	291	5	102	102	NUM
ajmsi-3181	291	6	,	,	PUNCT
ajmsi-3181	291	7	2024	2024	NUM
ajmsi-3181	291	8	treatment	treatment	NOUN
ajmsi-3181	291	9	of	of	ADP
ajmsi-3181	291	10	bacterial	bacterial	ADJ
ajmsi-3181	291	11	infections	infection	NOUN
ajmsi-3181	291	12	.	.	PUNCT
ajmsi-3181	292	1	nature	nature	NOUN
ajmsi-3181	292	2	reviews	review	VERB
ajmsi-3181	292	3	materials	material	NOUN
ajmsi-3181	292	4	,	,	PUNCT
ajmsi-3181	292	5	7(1	7(1	NUM
ajmsi-3181	292	6	)	)	PUNCT
ajmsi-3181	292	7	,	,	PUNCT
ajmsi-3181	292	8	39	39	NUM
ajmsi-3181	292	9	-	-	SYM
ajmsi-3181	292	10	54	54	NUM
ajmsi-3181	292	11	.	.	PUNCT
ajmsi-3181	293	1	khan	khan	PROPN
ajmsi-3181	293	2	,	,	PUNCT
ajmsi-3181	293	3	f.	f.	PROPN
ajmsi-3181	293	4	y.	y.	PROPN
ajmsi-3181	293	5	,	,	PUNCT
ajmsi-3181	293	6	elshafie	elshafie	NOUN
ajmsi-3181	293	7	,	,	PUNCT
ajmsi-3181	293	8	s.	s.	PROPN
ajmsi-3181	293	9	s.	s.	PROPN
ajmsi-3181	293	10	,	,	PUNCT
ajmsi-3181	293	11	almaslamani	almaslamani	PROPN
ajmsi-3181	293	12	,	,	PUNCT
ajmsi-3181	293	13	m.	m.	NOUN
ajmsi-3181	293	14	,	,	PUNCT
ajmsi-3181	293	15	abu	abu	PROPN
ajmsi-3181	293	16	-	-	PUNCT
ajmsi-3181	293	17	khattab	khattab	NOUN
ajmsi-3181	293	18	,	,	PUNCT
ajmsi-3181	293	19	m.	m.	NOUN
ajmsi-3181	293	20	,	,	PUNCT
ajmsi-3181	293	21	el	el	PROPN
ajmsi-3181	293	22	hiday	hiday	PROPN
ajmsi-3181	293	23	,	,	PUNCT
ajmsi-3181	293	24	a.	a.	PROPN
ajmsi-3181	293	25	h.	h.	PROPN
ajmsi-3181	293	26	,	,	PUNCT
ajmsi-3181	293	27	errayes	errayes	PROPN
ajmsi-3181	293	28	,	,	PUNCT
ajmsi-3181	293	29	m.	m.	NOUN
ajmsi-3181	293	30	,	,	PUNCT
ajmsi-3181	293	31	&	&	CCONJ
ajmsi-3181	293	32	almaslamani	almaslamani	PROPN
ajmsi-3181	293	33	,	,	PUNCT
ajmsi-3181	293	34	e.	e.	PROPN
ajmsi-3181	293	35	(	(	PUNCT
ajmsi-3181	293	36	2010	2010	NUM
ajmsi-3181	293	37	)	)	PUNCT
ajmsi-3181	293	38	.	.	PUNCT
ajmsi-3181	294	1	epidemiology	epidemiology	NOUN
ajmsi-3181	294	2	of	of	ADP
ajmsi-3181	294	3	bacteraemia	bacteraemia	NOUN
ajmsi-3181	294	4	in	in	ADP
ajmsi-3181	294	5	hamad	hamad	PROPN
ajmsi-3181	294	6	general	general	PROPN
ajmsi-3181	294	7	hospital	hospital	PROPN
ajmsi-3181	294	8	,	,	PUNCT
ajmsi-3181	294	9	qatar	qatar	PROPN
ajmsi-3181	294	10	:	:	PUNCT
ajmsi-3181	294	11	a	a	DET
ajmsi-3181	294	12	one	one	NUM
ajmsi-3181	294	13	year	year	NOUN
ajmsi-3181	294	14	hospital	hospital	NOUN
ajmsi-3181	294	15	-	-	PUNCT
ajmsi-3181	294	16	based	base	VERB
ajmsi-3181	294	17	study	study	NOUN
ajmsi-3181	294	18	.	.	PUNCT
ajmsi-3181	295	1	travel	travel	NOUN
ajmsi-3181	295	2	medicine	medicine	NOUN
ajmsi-3181	295	3	and	and	CCONJ
ajmsi-3181	295	4	infectious	infectious	ADJ
ajmsi-3181	295	5	disease	disease	NOUN
ajmsi-3181	295	6	,	,	PUNCT
ajmsi-3181	295	7	8(6	8(6	NUM
ajmsi-3181	295	8	)	)	PUNCT
ajmsi-3181	295	9	,	,	PUNCT
ajmsi-3181	295	10	377	377	NUM
ajmsi-3181	295	11	-	-	SYM
ajmsi-3181	295	12	387	387	NUM
ajmsi-3181	295	13	.	.	PUNCT
ajmsi-3181	296	1	kim	kim	PROPN
ajmsi-3181	296	2	,	,	PUNCT
ajmsi-3181	296	3	y.	y.	PROPN
ajmsi-3181	296	4	a.	a.	PROPN
ajmsi-3181	296	5	,	,	PUNCT
ajmsi-3181	296	6	&	&	CCONJ
ajmsi-3181	296	7	park	park	PROPN
ajmsi-3181	296	8	,	,	PUNCT
ajmsi-3181	296	9	y.	y.	PROPN
ajmsi-3181	296	10	s.	s.	PROPN
ajmsi-3181	296	11	(	(	PUNCT
ajmsi-3181	296	12	2018	2018	NUM
ajmsi-3181	296	13	)	)	PUNCT
ajmsi-3181	296	14	.	.	PUNCT
ajmsi-3181	297	1	epidemiology	epidemiology	NOUN
ajmsi-3181	297	2	and	and	CCONJ
ajmsi-3181	297	3	treatment	treatment	NOUN
ajmsi-3181	297	4	of	of	ADP
ajmsi-3181	297	5	antimicrobialresistant	antimicrobialresistant	ADJ
ajmsi-3181	297	6	gram	gram	NOUN
ajmsi-3181	297	7	-	-	PUNCT
ajmsi-3181	297	8	negative	negative	ADJ
ajmsi-3181	297	9	bacteria	bacteria	NOUN
ajmsi-3181	297	10	in	in	ADP
ajmsi-3181	297	11	korea	korea	PROPN
ajmsi-3181	297	12	.	.	PUNCT
ajmsi-3181	298	1	the	the	DET
ajmsi-3181	298	2	korean	korean	ADJ
ajmsi-3181	298	3	journal	journal	NOUN
ajmsi-3181	298	4	of	of	ADP
ajmsi-3181	298	5	internal	internal	ADJ
ajmsi-3181	298	6	medicine	medicine	NOUN
ajmsi-3181	298	7	,	,	PUNCT
ajmsi-3181	298	8	33(2	33(2	NUM
ajmsi-3181	298	9	)	)	PUNCT
ajmsi-3181	298	10	,	,	PUNCT
ajmsi-3181	298	11	247	247	NUM
ajmsi-3181	298	12	.	.	PUNCT
ajmsi-3181	299	1	kitaya	kitaya	PROPN
ajmsi-3181	299	2	,	,	PUNCT
ajmsi-3181	299	3	s.	s.	PROPN
ajmsi-3181	299	4	,	,	PUNCT
ajmsi-3181	299	5	kanamori	kanamori	PROPN
ajmsi-3181	299	6	,	,	PUNCT
ajmsi-3181	299	7	h.	h.	PROPN
ajmsi-3181	299	8	,	,	PUNCT
ajmsi-3181	299	9	katori	katori	PROPN
ajmsi-3181	299	10	,	,	PUNCT
ajmsi-3181	299	11	y.	y.	PROPN
ajmsi-3181	299	12	,	,	PUNCT
ajmsi-3181	299	13	&	&	CCONJ
ajmsi-3181	299	14	tokuda	tokuda	PROPN
ajmsi-3181	299	15	,	,	PUNCT
ajmsi-3181	299	16	k.	k.	PROPN
ajmsi-3181	299	17	(	(	PUNCT
ajmsi-3181	299	18	2023	2023	NUM
ajmsi-3181	299	19	)	)	PUNCT
ajmsi-3181	299	20	.	.	PUNCT
ajmsi-3181	300	1	impact	impact	NOUN
ajmsi-3181	300	2	of	of	ADP
ajmsi-3181	300	3	persistent	persistent	ADJ
ajmsi-3181	300	4	multidrug	multidrug	NOUN
ajmsi-3181	300	5	-	-	PUNCT
ajmsi-3181	300	6	resistant	resistant	ADJ
ajmsi-3181	300	7	gram	gram	NOUN
ajmsi-3181	300	8	-	-	PUNCT
ajmsi-3181	300	9	negative	negative	ADJ
ajmsi-3181	300	10	bacteremia	bacteremia	NOUN
ajmsi-3181	300	11	on	on	ADP
ajmsi-3181	300	12	clinical	clinical	ADJ
ajmsi-3181	300	13	outcome	outcome	NOUN
ajmsi-3181	300	14	and	and	CCONJ
ajmsi-3181	300	15	mortality	mortality	NOUN
ajmsi-3181	300	16	.	.	PUNCT
ajmsi-3181	301	1	antibiotics	antibiotic	NOUN
ajmsi-3181	301	2	,	,	PUNCT
ajmsi-3181	301	3	12(2	12(2	NUM
ajmsi-3181	301	4	)	)	PUNCT
ajmsi-3181	301	5	,	,	PUNCT
ajmsi-3181	301	6	313	313	NUM
ajmsi-3181	301	7	.	.	PUNCT
ajmsi-3181	302	1	kwiecińska	kwiecińska	ADJ
ajmsi-3181	302	2	-	-	PUNCT
ajmsi-3181	302	3	piróg	piróg	NOUN
ajmsi-3181	302	4	,	,	PUNCT
ajmsi-3181	302	5	j.	j.	PROPN
ajmsi-3181	302	6	,	,	PUNCT
ajmsi-3181	302	7	skowron	skowron	PROPN
ajmsi-3181	302	8	,	,	PUNCT
ajmsi-3181	302	9	k.	k.	PROPN
ajmsi-3181	302	10	,	,	PUNCT
ajmsi-3181	302	11	&	&	CCONJ
ajmsi-3181	302	12	gospodarekkomkowska	gospodarekkomkowska	PROPN
ajmsi-3181	302	13	,	,	PUNCT
ajmsi-3181	302	14	e.	e.	PROPN
ajmsi-3181	302	15	(	(	PUNCT
ajmsi-3181	302	16	2018	2018	NUM
ajmsi-3181	302	17	)	)	PUNCT
ajmsi-3181	302	18	.	.	PUNCT
ajmsi-3181	303	1	primary	primary	ADJ
ajmsi-3181	303	2	and	and	CCONJ
ajmsi-3181	303	3	secondary	secondary	ADJ
ajmsi-3181	303	4	bacteremia	bacteremia	NOUN
ajmsi-3181	303	5	caused	cause	VERB
ajmsi-3181	303	6	by	by	ADP
ajmsi-3181	303	7	spp	spp	NOUN
ajmsi-3181	303	8	.	.	PUNCT
ajmsi-3181	303	9	:	:	PUNCT
ajmsi-3181	304	1	epidemiology	epidemiology	NOUN
ajmsi-3181	304	2	,	,	PUNCT
ajmsi-3181	304	3	strains	strain	VERB
ajmsi-3181	304	4	susceptibility	susceptibility	NOUN
ajmsi-3181	304	5	and	and	CCONJ
ajmsi-3181	304	6	biofilm	biofilm	NOUN
ajmsi-3181	304	7	formation	formation	NOUN
ajmsi-3181	304	8	.	.	PUNCT
ajmsi-3181	305	1	polish	polish	PROPN
ajmsi-3181	305	2	journal	journal	PROPN
ajmsi-3181	305	3	of	of	ADP
ajmsi-3181	305	4	microbiology	microbiology	NOUN
ajmsi-3181	305	5	,	,	PUNCT
ajmsi-3181	305	6	67(4	67(4	NUM
ajmsi-3181	305	7	)	)	PUNCT
ajmsi-3181	305	8	,	,	PUNCT
ajmsi-3181	305	9	471	471	NUM
ajmsi-3181	305	10	-	-	SYM
ajmsi-3181	305	11	478	478	NUM
ajmsi-3181	305	12	.	.	PUNCT
ajmsi-3181	306	1	laupland	laupland	NOUN
ajmsi-3181	306	2	,	,	PUNCT
ajmsi-3181	306	3	k.	k.	PROPN
ajmsi-3181	306	4	,	,	PUNCT
ajmsi-3181	306	5	svenson	svenson	PROPN
ajmsi-3181	306	6	,	,	PUNCT
ajmsi-3181	306	7	l.	l.	PROPN
ajmsi-3181	306	8	,	,	PUNCT
ajmsi-3181	306	9	gregson	gregson	PROPN
ajmsi-3181	306	10	,	,	PUNCT
ajmsi-3181	306	11	d.	d.	PROPN
ajmsi-3181	306	12	,	,	PUNCT
ajmsi-3181	306	13	&	&	CCONJ
ajmsi-3181	306	14	church	church	PROPN
ajmsi-3181	306	15	,	,	PUNCT
ajmsi-3181	306	16	d.	d.	PROPN
ajmsi-3181	306	17	(	(	PUNCT
ajmsi-3181	306	18	2011	2011	NUM
ajmsi-3181	306	19	)	)	PUNCT
ajmsi-3181	306	20	.	.	PUNCT
ajmsi-3181	307	1	long	long	ADJ
ajmsi-3181	307	2	-	-	PUNCT
ajmsi-3181	307	3	term	term	NOUN
ajmsi-3181	307	4	mortality	mortality	NOUN
ajmsi-3181	307	5	associated	associate	VERB
ajmsi-3181	307	6	with	with	ADP
ajmsi-3181	307	7	community	community	NOUN
ajmsi-3181	307	8	-	-	PUNCT
ajmsi-3181	307	9	onset	onset	VERB
ajmsi-3181	307	10	bloodstream	bloodstream	NOUN
ajmsi-3181	307	11	infection	infection	NOUN
ajmsi-3181	307	12	.	.	PUNCT
ajmsi-3181	308	1	infection	infection	NOUN
ajmsi-3181	308	2	,	,	PUNCT
ajmsi-3181	308	3	39	39	NUM
ajmsi-3181	308	4	,	,	PUNCT
ajmsi-3181	308	5	405	405	NUM
ajmsi-3181	308	6	-	-	SYM
ajmsi-3181	308	7	410	410	NUM
ajmsi-3181	308	8	.	.	PUNCT
ajmsi-3181	309	1	lee	lee	PROPN
ajmsi-3181	309	2	,	,	PUNCT
ajmsi-3181	309	3	c.-c	c.-c	PROPN
ajmsi-3181	309	4	.	.	PUNCT
ajmsi-3181	309	5	,	,	PUNCT
ajmsi-3181	309	6	hsieh	hsieh	PROPN
ajmsi-3181	309	7	,	,	PUNCT
ajmsi-3181	309	8	c.-c	c.-c	PROPN
ajmsi-3181	309	9	.	.	PUNCT
ajmsi-3181	309	10	,	,	PUNCT
ajmsi-3181	309	11	yang	yang	PROPN
ajmsi-3181	309	12	,	,	PUNCT
ajmsi-3181	309	13	c.-y	c.-y	NOUN
ajmsi-3181	309	14	.	.	PUNCT
ajmsi-3181	309	15	,	,	PUNCT
ajmsi-3181	309	16	hong	hong	PROPN
ajmsi-3181	309	17	,	,	PUNCT
ajmsi-3181	309	18	m.-y	m.-y	PROPN
ajmsi-3181	309	19	.	.	PUNCT
ajmsi-3181	309	20	,	,	PUNCT
ajmsi-3181	309	21	lee	lee	PROPN
ajmsi-3181	309	22	,	,	PUNCT
ajmsi-3181	309	23	c.-h	c.-h	PROPN
ajmsi-3181	309	24	.	.	PROPN
ajmsi-3181	309	25	,	,	PUNCT
ajmsi-3181	309	26	tang	tang	PROPN
ajmsi-3181	309	27	,	,	PUNCT
ajmsi-3181	309	28	h.-j	h.-j	PROPN
ajmsi-3181	309	29	.	.	PROPN
ajmsi-3181	309	30	,	,	PUNCT
ajmsi-3181	309	31	&	&	CCONJ
ajmsi-3181	309	32	ko	ko	PROPN
ajmsi-3181	309	33	,	,	PUNCT
ajmsi-3181	309	34	w.-c	w.-c	NOUN
ajmsi-3181	309	35	.	.	PUNCT
ajmsi-3181	310	1	(	(	PUNCT
ajmsi-3181	310	2	2019	2019	NUM
ajmsi-3181	310	3	)	)	PUNCT
ajmsi-3181	310	4	.	.	PUNCT
ajmsi-3181	311	1	short	short	ADJ
ajmsi-3181	311	2	versus	versus	ADP
ajmsi-3181	311	3	long	long	ADJ
ajmsi-3181	311	4	duration	duration	NOUN
ajmsi-3181	311	5	antimicrobial	antimicrobial	ADJ
ajmsi-3181	311	6	treatment	treatment	NOUN
ajmsi-3181	311	7	for	for	ADP
ajmsi-3181	311	8	communityonset	communityonset	NOUN
ajmsi-3181	311	9	bacteraemia	bacteraemia	NOUN
ajmsi-3181	311	10	:	:	PUNCT
ajmsi-3181	311	11	a	a	DET
ajmsi-3181	311	12	propensity	propensity	NOUN
ajmsi-3181	311	13	score	score	NOUN
ajmsi-3181	311	14	matching	matching	NOUN
ajmsi-3181	311	15	study	study	NOUN
ajmsi-3181	311	16	.	.	PUNCT
ajmsi-3181	312	1	international	international	ADJ
ajmsi-3181	312	2	journal	journal	PROPN
ajmsi-3181	312	3	of	of	ADP
ajmsi-3181	312	4	antimicrobial	antimicrobial	ADJ
ajmsi-3181	312	5	agents	agent	NOUN
ajmsi-3181	312	6	,	,	PUNCT
ajmsi-3181	312	7	54(2	54(2	NUM
ajmsi-3181	312	8	)	)	PUNCT
ajmsi-3181	312	9	,	,	PUNCT
ajmsi-3181	312	10	176	176	NUM
ajmsi-3181	312	11	-	-	SYM
ajmsi-3181	312	12	183	183	NUM
ajmsi-3181	312	13	.	.	PUNCT
ajmsi-3181	313	1	lester	lester	PROPN
ajmsi-3181	313	2	,	,	PUNCT
ajmsi-3181	313	3	r.	r.	PROPN
ajmsi-3181	313	4	,	,	PUNCT
ajmsi-3181	313	5	musicha	musicha	PROPN
ajmsi-3181	313	6	,	,	PUNCT
ajmsi-3181	313	7	p.	p.	PROPN
ajmsi-3181	313	8	,	,	PUNCT
ajmsi-3181	313	9	van	van	PROPN
ajmsi-3181	313	10	ginneken	ginneken	PROPN
ajmsi-3181	313	11	,	,	PUNCT
ajmsi-3181	313	12	n.	n.	NOUN
ajmsi-3181	313	13	,	,	PUNCT
ajmsi-3181	313	14	dramowski	dramowski	PROPN
ajmsi-3181	313	15	,	,	PUNCT
ajmsi-3181	313	16	a.	a.	NOUN
ajmsi-3181	313	17	,	,	PUNCT
ajmsi-3181	313	18	hamer	hamer	PROPN
ajmsi-3181	313	19	,	,	PUNCT
ajmsi-3181	313	20	d.	d.	PROPN
ajmsi-3181	313	21	h.	h.	PROPN
ajmsi-3181	313	22	,	,	PUNCT
ajmsi-3181	313	23	garner	garner	NOUN
ajmsi-3181	313	24	,	,	PUNCT
ajmsi-3181	313	25	p.	p.	PROPN
ajmsi-3181	313	26	,	,	PUNCT
ajmsi-3181	313	27	&	&	CCONJ
ajmsi-3181	313	28	feasey	feasey	ADJ
ajmsi-3181	313	29	,	,	PUNCT
ajmsi-3181	313	30	n.	n.	NOUN
ajmsi-3181	313	31	a.	a.	NOUN
ajmsi-3181	313	32	(	(	PUNCT
ajmsi-3181	313	33	2020	2020	NUM
ajmsi-3181	313	34	)	)	PUNCT
ajmsi-3181	313	35	.	.	PUNCT
ajmsi-3181	314	1	prevalence	prevalence	NOUN
ajmsi-3181	314	2	and	and	CCONJ
ajmsi-3181	314	3	outcome	outcome	NOUN
ajmsi-3181	314	4	of	of	ADP
ajmsi-3181	314	5	bloodstream	bloodstream	NOUN
ajmsi-3181	314	6	infections	infection	NOUN
ajmsi-3181	314	7	due	due	ADJ
ajmsi-3181	314	8	to	to	ADP
ajmsi-3181	314	9	third	third	ADJ
ajmsi-3181	314	10	-	-	PUNCT
ajmsi-3181	314	11	generation	generation	NOUN
ajmsi-3181	314	12	cephalosporinresistant	cephalosporinresistant	NOUN
ajmsi-3181	314	13	enterobacteriaceae	enterobacteriaceae	PROPN
ajmsi-3181	314	14	in	in	ADP
ajmsi-3181	314	15	sub	sub	ADJ
ajmsi-3181	314	16	-	-	ADJ
ajmsi-3181	314	17	saharan	saharan	ADJ
ajmsi-3181	314	18	africa	africa	PROPN
ajmsi-3181	314	19	:	:	PUNCT
ajmsi-3181	314	20	a	a	DET
ajmsi-3181	314	21	systematic	systematic	ADJ
ajmsi-3181	314	22	review	review	NOUN
ajmsi-3181	314	23	.	.	PUNCT
ajmsi-3181	315	1	journal	journal	PROPN
ajmsi-3181	315	2	of	of	ADP
ajmsi-3181	315	3	antimicrobial	antimicrobial	ADJ
ajmsi-3181	315	4	chemotherapy	chemotherapy	NOUN
ajmsi-3181	315	5	,	,	PUNCT
ajmsi-3181	315	6	75(3	75(3	NUM
ajmsi-3181	315	7	)	)	PUNCT
ajmsi-3181	315	8	,	,	PUNCT
ajmsi-3181	315	9	492	492	NUM
ajmsi-3181	315	10	-	-	SYM
ajmsi-3181	315	11	507	507	NUM
ajmsi-3181	315	12	.	.	PUNCT
ajmsi-3181	316	1	mahmoudi	mahmoudi	NOUN
ajmsi-3181	316	2	,	,	PUNCT
ajmsi-3181	316	3	s.	s.	PROPN
ajmsi-3181	316	4	,	,	PUNCT
ajmsi-3181	316	5	pourakbari	pourakbari	PROPN
ajmsi-3181	316	6	,	,	PUNCT
ajmsi-3181	316	7	b.	b.	PROPN
ajmsi-3181	316	8	,	,	PUNCT
ajmsi-3181	316	9	rostamyan	rostamyan	ADJ
ajmsi-3181	316	10	,	,	PUNCT
ajmsi-3181	316	11	m.	m.	NOUN
ajmsi-3181	316	12	,	,	PUNCT
ajmsi-3181	316	13	raji	raji	PROPN
ajmsi-3181	316	14	,	,	PUNCT
ajmsi-3181	316	15	h.	h.	PROPN
ajmsi-3181	316	16	,	,	PUNCT
ajmsi-3181	316	17	sadeghi	sadeghi	PROPN
ajmsi-3181	316	18	,	,	PUNCT
ajmsi-3181	316	19	r.	r.	PROPN
ajmsi-3181	316	20	h.	h.	PROPN
ajmsi-3181	316	21	,	,	PUNCT
ajmsi-3181	316	22	&	&	CCONJ
ajmsi-3181	316	23	mamishi	mamishi	PROPN
ajmsi-3181	316	24	,	,	PUNCT
ajmsi-3181	316	25	s.	s.	PROPN
ajmsi-3181	316	26	(	(	PUNCT
ajmsi-3181	316	27	2023	2023	NUM
ajmsi-3181	316	28	)	)	PUNCT
ajmsi-3181	316	29	.	.	PUNCT
ajmsi-3181	317	1	antimicrobial	antimicrobial	ADJ
ajmsi-3181	317	2	resistance	resistance	NOUN
ajmsi-3181	317	3	patterns	pattern	NOUN
ajmsi-3181	317	4	of	of	ADP
ajmsi-3181	317	5	gram	gram	NOUN
ajmsi-3181	317	6	-	-	PUNCT
ajmsi-3181	317	7	negative	negative	ADJ
ajmsi-3181	317	8	bacteria	bacteria	NOUN
ajmsi-3181	317	9	in	in	ADP
ajmsi-3181	317	10	an	an	DET
ajmsi-3181	317	11	iranian	iranian	ADJ
ajmsi-3181	317	12	referral	referral	ADJ
ajmsi-3181	317	13	pediatric	pediatric	ADJ
ajmsi-3181	317	14	hospital	hospital	NOUN
ajmsi-3181	317	15	:	:	PUNCT
ajmsi-3181	317	16	a	a	DET
ajmsi-3181	317	17	present	present	ADJ
ajmsi-3181	317	18	danger	danger	NOUN
ajmsi-3181	317	19	of	of	ADP
ajmsi-3181	317	20	new	new	ADJ
ajmsi-3181	317	21	delhi	delhi	PROPN
ajmsi-3181	317	22	metallo	metallo	PROPN
ajmsi-3181	317	23	-	-	PUNCT
ajmsi-3181	317	24	β	β	NOUN
ajmsi-3181	317	25	-	-	PUNCT
ajmsi-3181	317	26	lactamase	lactamase	ADJ
ajmsi-3181	317	27	.	.	PUNCT
ajmsi-3181	318	1	infectious	infectious	ADJ
ajmsi-3181	318	2	disordersdrug	disordersdrug	ADJ
ajmsi-3181	318	3	targets	target	NOUN
ajmsi-3181	318	4	(	(	PUNCT
ajmsi-3181	318	5	formerly	formerly	ADV
ajmsi-3181	318	6	current	current	ADJ
ajmsi-3181	318	7	drug	drug	NOUN
ajmsi-3181	318	8	targets	target	NOUN
ajmsi-3181	318	9	-	-	PUNCT
ajmsi-3181	318	10	infectious	infectious	ADJ
ajmsi-3181	318	11	disorders	disorder	NOUN
ajmsi-3181	318	12	)	)	PUNCT
ajmsi-3181	318	13	,	,	PUNCT
ajmsi-3181	318	14	23(6	23(6	NUM
ajmsi-3181	318	15	)	)	PUNCT
ajmsi-3181	318	16	,	,	PUNCT
ajmsi-3181	318	17	7	7	NUM
ajmsi-3181	318	18	-	-	SYM
ajmsi-3181	318	19	14	14	NUM
ajmsi-3181	318	20	.	.	PUNCT
ajmsi-3181	319	1	sathya	sathya	PROPN
ajmsi-3181	319	2	kumar	kumar	PROPN
ajmsi-3181	319	3	,	,	PUNCT
ajmsi-3181	319	4	a.	a.	NOUN
ajmsi-3181	319	5	m.	m.	NOUN
ajmsi-3181	319	6	,	,	PUNCT
ajmsi-3181	319	7	george	george	PROPN
ajmsi-3181	319	8	,	,	PUNCT
ajmsi-3181	319	9	m.	m.	NOUN
ajmsi-3181	319	10	m.	m.	NOUN
ajmsi-3181	319	11	,	,	PUNCT
ajmsi-3181	319	12	bhanuprasad	bhanuprasad	PROPN
ajmsi-3181	319	13	,	,	PUNCT
ajmsi-3181	319	14	k.	k.	PROPN
ajmsi-3181	319	15	,	,	PUNCT
ajmsi-3181	319	16	john	john	PROPN
ajmsi-3181	319	17	,	,	PUNCT
ajmsi-3181	319	18	g.	g.	PROPN
ajmsi-3181	319	19	m.	m.	PROPN
ajmsi-3181	319	20	,	,	PUNCT
ajmsi-3181	319	21	korula	korula	PROPN
ajmsi-3181	319	22	,	,	PUNCT
ajmsi-3181	319	23	a.	a.	PROPN
ajmsi-3181	319	24	,	,	PUNCT
ajmsi-3181	319	25	abraham	abraham	PROPN
ajmsi-3181	319	26	,	,	PUNCT
ajmsi-3181	319	27	a.	a.	PROPN
ajmsi-3181	319	28	,	,	PUNCT
ajmsi-3181	319	29	mathews	mathews	PROPN
ajmsi-3181	319	30	,	,	PUNCT
ajmsi-3181	319	31	v.	v.	PROPN
ajmsi-3181	319	32	,	,	PUNCT
ajmsi-3181	319	33	kulkarni	kulkarni	PROPN
ajmsi-3181	319	34	,	,	PUNCT
ajmsi-3181	319	35	u.	u.	PROPN
ajmsi-3181	319	36	p.	p.	PROPN
ajmsi-3181	319	37	,	,	PUNCT
ajmsi-3181	319	38	shankar	shankar	PROPN
ajmsi-3181	319	39	,	,	PUNCT
ajmsi-3181	319	40	c.	c.	PROPN
ajmsi-3181	319	41	,	,	PUNCT
ajmsi-3181	319	42	&	&	CCONJ
ajmsi-3181	319	43	premkumar	premkumar	PROPN
ajmsi-3181	319	44	,	,	PUNCT
ajmsi-3181	319	45	p.	p.	PROPN
ajmsi-3181	319	46	s.	s.	PROPN
ajmsi-3181	319	47	(	(	PUNCT
ajmsi-3181	319	48	2023	2023	NUM
ajmsi-3181	319	49	)	)	PUNCT
ajmsi-3181	319	50	.	.	PUNCT
ajmsi-3181	320	1	persistent	persistent	ADJ
ajmsi-3181	320	2	bacteremia	bacteremia	NOUN
ajmsi-3181	320	3	predicts	predict	VERB
ajmsi-3181	320	4	poor	poor	ADJ
ajmsi-3181	320	5	outcomes	outcome	NOUN
ajmsi-3181	320	6	among	among	ADP
ajmsi-3181	320	7	neutropenic	neutropenic	ADJ
ajmsi-3181	320	8	patients	patient	NOUN
ajmsi-3181	320	9	with	with	ADP
ajmsi-3181	320	10	carbapenem	carbapenem	NOUN
ajmsi-3181	320	11	-	-	PUNCT
ajmsi-3181	320	12	resistant	resistant	ADJ
ajmsi-3181	320	13	gram	gram	NOUN
ajmsi-3181	320	14	-	-	PUNCT
ajmsi-3181	320	15	negative	negative	ADJ
ajmsi-3181	320	16	bloodstream	bloodstream	NOUN
ajmsi-3181	320	17	infections	infection	NOUN
ajmsi-3181	320	18	receiving	receive	VERB
ajmsi-3181	320	19	appropriate	appropriate	ADJ
ajmsi-3181	320	20	therapy	therapy	NOUN
ajmsi-3181	320	21	.	.	PUNCT
ajmsi-3181	321	1	annals	annal	NOUN
ajmsi-3181	321	2	of	of	ADP
ajmsi-3181	321	3	clinical	clinical	ADJ
ajmsi-3181	321	4	microbiology	microbiology	NOUN
ajmsi-3181	321	5	and	and	CCONJ
ajmsi-3181	321	6	antimicrobials	antimicrobial	NOUN
ajmsi-3181	321	7	,	,	PUNCT
ajmsi-3181	321	8	22(1	22(1	NUM
ajmsi-3181	321	9	)	)	PUNCT
ajmsi-3181	321	10	,	,	PUNCT
ajmsi-3181	321	11	12	12	NUM
ajmsi-3181	321	12	.	.	PUNCT
ajmsi-3181	322	1	sid	sid	PROPN
ajmsi-3181	322	2	ahmed	ahmed	PROPN
ajmsi-3181	322	3	,	,	PUNCT
ajmsi-3181	322	4	m.	m.	NOUN
ajmsi-3181	322	5	a.	a.	PROPN
ajmsi-3181	322	6	,	,	PUNCT
ajmsi-3181	322	7	petkar	petkar	PROPN
ajmsi-3181	322	8	,	,	PUNCT
ajmsi-3181	322	9	h.	h.	PROPN
ajmsi-3181	322	10	m.	m.	PROPN
ajmsi-3181	322	11	,	,	PUNCT
ajmsi-3181	322	12	saleh	saleh	NOUN
ajmsi-3181	322	13	,	,	PUNCT
ajmsi-3181	322	14	t.	t.	NOUN
ajmsi-3181	322	15	m.	m.	NOUN
ajmsi-3181	322	16	,	,	PUNCT
ajmsi-3181	322	17	albirair	albirair	NOUN
ajmsi-3181	322	18	,	,	PUNCT
ajmsi-3181	322	19	m.	m.	NOUN
ajmsi-3181	322	20	,	,	PUNCT
ajmsi-3181	322	21	arisgado	arisgado	VERB
ajmsi-3181	322	22	,	,	PUNCT
ajmsi-3181	322	23	l.	l.	PROPN
ajmsi-3181	322	24	a.	a.	PROPN
ajmsi-3181	322	25	,	,	PUNCT
ajmsi-3181	322	26	eltayeb	eltayeb	PROPN
ajmsi-3181	322	27	,	,	PUNCT
ajmsi-3181	322	28	f.	f.	PROPN
ajmsi-3181	322	29	k.	k.	PROPN
ajmsi-3181	322	30	,	,	PUNCT
ajmsi-3181	322	31	mahmoud	mahmoud	PROPN
ajmsi-3181	322	32	hamed	hamed	PROPN
ajmsi-3181	322	33	,	,	PUNCT
ajmsi-3181	322	34	m.	m.	NOUN
ajmsi-3181	322	35	,	,	PUNCT
ajmsi-3181	322	36	al	al	PROPN
ajmsi-3181	322	37	-	-	PUNCT
ajmsi-3181	322	38	maslamani	maslamani	ADJ
ajmsi-3181	322	39	,	,	PUNCT
ajmsi-3181	322	40	m.	m.	NOUN
ajmsi-3181	322	41	a.	a.	PROPN
ajmsi-3181	322	42	,	,	PUNCT
ajmsi-3181	322	43	al	al	PROPN
ajmsi-3181	322	44	khal	khal	PROPN
ajmsi-3181	322	45	,	,	PUNCT
ajmsi-3181	322	46	a.	a.	PROPN
ajmsi-3181	322	47	l.	l.	PROPN
ajmsi-3181	322	48	,	,	PUNCT
ajmsi-3181	322	49	&	&	CCONJ
ajmsi-3181	322	50	alsoub	alsoub	PROPN
ajmsi-3181	322	51	,	,	PUNCT
ajmsi-3181	322	52	h.	h.	PROPN
ajmsi-3181	322	53	(	(	PUNCT
ajmsi-3181	322	54	2023	2023	NUM
ajmsi-3181	322	55	)	)	PUNCT
ajmsi-3181	322	56	.	.	PUNCT
ajmsi-3181	323	1	the	the	DET
ajmsi-3181	323	2	epidemiology	epidemiology	NOUN
ajmsi-3181	323	3	and	and	CCONJ
ajmsi-3181	323	4	microbiological	microbiological	ADJ
ajmsi-3181	323	5	characteristics	characteristic	NOUN
ajmsi-3181	323	6	of	of	ADP
ajmsi-3181	323	7	infections	infection	NOUN
ajmsi-3181	323	8	caused	cause	VERB
ajmsi-3181	323	9	by	by	ADP
ajmsi-3181	323	10	gram	gram	NOUN
ajmsi-3181	323	11	-	-	PUNCT
ajmsi-3181	323	12	negative	negative	ADJ
ajmsi-3181	323	13	bacteria	bacteria	NOUN
ajmsi-3181	323	14	in	in	ADP
ajmsi-3181	323	15	qatar	qatar	PROPN
ajmsi-3181	323	16	:	:	PUNCT
ajmsi-3181	323	17	national	national	ADJ
ajmsi-3181	323	18	surveillance	surveillance	NOUN
ajmsi-3181	323	19	from	from	ADP
ajmsi-3181	323	20	the	the	DET
ajmsi-3181	323	21	study	study	NOUN
ajmsi-3181	323	22	for	for	ADP
ajmsi-3181	323	23	monitoring	monitoring	NOUN
ajmsi-3181	323	24	of	of	ADP
ajmsi-3181	323	25	antimicrobial	antimicrobial	ADJ
ajmsi-3181	323	26	resistance	resistance	NOUN
ajmsi-3181	323	27	trends	trend	NOUN
ajmsi-3181	323	28	(	(	PUNCT
ajmsi-3181	323	29	smart	smart	ADJ
ajmsi-3181	323	30	):	):	PUNCT
ajmsi-3181	323	31	2017	2017	NUM
ajmsi-3181	323	32	to	to	ADP
ajmsi-3181	323	33	2019	2019	NUM
ajmsi-3181	323	34	.	.	PUNCT
ajmsi-3181	324	1	jac	jac	NOUN
ajmsi-3181	324	2	-	-	PUNCT
ajmsi-3181	324	3	antimicrobial	antimicrobial	ADJ
ajmsi-3181	324	4	resistance	resistance	NOUN
ajmsi-3181	324	5	,	,	PUNCT
ajmsi-3181	324	6	5(4	5(4	NUM
ajmsi-3181	324	7	)	)	PUNCT
ajmsi-3181	324	8	,	,	PUNCT
ajmsi-3181	324	9	dlad086	dlad086	PROPN
ajmsi-3181	324	10	.	.	PROPN
ajmsi-3181	324	11	spellberg	spellberg	PROPN
ajmsi-3181	324	12	,	,	PUNCT
ajmsi-3181	324	13	b.	b.	PROPN
ajmsi-3181	324	14	,	,	PUNCT
ajmsi-3181	324	15	&	&	CCONJ
ajmsi-3181	324	16	rice	rice	PROPN
ajmsi-3181	324	17	,	,	PUNCT
ajmsi-3181	324	18	l.	l.	PROPN
ajmsi-3181	324	19	b.	b.	PROPN
ajmsi-3181	324	20	(	(	PUNCT
ajmsi-3181	324	21	2019	2019	NUM
ajmsi-3181	324	22	)	)	PUNCT
ajmsi-3181	324	23	.	.	PUNCT
ajmsi-3181	325	1	duration	duration	NOUN
ajmsi-3181	325	2	of	of	ADP
ajmsi-3181	325	3	antibiotic	antibiotic	ADJ
ajmsi-3181	325	4	therapy	therapy	NOUN
ajmsi-3181	325	5	:	:	PUNCT
ajmsi-3181	325	6	shorter	short	ADJ
ajmsi-3181	325	7	is	be	AUX
ajmsi-3181	325	8	better	well	ADJ
ajmsi-3181	325	9	.	.	PUNCT
ajmsi-3181	326	1	annals	annal	NOUN
ajmsi-3181	326	2	of	of	ADP
ajmsi-3181	326	3	internal	internal	ADJ
ajmsi-3181	326	4	medicine	medicine	NOUN
ajmsi-3181	326	5	,	,	PUNCT
ajmsi-3181	326	6	171(3	171(3	NUM
ajmsi-3181	326	7	)	)	PUNCT
ajmsi-3181	326	8	,	,	PUNCT
ajmsi-3181	326	9	210	210	NUM
ajmsi-3181	326	10	-	-	SYM
ajmsi-3181	326	11	211	211	NUM
ajmsi-3181	326	12	.	.	PUNCT
ajmsi-3181	327	1	timsit	timsit	NOUN
ajmsi-3181	327	2	,	,	PUNCT
ajmsi-3181	327	3	j.-f	j.-f	PROPN
ajmsi-3181	327	4	.	.	PUNCT
ajmsi-3181	327	5	,	,	PUNCT
ajmsi-3181	327	6	ruppé	ruppé	PROPN
ajmsi-3181	327	7	,	,	PUNCT
ajmsi-3181	327	8	e.	e.	PROPN
ajmsi-3181	327	9	,	,	PUNCT
ajmsi-3181	327	10	barbier	barbier	PROPN
ajmsi-3181	327	11	,	,	PUNCT
ajmsi-3181	327	12	f.	f.	PROPN
ajmsi-3181	327	13	,	,	PUNCT
ajmsi-3181	327	14	tabah	tabah	PROPN
ajmsi-3181	327	15	,	,	PUNCT
ajmsi-3181	327	16	a.	a.	PROPN
ajmsi-3181	327	17	,	,	PUNCT
ajmsi-3181	327	18	&	&	CCONJ
ajmsi-3181	327	19	bassetti	bassetti	PROPN
ajmsi-3181	327	20	,	,	PUNCT
ajmsi-3181	327	21	m.	m.	NOUN
ajmsi-3181	327	22	(	(	PUNCT
ajmsi-3181	327	23	2020	2020	NUM
ajmsi-3181	327	24	)	)	PUNCT
ajmsi-3181	327	25	.	.	PUNCT
ajmsi-3181	328	1	bloodstream	bloodstream	NOUN
ajmsi-3181	328	2	infections	infection	NOUN
ajmsi-3181	328	3	in	in	ADP
ajmsi-3181	328	4	critically	critically	ADV
ajmsi-3181	328	5	ill	ill	ADJ
ajmsi-3181	328	6	patients	patient	NOUN
ajmsi-3181	328	7	:	:	PUNCT
ajmsi-3181	328	8	an	an	DET
ajmsi-3181	328	9	expert	expert	ADJ
ajmsi-3181	328	10	statement	statement	NOUN
ajmsi-3181	328	11	.	.	PUNCT
ajmsi-3181	329	1	intensive	intensive	ADJ
ajmsi-3181	329	2	care	care	NOUN
ajmsi-3181	329	3	medicine	medicine	NOUN
ajmsi-3181	329	4	,	,	PUNCT
ajmsi-3181	329	5	46	46	NUM
ajmsi-3181	329	6	,	,	PUNCT
ajmsi-3181	329	7	266	266	NUM
ajmsi-3181	329	8	-	-	SYM
ajmsi-3181	329	9	284	284	NUM
ajmsi-3181	329	10	.	.	PUNCT
ajmsi-3181	330	1	tumbarello	tumbarello	PROPN
ajmsi-3181	330	2	,	,	PUNCT
ajmsi-3181	330	3	m.	m.	NOUN
ajmsi-3181	330	4	,	,	PUNCT
ajmsi-3181	330	5	viale	viale	NOUN
ajmsi-3181	330	6	,	,	PUNCT
ajmsi-3181	330	7	p.	p.	NOUN
ajmsi-3181	330	8	,	,	PUNCT
ajmsi-3181	330	9	viscoli	viscoli	PROPN
ajmsi-3181	330	10	,	,	PUNCT
ajmsi-3181	330	11	c.	c.	PROPN
ajmsi-3181	330	12	,	,	PUNCT
ajmsi-3181	330	13	trecarichi	trecarichi	PROPN
ajmsi-3181	330	14	,	,	PUNCT
ajmsi-3181	330	15	e.	e.	PROPN
ajmsi-3181	330	16	m.	m.	PROPN
ajmsi-3181	330	17	,	,	PUNCT
ajmsi-3181	330	18	tumietto	tumietto	NOUN
ajmsi-3181	330	19	,	,	PUNCT
ajmsi-3181	330	20	f.	f.	PROPN
ajmsi-3181	330	21	,	,	PUNCT
ajmsi-3181	330	22	marchese	marchese	PROPN
ajmsi-3181	330	23	,	,	PUNCT
ajmsi-3181	330	24	a.	a.	NOUN
ajmsi-3181	330	25	,	,	PUNCT
ajmsi-3181	330	26	spanu	spanu	NOUN
ajmsi-3181	330	27	,	,	PUNCT
ajmsi-3181	330	28	t.	t.	PROPN
ajmsi-3181	330	29	,	,	PUNCT
ajmsi-3181	330	30	ambretti	ambretti	PROPN
ajmsi-3181	330	31	,	,	PUNCT
ajmsi-3181	330	32	s.	s.	PROPN
ajmsi-3181	330	33	,	,	PUNCT
ajmsi-3181	330	34	ginocchio	ginocchio	PROPN
ajmsi-3181	330	35	,	,	PUNCT
ajmsi-3181	330	36	f.	f.	PROPN
ajmsi-3181	330	37	,	,	PUNCT
ajmsi-3181	330	38	&	&	CCONJ
ajmsi-3181	330	39	cristini	cristini	PROPN
ajmsi-3181	330	40	,	,	PUNCT
ajmsi-3181	330	41	f.	f.	PROPN
ajmsi-3181	330	42	(	(	PUNCT
ajmsi-3181	330	43	2012	2012	NUM
ajmsi-3181	330	44	)	)	PUNCT
ajmsi-3181	330	45	.	.	PUNCT
ajmsi-3181	331	1	predictors	predictor	NOUN
ajmsi-3181	331	2	of	of	ADP
ajmsi-3181	331	3	mortality	mortality	NOUN
ajmsi-3181	331	4	in	in	ADP
ajmsi-3181	331	5	bloodstream	bloodstream	NOUN
ajmsi-3181	331	6	infections	infection	NOUN
ajmsi-3181	331	7	caused	cause	VERB
ajmsi-3181	331	8	by	by	ADP
ajmsi-3181	331	9	klebsiella	klebsiella	NOUN
ajmsi-3181	331	10	pneumoniae	pneumoniae	ADJ
ajmsi-3181	331	11	carbapenemase	carbapenemase	NOUN
ajmsi-3181	331	12	–	–	PUNCT
ajmsi-3181	331	13	producing	produce	VERB
ajmsi-3181	331	14	k.	k.	NOUN
ajmsi-3181	331	15	pneumoniae	pneumoniae	NOUN
ajmsi-3181	331	16	:	:	PUNCT
ajmsi-3181	331	17	importance	importance	NOUN
ajmsi-3181	331	18	of	of	ADP
ajmsi-3181	331	19	combination	combination	NOUN
ajmsi-3181	331	20	therapy	therapy	NOUN
ajmsi-3181	331	21	.	.	PUNCT
ajmsi-3181	332	1	clinical	clinical	ADJ
ajmsi-3181	332	2	infectious	infectious	ADJ
ajmsi-3181	332	3	diseases	disease	NOUN
ajmsi-3181	332	4	,	,	PUNCT
ajmsi-3181	332	5	55(7	55(7	NUM
ajmsi-3181	332	6	)	)	PUNCT
ajmsi-3181	332	7	,	,	PUNCT
ajmsi-3181	332	8	943	943	NUM
ajmsi-3181	332	9	-	-	SYM
ajmsi-3181	332	10	950	950	NUM
ajmsi-3181	332	11	.	.	PUNCT
ajmsi-3181	333	1	turjeman	turjeman	NOUN
ajmsi-3181	333	2	,	,	PUNCT
ajmsi-3181	333	3	a.	a.	PROPN
ajmsi-3181	333	4	,	,	PUNCT
ajmsi-3181	333	5	von	von	PROPN
ajmsi-3181	333	6	dach	dach	PROPN
ajmsi-3181	333	7	,	,	PUNCT
ajmsi-3181	333	8	e.	e.	PROPN
ajmsi-3181	333	9	,	,	PUNCT
ajmsi-3181	333	10	molina	molina	PROPN
ajmsi-3181	333	11	,	,	PUNCT
ajmsi-3181	333	12	j.	j.	PROPN
ajmsi-3181	333	13	,	,	PUNCT
ajmsi-3181	333	14	franceschini	franceschini	PROPN
ajmsi-3181	333	15	,	,	PUNCT
ajmsi-3181	333	16	e.	e.	PROPN
ajmsi-3181	333	17	,	,	PUNCT
ajmsi-3181	333	18	koppel	koppel	PROPN
ajmsi-3181	333	19	,	,	PUNCT
ajmsi-3181	333	20	f.	f.	PROPN
ajmsi-3181	333	21	,	,	PUNCT
ajmsi-3181	333	22	yelin	yelin	PROPN
ajmsi-3181	333	23	,	,	PUNCT
ajmsi-3181	333	24	d.	d.	PROPN
ajmsi-3181	333	25	,	,	PUNCT
ajmsi-3181	333	26	dishon	dishon	PROPN
ajmsi-3181	333	27	-	-	PUNCT
ajmsi-3181	333	28	benattar	benattar	NOUN
ajmsi-3181	333	29	,	,	PUNCT
ajmsi-3181	333	30	y.	y.	PROPN
ajmsi-3181	333	31	,	,	PUNCT
ajmsi-3181	333	32	mussini	mussini	PROPN
ajmsi-3181	333	33	,	,	PUNCT
ajmsi-3181	333	34	c.	c.	NOUN
ajmsi-3181	333	35	,	,	PUNCT
ajmsi-3181	333	36	rodríguez	rodríguez	NOUN
ajmsi-3181	333	37	-	-	PUNCT
ajmsi-3181	333	38	baño	baño	PROPN
ajmsi-3181	333	39	,	,	PUNCT
ajmsi-3181	333	40	j.	j.	PROPN
ajmsi-3181	333	41	,	,	PUNCT
ajmsi-3181	333	42	&	&	CCONJ
ajmsi-3181	333	43	cisneros	cisneros	PROPN
ajmsi-3181	333	44	,	,	PUNCT
ajmsi-3181	333	45	j.	j.	PROPN
ajmsi-3181	333	46	m.	m.	PROPN
ajmsi-3181	333	47	(	(	PUNCT
ajmsi-3181	333	48	2023	2023	NUM
ajmsi-3181	333	49	)	)	PUNCT
ajmsi-3181	333	50	.	.	PUNCT
ajmsi-3181	334	1	duration	duration	NOUN
ajmsi-3181	334	2	of	of	ADP
ajmsi-3181	334	3	antibiotic	antibiotic	ADJ
ajmsi-3181	334	4	treatment	treatment	NOUN
ajmsi-3181	334	5	for	for	ADP
ajmsi-3181	334	6	gram	gram	NOUN
ajmsi-3181	334	7	-	-	PUNCT
ajmsi-3181	334	8	negative	negative	ADJ
ajmsi-3181	334	9	bacteremia	bacteremia	NOUN
ajmsi-3181	334	10	:	:	PUNCT
ajmsi-3181	334	11	systematic	systematic	ADJ
ajmsi-3181	334	12	review	review	NOUN
ajmsi-3181	334	13	and	and	CCONJ
ajmsi-3181	334	14	individual	individual	ADJ
ajmsi-3181	334	15	participant	participant	ADJ
ajmsi-3181	334	16	data	datum	NOUN
ajmsi-3181	334	17	(	(	PUNCT
ajmsi-3181	334	18	ipd	ipd	PROPN
ajmsi-3181	334	19	)	)	PUNCT
ajmsi-3181	334	20	meta	meta	ADJ
ajmsi-3181	334	21	-	-	PUNCT
ajmsi-3181	334	22	analysis	analysis	NOUN
ajmsi-3181	334	23	.	.	PUNCT
ajmsi-3181	335	1	eclinicalmedicine	eclinicalmedicine	NOUN
ajmsi-3181	335	2	,	,	PUNCT
ajmsi-3181	335	3	55	55	NUM
ajmsi-3181	335	4	,	,	PUNCT
ajmsi-3181	335	5	101755	101755	NUM
ajmsi-3181	335	6	.	.	PUNCT
ajmsi-3181	336	1	wareth	wareth	PROPN
ajmsi-3181	336	2	,	,	PUNCT
ajmsi-3181	336	3	g.	g.	PROPN
ajmsi-3181	336	4	,	,	PUNCT
ajmsi-3181	336	5	dadar	dadar	PROPN
ajmsi-3181	336	6	,	,	PUNCT
ajmsi-3181	336	7	m.	m.	NOUN
ajmsi-3181	336	8	,	,	PUNCT
ajmsi-3181	336	9	ali	ali	PROPN
ajmsi-3181	336	10	,	,	PUNCT
ajmsi-3181	336	11	h.	h.	PROPN
ajmsi-3181	336	12	,	,	PUNCT
ajmsi-3181	336	13	hamdy	hamdy	PROPN
ajmsi-3181	336	14	,	,	PUNCT
ajmsi-3181	336	15	m.	m.	PROPN
ajmsi-3181	336	16	e.	e.	PROPN
ajmsi-3181	336	17	,	,	PUNCT
ajmsi-3181	336	18	al‐talhy	al‐talhy	ADV
ajmsi-3181	336	19	,	,	PUNCT
ajmsi-3181	336	20	a.	a.	NOUN
ajmsi-3181	336	21	m.	m.	NOUN
ajmsi-3181	336	22	,	,	PUNCT
ajmsi-3181	336	23	elkharsawi	elkharsawi	PROPN
ajmsi-3181	336	24	,	,	PUNCT
ajmsi-3181	336	25	a.	a.	PROPN
ajmsi-3181	336	26	r.	r.	PROPN
ajmsi-3181	336	27	,	,	PUNCT
ajmsi-3181	336	28	tawab	tawab	ADV
ajmsi-3181	336	29	,	,	PUNCT
ajmsi-3181	336	30	a.	a.	PROPN
ajmsi-3181	336	31	a.	a.	PROPN
ajmsi-3181	336	32	a.	a.	PROPN
ajmsi-3181	336	33	e.	e.	PROPN
ajmsi-3181	336	34	,	,	PUNCT
ajmsi-3181	336	35	&	&	CCONJ
ajmsi-3181	336	36	neubauer	neubauer	PROPN
ajmsi-3181	336	37	,	,	PUNCT
ajmsi-3181	336	38	h.	h.	PROPN
ajmsi-3181	336	39	(	(	PUNCT
ajmsi-3181	336	40	2022	2022	NUM
ajmsi-3181	336	41	)	)	PUNCT
ajmsi-3181	336	42	.	.	PUNCT
ajmsi-3181	337	1	the	the	DET
ajmsi-3181	337	2	perspective	perspective	NOUN
ajmsi-3181	337	3	of	of	ADP
ajmsi-3181	337	4	antibiotic	antibiotic	ADJ
ajmsi-3181	337	5	therapeutic	therapeutic	ADJ
ajmsi-3181	337	6	challenges	challenge	NOUN
ajmsi-3181	337	7	of	of	ADP
ajmsi-3181	337	8	brucellosis	brucellosis	NOUN
ajmsi-3181	337	9	in	in	ADP
ajmsi-3181	337	10	the	the	DET
ajmsi-3181	337	11	middle	middle	PROPN
ajmsi-3181	337	12	east	east	PROPN
ajmsi-3181	337	13	and	and	CCONJ
ajmsi-3181	337	14	north	north	ADJ
ajmsi-3181	337	15	african	african	ADJ
ajmsi-3181	337	16	countries	country	NOUN
ajmsi-3181	337	17	:	:	PUNCT
ajmsi-3181	337	18	current	current	ADJ
ajmsi-3181	337	19	situation	situation	NOUN
ajmsi-3181	337	20	and	and	CCONJ
ajmsi-3181	337	21	therapeutic	therapeutic	ADJ
ajmsi-3181	337	22	management	management	NOUN
ajmsi-3181	337	23	.	.	PUNCT
ajmsi-3181	338	1	transboundary	transboundary	NOUN
ajmsi-3181	338	2	and	and	CCONJ
ajmsi-3181	338	3	emerging	emerge	VERB
ajmsi-3181	338	4	diseases	disease	NOUN
ajmsi-3181	338	5	,	,	PUNCT
ajmsi-3181	338	6	69(5	69(5	NUM
ajmsi-3181	338	7	)	)	PUNCT
ajmsi-3181	338	8	,	,	PUNCT
ajmsi-3181	338	9	e1253	e1253	NOUN
ajmsi-3181	338	10	-	-	PUNCT
ajmsi-3181	338	11	e1268	e1268	PROPN
ajmsi-3181	338	12	.	.	PUNCT
ajmsi-3181	339	1	yahav	yahav	PROPN
ajmsi-3181	339	2	,	,	PUNCT
ajmsi-3181	339	3	d.	d.	PROPN
ajmsi-3181	339	4	,	,	PUNCT
ajmsi-3181	339	5	franceschini	franceschini	PROPN
ajmsi-3181	339	6	,	,	PUNCT
ajmsi-3181	339	7	e.	e.	PROPN
ajmsi-3181	339	8	,	,	PUNCT
ajmsi-3181	339	9	koppel	koppel	PROPN
ajmsi-3181	339	10	,	,	PUNCT
ajmsi-3181	339	11	f.	f.	PROPN
ajmsi-3181	339	12	,	,	PUNCT
ajmsi-3181	339	13	turjeman	turjeman	NOUN
ajmsi-3181	339	14	,	,	PUNCT
ajmsi-3181	339	15	a.	a.	NOUN
ajmsi-3181	339	16	,	,	PUNCT
ajmsi-3181	339	17	babich	babich	PROPN
ajmsi-3181	339	18	,	,	PUNCT
ajmsi-3181	339	19	t.	t.	NOUN
ajmsi-3181	339	20	,	,	PUNCT
ajmsi-3181	339	21	bitterman	bitterman	NOUN
ajmsi-3181	339	22	,	,	PUNCT
ajmsi-3181	339	23	r.	r.	PROPN
ajmsi-3181	339	24	,	,	PUNCT
ajmsi-3181	339	25	neuberger	neuberger	PROPN
ajmsi-3181	339	26	,	,	PUNCT
ajmsi-3181	339	27	a.	a.	NOUN
ajmsi-3181	339	28	,	,	PUNCT
ajmsi-3181	339	29	ghanem	ghanem	PROPN
ajmsi-3181	339	30	-	-	PUNCT
ajmsi-3181	339	31	zoubi	zoubi	PROPN
ajmsi-3181	339	32	,	,	PUNCT
ajmsi-3181	339	33	n.	n.	PROPN
ajmsi-3181	339	34	,	,	PUNCT
ajmsi-3181	339	35	santoro	santoro	PROPN
ajmsi-3181	339	36	,	,	PUNCT
ajmsi-3181	339	37	a.	a.	PROPN
ajmsi-3181	339	38	,	,	PUNCT
ajmsi-3181	339	39	&	&	CCONJ
ajmsi-3181	339	40	eliakim	eliakim	PROPN
ajmsi-3181	339	41	-	-	PUNCT
ajmsi-3181	339	42	raz	raz	PROPN
ajmsi-3181	339	43	,	,	PUNCT
ajmsi-3181	339	44	n.	n.	NOUN
ajmsi-3181	339	45	(	(	PUNCT
ajmsi-3181	339	46	2019	2019	NUM
ajmsi-3181	339	47	)	)	PUNCT
ajmsi-3181	339	48	.	.	PUNCT
ajmsi-3181	340	1	seven	seven	NUM
ajmsi-3181	340	2	versus	versus	ADP
ajmsi-3181	340	3	14	14	NUM
ajmsi-3181	340	4	days	day	NOUN
ajmsi-3181	340	5	of	of	ADP
ajmsi-3181	340	6	antibiotic	antibiotic	ADJ
ajmsi-3181	340	7	therapy	therapy	NOUN
ajmsi-3181	340	8	for	for	ADP
ajmsi-3181	340	9	uncomplicated	uncomplicated	ADJ
ajmsi-3181	340	10	gram	gram	NOUN
ajmsi-3181	340	11	-	-	PUNCT
ajmsi-3181	340	12	negative	negative	ADJ
ajmsi-3181	340	13	bacteremia	bacteremia	NOUN
ajmsi-3181	340	14	:	:	PUNCT
ajmsi-3181	340	15	a	a	DET
ajmsi-3181	340	16	noninferiority	noninferiority	NOUN
ajmsi-3181	340	17	randomised	randomise	VERB
ajmsi-3181	340	18	controlled	control	VERB
ajmsi-3181	340	19	trial	trial	NOUN
ajmsi-3181	340	20	.	.	PUNCT
ajmsi-3181	341	1	clinical	clinical	ADJ
ajmsi-3181	341	2	infectious	infectious	ADJ
ajmsi-3181	341	3	diseases	disease	NOUN
ajmsi-3181	341	4	,	,	PUNCT
ajmsi-3181	341	5	69(7	69(7	NOUN
ajmsi-3181	341	6	)	)	PUNCT
ajmsi-3181	341	7	,	,	PUNCT
ajmsi-3181	341	8	1091	1091	NUM
ajmsi-3181	341	9	-	-	SYM
ajmsi-3181	341	10	1098	1098	NUM
ajmsi-3181	341	11	.	.	PUNCT
ajmsi-3181	342	1	yezli	yezli	NOUN
ajmsi-3181	342	2	,	,	PUNCT
ajmsi-3181	342	3	s.	s.	PROPN
ajmsi-3181	342	4	,	,	PUNCT
ajmsi-3181	342	5	shibl	shibl	PROPN
ajmsi-3181	342	6	,	,	PUNCT
ajmsi-3181	342	7	a.	a.	NOUN
ajmsi-3181	342	8	m.	m.	NOUN
ajmsi-3181	342	9	,	,	PUNCT
ajmsi-3181	342	10	livermore	livermore	PROPN
ajmsi-3181	342	11	,	,	PUNCT
ajmsi-3181	342	12	d.	d.	PROPN
ajmsi-3181	342	13	m.	m.	PROPN
ajmsi-3181	342	14	,	,	PUNCT
ajmsi-3181	342	15	&	&	CCONJ
ajmsi-3181	342	16	memish	memish	PROPN
ajmsi-3181	342	17	,	,	PUNCT
ajmsi-3181	342	18	z.	z.	PROPN
ajmsi-3181	342	19	a.	a.	PROPN
ajmsi-3181	342	20	(	(	PUNCT
ajmsi-3181	342	21	2014	2014	NUM
ajmsi-3181	342	22	)	)	PUNCT
ajmsi-3181	342	23	.	.	PUNCT
ajmsi-3181	343	1	prevalence	prevalence	NOUN
ajmsi-3181	343	2	and	and	CCONJ
ajmsi-3181	343	3	antimicrobial	antimicrobial	ADJ
ajmsi-3181	343	4	resistance	resistance	NOUN
ajmsi-3181	343	5	among	among	ADP
ajmsi-3181	343	6	gram	gram	NOUN
ajmsi-3181	343	7	-	-	PUNCT
ajmsi-3181	343	8	negative	negative	ADJ
ajmsi-3181	343	9	pathogens	pathogen	NOUN
ajmsi-3181	343	10	in	in	ADP
ajmsi-3181	343	11	saudi	saudi	PROPN
ajmsi-3181	343	12	arabia	arabia	PROPN
ajmsi-3181	343	13	.	.	PUNCT
ajmsi-3181	344	1	journal	journal	PROPN
ajmsi-3181	344	2	of	of	ADP
ajmsi-3181	344	3	chemotherapy	chemotherapy	PROPN
ajmsi-3181	344	4	,	,	PUNCT
ajmsi-3181	344	5	26(5	26(5	NUM
ajmsi-3181	344	6	)	)	PUNCT
ajmsi-3181	344	7	,	,	PUNCT
ajmsi-3181	344	8	257	257	NUM
ajmsi-3181	344	9	-	-	SYM
ajmsi-3181	344	10	272	272	NUM
ajmsi-3181	344	11	.	.	PUNCT